{
  "accuracy": 0.7551020408163265,
  "correct": 37,
  "total": 49,
  "parameters": {
    "max_results": 10,
    "hybrid_search": true,
    "neural_ratio": 0.5,
    "gemini_model": "gemini/gemini-2.0-flash-exp"
  },
  "detailed_results": [
    {
      "question": "Has anyone shown a gene therapy that is delivered via an aerosol?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Inhalation delivery technology for genome-editing of respiratory diseases",
          "author": "Michael Y T Chow, Rachel Yoon Kyung Chang, Hak-Kim  Chan",
          "published_date": "2023-11-09T20:29:42.827000+00:00",
          "summary": "This review discusses the potential for inhalable CRISPR/Cas9 gene therapy for lung diseases.  While the technology shows promise for delivering high concentrations of gene-editing tools to the lungs while minimizing systemic effects, the authors note that progress is hampered by a lack of effective inhalation delivery methods for the necessary biologics (genes and proteins).  The review focuses on strategies to improve formulation and delivery of these components via aerosol, suggesting that adapting existing techniques could accelerate the development of inhalable CRISPR/Cas9 therapies.  The article does not describe any *currently existing* aerosolized gene therapies, but rather explores the feasibility and challenges of creating them.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0169409X20300478"
        },
        {
          "title": "Inhalation delivery technology for genome-editing of respiratory diseases",
          "author": "M. Y. Chow,R. Chang,H. Chan",
          "published_date": "2023-10-26T19:28:51+00:00",
          "summary": "Yes, this review article discusses the potential for aerosol delivery of CRISPR/Cas9 gene therapy for respiratory diseases.  While acknowledging the lack of current clinical translation, the authors review existing inhalation formulations for genes and proteins, suggesting that adapting these methods could accelerate the development of inhalable CRISPR/Cas9 therapies.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32512029"
        },
        {
          "title": "Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes - PubMed",
          "author": "Tony Le Gall 1 ,",
          "published_date": "2021-12-23T00:00:00+00:00",
          "summary": "Yes.  The PubMed abstract describes aerosol-mediated non-viral lung gene therapy using aminoglycoside-based cationic liposomes.  The authors cite progress in cystic fibrosis clinical settings using a lipidic formulation (GL67A) as evidence of this approach's viability, while also noting the need for more effective gene transfer agents.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35056921/"
        },
        {
          "title": "Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System",
          "author": "Wolfgang  Hohenforst-Schmidt, University of Wuerzburg, Coburg, Germany, Paul  Zarogoulidis, Aristotle University of Thessaloniki, Thessaloniki, Greece, Bernd  Linsmeier, Medinos Clinic Sonneberg, Sonneberg, Germany, Ioannis  Kioumis, Aristotle University of Thessaloniki, Thessaloniki, Greece, Qiang  Li, Changhai Hospital/First Affiliated Hospital of the Second Military Medical University, Shanghai, China, Haidong  Huang, Changhai Hospital/First Affiliated Hospital of the Second Military Medical University, Shanghai, China, Despoina  Sachpatzidou, Experimental Animal Laboratory, Anticancer Hospital, Thessaloniki, Greece, Sofia  Lampaki, Aristotle University of Thessaloniki, Thessaloniki, Greece, John  Organtzis, Aristotle University of Thessaloniki, Thessaloniki, Greece, Kalliopi  Domvri, Aristotle University of Thessaloniki, Thessaloniki, Greece, Leonidas  Sakkas, ``G. Papanikolaou`` General Hospital, Thessaloniki, Greece, George A Zachariadis, Laboratory of Analytical Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece, Konstantinos N Archontas, Laboratory of Analytical Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece, Anastasios  Kallianos, Aggeliki  Rapti, Lonny  Yarmus, Johns Hopkins University, Baltimore, U.S.A, Konstantinos  Zarogoulidis, Aristotle University of Thessaloniki, Thessaloniki, Greece, Johannes  Brachmann, University of Wuerzburg, Coburg, Germany",
          "published_date": "2023-11-09T20:23:54.009000+00:00",
          "summary": "Yes, this study used an adenoviral vector (Ad-h-ABCA10) expressing the human ABCA10 transgene, delivered via aerosol, to enhance the effectiveness of inhaled cisplatin chemotherapy in treating lung cancer.\n",
          "url": "https://www.jcancer.org/v05p0344.htm"
        },
        {
          "title": "An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy",
          "author": "Gregg A. Duncan,Namho Kim,Y. Colon-Cortes,Jason J. Rodriguez,M. Mazur,S. Birket,S. Rowe,N. West,A. Livraghi-Butrico,R. Boucher,J. Hanes,G. Aslanidi,J. S. Suk",
          "published_date": "2023-10-26T19:31:06.974000+00:00",
          "summary": "Yes, the study describes attempts at inhaled gene therapy using adeno-associated viral (AAV) vectors.  However, past trials with AAV serotype 2 and adenovirus vectors failed due to inefficient gene transfer and immune responses.  This research focuses on developing an AAV vector that can penetrate the mucus barrier, a significant obstacle to successful inhaled gene therapy.\n",
          "url": "http://www.cell.com/article/S2329050118300354/pdf"
        },
        {
          "title": "Aerosol Inhalation of Gene Delivery Therapy for Pulmonary ...",
          "author": "Yiheng Huang 1 ,",
          "published_date": "2024-07-25T00:00:00+00:00",
          "summary": "Yes, this PubMed review article discusses aerosol gene delivery therapy for pulmonary diseases.  The authors review various gene carriers (viral and non-viral vectors) and types of genes (DNA, mRNA, siRNA, CRISPR/Cas9) delivered via aerosol, citing examples of its use in treating SARS-CoV-2, cystic fibrosis, and lung cancer.  The key challenge is selecting appropriate formulations to overcome physiological barriers.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39199292/"
        },
        {
          "title": "Aerosol Inhalation of Gene Delivery Therapy for Pulmonary ...",
          "author": "Hecheng Li",
          "published_date": "2024-07-25T00:00:00+00:00",
          "summary": "Yes, aerosol delivery of gene therapy is being actively researched for treating pulmonary diseases.  The review article discusses various gene carriers (viral and non-viral vectors) and types of genes (DNA, mRNA, siRNA, CRISPR/Cas9) delivered via aerosol inhalation, showing efficacy in treating diseases like SARS-CoV-2, cystic fibrosis, and lung cancer.  The key challenge is finding suitable formulations to overcome physiological barriers in the lungs.\n",
          "url": "https://www.mdpi.com/2218-273X/14/8/904"
        },
        {
          "title": "Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa ...",
          "author": "",
          "published_date": "2020-01-10T00:00:00+00:00",
          "summary": "Yes, this study demonstrates aerosol delivery of synthetic mRNA encoding a broadly neutralizing antibody against HIV to the vaginal mucosa of sheep and rhesus macaques.  The mRNA, delivered in water, resulted in sustained antibody expression for over 28 days in sheep and prevented SHIV infection in *ex vivo* macaque explants.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7054722/"
        },
        {
          "title": "Effective pulmonary delivery of an aerosolized plasmid DNA ...",
          "author": "Anushi E Rajapaksa, Monash University, Wellington Road, 3800, Clayton, Australia, Jenny J Ho, Monash University, Wellington Road, 3800, Clayton, Australia, Aisha  Qi, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, Rob  Bischof, Monash University, Wellington Road, 3800, Clayton, Australia, Tri-Hung  Nguyen, Monash University, 3800, Monash, Parkville, Australia, Michelle  Tate, Monash Institute of Medical Research, 3800, Clayton, Australia, David  Piedrafita, Monash University, Wellington Road, 3800, Clayton, Australia, Michelle P Mcintosh, Monash University, 3800, Monash, Parkville, Australia, Leslie Y Yeo, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, Els  Meeusen, Ross L Coppel, Nursing and Health Sciences, Wellington Road, 3800, Clayton, Australia, James R Friend, RMIT University, 124 La Trobe Street, 3000, Melbourne, Australia, james.friend@rmit.edu.au",
          "published_date": "2023-11-09T20:03:59.707000+00:00",
          "summary": "Yes. This study demonstrates successful aerosolized delivery of a plasmid DNA (pDNA) vaccine encoding an influenza A virus surface glycoprotein to sheep using a novel surface acoustic wave (SAW) nebulizer.  The SAW nebulizer produced pDNA aerosols of a size suitable for deep lung delivery, resulting in effective systemic and mucosal antibody responses in rats and successful gene expression in mice. This represents the first successful aerosolized pDNA vaccine delivery in a large animal model.\n",
          "url": "https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-60"
        },
        {
          "title": "EFFICIENT GENE DELIVERY TO PIGLET LUNGS ...",
          "author": "Parton, Lance A",
          "published_date": "1996-04-01T00:00:00+00:00",
          "summary": "Yes, this 1996 study demonstrated aerosol delivery of genes complexed with cationic liposomes to piglet lungs.  A novel aerosol device achieved 20-30% deposition of a tracer.  \u03b2-galactosidase expression was observed in airway epithelial cells without evidence of inflammation, suggesting this method may be effective and safe for lung-specific gene therapy.\n",
          "url": "https://www.nature.com/articles/pr19961553"
        }
      ],
      "full_explanation": "Several studies have demonstrated the successful delivery of gene therapy via aerosol. \n\n*   **Le Gall (2021)** describes \"aerosol-mediated non-viral lung gene therapy using aminoglycoside-based cationic liposomes\" and cites the use of lipidic formulations for gene delivery in cystic fibrosis clinical settings, thus demonstrating that aerosol gene therapy is an established area of research. [https://pubmed.ncbi.nlm.nih.gov/35056921/](https://pubmed.ncbi.nlm.nih.gov/35056921/)\n\n*   **Hohenforst-Schmidt et al. (2023)** successfully used an \"adenoviral vector (Ad-h-ABCA10)... delivered via aerosol\" to enhance chemotherapy effectiveness in lung cancer. This is a clear example of gene therapy delivered by aerosol. [https://www.jcancer.org/v05p0344.htm](https://www.jcancer.org/v05p0344.htm)\n\n*   **Duncan et al. (2023)** explored the use of \"inhaled gene therapy using adeno-associated viral (AAV) vectors\", noting previous attempts at this approach. [http://www.cell.com/article/S2329050118300354/pdf](http://www.cell.com/article/S2329050118300354/pdf)\n\n*   **Huang (2024) and Li (2024)** each authored a review article discussing \"aerosol gene delivery therapy for pulmonary diseases.\" These reviews indicate that many gene carriers and types of genes have been delivered by aerosol, including viral and non-viral vectors, DNA, mRNA, siRNA, and CRISPR/Cas9, demonstrating the breadth of research in this area. [https://pubmed.ncbi.nlm.nih.gov/39199292/](https://pubmed.ncbi.nlm.nih.gov/39199292/) and [https://www.mdpi.com/2218-273X/14/8/904](https://www.mdpi.com/2218-273X/14/8/904)\n\n*   **Rajapaksa et al. (2023)** demonstrated the successful use of an aerosolized plasmid DNA (pDNA) vaccine in sheep and other models showing effective gene expression, indicating that this approach is viable. [https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-60](https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-60)\n\n*   **Parton (1996)** demonstrated successful gene delivery to piglet lungs via aerosol using cationic liposomes as a carrier, showing that this method has been studied since the 1990s. [https://www.nature.com/articles/pr19961553](https://www.nature.com/articles/pr19961553)\n\nThe reviews by **Chow et al. (2023)** also speak to the active area of research related to aerosolized gene therapies even though they themselves do not contain studies that have used it directly. [https://www.sciencedirect.com/science/article/pii/S0169409X20300478](https://www.sciencedirect.com/science/article/pii/S0169409X20300478) and [https://pubmed.ncbi.nlm.nih.gov/32512029](https://pubmed.ncbi.nlm.nih.gov/32512029)\nWhile the research question did not specify the specific gene therapy needed, all of these studies have shown gene therapy delivered through aerosol methods. The study by Unknown on aerosol delivery of synthetic mRNA to vaginal mucosa is not relevant as it is not for gene therapy to lungs. [https://pmc.ncbi.nlm.nih.gov/articles/PMC7054722/](https://pmc.ncbi.nlm.nih.gov/articles/PMC7054722/)"
    },
    {
      "question": "Has anyone identified all the potential functions of intrinsically disordered proteins (IDPs)?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Intrinsically disordered regions that drive phase separation form a robustly distinct protein class",
          "author": "Ayyam Y. Ibrahim,Nathan Khaodeuanepheng,Dhanush L. Amarasekara,J. Correia,Karen A. Lewis,Nicholas C. Fitzkee,L. Hough,S. Whitten",
          "published_date": "2023-10-26T19:30:38.732000+00:00",
          "summary": "No, the paper does not identify all potential functions of intrinsically disordered proteins (IDPs).  It focuses on a subset: intrinsically disordered regions (IDRs) that drive protein phase separation, a process crucial for forming membrane-less organelles involved in various biological functions like stress response and ribosome biogenesis.  The research developed a predictor (ParSe) to identify these specific IDRs, highlighting that multiple mechanisms contribute to phase separation, but it doesn't encompass the full range of IDP functions.\n",
          "url": "http://www.jbc.org/article/S0021925822012443/pdf"
        },
        {
          "title": "Intrinsically Disordered Proteins: An Overview",
          "author": "Rakesh Trivedi,H. Nagarajaram",
          "published_date": "2023-10-26T19:30:59.305000+00:00",
          "summary": "No, a complete catalog of all potential functions of intrinsically disordered proteins (IDPs) has not been identified.  The text describes two paradigms of protein function: the traditional \"structure-function paradigm\" and the more recent \"disorder-function paradigm\" which acknowledges the functional roles of IDPs despite their lack of stable 3D structure. While research has shown IDPs contribute to functional promiscuity, the full extent of their roles remains an active area of investigation.\n",
          "url": "https://www.mdpi.com/1422-0067/23/22/14050/pdf?version=1668429018"
        },
        {
          "title": "Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein",
          "author": "Rajkamal Balu; Nisal Wanasingha; Jitendra P Mata; Agata Rekas; Susan Barrett; Geoff Dumsday; Aaron W Thornton; Anita J Hill; Namita Roy Choudhury; Naba K Dutta",
          "published_date": "2023-04-13T16:58:57.212000+00:00",
          "summary": "No, the provided text does not claim that all potential functions of intrinsically disordered proteins (IDPs) have been identified.  The text focuses on the impact of macromolecular crowding on the structure and dynamics of a specific IDP, Rec1-resilin, and mentions that IDPs are involved in various biological processes including cell signaling, regulation, transcription elongation, membrane-less organelles, and homeostasis.  However, it explicitly states that these are only *some* of their roles, not an exhaustive list.\n",
          "url": "https://www.science.org/doi/10.1126/sciadv.abq2202"
        },
        {
          "title": "Intrinsic Disorder as a Natural Preservative: High Levels of Intrinsic Disorder in Proteins Found in the 2600-Year-Old Human Brain",
          "author": "A. Mohammed,V. Uversky",
          "published_date": "2023-10-26T19:29:32.669000+00:00",
          "summary": "No, the research described in this article does not identify all potential functions of intrinsically disordered proteins (IDPs).  The study focuses on the unusually high levels of IDPs found in a 2600-year-old human brain and analyzes their interaction networks, but doesn't aim to comprehensively catalog all IDP functions.  The research uses various bioinformatics tools to analyze the identified proteins' disorder and interactions, but this is a specific investigation, not a complete functional characterization of all IDPs.\n",
          "url": "https://www.mdpi.com/2079-7737/11/12/1704/pdf?version=1669367869"
        },
        {
          "title": "The Ligand of Ate1 is intrinsically disordered and participates in nucleolar phase separation regulated by Jumonji Domain Containing 6 | Proceedings of the National Academy of Sciences",
          "author": "Akshaya Arva; Yasar Arfat T Kasu; Jennifer Duncan; Mosleh A Alkhatatbeh; Christopher S Brower; Arva; Akshaya; Kasu; Yasar Arfat T; Duncan; Jennifer; Alkhatatbeh; Mosleh A; Brower; Christopher S",
          "published_date": "2023-02-23T00:40:24.840000+00:00",
          "summary": "No, the functions of intrinsically disordered proteins (IDPs) are not fully identified.  This research paper focuses on one IDP, Ligand of Ate1 (Liat1), which participates in liquid-liquid phase separation (LLPS) in the nucleolus, a process regulated by Jumonji Domain Containing 6 (Jmjd6).  While this study reveals a specific function of one IDP, it highlights the ongoing research needed to fully understand the diverse roles of IDPs in cellular processes.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.2015887118"
        },
        {
          "title": "Intrinsically Disordered Proteins: An Overview - PMC",
          "author": "",
          "published_date": "2022-11-14T00:00:00+00:00",
          "summary": "No, a complete understanding of all potential functions of intrinsically disordered proteins (IDPs) has not yet been achieved.  While research has established that IDPs play various roles due to their conformational flexibility (e.g., protein binding, enabling functional promiscuity), the review highlights this is an ongoing area of study.  The \"disorder-function paradigm\" is a relatively recent model, and further research is needed to fully elucidate all functions of IDPs.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9693201/"
        },
        {
          "title": "Intrinsically Disordered Proteins in Cellular Signaling and ...",
          "author": "",
          "published_date": "2014-05-01T00:00:00+00:00",
          "summary": "No, a complete catalog of all IDP functions is not yet available.  Research since the mid-1990s has revealed their widespread importance in eukaryotic cells, particularly in signaling and regulation.  IDPs are involved in diverse processes including regulation of transcription and translation, cell cycle control, assembly of macromolecular machines (like ribosomes), chromatin organization, and formation of membrane-less organelles. However, given their dynamic nature and involvement in numerous complex interactions, identifying *all* their functions remains an ongoing area of research.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4405151/"
        },
        {
          "title": "Identification of a Drug Targeting an Intrinsically ...",
          "author": "Abi\u00e1n, Olga",
          "published_date": "2017-01-05T00:00:00+00:00",
          "summary": "No, the exact functions of intrinsically disordered proteins (IDPs) are not fully understood.  The provided research focuses on NUPR1, an IDP implicated in pancreatic adenocarcinoma.  While NUPR1's involvement in cell migration, invasion, adhesion, apoptosis, and chemoresistance is known, its complete functional role remains partially determined.  The study highlights the challenge of identifying all potential functions of IDPs due to their dynamic nature and lack of well-defined structure.\n",
          "url": "https://www.nature.com/articles/srep39732"
        },
        {
          "title": "Experimental methods to study the structure and dynamics ...",
          "author": "A. Abyzov, N. Salvi, R. Schneider, D. Maurin, R.W.H. Ruigrok, M.R. Jensen, M. Blackledge",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "No, a complete understanding of all potential functions of intrinsically disordered proteins (IDPs) has not yet been achieved.  While research in the early 2000s highlighted the prevalence and importance of IDPs and intrinsically disordered regions (IDRs),  their study was historically hampered by a lack of suitable experimental methods.  Although many functions are known,  the field is still actively exploring the full range of IDP roles.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2665928X24000151"
        },
        {
          "title": "On the roles of intrinsically disordered proteins and regions in ...",
          "author": "Uversky, Vladimir N.",
          "published_date": "2021-08-30T00:00:00+00:00",
          "summary": "No, the functions of intrinsically disordered proteins (IDPs) are not fully identified.  Research, as shown in this article, is ongoing, with thirteen studies presented describing IDP signaling molecules across various organisms and their roles in cell signaling and regulation. While significant progress has been made in understanding their diverse roles in biological processes, complete characterization remains an open area of investigation.\n",
          "url": "https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00774-3"
        }
      ],
      "full_explanation": "The provided research papers consistently indicate that the potential functions of intrinsically disordered proteins (IDPs) have not been fully identified. While the papers discuss various functions and roles of IDPs, none claim to have identified all of them. Several papers explicitly state this is an ongoing area of research. For example, Trivedi & Nagarajaram (2023) in \"Intrinsically Disordered Proteins: An Overview\" state that \"the full extent of their roles remains an active area of investigation\" (URL: https://www.mdpi.com/1422-0067/23/22/14050/pdf?version=1668429018). Similarly, the paper \"Intrinsically Disordered Proteins: An Overview - PMC\" (2022) concludes that \"further research is needed to fully elucidate all functions of IDPs\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9693201/). The paper by Unknown (2014) \"Intrinsically Disordered Proteins in Cellular Signaling and...\" acknowledges that while many roles are known, \"... identifying *all* their functions remains an ongoing area of research\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4405151/). Balu et al. (2023), in \"Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein,\" mention that IDPs are involved in various processes, but specifically clarify that these are \"only *some* of their roles, not an exhaustive list.\" (URL: https://www.science.org/doi/10.1126/sciadv.abq2202). Other papers like Ibrahim et al. (2023) \"Intrinsically disordered regions that drive phase separation form a robustly distinct protein class\", (URL: http://www.jbc.org/article/S0021925822012443/pdf) and Arva et al. (2023) \"The Ligand of Ate1 is intrinsically disordered and participates in nucleolar phase separation regulated by Jumonji Domain Containing 6 | Proceedings of the National Academy of Sciences\" (URL: https://www.pnas.org/doi/10.1073/pnas.2015887118) focus on *specific* functions of IDPs, not a comprehensive list. Additionally, Abyzov et al. (2024) \"Experimental methods to study the structure and dynamics...\" (URL: https://www.sciencedirect.com/science/article/pii/S2665928X24000151) highlights the continued need for research and new methods to study IDPs and Uversky (2021) \"On the roles of intrinsically disordered proteins and regions in...\" states that complete characterization is an ongoing open area of investigation (URL: https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00774-3)."
    },
    {
      "question": "Has anyone developed a means to model multiple length scales in biological simulations?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A Multi-Scale Approach to Modeling E. coli Chemotaxis",
          "author": "Eran  Agmon, Stanford University, 94305, Stanford, CA, USA, eagmon@stanford.edu, Ryan K Spangler, Stanford University, 94305, Stanford, CA, USA, spanglry@stanford.edu",
          "published_date": "2023-11-09T20:31:34.917000+00:00",
          "summary": "Yes.  This paper describes a multi-scale model of *E. coli* chemotaxis using Vivarium, a computational biology engine.  The model integrates sub-models of metabolism/transport, gene expression (transcription, translation, etc.), and flagella/chemoreceptor activity, linking different scales of biological processes within a single simulation.\n",
          "url": "https://www.mdpi.com/1099-4300/22/10/1101"
        },
        {
          "title": "The scaling of goals from cellular to anatomical homeostasis: an evolutionary simulation, experiment and analysis",
          "author": "L. Pio-Lopez,J. Bischof,Jennifer V. LaPalme,M. Levin",
          "published_date": "2023-10-26T19:28:53.608000+00:00",
          "summary": "Yes, this research uses a TAME framework-based simulation to model the scaling of goals from cellular to anatomical homeostasis.  The 2D neural cellular automata model demonstrates how low-level metabolic homeostasis in individual cells can evolve into tissue-level emergent behavior, solving a morphogenesis problem (the French flag problem).  The simulation shows the evolution of complex setpoints in cell collectives, exhibiting features like stress propagation, robustness, and long-term stability.  These findings were further supported by experiments on planarian regeneration.  The study suggests a quantitative approach to understanding how evolution scales minimal goal-directed behavior into higher-level problem-solving in morphogenesis.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37065270"
        },
        {
          "title": "Capturing the mechanosensitivity of cell proliferation in models of epithelium",
          "author": "View ORCID ProfileKevin H\u00f6llring",
          "published_date": "2023-02-03T00:00:00+00:00",
          "summary": "This bioRxiv preprint presents a model of cell proliferation in 2D epithelia that incorporates cell-cell and cell-matrix interactions, capturing both short and long time- and length-scale behaviors.  The model distinguishes between growing and dividing cells and uses a density-driven mean-field approach, validated by in vitro and in silico experiments. The researchers show that mechanoresponse leads to large-scale density structures, described by nonlinear delayed Fisher-Kolmogorov-like equations.  The work focuses on long time- and length-scale modeling of tissue growth incorporating cell proliferation.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.01.31.526438v1"
        },
        {
          "title": "Multi-scale Modeling and Experimental Data Enable Structural Models of the Escherichia Coli Peptidoglycan to be Constructed on the Whole-Cell Scale",
          "author": "View ORCID ProfileZachary J. Wehrspan, View ORCID ProfileAdrian H. Elcock",
          "published_date": "2023-06-04T00:00:00+00:00",
          "summary": "Yes.  Researchers have developed a multi-scale computational modeling approach to construct whole-cell models of *Escherichia coli* peptidoglycan (PG), a gigaDalton molecule.  Their method incorporates diverse experimental data, including glycan strand length distributions and lipoprotein partitioning, to create realistic 3D models.  The resulting models are used to estimate pore size distributions and analyze protein diffusion within the periplasm.  This work demonstrates the feasibility of simulating PG at the whole-cell scale.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.06.04.543634v1"
        },
        {
          "title": "Robust formation of metachronal waves in directional chains of phase oscillators.",
          "author": "A. Quillen",
          "published_date": "2023-10-26T19:32:02.269000+00:00",
          "summary": "This paper models metachronal waves in chains of phase oscillators, focusing on directional interactions (lacking reversal symmetry).  While it doesn't explicitly address multi-scale modeling, the use of both discrete phase oscillator systems and a continuum approximation suggests an implicit consideration of different length scales. The paper investigates how these different modeling approaches relate to the emergence of metachronal waves, but does not directly compare or integrate them to explicitly address multiple length scales in a single simulation.\n",
          "url": "https://arxiv.org/pdf/2212.06559.pdf"
        },
        {
          "title": "Multi-scale Modeling in Biology: How to Bridge the Gaps ...",
          "author": "",
          "published_date": "2011-06-23T00:00:00+00:00",
          "summary": "Yes, the paper reviews multi-scale modeling methodologies used in computational and systems biology to address the challenge of bridging different spatial and temporal scales in biological systems.  A key unsolved issue is representing high-dimensional lower-scale models within low-dimensional higher-scale models to study complex dynamics across scales.  The authors discuss various modeling approaches and the gaps between them, along with potential methods for bridging these scales.  The paper uses cardiac excitation as an example of multi-scale regulation, showing how randomness decreases as the scale increases from ion channels to the whole heart.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3190585/"
        },
        {
          "title": "How computational models can help unlock biological ...",
          "author": "Author links open overlay panel G Wayne Brodland",
          "published_date": "2023-12-04T03:09:35.364000+00:00",
          "summary": "Yes, the article discusses computational models that integrate information across multiple length scales in biological simulations, specifically mentioning their use in modeling embryogenesis.  These models aim to replicate system behavior based on known component properties, bridging different fields of study and serving as a complement to experimental and theoretical research.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1084952115001287"
        },
        {
          "title": "Modeling Biology Spanning Different Scales: An Open ...",
          "author": "",
          "published_date": "2014-07-17T00:00:00+00:00",
          "summary": "Yes.  This paper discusses the challenge of creating multiscale models in biology, acknowledging the need for computational and mathematical models spanning different space and time scales to understand biological systems.  The authors highlight this as a crucial, though currently formidable, challenge in modern biology.\n",
          "url": "https://www.researchgate.net/publication/263809652_Modeling_Biology_Spanning_Different_Scales_An_Open_Challenge"
        },
        {
          "title": "Mathematical and computational modeling in biology at ...",
          "author": "El-Magd, Rabab M Abou",
          "published_date": "2014-12-27T00:00:00+00:00",
          "summary": "Yes, this 2014 review article discusses mathematical and computational modeling in biology across multiple scales, from populations of organisms down to the atomic level.  It covers methods like differential equations for large-scale systems and molecular dynamics for biomolecules, highlighting the challenge of bridging these scales.  The article also explores the maximum entropy principle as a tool for inference across scales.\n",
          "url": "https://tbiomed.biomedcentral.com/articles/10.1186/1742-4682-11-52"
        },
        {
          "title": "Multiscale Modeling and Numerical Simulations",
          "author": "Guoqing Hu, Dongqing Li",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "Yes, multiscale modeling is used to simulate biological processes across multiple length scales, from the molecular level to the continuum level.  This approach is particularly relevant for microfluidic and nanofluidic phenomena in Lab-on-a-Chip devices.  Several cited papers detail hybrid atomistic-continuum methods and techniques for simulating fluid flow at these scales.  These methods address challenges in modeling systems spanning vastly different size ranges, such as those seen in biological processes like translation, gene regulation, and cell communication.\n",
          "url": "https://link.springer.com/doi/10.1007/978-0-387-48998-8_1075"
        }
      ],
      "full_explanation": "Several papers demonstrate that researchers have developed methods to model multiple length scales in biological simulations.\n\n*   **Agmon and Spangler (2023)** specifically describes a multi-scale model of *E. coli* chemotaxis, integrating models of metabolism, gene expression, and flagella/chemoreceptor activity across different scales, using a computational biology engine called Vivarium. This directly addresses the research question by linking different biological scales within a single simulation. URL: https://www.mdpi.com/1099-4300/22/10/1101\n*   **Pio-Lopez et al. (2023)** uses a TAME framework to simulate how goals scale from cellular to anatomical levels, demonstrating emergent tissue behavior from cellular homeostasis. This study is significant as it tackles the evolution of complex setpoints in cell collectives and provides an approach to modeling the transition from cell-level to tissue-level scales. URL: https://pubmed.ncbi.nlm.nih.gov/37065270\n*   **H\u00f6llring (2023)** presents a model that incorporates cell-cell and cell-matrix interactions to model cell proliferation in 2D epithelia. This model accounts for both short and long time- and length-scale behaviors, and it demonstrates that mechanoresponse can lead to large-scale density structures, clearly addressing the multi-scale aspect in tissue modeling. URL: https://www.biorxiv.org/content/10.1101/2023.01.31.526438v1\n*   **Wehrspan and Elcock (2023)** have developed a multi-scale approach to construct whole-cell models of *E. coli* peptidoglycan. This includes integrating diverse experimental data to create realistic 3D models and using them to analyze protein diffusion, which clearly demonstrates the use of modeling across different scales within a cell. URL: https://www.biorxiv.org/content/10.1101/2023.06.04.543634v1\n*   A paper from 2011 titled **\"Multi-scale Modeling in Biology: How to Bridge the Gaps...\"** reviews methodologies used to address the challenges of bridging spatial and temporal scales in biological systems. It discusses existing modeling approaches and the gaps between them, highlighting the existing awareness and work being done in this area. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3190585/\n*   **Brodland (2023)** discusses how computational models integrate information across multiple length scales, using examples in embryogenesis. This article shows that multi-scale models are being actively used to replicate biological system behavior. URL: https://www.sciencedirect.com/science/article/pii/S1084952115001287\n*   The paper **\"Modeling Biology Spanning Different Scales: An Open ...\"** (2014) specifically identifies the need for models spanning different space and time scales. URL: https://www.researchgate.net/publication/263809652_Modeling_Biology_Spanning_Different_Scales_An_Open_Challenge\n*   **El-Magd (2014)** reviews modeling across multiple scales, from populations to atoms, and covers both differential equations and molecular dynamics, highlighting the need for bridging these diverse scales. URL: https://tbiomed.biomedcentral.com/articles/10.1186/1742-4682-11-52\n*   **Hu and Li (2024)** describe the application of multi-scale modeling to microfluidic and nanofluidic phenomena, bridging the molecular level to the continuum level, and showing how these methods address challenges in modeling systems with vastly different sizes. URL: https://link.springer.com/doi/10.1007/978-0-387-48998-8_1075\nThese papers collectively confirm that research into modeling biological systems at multiple length scales has been actively undertaken and developed."
    },
    {
      "question": "Has anyone Measured how well different people use search engines?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Measuring the Utility of Search Engine Result Pages | The 41st International ACM SIGIR Conference on Research & Development in Information Retrieval",
          "author": "View Profile",
          "published_date": "2018-06-27T00:00:00+00:00",
          "summary": "This paper introduces a new measure for evaluating the utility of Search Engine Result Pages (SERPs), based on information foraging theory.  The authors argue that existing measures are inadequate for the heterogeneous nature of modern SERPs (including web results, ads, and specialized answers). Their proposed measure accounts for both the utility gained and the cost incurred by users, using a model that adapts to user behavior based on the rate of information gain.  The method was tested on 1000 popular queries, comparing it to common measures and showing it better reflects user behavior (stopping rank and time spent).  The research directly connects models of how people search with how we measure search effectiveness.\n",
          "url": "https://dl.acm.org/doi/10.1145/3209978.3210027"
        },
        {
          "title": "Measuring personalization of web search",
          "author": "Anik\u00f3 Hann\u00e1k,Piotr Sapiezynski,A. M. Kakhki,B. Krishnamurthy,D. Lazer,A. Mislove,Christo Wilson",
          "published_date": "2023-10-26T19:30:31.092000+00:00",
          "summary": "This paper measures the personalization of web search results on Google and Bing.  The study found that, on average, 11.7% of Google search results and 15.8% of Bing results differed due to personalization.  Surprisingly, the only user attributes significantly impacting personalization were logged-in status and IP address; other factors did not produce results beyond baseline noise levels.  The researchers developed a methodology applicable to other search services and suggest periodic application to track changes in search engine personalization over time.  The study does *not* directly measure how well different people use search engines, but rather the extent to which search results are personalized for different users.\n",
          "url": "https://arxiv.org/pdf/1706.05011.pdf"
        },
        {
          "title": "Large Language Models vs. Search Engines: Evaluating User Preferences Across Varied Information Retrieval Scenarios",
          "author": "[Submitted on 11 Jan 2024]",
          "published_date": "2024-01-11T00:00:00+00:00",
          "summary": "A study (N=100 US internet users) compared user preferences between search engines and LLMs across 20 information retrieval scenarios.  Results showed a preference for search engines for fact-based queries and LLMs for tasks requiring nuanced understanding.  This directly addresses the user's query by highlighting a measurement of how users utilize search engines (in comparison to LLMs) in various situations.\n",
          "url": "http://arxiv.org/abs/2401.05761"
        },
        {
          "title": "Chrome_Browsing_Behavior (3)",
          "author": "KCR",
          "published_date": null,
          "summary": "This research paper analyzes the browsing behavior of hundreds of millions of Google Chrome users.  While it doesn't directly measure *how well* different people use search engines, it does examine the frequency with which users access search engines (alongside other website categories) on both desktop and mobile devices, broken down by geographic location.  The study reveals that search engines are among the most frequently loaded websites globally,  but it doesn't provide a metric for search engine *effectiveness* or user proficiency.\n",
          "url": "https://zakird.com/papers/browsing.pdf"
        },
        {
          "title": "Measuring personalization of web search",
          "author": "Anik\u00f3 Hann\u00e1k,Piotr Sapiezynski,A. M. Kakhki,B. Krishnamurthy,D. Lazer,A. Mislove,Christo Wilson",
          "published_date": "2023-10-26T19:30:31.092000+00:00",
          "summary": "This paper measures personalization in Google and Bing web search, not user search engine proficiency.  The authors developed a methodology to quantify the extent of personalization, finding that 11.7% of Google results and 15.8% of Bing results differed due to personalization.  Surprisingly, only logged-in accounts and IP addresses measurably affected personalization; other user attributes did not.  The study represents an initial step towards understanding personalization in web search.\n",
          "url": "https://arxiv.org/pdf/1706.05011.pdf"
        },
        {
          "title": "Main findings",
          "author": "By , Joanna Brenner and Lee Rainie",
          "published_date": "2012-03-09T00:00:00+00:00",
          "summary": "A 2012 Pew Research Center study found that search engine use varies significantly across demographics.  Younger adults, college-educated individuals, and those with higher incomes use search engines more frequently.  While white and Black online adults use search engines more than Hispanics, white adults use them more often on a given day.  Furthermore, younger users (18-29) express more confidence in search engine fairness and accuracy than older users.  Women also report slightly higher trust in accuracy than men, and higher-income individuals show similar trends.\n",
          "url": "https://www.pewresearch.org/internet/2012/03/09/main-findings-11/"
        },
        {
          "title": "A study of results overlap and uniqueness among major ...",
          "author": "K. Bharat",
          "published_date": "2006-09-01T00:00:00+00:00",
          "summary": "This study focuses on the overlap in search results across different search engines (Google, MSN, Yahoo!, Ask Jeeves) rather than individual user performance.  While it mentions millions of people use search engines daily, the research itself doesn't measure how well different people utilize these engines.  The paper's goal was to quantify the degree of overlap (or lack thereof) in results returned for the same queries across various search engines.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0306457305001500"
        },
        {
          "title": "Evaluation of Search Engines: A Conceptual Model and ...",
          "author": "",
          "published_date": "2013-02-21T00:00:00+00:00",
          "summary": "This research paper develops a conceptual model to evaluate search engines, focusing on factors influencing user evaluation and the criteria for effective and efficient evaluation.  It examines user satisfaction and usage as key success variables,  investigating why users favor specific search engines and switch between them. While the paper doesn't directly measure how *different* people use search engines, it addresses the underlying factors influencing user behavior and preferences, providing a framework for future research in this area.\n",
          "url": "https://www.researchgate.net/publication/315446518_Evaluation_of_Search_Engines_A_Conceptual_Model_and_Research_Issues"
        },
        {
          "title": "The Impact of Search Engine Selection and Sorting Criteria ...",
          "author": "",
          "published_date": "2014-04-02T00:00:00+00:00",
          "summary": "This study investigated how search engine results influence users' views on vaccination.  Two experiments manipulated search results to show either mostly pro-vaccine or mostly anti-vaccine websites.  Results showed that exposure to primarily pro-vaccine sites increased participants' knowledge of and positive attitudes towards vaccination. Conversely, exposure to mainly anti-vaccine sites increased fear of side effects and decreased positive views.  The study highlights the significant impact of search engine algorithms on users' health information seeking, suggesting users are often unaware of the bias in search results.  While the study focuses on vaccination, it implicitly addresses the broader question of how effectively different individuals utilize search engines by demonstrating a considerable impact of algorithm-driven results on user comprehension and beliefs.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4004139/"
        },
        {
          "title": "A Study On Online Search By People Using Search Engine",
          "author": "",
          "published_date": "2017-05-26T00:00:00+00:00",
          "summary": "This study qualitatively investigated how users search online using a search engine.  Eleven participants were interviewed using fifteen open-ended questions.  The research aimed to understand user behavior and information-seeking practices, offering insights into how people utilize search engines.  The study does not, however, provide quantitative measurements comparing the search engine proficiency of different individuals.\n",
          "url": "https://www.researchgate.net/publication/328527875_A_Study_On_Online_Search_By_People_Using_Search_Engine"
        }
      ],
      "full_explanation": "While no single paper directly measures a 'proficiency score' for individual search engine users, several papers address aspects of the research question and provide relevant insights into how different people use search engines, and how effectively they do so.\n\nThe paper titled \"Large Language Models vs. Search Engines: Evaluating User Preferences Across Varied Information Retrieval Scenarios\" directly relates to the research question by comparing how users choose between search engines and LLMs for different tasks. This measures the effectiveness of search engine use in different situations by assessing user preference, which inherently relates to how users perceive their own search effectiveness. (URL: http://arxiv.org/abs/2401.05761).\n\nThe Pew Research Center study \"Main findings\" from 2012 highlights that search engine usage varies across demographics, stating that younger adults, college-educated individuals, and those with higher incomes use search engines more frequently. It further suggests variance in the level of trust in search engines based on demographics, with younger users expressing more confidence than older users. This demonstrates that groups of people use search engines in different ways and at different rates. (URL: https://www.pewresearch.org/internet/2012/03/09/main-findings-11/)\n\nThe paper \"The Impact of Search Engine Selection and Sorting Criteria ...\" implicitly addresses the research question by showing how search results (determined by search algorithms) impact user beliefs and understanding, demonstrating differences in how effectively individuals can find and process accurate information based on the search results they receive. This implies that some people may be more impacted by biased results than others, thus affecting their search effectiveness. (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4004139/)\n\nFinally, although qualitative, \"A Study On Online Search By People Using Search Engine\" offers insights into how people use search engines and therefore touches upon the idea that different people have different behaviours when using them. (URL: https://www.researchgate.net/publication/328527875_A_Study_On_Online_Search_By_People_Using_Search_Engine)"
    },
    {
      "question": "Has anyone built a high throughput measurement technique for electrochemical measurements to evolve enzymes?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics",
          "author": "View ORCID ProfileC.J. Markin",
          "published_date": "2020-11-25T00:00:00+00:00",
          "summary": "This paper describes HT-MEK, a high-throughput microfluidic platform for enzyme characterization.  While not directly focused on electrochemical measurements, it performs >670,000 kinetic reactions on >1500 enzyme variants to determine kinetic and physical constants.  The authors use this to map functional regions of an enzyme, revealing how sequence affects function.  The technique could potentially be adapted for electrochemical measurements in future applications.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full"
        },
        {
          "title": "What can electrochemistry tell us about individual enzymes?",
          "author": "Connor  Davis, University of California at Santa, 93106, Barbara, Santa Barbara, CA, United States, Stephanie X Wang, University of California at Santa Barbara, 93106, Santa Barbara, CA, United States, Lior  Sepunaru, University of California at Santa Barbara, 93106, Santa Barbara, CA, United States",
          "published_date": "2023-11-09T20:31:14.449000+00:00",
          "summary": "This article reviews electrochemical techniques for studying individual enzymes, focusing on nano-impact electrochemistry (NIE) and electrochemical scanning tunneling microscopy (ECSTM).  While NIE can measure single-enzyme activity, its high-throughput application for freely diffusing enzymes is uncertain. ECSTM offers an alternative, measuring an enzyme's electronic conductivity, which reflects substrate binding, oxidation state, and structural changes.  The article doesn't address high-throughput methods for *evolving* enzymes via electrochemical measurements; it focuses on characterizing individual enzymes using existing techniques.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2451910320301848"
        },
        {
          "title": "Measurements drive progress in directed evolution for precise engineering of biological systems.",
          "author": "Drew S Tack, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Eugenia F Romantseva, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Peter D Tonner, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Abe  Pressman, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Jayan  Rammohan, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, Elizabeth A Strychalski, National Institute of Standards and Technology, 20898, Gaithersburg, MD, USA, elizabeth.strychalski@nist.gov",
          "published_date": "2023-11-09T20:31:00.743000+00:00",
          "summary": "The provided text focuses on the general use of high-throughput measurements in directed evolution to engineer biological systems, not specifically electrochemical measurements for enzyme evolution.  Therefore, the answer to your query is not directly addressed in this article.  The abstract highlights the increasing use of high-throughput methods for measuring phenotypes and genotypes to improve directed evolution, but doesn't offer specifics on electrochemical techniques for enzyme engineering.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2452310020300366"
        },
        {
          "title": "High-Throughput Screening of Catalytic H2 Production.",
          "author": "Jamin  Koo, Tim  Schnabel, Sylvie  Liong, Niklaus H Evitt, James R Swartz, jswartz@stanford.edu",
          "published_date": "2023-11-09T20:19:40.240000+00:00",
          "summary": "Yes, a high-throughput H2 production assay device (H2 PAD) has been developed to screen for improved biological H2 production.  This device uses a chemo-optical response from Pd/WO3 thin films to measure H2 production in 96 reactions simultaneously. Using this, researchers identified a [FeFe] hydrogenase mutant with nearly 3-fold higher H2 production and an FNR mutant enabling a 60% increase in NADPH-driven H2 production.  While not explicitly electrochemical, the H2 PAD enables directed evolution of enzymes by high-throughput screening of their catalytic activity.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/anie.201610260"
        },
        {
          "title": "Growth amplification in ultrahigh-throughput microdroplet screening increases sensitivity of clonal enzyme assays and minimizes phenotypic variation.",
          "author": "P. Zurek,R. Hours,U. Schell,Ahir Pushpanath,F. Hollfelder",
          "published_date": "2023-10-26T19:30:39.676000+00:00",
          "summary": "This research describes a high-throughput microfluidic screening method for enzyme activity assays, significantly increasing sensitivity and minimizing variation.  While not directly electrochemical, it uses compartmentalized cells in microdroplets to amplify enzyme production and measure activity, enabling efficient screening of millions of enzyme variants per day.  The improved sensitivity is particularly relevant for finding and evolving enzymes with initially weak activities, a key challenge in directed evolution.  The method focuses on optical interrogation of chromogenic or fluorogenic reactions within the droplets.\n",
          "url": "https://pubs.rsc.org/en/content/articlepdf/2021/lc/d0lc00830c"
        },
        {
          "title": "Evolution of enzymes with new specificity by high ...",
          "author": "Kil Koang Kwon, Dae-Hee  Lee, Su Jin Kim, Su-Lim  Choi, Eugene  Rha, Soo-Jin  Yeom, Bindu  Subhadra, Jinhyuk  Lee, Korean Bioinformation Centre (KOBIC), 305-806, Daejeon, Korea Research, Korea, Ki Jun Jeong, kjjeong@kaist.ac.kr, Seung-Goo  Lee, sglee@kribb.re.kr",
          "published_date": "2023-11-09T20:21:37.320000+00:00",
          "summary": "This research used a high-throughput flow cytometry method to evolve the specificity of tryptophan-indole lyase (TIL) enzymes.  A DmpR-based genetic circuit detected phenolic compounds produced by TIL variants, enabling rapid screening of numerous mutants.  While not electrochemical, this approach demonstrates a high-throughput method for enzyme evolution based on the detection of enzymatic products.\n",
          "url": "https://www.nature.com/articles/s41598-018-20943-8"
        },
        {
          "title": "Ultrahigh-throughput screening-assisted in vivo directed ...",
          "author": "Zhang, Guoqiang",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "This research describes a high-throughput *in vivo* directed evolution system for enzyme engineering.  While not directly electrochemical, it uses ultrahigh-throughput screening (microfluidic droplet screening and fluorescence-activated cell sorting) coupled with a thermally-responsive mutagenesis system in *E. coli* to evolve enzymes (\u03b2-lactamase, \u03b1-amylase) and biosynthetic pathways (resveratrol).  The system significantly increased mutation rates, resulting in improved enzyme activity and product yield.  The study doesn't involve electrochemical measurements for enzyme evolution, but does present a high-throughput method for evolving enzymes based on other screening techniques.\n",
          "url": "https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-024-02457-w"
        },
        {
          "title": "High Throughput Screening and Selection Methods for ...",
          "author": "",
          "published_date": "2014-10-03T00:00:00+00:00",
          "summary": "This article reviews high-throughput screening and selection methods for directed enzyme evolution, focusing on methods compatible with phenotypic analysis.  While it details various high-throughput screening methods (e.g., using microtiter plates, fluorescence-activated cell sorting (FACS)), it does *not* discuss high-throughput electrochemical measurement techniques for enzyme evolution.  Therefore, the answer to your query is not found within this paper.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4461044/"
        },
        {
          "title": "High-Throughput Screening Technology in Industrial ...",
          "author": "M. Wehrs",
          "published_date": "2020-08-01T00:00:00+00:00",
          "summary": "This article describes high-throughput screening (HTS) techniques in industrial biotechnology, focusing on methods for improving microorganisms used in industrial processes.  While it details various spectroscopic methods (UV/Vis, fluorescence) for HTS, it does *not* discuss high-throughput electrochemical measurements for enzyme evolution.  The article mentions using microorganisms as \"cell factories\" to produce various products and improving them through techniques like adaptive laboratory evolution (ALE), but doesn't address electrochemical methods in this context.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0167779920300019"
        },
        {
          "title": "Enabling high-throughput enzyme discovery and ...",
          "author": "Beckham, Gregg T.",
          "published_date": "2024-06-24T00:00:00+00:00",
          "summary": "This research describes a low-cost, robot-assisted pipeline for high-throughput enzyme discovery and engineering.  While it focuses on improving enzyme production and analysis (not specifically electrochemical measurements), the automation addresses the need for efficient processing of large numbers of enzyme variants.  The system aims to overcome limitations of traditional methods like *E. coli* expression and purification, which lack the throughput needed for high-volume enzyme screening.  The paper does not directly address electrochemical measurement techniques for enzyme evolution.\n",
          "url": "https://www.nature.com/articles/s41598-024-64938-0"
        }
      ],
      "full_explanation": "While several papers discuss high-throughput methods for enzyme characterization and evolution, none of them describe a *high-throughput measurement technique for electrochemical measurements to evolve enzymes*. \n\n*   **Paper 1** (\"Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics\") describes a high-throughput microfluidic platform (HT-MEK) that performs kinetic reactions on many enzyme variants but doesn't involve electrochemical measurements. While the paper suggests it could potentially be adapted for electrochemical measurements, the research itself has not been done yet. [https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full](https://www.biorxiv.org/content/10.1101/2020.11.24.383182v1.full)\n\n*   **Paper 2** (\"What can electrochemistry tell us about individual enzymes?\") reviews electrochemical techniques for studying single enzymes (NIE and ECSTM). These are not focused on *evolving* enzymes or performing high-throughput measurements, but on understanding the function of individual enzymes. [https://www.sciencedirect.com/science/article/pii/S2451910320301848](https://www.sciencedirect.com/science/article/pii/S2451910320301848)\n\n*  **Paper 4** (\"High-Throughput Screening of Catalytic H2 Production.\") introduces a high-throughput method for measuring hydrogen production from enzymes using a chemo-optical response, but this is not an electrochemical measurement. While relevant to high-throughput enzyme evolution, it does not use electrochemical techniques. [https://onlinelibrary.wiley.com/doi/10.1002/anie.201610260](https://onlinelibrary.wiley.com/doi/10.1002/anie.201610260)\n\nThe other provided papers all describe non-electrochemical high-throughput methods for enzyme evolution or characterization. While these other methods are relevant to the general idea of high-throughput enzyme engineering, they do not address the specific electrochemical focus of the research question."
    },
    {
      "question": "Has anyone shown saunas can improve human health in anyway in an RCT?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study",
          "author": "Laukkanen, Jari",
          "published_date": "2018-12-07T16:15:11+00:00",
          "summary": "This prospective cohort study (not an RCT) of 1688 participants (mean age 63) found that sauna bathing frequency was associated with reduced cardiovascular mortality in both men and women over a 15-year follow-up.  The risk decreased linearly with increased sauna use.  While the study investigated the relationship between sauna habits and CVD mortality, and the improvement in CVD mortality risk prediction by adding sauna habits to conventional risk factors, it did not utilize a randomized controlled trial design.\n",
          "url": "https://jyx.jyu.fi/handle/123456789/60594"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study - BMC Medicine",
          "author": "Laukkanen; Tanjaniina; Kunutsor; Setor K; Khan; Hassan; Willeit; Peter; Zaccardi; Francesco; Jari A",
          "published_date": "2023-02-07T05:46:00.626000+00:00",
          "summary": "This prospective cohort study (not a randomized controlled trial, RCT) of 1688 participants (mean age 63) found a strong inverse association between sauna bathing frequency and duration and fatal cardiovascular disease (CVD) events in both men and women over a 15-year period.  Adding sauna frequency to existing CVD risk prediction models improved accuracy.  While not an RCT, the study suggests a potential health benefit, specifically reduced CVD mortality risk, linked to sauna use.\n",
          "url": "https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1198-0"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study - PubMed",
          "author": "Tanjaniina Laukkanen 1 2 ,",
          "published_date": "2018-11-29T00:00:00+00:00",
          "summary": "This prospective cohort study (not a randomized controlled trial, RCT) of 1688 participants (mean age 63) found a strong inverse association between sauna bathing frequency and duration and cardiovascular mortality in both men and women over a 15-year follow-up.  Increased sauna use (2-3 or 4-7 sessions/week) was associated with significantly reduced risk of fatal cardiovascular events, even after adjusting for other risk factors.  Adding sauna frequency to a CVD risk prediction model improved its accuracy.  While not an RCT, the study suggests a positive association between sauna use and cardiovascular health.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30486813/"
        },
        {
          "title": "Combined Effect of Sauna Bathing and Cardiorespiratory Fitness on the Risk of Sudden Cardiac Deaths in Caucasian Men: A Long-term Prospective Cohort Study",
          "author": "Joshua A Beckman; Esther S H Kim",
          "published_date": "2023-02-23T19:31:24.936000+00:00",
          "summary": "A prospective cohort study of 2291 Caucasian men found that frequent sauna bathing (3-7 sessions/week) was associated with a lower risk of sudden cardiac death (SCD), although the effect was more pronounced when combined with high cardiorespiratory fitness.  While not a randomized controlled trial (RCT), this study suggests a potential positive health benefit of sauna use, specifically regarding SCD risk reduction.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0033062018300586"
        },
        {
          "title": "Joint associations of sauna bathing and cardiorespiratory fitness on cardiovascular and all-cause mortality risk: a long-term prospective cohort study - PubMed",
          "author": "Setor K Kunutsor 1 ,",
          "published_date": "2023-01-01T00:00:00+00:00",
          "summary": "This study is a prospective cohort study, not a randomized controlled trial (RCT), investigating the association between sauna bathing frequency and cardiorespiratory fitness on cardiovascular and all-cause mortality.  Results showed that high cardiorespiratory fitness and frequent sauna bathing (3-7 sessions/week) were associated with substantially lower risks of cardiovascular and all-cause mortality compared to either factor alone.  While the study demonstrates a correlation, it does not provide the level of causal evidence an RCT would offer.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28972808/"
        },
        {
          "title": "Effects of regular sauna bathing in conjunction with ...",
          "author": "Earric Lee 1 ,",
          "published_date": "2022-01-09T00:00:00+00:00",
          "summary": "Yes, a randomized controlled trial (RCT) showed that regular sauna bathing, combined with exercise, improved cardiovascular function in sedentary adults with cardiovascular disease risk factors.  The study found that the combination led to greater improvements in cardiorespiratory fitness, lower systolic blood pressure, and lower total cholesterol levels compared to exercise alone.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35785965/"
        },
        {
          "title": "Clinical Effects of Regular Dry Sauna Bathing",
          "author": "",
          "published_date": "2018-04-24T00:00:00+00:00",
          "summary": "A systematic review of 40 studies (including 13 randomized controlled trials) on the health effects of regular dry sauna bathing found potential health benefits.  However, most studies were small, and  the review notes a need for more high-quality research to confirm these benefits and determine optimal usage. Only one small RCT (n=10) reported a negative effect (reversible male spermatogenesis disruption), highlighting the need for further investigation into potential adverse effects.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/"
        },
        {
          "title": "Sauna bathing is associated with reduced cardiovascular ...",
          "author": "Laukkanen; Tanjaniina; Kunutsor; Setor K; Khan; Hassan; Willeit; Peter; Zaccardi; Francesco; Jari A",
          "published_date": "2023-02-07T05:46:00.626000+00:00",
          "summary": "This study, a prospective cohort study (not an RCT), found a strong inverse association between sauna bathing frequency and duration and fatal cardiovascular disease (CVD) events in middle-aged to elderly men and women.  Higher sauna use improved CVD mortality risk prediction models.  While not an RCT, the results suggest a potential health benefit.\n",
          "url": "https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1198-0"
        },
        {
          "title": "Are There Benefits from Using Saunas?",
          "author": "How we reviewed this article:",
          "published_date": "2016-05-23T07:00:00+00:00",
          "summary": "A 2008 study on individuals with chronic musculoskeletal diseases (including rheumatoid and ankylosing spondylitis) found that sauna sessions improved pain, stiffness, and fatigue over four weeks.  However, the improvements weren't statistically significant, and the authors suggested trial sessions before incorporating sauna use into treatment.  The text does not cite any other randomized controlled trials (RCTs) demonstrating health benefits from saunas.\n",
          "url": "https://www.healthline.com/health/fitness-exercise/are-saunas-good-for-you"
        },
        {
          "title": "Sauna Bathing as an Alternative Adjunct Therapy in the",
          "author": "",
          "published_date": null,
          "summary": "This review article does not report the results of any randomized controlled trials (RCTs) investigating the effects of sauna use on human health.  While the authors cite numerous studies showing correlations between sauna use and reduced risks of cardiovascular disease, neurodegenerative disease, metabolic disease, and mental health disorders (e.g., 51% reduced annual cardiovascular mortality in men using saunas 4-7 times/week), these are observational studies, not RCTs.  The mechanisms suggested for these benefits involve improved cardiovascular function, increased heat shock protein expression, and improved thermoregulation, but these are not definitively proven through RCT methodology.\n",
          "url": "https://esmed.org/MRA/mra/article/download/3965/99193546945/"
        }
      ],
      "full_explanation": "The research question asks if anyone has shown saunas can improve human health in any way in an RCT (Randomized Controlled Trial). Based on the provided papers, at least one study has used an RCT design to investigate the health effects of sauna use. The paper titled \"Effects of regular sauna bathing in conjunction with ...\" (URL: https://pubmed.ncbi.nlm.nih.gov/35785965/) describes a study that used an RCT design. It found that regular sauna bathing combined with exercise improved cardiovascular function in sedentary adults with cardiovascular disease risk factors, showing improvements in cardiorespiratory fitness, systolic blood pressure, and cholesterol levels compared to exercise alone. Additionally, the paper titled \"Clinical Effects of Regular Dry Sauna Bathing\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/) mentions a systematic review of 40 studies, which included 13 RCTs investigating the health effects of dry sauna bathing, providing further evidence that RCTs have been conducted on this research question."
    },
    {
      "question": "Has anyone studied how concordant family members' perceptions of patient's goals of care/code status/decisions around CPR intubation are with patient's goals of cares? ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Goal-concordant care in the ICU: a conceptual framework for future research",
          "author": "A. Turnbull,C. Hartog",
          "published_date": "2023-10-26T19:30:46.871000+00:00",
          "summary": "Yes, the paper discusses challenges in determining concordance between patient and family member goals of care.  It highlights that many critically ill patients lack decision-making capacity, relying on family surrogates.  However, families are often unprepared, uncertain, or incorrect about patient goals and treatment limitations (including code status and decisions around CPR/intubation).  The authors propose using standardized questionnaires to collect this data longitudinally or retrospectively, acknowledging biases inherent in retrospective collection.  The study does not present specific results from such a study but rather proposes a framework for future research to address this very question.\n",
          "url": "https://link.springer.com/content/pdf/10.1007/s00134-017-4873-2.pdf"
        },
        {
          "title": "Patient-reported receipt of goal-concordant care among seriously ill outpatients - prevalence and associated factors.",
          "author": "Matthew E Modes, modes@uw.edu, Susan R Heckbert, Ruth A Engelberg, Elizabeth L Nielsen, J Randall Curtis, Erin K Kross",
          "published_date": "2023-11-09T20:29:40.032000+00:00",
          "summary": "This study analyzed patient-reported goal concordance in seriously ill outpatients, but did *not* examine concordance between patients' goals and family members' perceptions.  The study found that only 58% of 405 patients reported receiving care aligned with their prioritized health goals.  Concordance varied by patient goal: 86% of those prioritizing life extension reported concordant care, while only 51% of those prioritizing pain relief did.  Patients prioritizing pain relief were significantly more likely to report discordant care (relative risk ratio 22.20). The study suggests interventions should focus on improving care alignment for patients prioritizing pain relief.\n",
          "url": "http://jpsmjournal.com/retrieve/pii/S0885392420302463"
        },
        {
          "title": "Goal-Concordant Care After Severe Acute Brain Injury",
          "author": "Rutz Voumard; Rachel; Dugger; Kaley M; Kiker; Whitney A; Barber; Jason; Borasio; Gian Domenico; Curtis; J Randall; Jox; Ralf J; Creutzfeldt; Claire J",
          "published_date": "2023-02-06T12:32:54.802000+00:00",
          "summary": "This study investigated whether family members' perceptions of patients' goals of care align with actual patient goals after severe acute brain injury (SABI).  Researchers assessed family members' understanding of patients' wishes regarding life-sustaining treatment (LST), such as intubation and CPR, in the acute setting and again 6 months later.  The study aimed to determine the frequency of concordant care (where treatment aligns with perceived goals) and identify factors associated with concordance.  While the summary doesn't explicitly state whether the concordance was high or low, it directly addresses the user's question regarding the study of family members' perceptions versus actual patient goals in the context of end-of-life care decisions.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fneur.2021.710783/full"
        },
        {
          "title": "How often are hospitalized patients and providers on the same page with regard to the patient's primary recovery goal for hospitalization?",
          "author": "Jose F Figueroa, Harvard Medical School, Boston, Massachusetts, jffigueroa@partners.org, Jeffrey L Schnipper, Harvard Medical School, Boston, Massachusetts, Kelly  Mcnally, Diana  Stade, Stuart R Lipsitz, Harvard Medical School, Boston, Massachusetts, Anuj K Dalal, Harvard Medical School, Boston, Massachusetts",
          "published_date": "2023-11-09T20:15:17.402000+00:00",
          "summary": "This study examined concordance between hospitalized patients and their nurses and physicians regarding primary recovery goals, not family members' perceptions.  Researchers found poor agreement (kappa 0.09-0.20) between patients and providers on goals like \"be cured\" (patient preference) versus \"improve/maintain health\" (provider preference). Only 20.2% of patient-nurse-physician trios agreed on the primary goal.  While this study doesn't directly address family member concordance with patient goals of care, it highlights the challenge of aligning perspectives even within the immediate medical team.\n",
          "url": "https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.2569"
        },
        {
          "title": "Patient-Reported Receipt of Goal-Concordant Care Among Seriously Ill Outpatients-Prevalence and Associated Factors - PubMed",
          "author": "Matthew E Modes 1 ,",
          "published_date": "2022-11-01T00:00:00+00:00",
          "summary": "This study examined patient-reported receipt of goal-concordant care among seriously ill outpatients.  While it doesn't directly address family member perceptions, it does highlight a disparity: patients prioritizing pain relief were less likely to report receiving goal-concordant care (51%) compared to those prioritizing life extension (86%).  The study focused on patient-reported goals and the alignment of medical care with those goals, not on the concordance between patient and family member perceptions.  Therefore, it does not directly answer your question regarding family member perceptions of patient goals.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32389606/"
        },
        {
          "title": "Resuscitation team perceptions of family presence during ...",
          "author": "Kathleen Evanovich Zavotsky 1 ,",
          "published_date": "2014-11-01T00:00:00+00:00",
          "summary": "This study focuses on resuscitation team perceptions of family presence during CPR, not on the concordance between family members' and patients' goals of care regarding CPR or intubation.  Therefore, it does not directly address your query.  The research explores healthcare providers' views on allowing family presence during CPR, identifying challenges like education deficits and mixed feelings among team members.  While it touches on the impact of family presence, it doesn't investigate the alignment of family perceptions with the patient's wishes concerning medical interventions like CPR.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25356893/"
        },
        {
          "title": "Code Status Orders and Goals of Care in the Medical ICU",
          "author": "",
          "published_date": "2011-02-01T00:00:00+00:00",
          "summary": "A study of 100 MICU patients and their surrogates found discrepancies between patient/surrogate preferences and physician-ordered code status in 16 cases.  While most patients preferred full code status, few understood CPR components.  Further, 67.7% of patients/surrogates disagreed with their physicians on the most important goal of care.  The research highlights a lack of concordance between patient/surrogate perceptions and medical orders regarding end-of-life care, directly addressing the user's query about alignment of family and patient goals.\n",
          "url": "https://www.researchgate.net/publication/49809238_Code_Status_Orders_and_Goals_of_Care_in_the_Medical_ICU"
        },
        {
          "title": "Code status discussions in medical inpatients: Results of a ...",
          "author": "Authors:",
          "published_date": "2020-03-23T00:00:00+00:00",
          "summary": "This study surveyed 145 patients and 258 physicians in a Swiss hospital about code status discussions.  While it doesn't directly address family member concordance with patient goals of care regarding CPR or intubation, it does reveal significant discordance between patient recollection of code status discussions and physician documentation.  61.4% of patients didn't recall such a discussion, and in 23.7% of cases where a discussion was recalled, the patient's expressed preference differed from the documented code status.  Furthermore, a majority of physicians (72.4%) reported deciding DNR status without prior patient consultation, leading to increased conflict with patients and families.  The study highlights a need for improved communication and physician training regarding code status discussions, indirectly suggesting potential areas for future research on family member concordance with patient preferences.\n",
          "url": "https://www.researchgate.net/publication/340408424_Code_status_discussions_in_medical_inpatients_Results_of_a_survey_of_patients_and_physicians"
        },
        {
          "title": "Strategies for Collaborative Consideration of Patients ...",
          "author": "Kimberly Kopecky; Pete Pelletier; Pringl Miller",
          "published_date": "2023-02-07T20:30:58.006000+00:00",
          "summary": "This article focuses on required reconsideration discussions between medical professionals and patients (or surrogates) regarding Do-Not-Resuscitate (DNR) orders during perioperative periods.  While it doesn't directly address the concordance between family members' and patients' goals of care regarding CPR or intubation, it highlights the ethical and legal importance of respecting patient autonomy in these decisions.  The article emphasizes that automatically rescinding DNR orders is unethical and advocates for discussions to ensure patient preferences are understood and respected, even if those preferences might seem to conflict with medical interventions.  Further research is needed to specifically address the concordance question raised in your search query.\n",
          "url": "https://journalofethics.ama-assn.org/article/strategies-collaborative-consideration-patients-resuscitation-preferences/2020-04"
        },
        {
          "title": "Discordance Between Surrogate Care Goals and Medical ...",
          "author": "Amber R Comer, Susan E Hickman, James E Slaven, Patrick O Monahan, Greg A Sachs, Lucia D Wocial, Emily S Burke, Alexia M Torke",
          "published_date": "2023-11-09T20:30:05.393000+00:00",
          "summary": "This study investigated the agreement between the goals of care expressed by surrogate decision-makers (family members) for hospitalized, incapacitated older adults and the actual medical treatments received.  The research focused on whether the medical orders and treatments matched the family's stated preferences regarding care.  While the specific elements of \"code status\" and \"CPR/intubation\" aren't explicitly detailed, the study directly addresses the concordance between family perceptions of patient goals and the medical care provided, answering your query.\n",
          "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766000"
        }
      ],
      "full_explanation": "Several papers have directly addressed or are very relevant to the research question of whether family members' perceptions of a patient's goals of care, including code status and CPR/intubation decisions, are concordant with the patient's actual goals.\n\n*   **Rutz Voumard et al. (2023) \"Goal-Concordant Care After Severe Acute Brain Injury\"** (URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.710783/full) This study specifically examined the alignment between family members' understanding of patients' wishes regarding life-sustaining treatment (including intubation and CPR) after severe acute brain injury, and the actual patient goals, both in the acute setting and at 6 months follow up. This directly addresses the core question of family-patient goal concordance related to CPR/intubation decisions.\n\n*  **\"Code Status Orders and Goals of Care in the Medical ICU\" (2011)** (URL: https://www.researchgate.net/publication/49809238_Code_Status_Orders_and_Goals_of_Care_in_the_Medical_ICU) This study found discrepancies between patient/surrogate (family) preferences and physician-ordered code status in 16 cases. It also noted that 67.7% of patients/surrogates disagreed with physicians on the most important goal of care. The presence of disagreement between patient/surrogate perceptions directly pertains to the question of concordance in this case.\n\n* **Amber R Comer et al. (2023) \"Discordance Between Surrogate Care Goals and Medical...\"** (URL: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766000) This study investigated the agreement between goals of care expressed by surrogate decision-makers (family) for hospitalized incapacitated older adults and the actual medical treatments received. While not specifying CPR/intubation, the study directly addresses the concordance of family perceptions with medical care and therefore is relevant.\n\n*  **Turnbull & Hartog (2023) \"Goal-concordant care in the ICU: a conceptual framework for future research\"** (URL: https://link.springer.com/content/pdf/10.1007/s00134-017-4873-2.pdf). While this paper is primarily a framework for research, it explicitly acknowledges the problem that family surrogates are often incorrect about patient goals and treatment limitations, including code status and decisions about CPR/intubation. It thus acknowledges the importance of addressing the proposed research question and provides evidence for the fact it has been studied."
    },
    {
      "question": "Has anyone detected dyson sphere signatures?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Project Hephaistos \u2013 II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "No strong candidates for Dyson spheres (megastructures built by advanced civilizations to harness stellar energy) have been detected yet.  This study searched optical and infrared data from Gaia, 2MASS, and WISE, identifying seven potential candidates, all M-dwarfs, which require further analysis to rule out natural explanations for their infrared excess emission.\n",
          "url": "https://academic.oup.com/mnras/article/531/1/695/7665761"
        },
        {
          "title": "Project Hephaistos - II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-05T00:00:00+00:00",
          "summary": "A recent study (Project Hephaistos) searched for partial Dyson sphere signatures in data from Gaia, 2MASS, and WISE.  The researchers developed a pipeline incorporating a convolutional neural network to analyze five million objects, identifying seven potential candidates that warrant further investigation.  These candidates are all M-dwarfs exhibiting infrared excess emission not easily explained by known astrophysical phenomena.  While not a definitive detection, the study suggests potential Dyson sphere candidates.\n",
          "url": "https://arxiv.org/abs/2405.02927"
        },
        {
          "title": "Anomalous Variability of Dyson Megastructures",
          "author": null,
          "published_date": "2023-01-06T18:01:03.444000+00:00",
          "summary": "Several studies have searched for Dyson sphere signatures,  with mixed results.  While some objects have shown anomalous variability (like Tabby's star, KIC8462852),  explanations other than megastructures (e.g., exocomets) remain plausible.  Infrared surveys have identified potential candidates, but further investigation is needed to confirm their nature.  No definitive detection of Dyson spheres has been made.\n",
          "url": "https://arxiv.org/pdf/arxiv.org/ftp/arxiv/papers/1909/1909.08851.pdf"
        },
        {
          "title": "A Dyson Sphere around a black hole",
          "author": "Yu-Yang  Hsiao, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tomotsugu  Goto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tetsuya  Hashimoto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Daryl Joe D Santos, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Alvina Y L On, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ece  Kilerci-Eser, Sabanc\u0131 University, 34956, Istanbul, Turkey, Yi  Hang, Valerie  Wong, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Seong Jin Kim, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -W  Wu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -C  Ho, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ting-Yi  Lu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan",
          "published_date": "2023-11-16T01:35:15.834000+00:00",
          "summary": "No Dyson sphere signatures have been definitively detected.  However, this paper explores the feasibility of detecting a Dyson sphere around a black hole.  It suggests that waste heat radiation from such a structure might be detectable in ultraviolet, optical, near-infrared, and mid-infrared wavelengths using current telescopes like the Galaxy Evolution Explorer.  Detecting it would require model fitting to observed spectral energy distributions and measuring variability in radial velocity.\n",
          "url": "https://arxiv.org/pdf/2106.15181.pdf"
        },
        {
          "title": "A strategic \u201cviewfinder\u201d for SETI research",
          "author": "Massimo  Teodorani",
          "published_date": "2023-11-09T20:11:59.466000+00:00",
          "summary": "This paper proposes using Dyson sphere signatures (infrared excess and anomalous light curves) as a \"viewfinder\" to target SETI research.  It argues that the lack of successful SETI results stems from a lack of specific targets, and Dyson spheres offer a way to identify potentially technologically advanced civilizations.  However, the paper itself is a review and proposal, not a report of any detections; it does not claim that Dyson sphere signatures have been detected.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0094576514002495"
        },
        {
          "title": "II. Dyson sphere candidates from Gaia DR3, 2MASS, and ...",
          "author": "Suazo; Mat\u00edas; Zackrisson; Erik; Mahto; Priyatam K; Lundell; Fabian; Nettelblad; Carl; Korn; Andreas J; Wright; Jason T; Majumdar; Suman",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "No strong candidates for Dyson spheres have been detected in previous searches.  A new study analyzed data from Gaia, 2MASS, and WISE to search for partial Dyson spheres, identifying seven potential candidates for further investigation.  These candidates are all M-dwarfs exhibiting infrared excess emission not easily explained by known astrophysical phenomena.\n",
          "url": "https://academic.oup.com/mnras/article/531/1/695/7665761"
        },
        {
          "title": "Dyson spheres: astronomers report potential candidates for ...",
          "author": "Simon Goodwin",
          "published_date": "2024-05-22T00:00:00+00:00",
          "summary": "A recent study identified seven potential Dyson sphere candidates\u2014megastructures that would harness a star's energy\u2014based on excess infrared radiation.  While these candidates don't fit typical models for gas and dust clouds, other natural explanations are possible.  The researchers emphasize the need for further investigation, including looking for dips in visible light from the stars as the megastructures might transit.  Previous excitement around Tabby's star (KIC 8462852), which showed unusual light dips, ultimately yielded natural explanations.  The existence of Dyson spheres remains speculative, as advanced civilizations might find other ways to obtain energy.\n",
          "url": "https://theconversation.com/dyson-spheres-astronomers-report-potential-candidates-for-alien-megastructures-heres-what-to-make-of-it-230364"
        },
        {
          "title": "Did a NASA telescope detect cosmic 'hot dogs' or Dyson ...",
          "author": "Robert Lea",
          "published_date": "2024-10-02T13:00:01+00:00",
          "summary": "A recent paper in the Monthly Notices of the Royal Astronomical Society reported seven unusual objects that *might* be Dyson spheres \u2013 megastructures built by advanced alien civilizations to harvest stellar energy.  However, a NASA scientist disputes this, suggesting the signals are more likely from dusty galaxies with black holes, nicknamed \"Hot DOGs.\"  The search for Dyson sphere signatures continues, with projects like Project Hephaistos analyzing data from WISE and other telescopes.\n",
          "url": "https://www.space.com/hot-dogs-wise-nasa-dyson-spheres"
        },
        {
          "title": "New Study Suggests of Dyson Spheres, Possible Alien ...",
          "author": "Darren Orf",
          "published_date": "2024-05-14T00:00:00+00:00",
          "summary": "Two recent studies analyzing data from space telescopes like Gaia and WISE have identified several stars exhibiting excess infrared radiation, consistent with potential Dyson sphere signatures.  While not definitive proof of alien megastructures, the findings present compelling candidates that cannot be easily explained by known natural phenomena.  The studies employed sophisticated methods to filter out false positives, focusing on anomalous infrared excesses.  These results have been accepted for publication in the *Monthly Notices of the Royal Astronomical Society*.\n",
          "url": "https://www.popularmechanics.com/space/deep-space/a60780331/dyson-sphere-evidence-alien-civilizations/"
        },
        {
          "title": "Astronomers Are on the Hunt for Dyson Spheres",
          "author": "Evan Gough; Universe Today",
          "published_date": "2024-05-13T00:00:00+00:00",
          "summary": "The provided text contains only website navigation and structure; there is no article text describing the search for Dyson spheres or any detection attempts.  Therefore, I cannot answer whether anyone has detected Dyson sphere signatures based on this webpage.\n",
          "url": "https://astrobiology.arizona.edu/news/astronomers-are-hunt-dyson-spheres"
        }
      ],
      "full_explanation": "Several papers indicate that the search for Dyson sphere signatures has been conducted, although no definitive detection has been made. Specifically, the papers \"Project Hephaistos \u2013 II. Dyson sphere candidates from Gaia DR3, 2MASS, and WISE\" (URL: https://academic.oup.com/mnras/article/531/1/695/7665761 and https://arxiv.org/abs/2405.02927) describe a recent study that analyzed data from multiple telescopes, identifying seven potential candidates based on excess infrared radiation. These papers clearly state that the researchers were searching for \"partial Dyson sphere signatures\" which indicates attempts to detect them. The paper \"Anomalous Variability of Dyson Megastructures\" (URL: https://arxiv.org/pdf/arxiv.org/ftp/arxiv/papers/1909/1909.08851.pdf) also mentions that several studies have searched for Dyson sphere signatures, although without definitive results. The article \"Dyson spheres: astronomers report potential candidates for...\" (URL: https://theconversation.com/dyson-spheres-astronomers-report-potential-candidates-for-alien-megastructures-heres-what-to-make-of-it-230364) and \"New Study Suggests of Dyson Spheres, Possible Alien ...\" (URL: https://www.popularmechanics.com/space/deep-space/a60780331/dyson-sphere-evidence-alien-civilizations/) both highlight the same recent studies that produced potential candidates. Additionally, the paper \"A strategic \u201cviewfinder\u201d for SETI research\" (URL: https://www.sciencedirect.com/science/article/pii/S0094576514002495) discusses using Dyson sphere signatures as a target for SETI, implying previous attempts to detect them, even though it is not reporting any specific detections itself. Finally, the paper \"Did a NASA telescope detect cosmic 'hot dogs' or Dyson...\" (URL: https://www.space.com/hot-dogs-wise-nasa-dyson-spheres) also discusses recent work searching for dyson spheres. All of this evidence strongly suggests that the research question of detecting Dyson sphere signatures has been explored before. While no definitive detection has been confirmed, researchers are actively searching and reporting on potential candidates."
    },
    {
      "question": "Has anyone done a practical engineering analysis of starting a dyson sphere?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Stellar engines: Design considerations for maximizing acceleration",
          "author": "Matthew E Caplan, Illinois State University, 61761, Normal, IL, USA, Acta  Astronautica, Illinois State University, 61761, Normal, IL, USA",
          "published_date": "2023-11-09T20:26:49.925000+00:00",
          "summary": "This scientific article analyzes two designs for stellar engines, large-scale structures capable of moving stars.  While not directly addressing Dyson sphere construction, it does model the engineering challenges of moving a star using a massive solar sail (\"passive\" engine) and a thermonuclear-powered jet (\"active\" engine). The analysis calculates achievable accelerations (10\u207b\u00b9\u00b2 m/s\u00b2 for the passive, up to 10\u207b\u2079 m/s\u00b2 for the active engine), providing insights into the immense engineering requirements involved in such megaprojects.  The study does not, however, discuss the practical engineering of constructing a Dyson sphere itself, only the propulsion of the star it might encompass.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0094576519312457"
        },
        {
          "title": "Review and viability of a Dyson Swarm as a form of Dyson Sphere",
          "author": "Jack Smith",
          "published_date": "2023-10-26T19:30:27.197000+00:00",
          "summary": "This undergraduate physics paper analyzes the feasibility of a Dyson swarm as an alternative to a Dyson sphere.  While acknowledging the theoretical concept of a Dyson sphere, the author argues that a swarm of smaller objects is far more practical due to reduced construction costs, improved resilience to impacts, and scalability.  The paper doesn't provide a detailed engineering plan for *starting* a Dyson sphere or swarm, but its focus on comparative feasibility implies that a full engineering analysis would likely favor the swarm approach due to its inherent advantages.\n",
          "url": "https://arxiv.org/pdf/2109.11443.pdf"
        },
        {
          "title": "A Dyson Sphere around a black hole",
          "author": "Yu-Yang  Hsiao, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tomotsugu  Goto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Tetsuya  Hashimoto, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Daryl Joe D Santos, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Alvina Y L On, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ece  Kilerci-Eser, Sabanc\u0131 University, 34956, Istanbul, Turkey, Yi  Hang, Valerie  Wong, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Seong Jin Kim, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -W  Wu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, -C  Ho, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan, Ting-Yi  Lu, National Tsing Hua University, Section 2. Kuang-Fu Road, 101, 30013, Hsinchu, Taiwan",
          "published_date": "2023-11-16T01:35:15.834000+00:00",
          "summary": "This paper does not present a practical engineering analysis of building a Dyson sphere, but rather investigates the feasibility of constructing one around a black hole as a potential source of energy for a highly advanced civilization.  The authors explore six potential energy sources (cosmic microwave background, Hawking radiation, accretion disk, Bondi accretion, corona, and relativistic jets), concluding that an accretion disk offers the most substantial energy output, potentially sufficient for a Type II civilization. The study also discusses the detectability of such a structure through waste heat radiation.\n",
          "url": "https://arxiv.org/pdf/2106.15181.pdf"
        },
        {
          "title": "The Star Tug: An active stellar engine capable of accelerating a star to relativistic velocities",
          "author": "V. Badescu",
          "published_date": "2020-11-01T00:00:00+00:00",
          "summary": "The provided text focuses on stellar engines, specifically an \"active\" stellar engine design that uses a Dyson sphere to gather energy and propel a star.  While it discusses the role of a Dyson sphere in powering this type of stellar engine, it does not delve into the practical engineering analysis of *building* a Dyson sphere itself.  Therefore, the answer to the query is no, this paper does not offer a practical engineering analysis of constructing a Dyson sphere.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0094576520304239"
        },
        {
          "title": "Review and viability of a Dyson Swarm as a form of Dyson Sphere",
          "author": "Jack Smith",
          "published_date": "2023-04-13T18:31:10.373000+00:00",
          "summary": "No practical engineering analysis of constructing a complete Dyson sphere exists, as it's considered mechanically impossible due to instability and material requirements. However, a Dyson swarm, composed of numerous smaller independent energy collectors, is considered more viable.  While the paper doesn't detail a full engineering plan for a swarm, it discusses advantages such as reduced impact vulnerability, faster construction, and scalability, allowing energy collection to increase alongside the number of collectors.  The feasibility of such a project remains theoretical.\n",
          "url": "https://iopscience.iop.org/article/10.1088/1402-4896/ac9e78/meta"
        },
        {
          "title": "(PDF) DYSON SPHERE RESEARCH PAPER",
          "author": "",
          "published_date": "2019-06-04T00:00:00+00:00",
          "summary": "This research paper on Dyson spheres does not present a practical engineering analysis of constructing one.  It discusses the theoretical concept of a Dyson sphere as a solution to increasing energy demands of advancing civilizations (Type 1, 2, and 3), noting that while a Dyson sphere offers a large, clean energy source, it would be extremely difficult to realize.  The paper does not detail any engineering feasibility studies or plans.\n",
          "url": "https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER"
        },
        {
          "title": "Dyson sphere",
          "author": null,
          "published_date": "2023-02-06T22:31:11.519000+00:00",
          "summary": "No practical engineering analysis of constructing a Dyson sphere exists. While Freeman Dyson's 1960 paper popularized the concept as a means for advanced civilizations to harvest stellar energy, it focused on energy collection, not construction.  Later proposals in exploratory engineering and science fiction have explored various designs, but a comprehensive engineering analysis detailing the feasibility of building such a megastructure is absent.  Dyson himself considered a solid shell enclosing a star to be the least plausible variant.\n",
          "url": "https://en.wikipedia.org/wiki/Dyson_sphere"
        },
        {
          "title": "Would building a Dyson sphere be worth it? We ran the ...",
          "author": "Paul Sutter - Mar 27, 2023 11:40 am UTC",
          "published_date": "2023-03-27T11:40:34+00:00",
          "summary": "No, the article states that a practical engineering analysis of building a Dyson sphere is currently impossible.  The author, a theoretical cosmologist, acknowledges the lack of knowledge regarding the necessary technologies and the immense scale of the project.  While the article uses physics to explore the energy requirements and feasibility from a theoretical perspective, it emphasizes the limitations of current understanding and the numerous simplifying assumptions needed for any calculation.\n",
          "url": "https://arstechnica.com/science/2023/03/building-a-dyson-sphere-whats-the-payback-time-of-disassembling-a-planet/"
        },
        {
          "title": "Have Scientists Found 'Potential Evidence' of Dyson ...",
          "author": "EditorDavid hypothetical-megastructures dept",
          "published_date": "2024-06-15T00:00:00+00:00",
          "summary": "This article discusses recent studies identifying potential infrared signatures around seven stars that *could* be interpreted as Dyson spheres, massive energy-harvesting structures hypothesized by Freeman Dyson.  However, the article emphasizes that these infrared anomalies could also be explained by natural phenomena (e.g., colliding planets, background galaxies, young stars with debris disks).  Further research is needed, potentially using the James Webb Space Telescope, to rule out these alternative explanations.  The article does *not* include any practical engineering analysis of constructing a Dyson sphere.\n",
          "url": "https://science.slashdot.org/story/24/06/15/1855235/have-scientists-found-potential-evidence-of-dyson-spheres?utm_source=rss1.0mainlinkanon&utm_medium=feed"
        },
        {
          "title": "(PDF) Dyson spheres",
          "author": "Authors:",
          "published_date": "2020-01-01T00:00:00+00:00",
          "summary": "This paper reviews the concept of Dyson spheres, addressing their purpose, engineering challenges, and detectability.  It highlights the instability of monolithic Dyson sphere designs due to gravity and radiation pressure, and proposes a model for radiative coupling between a star and orbiting material. While the paper delves into theoretical aspects and optimal sizing under various purposes (low-entropy emission, dissipative work, computation), it doesn't present a practical engineering analysis of *starting* a Dyson sphere construction.  Therefore, the answer to your query is no, not in this paper.\n",
          "url": "https://www.researchgate.net/publication/342632672_Dyson_spheres"
        }
      ],
      "full_explanation": "None of the provided papers offer a practical engineering analysis of *starting* a Dyson sphere. While several papers discuss Dyson spheres and related concepts, they primarily focus on theoretical feasibility, alternative designs like Dyson swarms, or the implications of such structures. \n\nSpecifically:\n\n*   The paper \"Stellar engines: Design considerations for maximizing acceleration\" (https://www.sciencedirect.com/science/article/pii/S0094576519312457) analyzes stellar engine designs, not the construction of Dyson spheres themselves, it is instead focused on the mechanics of moving a star using massive structures.\n\n*   Both \"Review and viability of a Dyson Swarm as a form of Dyson Sphere\" papers (https://arxiv.org/pdf/2109.11443.pdf and https://iopscience.iop.org/article/10.1088/1402-4896/ac9e78/meta) discuss the practicality of Dyson *swarms* as opposed to a solid sphere, and don't offer engineering plans for construction, either for a sphere or a swarm. They focus on the relative advantages of a swarm approach compared to a complete Dyson sphere.\n\n*  The paper \"A Dyson Sphere around a black hole\" (https://arxiv.org/pdf/2106.15181.pdf) explores the feasibility of a Dyson sphere around a black hole and potential energy sources, not the practical engineering of construction.\n\n*   \"The Star Tug: An active stellar engine capable of accelerating a star to relativistic velocities\" (https://www.sciencedirect.com/science/article/abs/pii/S0094576520304239) discusses a stellar engine that uses a Dyson sphere to gather energy, but does not analyze how to *build* that Dyson sphere.\n\n*   The \"DYSON SPHERE RESEARCH PAPER\" (https://www.researchgate.net/publication/333603778_DYSON_SPHERE_RESEARCH_PAPER), the \u201cDyson sphere\u201d (https://en.wikipedia.org/wiki/Dyson_sphere), and the paper \u201c(PDF) Dyson spheres\u201d (https://www.researchgate.net/publication/342632672_Dyson_spheres) all discuss the theoretical concept of Dyson spheres and their challenges but do not offer a practical engineering analysis of starting their construction.\n\n*   The article \"Would building a Dyson sphere be worth it? We ran the ...\" (https://arstechnica.com/science/2023/03/building-a-dyson-sphere-whats-the-payback-time-of-disassembling-a-planet/) explicitly states that a practical engineering analysis of building a Dyson sphere is currently impossible.\n\n*   Finally, \"Have Scientists Found 'Potential Evidence' of Dyson ...\" (https://science.slashdot.org/story/24/06/15/1855235/have-scientists-found-potential-evidence-of-dyson-spheres?utm_source=rss1.0mainlinkanon&utm_medium=feed) discusses potential observations of Dyson sphere-like structures but does not present any construction analysis.\n\nIn conclusion, while the papers discuss Dyson spheres and related topics, none provide a practical engineering analysis of *starting* their construction, making the research question novel."
    },
    {
      "question": "Has anyone tried betaine as a treatment for Alzheimer's disease",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Reversal of cognitive decline: A novel therapeutic program",
          "author": "Bredesen, Dale E.",
          "published_date": "2014-09-27T00:00:00+00:00",
          "summary": "This research paper describes a novel therapeutic program for Alzheimer's disease (AD) and related cognitive decline that showed improvement in 9 out of 10 patients within 3-6 months.  The program uses multiple modalities for metabolic enhancement and is personalized.  The study does *not* mention betaine as a treatment.\n",
          "url": "https://www.aging-us.com/article/100690/text"
        },
        {
          "title": "Reversal of cognitive decline: A novel therapeutic program",
          "author": "Dale E Bredesen",
          "published_date": "2023-02-27T02:47:00.276000+00:00",
          "summary": "This research article describes a novel therapeutic program for Alzheimer's disease and related cognitive decline, showing promising results in a small trial (10 patients).  The program uses multiple modalities to achieve metabolic enhancement.  The study does *not* mention betaine as a treatment.  Nine out of ten patients showed improvement in cognition within 3-6 months, with improvements sustained for up to 2.5 years.  The authors suggest a larger trial is warranted.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221920/"
        },
        {
          "title": "A unique and promising combination of medications for the treatment of Alzheimer's disease.",
          "author": "James D Weinstein, Marshall University School of Medicine, 1600 Medical Center Dr, 25701, Huntington, WV, United States, jweinstein3438@gmail.com",
          "published_date": "2023-11-09T20:21:11.893000+00:00",
          "summary": "This research paper proposes a new combination therapy for Alzheimer's disease using Trental, Nicergoline, Nilotinib, Methylene blue, and vitamin B6 pyridoxamine.  The treatment targets four major pathological processes of the disease.  Betaine is not mentioned as part of this proposed treatment.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0306987717309787"
        },
        {
          "title": "Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer\u2019s Disease",
          "author": "Xiaoli Pan; Zhichun Chen; Guoqiang Fei; Shumei Pan; Weiqi Bao; Shuhua Ren; Yihui Guan; Chunjiu Zhong",
          "published_date": "2023-02-06T17:37:30.045000+00:00",
          "summary": "This study did not investigate betaine as a treatment for Alzheimer's disease.  Instead, it examined the effects of benfotiamine, a thiamine derivative, on cognitive ability in patients with mild to moderate Alzheimer's.  Over 18 months, patients receiving daily benfotiamine showed a significant improvement in Mini-Mental State Examination (MMSE) scores, indicating improved cognitive function.  This improvement was observed regardless of amyloid plaque levels in the brain.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567484/"
        },
        {
          "title": "Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer\u2019s Disease",
          "author": "",
          "published_date": "2019-01-01T00:00:00+00:00",
          "summary": "This study investigated hydromethylthionine, not betaine, as a treatment for mild to moderate Alzheimer's disease.  Two Phase III trials showed no overall benefit from doses ranging from 150-250mg/day compared to 8mg/day. However, further analysis revealed a concentration-dependent effect:  low plasma concentrations (0.3-0.8 ng/ml) correlated with improvements in cognitive decline and brain atrophy, while higher concentrations did not provide additional benefit.  A new placebo-controlled trial is underway to test a 16mg/day dose.  The study does not mention betaine as a treatment.\n",
          "url": "https://content.iospress.com/articles/journal-of-alzheimers-disease/jad190772"
        },
        {
          "title": "Betaine attenuates Alzheimer-like pathological changes ...",
          "author": "Gao-Shang Chai 1 ,",
          "published_date": "2014-11-01T00:00:00+00:00",
          "summary": "Yes, a 2013 study (Gao-Shang Chai et al.) in the Journal of Neurochemistry found that betaine supplementation in hyperhomocysteinemic rats ameliorated memory deficits and Alzheimer's-like pathological changes induced by homocysteine.  Betaine improved long-term potentiation, increased dendritic branching, and reduced tau hyperphosphorylation and amyloid-beta production.  The study suggests betaine as a promising candidate for treating Alzheimer's-related symptoms associated with high homocysteine levels.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23157378/"
        },
        {
          "title": "Making the case for prophylactic use of betaine to promote ...",
          "author": "Leena S. KnightThomas A. Knight*",
          "published_date": "2023-09-22T00:00:00+00:00",
          "summary": "This review article discusses the potential neuroprotective effects of betaine, noting its benefits in maintaining osmotic balance and acting as a methyl donor.  While the authors primarily focus on betaine's prophylactic use against concussion in young athletes, they mention its potential in neurological disorders, including Alzheimer's disease, citing its anti-convulsant properties and cognitive benefits observed in elderly populations.  However, the article does not present any data on clinical trials specifically testing betaine as a treatment for Alzheimer's.  Further research is needed to explore this application.\n",
          "url": "https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1214976/full"
        },
        {
          "title": "Betaine Mitigates Amyloid-\u03b2-Associated ...",
          "author": "",
          "published_date": "2023-07-25T00:00:00+00:00",
          "summary": "This study investigated betaine's effect on amyloid-\u03b2 (A\u03b2)-induced neuroinflammation in microglial cells, a key factor in Alzheimer's Disease (AD).  Researchers found that betaine effectively reduced inflammatory factors (IL-1\u03b2, IL-18, TNF-\u03b1) in an *in vitro* model by suppressing the NLRP3 inflammasome and NF-\u03baB signaling pathways.  The results suggest betaine holds promise as a potential therapeutic modulator for AD, warranting further investigation.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10473109/"
        },
        {
          "title": "Betaine reduces \u03b2-amyloid-induced paralysis through ...",
          "author": "Anne Leiteritz,Benjamin Dilberger,U. Wenzel,Elena Fitzenberger",
          "published_date": "2023-10-26T19:30:50.811000+00:00",
          "summary": "Studies using a *C. elegans* model of Alzheimer's disease show that betaine reduces \u03b2-amyloid-induced paralysis.  This effect is not through the expected remethylation pathway, but rather through the transsulfuration pathway mediated by cystathionine-\u03b2-synthase.  While promising in this model,  human trials are needed to determine if betaine is an effective Alzheimer's treatment.\n",
          "url": "https://genesandnutrition.biomedcentral.com/articles/10.1186/s12263-018-0611-9"
        },
        {
          "title": "Betaine alleviates cognitive impairment induced by ...",
          "author": "Z. Yang, D.D. Zhou, S.Y. Huang, A.P. Fang, H.B. Li, H.L. Zhu",
          "published_date": "2024-02-01T00:00:00+00:00",
          "summary": "This study investigated whether betaine could alleviate cognitive impairment caused by high homocysteine levels, a risk factor for dementia.  The research indicates that betaine may mitigate cognitive impairment by reducing microglial pyroptosis (a type of inflammatory cell death) through an m6A-YTHDF2-dependent mechanism. While the study doesn't directly address Alzheimer's disease, its findings suggest a potential therapeutic avenue for conditions involving cognitive impairment and elevated homocysteine.  More research is needed to determine betaine's efficacy as a treatment for Alzheimer's specifically.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2213231724000028"
        }
      ],
      "full_explanation": "Several research papers indicate that the use of betaine as a treatment for Alzheimer's disease, or its related symptoms, has been investigated. Specifically, the paper by Gao-Shang Chai et al. (2014-11-01) found that \"betaine supplementation in hyperhomocysteinemic rats ameliorated memory deficits and Alzheimer's-like pathological changes induced by homocysteine\" and further suggests \"betaine as a promising candidate for treating Alzheimer's-related symptoms associated with high homocysteine levels\" (URL: https://pubmed.ncbi.nlm.nih.gov/23157378/).  Additionally, another paper titled \"Betaine Mitigates Amyloid-\u03b2-Associated ...\" (Published: 2023-07-25) found that betaine \"effectively reduced inflammatory factors... in an *in vitro* model\", suggesting betaine \"holds promise as a potential therapeutic modulator for AD\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10473109/). Further research into the use of betaine as a treatment for Alzheimer's is detailed in the paper \"Betaine reduces \u03b2-amyloid-induced paralysis through ...\" (Published: 2023-10-26) which stated that betaine reduces amyloid-beta-induced paralysis in a *C. elegans* model of Alzheimer's disease (URL: https://genesandnutrition.biomedcentral.com/articles/10.1186/s12263-018-0611-9). Finally, the paper \"Betaine alleviates cognitive impairment induced by ...\" (Published: 2024-02-01) indicates that betaine may mitigate cognitive impairment caused by high homocysteine levels, a risk factor for dementia, suggesting a potential therapeutic avenue (URL: https://www.sciencedirect.com/science/article/pii/S2213231724000028).\nWhile the review article \"Making the case for prophylactic use of betaine to promote ...\" (Published: 2023-09-22) mentions betaine's potential for neurological disorders including Alzheimer's, it does not present data from clinical trials that have directly tested betaine as a treatment (URL: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1214976/full)."
    },
    {
      "question": "Has anyone investigated the mechanism of increased cardiac output in patients treated with both milrinone and a beta blocker?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Systemic Hemodynamic and Myocardial Metabolic Effects of Isoproterenol and Angiotensin After Open\u2010Heart Surgery",
          "author": "Hiltrud S Mueller, New York University School of Medicine, New York, New York, John J Gregory, New York University School of Medicine, New York, New York, Stanley  Giannelli, New York University School of Medicine, New York, New York, Stephen M Ayres, New York University School of Medicine, New York, New York",
          "published_date": "2023-11-09T20:08:37.636000+00:00",
          "summary": "This study does not investigate the combined effects of milrinone and beta-blockers on cardiac output.  It examines the effects of isoproterenol (a beta-agonist) and angiotensin on cardiac index (a measure of cardiac output) in patients after open-heart surgery.  Isoproterenol increased cardiac index, while angiotensin decreased it.  The study does not include milrinone or beta-blockers.\n",
          "url": "https://www.ahajournals.org/doi/10.1161/01.CIR.42.3.491"
        },
        {
          "title": "Isoproterenol for the treatment of circulatory shock.",
          "author": "",
          "published_date": "2023-11-09T20:25:04.026000+00:00",
          "summary": "This article focuses on isoproterenol's use in circulatory shock, not the combined use of milrinone and beta-blockers.  Therefore, it does not contain information relevant to your search query regarding the mechanism of increased cardiac output in patients receiving this specific drug combination.\n",
          "url": "https://annals.org/article.aspx?doi=10.7326/0003-4819-70-3-638"
        },
        {
          "title": "Intravenous inotropic agents in heart failure.",
          "author": "",
          "published_date": "2023-11-09T20:14:24.768000+00:00",
          "summary": "This article discusses the use of inotropic agents in heart failure, noting their limited value and association with increased mortality despite increasing cardiac contractility and output.  The provided text does *not* address the specific mechanism of increased cardiac output when using a combination of milrinone and a beta-blocker.  Therefore, no information relevant to your query is present in this article.\n",
          "url": "https://www.magonlinelibrary.com/doi/10.12968/hmed.2008.69.1.28037"
        },
        {
          "title": "Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholomines and mechanical cardiac assist.",
          "author": "Hiltrud  Mueller, Stephen M Ayres, Staniey  Giannelli, E Foster Conklin, James T Mazzara, William J Grace",
          "published_date": "2023-11-09T20:06:08.681000+00:00",
          "summary": "This study did not investigate the combined effects of milrinone and beta-blockers on cardiac output.  The research focused on the effects of isoproterenol (a beta-agonist), l-norepinephrine, and intra-aortic counterpulsation on hemodynamics and myocardial metabolism in patients with cardiogenic shock due to acute myocardial infarction.  While isoproterenol increased cardiac index, it worsened myocardial oxygenation. L-norepinephrine improved myocardial perfusion and oxygenation but didn't increase cardiac output. Intra-aortic counterpulsation improved both myocardial metabolism and systemic perfusion.  The study offers no insight into the interaction of milrinone and beta-blockers.\n",
          "url": "https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.2164-0947.1972.tb02686.x"
        },
        {
          "title": "Effect of Isoproterenol, l\u2010Norepinephrine, and Intraaortic Counterpulsation on Hemodynamics and Myocardial Metabolism in Shock following Acute Myocardial Infarction",
          "author": "Hiltrud  Mueller, New York University, New York, New York, Stephen M Ayres, New York University, New York, New York, Stanley  Giannelli, New York University, New York, New York, E  Foster Conklin, New York University, New York, New York, James T Mazzara, New York University, New York, New York, William J Grace, New York University, New York, New York",
          "published_date": "2023-11-09T20:08:35.138000+00:00",
          "summary": "This study did not investigate the combined effects of milrinone and a beta-blocker on cardiac output.  It examined the effects of isoproterenol (a beta-agonist), l-norepinephrine, and intraaortic counterpulsation on hemodynamics in cardiogenic shock following acute myocardial infarction. Isoproterenol increased cardiac index but worsened myocardial oxygenation. L-norepinephrine improved myocardial perfusion but didn't affect cardiac output. Intraaortic counterpulsation improved both myocardial metabolism and systemic perfusion.  The study does not provide information relevant to the user's query regarding the combined use of milrinone and a beta-blocker.\n",
          "url": "https://www.ahajournals.org/doi/10.1161/01.CIR.45.2.335"
        },
        {
          "title": "Combined milrinone and enteral metoprolol therapy in patients with ...",
          "author": "",
          "published_date": "2008-08-04T00:00:00+00:00",
          "summary": "This study investigated the combined use of milrinone and enteral metoprolol in patients with septic shock and cardiac depression.  While the treatment resulted in a decreased heart rate and norepinephrine levels,  the cardiac index and cardiac power index remained unchanged, although stroke volume index increased.  The study does not, however, investigate the mechanism behind the increase in stroke volume index.  The authors suggest further research is needed to understand the effects of beta-blockers on septic cardiomyopathy.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2575588/"
        },
        {
          "title": "Intravenous Milrinone in Treatment of Advanced Congestive Heart ...",
          "author": "",
          "published_date": "2003-01-01T00:00:00+00:00",
          "summary": "This study investigated the combination of intravenous milrinone and oral beta-blockers in patients with severe congestive heart failure. While the study shows improved functional status and reduced hospital days with this combination therapy,  it doesn't delve into the mechanism of increased cardiac output resulting from the drug interaction.  The focus is on the overall clinical outcomes of the combined treatment, not the specific physiological mechanisms.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC161895/"
        },
        {
          "title": "Milrinone - an overview | ScienceDirect Topics",
          "author": "Info icon",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "The provided text focuses on milrinone's mechanism of action as a phosphodiesterase (PDE) inhibitor, increasing cAMP and thus intracellular calcium, leading to improved myocardial contractility and vasodilation.  It notes that while milrinone and dobutamine have similar downstream effects, milrinone may be preferred in patients on beta-blockers because it doesn't rely on beta-adrenergic receptors for contractility.  The text does *not* address the combined effects of milrinone and beta-blockers on cardiac output, so there's no information to answer your question regarding specific investigations into this combination.\n",
          "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/milrinone"
        },
        {
          "title": "A pragmatic approach to the use of inotropes ... - ScienceDirect.com",
          "author": "D. Farmakis, J. Parissis, A. Karavidas, et al.",
          "published_date": "2019-12-15T00:00:00+00:00",
          "summary": "This article focuses on the use of inotropes in acute and advanced heart failure, not on the combined use of milrinone and beta-blockers.  Therefore, it does not address the mechanism of increased cardiac output in patients receiving this specific combination therapy.  The paper discusses inotropes' mechanism of action (increasing cardiac contractility to raise cardiac output) and their appropriate use in low-output heart failure, but it doesn't analyze specific drug interactions like milrinone and beta-blockers.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0167527319325021"
        },
        {
          "title": "\u03b2-Adrenergic Receptor Blockade in Chronic Heart Failure | Circulation",
          "author": "Michael R Bristow",
          "published_date": "2023-12-04T04:02:18.951000+00:00",
          "summary": "This article focuses on the role of beta-adrenergic blockade in chronic heart failure, not the combined use of milrinone and beta-blockers to increase cardiac output.  Therefore, it does not contain information relevant to your query.\n",
          "url": "https://www.ahajournals.org/doi/10.1161/01.CIR.101.5.558"
        }
      ],
      "full_explanation": "While some studies have investigated the combined use of milrinone and beta-blockers, none of the provided papers specifically address the *mechanism* of increased cardiac output resulting from this combination. \n\nSeveral papers discuss the effects of these drugs separately or in combination, but do not delve into the underlying reasons for any observed changes in cardiac output. For example:\n\n*   The paper \"Combined milrinone and enteral metoprolol therapy in patients with...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2575588/) examines the combined use of milrinone and metoprolol in septic shock, and while it does note an increase in stroke volume index with this combination, it specifically states that the *mechanism* for this finding is not investigated and requires further research.\n*  The paper \"Intravenous Milrinone in Treatment of Advanced Congestive Heart ...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC161895/) reports improved outcomes with combined milrinone and beta-blocker therapy, but the study's focus is clinical outcomes rather than the *mechanism* of cardiac output increase. \n*   The paper \"Milrinone - an overview | ScienceDirect Topics\" (URL: https://www.sciencedirect.com/topics/medicine-and-dentistry/milrinone) describes milrinone's mechanism of action, including why it might be useful in patients on beta-blockers, but does *not* discuss the combined mechanism and increased cardiac output. \n\nTherefore, based on the information provided, no study has specifically investigated the mechanism of increased cardiac output when using milrinone and a beta-blocker together."
    },
    {
      "question": "Has anyone found a small molecule to increase ovarian reserve?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation.",
          "author": "Venkataraman  Sriraman, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, venkat.sriraman@emdserono.com, Deborah  Denis, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Daniel  De Matos, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Henry  Yu, EMD Serono Research and Development Institute, 01821, Billerica, MA, United States, Stephen  Palmer, TocopheRx, Suite 1077, 15 New England Executive Park, 01803, Burlington, MA, United States, Selva  Nataraja, TocopheRx, Suite 1077, 15 New England Executive Park, 01803, Burlington, MA, United States",
          "published_date": "2023-11-09T20:02:09.316000+00:00",
          "summary": "A study investigated Compound 5, a thiazolidinone derivative, as a potential follicle-stimulating hormone receptor (FSHR) modulator to improve ovarian function.  While Compound 5 successfully stimulated follicular development and ovulation in vitro and in vivo in animal models by increasing estradiol production and activating relevant signaling pathways, its poor oral bioavailability and genotoxicity preclude its clinical development as an oral medication to increase ovarian reserve.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0006295214001385"
        },
        {
          "title": "Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging",
          "author": "Zhang; Yu; Bai; Jie; Cui; Zhaokang; Li; Gao; Qian; Miao; Yilong; Xiong; Bo",
          "published_date": "2023-10-16T00:00:00+00:00",
          "summary": "This study found that the polyamine metabolite spermidine improves oocyte quality in aged females by enhancing mitophagy.  While it doesn't directly address increasing ovarian reserve, the improved oocyte quality suggests a potential pathway for future research into small molecules that could enhance fertility in women with diminished ovarian reserve.  The study does not itself identify a small molecule for increasing ovarian reserve.\n",
          "url": "https://www.nature.com/articles/s43587-023-00498-8"
        },
        {
          "title": "mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy",
          "author": "Robert J. Schneider",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "This study found that inhibiting the mTOR pathway, using the clinically available drug everolimus (mTORC1 inhibitor) or the experimental drug INK128 (mTORC1/2 inhibitor), preserved ovarian reserve and fertility in mice undergoing chemotherapy.  While this doesn't directly increase ovarian reserve, it prevents the chemotherapy-induced depletion, effectively maintaining fertility.  The findings suggest a potential pharmacologic approach to fertility preservation during chemotherapy, but not an increase in baseline ovarian reserve.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1617233114"
        },
        {
          "title": "Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice - PubMed",
          "author": "Username",
          "published_date": "2023-02-27T02:00:16.084000+00:00",
          "summary": "This study investigated whether rapamycin, an mTOR inhibitor, could maintain ovarian follicle reserve.  Three weeks of rapamycin treatment in mice suppressed primordial follicle development, maintaining the follicle pool size without harming oocyte developmental potential.  Similar results were seen in human ovarian cortical fragments grafted into mice.  While rapamycin doesn't *increase* ovarian reserve, it shows promise in *preserving* it, potentially benefiting middle-aged women and cancer patients undergoing germ cell-damaging therapies.  Therefore, it's a small molecule that *maintains*, but doesn't *increase*, ovarian reserve.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31887337/"
        },
        {
          "title": "Unraveling female reproductive senescence to enhance healthy longevity",
          "author": "Dong; Lu; Teh; Daniel Boon Loong; Kennedy; Brian Keith; Huang; Zhongwei",
          "published_date": "2023-01-02T00:00:00+00:00",
          "summary": "This research article discusses the decline in female fertility and the potential for intervention, but it does not report the discovery of a small molecule to increase ovarian reserve.  The article focuses on the biological mechanisms behind ovarian aging and menopause, highlighting the need for further research to develop strategies to mitigate these processes.  While it mentions manipulating aging pathways in animal models as a potential approach to prolonging reproductive lifespan, it does not detail specific successful interventions with small molecules.\n",
          "url": "https://www.nature.com/articles/s41422-022-00718-7%7C"
        },
        {
          "title": "Can ovarian aging be delayed by pharmacological strategies? - PMC",
          "author": "",
          "published_date": "2019-01-23T00:00:00+00:00",
          "summary": "This article reviews pharmacological strategies to delay ovarian aging, a process characterized by declining ovarian follicle quantity and quality.  While it discusses potential approaches like calorie restriction mimetics and antioxidants, it does not report the discovery of a specific small molecule to increase ovarian reserve.  The focus is on understanding the mechanisms of ovarian aging to inform future prevention and treatment strategies, rather than presenting established treatments.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/"
        },
        {
          "title": "Recent progress in the treatment of women with diminished ovarian ...",
          "author": "J. Cohen, N. Chabbert-Buffet, E. Darai",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "Current research on diminished ovarian reserve (DOR) focuses heavily on improving IVF outcomes, but there's no mention of a discovered small molecule specifically to increase ovarian reserve in this article.  The review discusses stem cell therapy and other treatment strategies showing increased pregnancy outcomes in ART, but doesn't highlight small molecule interventions.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S266716462100052X"
        },
        {
          "title": "Examining Use of Small-molecule Inhibitors in Preserving Fertility",
          "author": "medweb",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "Northwestern Medicine researchers found that a clinically available small-molecule mTOR inhibitor, when used alongside chemotherapy in mice, preserved ovarian function and fertility.  While it didn't increase ovarian reserve to pre-chemotherapy levels, it significantly prevented the chemotherapy-induced loss of immature follicles, resulting in normal birth rates.  Further research is needed to determine optimal dosage and effects on tumor growth.  This suggests a potential avenue for fertility preservation during cancer treatment, but doesn't directly demonstrate an increase in ovarian reserve independent of chemotherapy.\n",
          "url": "https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/"
        },
        {
          "title": "Poor ovarian reserve - PMC",
          "author": "",
          "published_date": "2015-11-01T00:00:00+00:00",
          "summary": "This research article on poor ovarian reserve (POR) focuses on diagnosis and management,  including IVF treatment.  It does not discuss the use of small molecules to increase ovarian reserve.  The article mentions various tests used to assess ovarian reserve (like anti-Mullerian hormone and antral follicle count) but doesn't explore pharmaceutical interventions beyond IVF.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4915288/"
        },
        {
          "title": "NADase CD38 is a key determinant of ovarian aging - Nature",
          "author": "Yang; Qingling; Chen; Wenhui; Cong; Luping; Wang; Mengchen; Li; Hui; Huan; Luo; Xiaoyan; Zhu; Jing; Zeng; Xinxin; Zhenye; Xu; Yining; Lei; Min; Zhao; Yanqing; Wei; Sun; Yingpu",
          "published_date": "2023-12-21T00:00:00+00:00",
          "summary": "This research article focuses on the role of NADase CD38 in ovarian aging, but it does not identify any small molecules that increase ovarian reserve.  The study explores the mechanisms of ovarian aging, linking it to factors like oxidative stress and mitochondrial dysfunction, but doesn't present findings on small molecule interventions to improve reserve.\n",
          "url": "https://www.nature.com/articles/s43587-023-00532-9"
        }
      ],
      "full_explanation": "While several studies explore ways to *preserve* ovarian reserve or improve oocyte quality, none of the provided papers demonstrate the discovery of a small molecule that directly *increases* ovarian reserve.\n\nSeveral papers focus on preserving ovarian function during chemotherapy using mTOR inhibitors. For instance, the paper \"mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy\" (https://www.pnas.org/doi/full/10.1073/pnas.1617233114) demonstrates that inhibiting the mTOR pathway with everolimus or INK128 can protect the ovarian reserve from chemotherapy-induced damage. Similarly, \"Examining Use of Small-molecule Inhibitors in Preserving Fertility\" (https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/) also notes the use of an mTOR inhibitor to preserve fertility during chemotherapy, and the paper \"Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice - PubMed\" (https://pubmed.ncbi.nlm.nih.gov/31887337/) shows that rapamycin can maintain follicle pool size, but does not increase it. However, these interventions focus on *preventing loss* rather than *increasing* the baseline ovarian reserve.\n\nThe study \"Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation\" (https://www.sciencedirect.com/science/article/pii/S0006295214001385) describes a compound that stimulates follicular development and ovulation, but it has poor oral bioavailability and genotoxicity. Furthermore, the study does not state that it increases the number of follicles beyond what was already present, meaning it doesn't address the increase of ovarian reserve.\n\nAnother study \"Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging\" (https://www.nature.com/articles/s43587-023-00498-8) shows that spermidine improves oocyte quality; however, it does not report an increase in ovarian reserve itself.\n\nWhile some of the review articles like \"Can ovarian aging be delayed by pharmacological strategies? - PMC\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/) and \"Recent progress in the treatment of women with diminished ovarian...\" (https://www.sciencedirect.com/science/article/pii/S266716462100052X) discuss possible strategies for preserving ovarian function and treating diminished ovarian reserve, none of them specifically identify a small molecule that has been shown to increase ovarian reserve. Other papers such as \"Poor ovarian reserve - PMC\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC4915288/) and \"NADase CD38 is a key determinant of ovarian aging - Nature\" (https://www.nature.com/articles/s43587-023-00532-9) and \"Unraveling female reproductive senescence to enhance healthy longevity\" (https://www.nature.com/articles/s41422-022-00718-7) delve into the mechanisms of ovarian aging, but again, do not present any findings for a small molecule to increase ovarian reserve.\n\nIn summary, while research has focused on ovarian preservation and improving oocyte quality, no studies in this set of papers have demonstrated a small molecule to directly *increase* ovarian reserve."
    },
    {
      "question": "Has anyone shown that quantum computing can be used for trainable ML models?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Arbitrary Polynomial Separations in Trainable Quantum Machine Learning",
          "author": "[Submitted on 13 Feb 2024 (v1), last revised 23 Dec 2024 (this version, v3)]",
          "published_date": "2024-02-13T00:00:00+00:00",
          "summary": "Yes. This arXiv paper demonstrates a hierarchy of efficiently trainable quantum neural networks (QNNs) that provably outperform classical neural networks (including Transformers) on a classical sequence modeling task.  The improvement is polynomial in memory, with an arbitrarily high degree of separation.  The authors attribute this advantage to contextuality within the QNNs.\n",
          "url": "https://arxiv.org/abs/2402.08606"
        },
        {
          "title": "Training Classical Neural Networks by Quantum Machine Learning",
          "author": "[Submitted on 26 Feb 2024]",
          "published_date": "2024-02-26T00:00:00+00:00",
          "summary": "Yes.  This arXiv preprint proposes a method to train classical neural networks using a quantum neural network (QNN).  The approach maps a classical NN with M parameters to a QNN with significantly fewer (polylog(M)) parameters, which are then updated to train the classical NN.  The trained QNN's results are directly applicable to classical computers, unlike many other quantum machine learning methods.  The authors demonstrate effectiveness on MNIST and Iris datasets.\n",
          "url": "https://arxiv.org/abs/2402.16465"
        },
        {
          "title": "A quantum algorithm for training wide and deep classical neural networks",
          "author": "Alexander  Zlokapa, Massachusetts Institute of Technology, 02139, Cambridge, Massachusetts, azlokapa@mit.edu, Hartmut  Neven, Google Quantum AI, 90291, Venice, California, Seth  Lloyd, Massachusetts Institute of Technology, 02139, Cambridge, Massachusetts",
          "published_date": "2023-11-16T01:35:17.737000+00:00",
          "summary": "Yes, this paper proposes a quantum algorithm for training wide and deep classical neural networks.  The authors demonstrate that under certain conditions (efficient state preparation and readout), their algorithm can achieve an exponential speedup over classical gradient descent for training a fully-connected neural network, matching the accuracy on the MNIST dataset.  They also provide empirical evidence suggesting logarithmic training time for convolutional neural networks with pooling.  The key is leveraging the connection between trainability via gradient descent and efficient quantum linear system solving.\n",
          "url": "https://arxiv.org/pdf/2107.09200.pdf"
        },
        {
          "title": "Towards provably efficient quantum algorithms for large-scale machine-learning models",
          "author": "Liu; Junyu; Minzhao; Jin-Peng; Ye; Ziyu; Wang; Yunfei; Alexeev; Yuri; Eisert; Jens; Jiang; Liang",
          "published_date": "2024-01-10T00:00:00+00:00",
          "summary": "Yes. This Nature article demonstrates that fault-tolerant quantum computing could offer provably efficient solutions for training large, sparse, and dissipative machine learning models using stochastic gradient descent.  The authors provide theoretical analysis and benchmark results (models with 7 million to 103 million parameters) showing potential quantum speedups, particularly in the early stages of training after model pruning.\n",
          "url": "https://www.nature.com/articles/s41467-023-43957-x"
        },
        {
          "title": "Subtleties in the trainability of quantum machine learning models",
          "author": "Thanasilp; Supanut; Wang; Samson; Nghiem; Nhat A; Coles; Patrick J; Cerezo; M",
          "published_date": "2021-10-27T00:00:00+00:00",
          "summary": "This arXiv paper investigates the trainability of Quantum Machine Learning (QML) models.  While QML aims to speed up machine learning using quantum computers,  the authors show that challenges exist in training these models, relating them to similar issues found in Variational Quantum Algorithms (VQAs).  The paper demonstrates that factors hindering VQA trainability also negatively impact QML, potentially causing \"barren plateaus\" where gradients vanish, making optimization difficult.  Furthermore, it introduces a novel challenge specific to QML: \"dataset-induced barren plateaus,\" arising from the use of training data and the method of encoding classical data into quantum states.  Therefore, while the paper explores trainable QML models, it highlights significant obstacles to overcome.\n",
          "url": "https://arxiv.org/abs/2110.14753"
        },
        {
          "title": "Systematic literature review: Quantum machine learning ...",
          "author": "",
          "published_date": "2024-02-01T00:00:00+00:00",
          "summary": "Yes, this systematic literature review (2017-2023) of 94 articles shows that quantum computing is being used to develop trainable machine learning models.  The review identifies quantum implementations of classical algorithms (like support vector machines and k-nearest neighbor) and classical deep learning algorithms (like quantum neural networks).  Image classification is a prominent application area. While promising, the review notes that current quantum hardware limitations restrict the full potential of quantum machine learning.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1574013724000030"
        },
        {
          "title": "Shadows of quantum machine learning",
          "author": "Dunjko, Vedran",
          "published_date": "2024-07-06T00:00:00+00:00",
          "summary": "Yes, the paper shows that standard quantum machine learning models for supervised learning can be expressed as linear models.  These models use parametrized quantum circuits to encode classical data and learn through the inner product of a data-encoding quantum state and a parameterized observable.  Furthermore, the paper demonstrates that this linear model framework encompasses quantum kernel models and more general data re-uploading models.\n",
          "url": "https://www.nature.com/articles/s41467-024-49877-8"
        },
        {
          "title": "Can Quantum Computing accelerate Generative AI?",
          "author": "Alexander Del Toro Barba (PhD)",
          "published_date": "2024-08-10T07:41:51+00:00",
          "summary": "The article discusses the intersection of quantum computing and machine learning (QML), exploring whether quantum computers can accelerate classical machine learning, including generative AI.  While it details various quantum algorithms (Quantum Annealers, Variational Quantum Eigensolvers, Quantum Support Vector Machines, etc.) used in QML, it doesn't present evidence of  quantum computing being used to train *trainable* ML models in the sense of directly accelerating the training process of classical models like neural networks.  The article focuses more on how quantum algorithms can enhance specific aspects of machine learning tasks rather than the training itself.\n",
          "url": "https://medium.com/@deltorobarba/can-quantum-computing-accelerate-generative-ai-b1df36398ac5"
        },
        {
          "title": "Quantum Leap: Beyond the Limits of Machine Learning",
          "author": "Simona Maggio",
          "published_date": "2024-02-02T00:00:00+00:00",
          "summary": "The article discusses Quantum Machine Learning (QML), exploring how quantum computing may accelerate machine learning, particularly for large language models (LLMs).  While it details the differences between quantum bits (qubits) and classical bits, and explains how quantum computers operate, it does *not* definitively state whether trainable ML models have been successfully implemented using quantum computing.  The text focuses more on the potential of QML and its theoretical advantages over classical methods for certain problems, rather than presenting concrete examples of existing, trainable quantum ML models.\n",
          "url": "https://blog.dataiku.com/quantum-leap-beyond-the-limits-of-machine-learning"
        },
        {
          "title": "Generalization in quantum machine learning from few ...",
          "author": "Caro; Matthias C; Huang; Hsin-Yuan; Cerezo; M; Sharma; Kunal; Sornborger; Andrew; Cincio; Lukasz; Coles; Patrick J",
          "published_date": "2023-02-06T09:42:08.450000+00:00",
          "summary": "Yes, the field of quantum machine learning (QML) explores using parameterized quantum circuits to analyze classical or quantum datasets.  While the trainability of QML models is an active area of research, studies indicate that QML models *can* offer advantages over classical models in certain circumstances, and may provide exponential advantage in sample complexity for quantum data analysis.  However, the paper notes that the generalization capabilities and necessary training data size for QML remain open questions.\n",
          "url": "https://www.nature.com/articles/s41467-022-32550-3"
        }
      ],
      "full_explanation": "The provided papers clearly demonstrate that the research question, \"Has anyone shown that quantum computing can be used for trainable ML models?\", has been explored and answered in the affirmative. Several papers detail different ways quantum computing can be leveraged for training machine learning models:\n\n*   **\"Arbitrary Polynomial Separations in Trainable Quantum Machine Learning\"** (https://arxiv.org/abs/2402.08606) directly addresses trainable quantum neural networks (QNNs), demonstrating their ability to outperform classical neural networks on sequence modeling tasks, attributing this to contextuality within the QNNs.\n*  **\"Training Classical Neural Networks by Quantum Machine Learning\"** (https://arxiv.org/abs/2402.16465) describes a method for training *classical* neural networks using a QNN, by mapping the classical network to a smaller QNN, with the results from training the QNN being applicable back to the classical setting.\n*   **\"A quantum algorithm for training wide and deep classical neural networks\"** (https://arxiv.org/pdf/2107.09200.pdf) presents a quantum algorithm that achieves exponential speedup in training fully connected neural networks compared to classical gradient descent, while still maintaining equivalent accuracy. It also suggests logarithmic training time for CNNs, all achieved with quantum computation.\n* **\"Towards provably efficient quantum algorithms for large-scale machine-learning models\"** (https://www.nature.com/articles/s41467-023-43957-x) shows that quantum computing can offer efficient solutions for training large, sparse, and dissipative machine learning models, providing theoretical analysis and benchmark results.\n*  **\"Systematic literature review: Quantum machine learning ...\"** (https://www.sciencedirect.com/science/article/pii/S1574013724000030) is a literature review showing that quantum computing is being used to develop trainable machine learning models including quantum implementations of classical algorithms (like support vector machines and k-nearest neighbor) and classical deep learning algorithms (like quantum neural networks).\n* **\"Shadows of quantum machine learning\"** (https://www.nature.com/articles/s41467-024-49877-8) demonstrates that quantum machine learning models for supervised learning can be viewed as linear models, learned via parametrized circuits that encode classical data.\n* **\"Generalization in quantum machine learning from few ...\"** (https://www.nature.com/articles/s41467-022-32550-3) shows that quantum machine learning (QML) models *can* offer advantages over classical models in certain circumstances and may provide exponential advantage in sample complexity for quantum data analysis.\n\nWhile \"Subtleties in the trainability of quantum machine learning models\" (https://arxiv.org/abs/2110.14753) discusses the *challenges* of training QML models (like barren plateaus), it also acknowledges the existence of, and research into, trainable QML models.\nThese papers collectively establish that research has been done showing the applicability of quantum computing to train ML models."
    },
    {
      "question": "Has anyone written a paper containing a differential equation for the rate at which ice might spread over a surface area ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Ice wicking",
          "author": "Katherine E Witt, Virginia Tech, 24061, Blacksburg, Virginia, USA, S Farzad Ahmadi, Virginia Tech, 24061, Blacksburg, Virginia, USA, Jonathan B Boreyko, Virginia Tech, 24061, Blacksburg, Virginia, USA, boreyko@vt.edu",
          "published_date": "2023-11-09T20:33:27.253000+00:00",
          "summary": "This paper studies liquid wicking across ice surfaces, finding that the rate of oil spreading across frost on a vertical surface follows a power law with a 1/3 time exponent, differing from Washburn's law (1/2 exponent) for porous media.  This deviation is attributed to the dendritic frost structure.  The study does *not* present a differential equation for ice spreading, but rather focuses on liquid spreading across ice.\n",
          "url": "https://journals.aps.org/prfluids/abstract/10.1103/PhysRevFluids.4.024002"
        },
        {
          "title": "How ice grows from premelting films and water droplets",
          "author": "D. Sibley,Pablo Llombart,E. Noya,A. Archer,L. G. Macdowell",
          "published_date": "2023-10-26T19:30:34.045000+00:00",
          "summary": "Yes, this paper develops a 1D mesoscopic model for ice growth, incorporating two non-conservative phase-field equations to govern the system's dynamics.  These equations, derived from an effective grand potential, model ice growth in supersaturated vapor (-5\u00b0C to 0\u00b0C).  While not explicitly stated as a single differential equation for the rate of ice spread across a surface area, the model simulates ice growth and identifies different kinetic regimes (e.g., alpha and beta premelted layer thicknesses) through numerical solutions of these phase-field equations.  The paper provides a kinetic phase diagram illustrating these regimes.\n",
          "url": "https://www.nature.com/articles/s41467-020-20318-6.pdf"
        },
        {
          "title": "The unsteady plane flow of ice-sheets: A parabolic problem with two moving boundaries",
          "author": "R C A Hindmarsh, University of Edinburgh, EH9 3JW, Edinburgh, UK, L W Morland, University of East Anglia, Norwich, UK, G S Boulton, University of Edinburgh, EH9 3JW, Edinburgh, UK, K  Hutter",
          "published_date": "2023-11-09T20:07:25.211000+00:00",
          "summary": "This paper presents finite difference algorithms to solve a one-dimensional nonlinear parabolic equation modeling unsteady plane flow of ice sheets.  The equation describes the ice sheet's response to climate change and can be used to infer past climate changes.  While the paper doesn't explicitly state a differential equation for the *rate* of ice spread over a *surface area*, it does model the ice sheet's flow using a parabolic equation with moving boundaries, which implicitly describes the ice's spreading over time.  Two solution algorithms are detailed.\n",
          "url": "https://www.tandfonline.com/doi/abs/10.1080/03091928708208812"
        },
        {
          "title": "A Simple Law for Ice-Shelf Calving",
          "author": "Richard B Alley, Huw J Horgan, Ian  Joughin, Kurt M Cuffey, Todd K Dupont, Byron R Parizek, Sridhar  Anandakrishnan, Jeremy  Bassis",
          "published_date": "2023-11-09T20:10:37.833000+00:00",
          "summary": "This Science paper proposes a relationship between ice-shelf calving rate and the along-flow spreading rate, suggesting that increased spreading (due to frictional buttressing loss) leads to faster calving and ice-sheet retreat.  However, the paper does *not* present a differential equation for the rate of ice spreading itself.\n",
          "url": "https://www.science.org/doi/10.1126/science.1162543"
        },
        {
          "title": "How ice grows: role of surface liquid films and water droplets",
          "author": "D. Sibley,Pablo Llombart,E. Noya,A. Archer,L. G. Macdowell",
          "published_date": "2023-10-26T19:30:37.801000+00:00",
          "summary": "This paper presents a mesoscopic model of liquid-film mediated ice growth, but it does not include a differential equation explicitly describing the rate of ice spread over a surface area.  The model identifies different growth regimes, including terrace spreading at low saturation and droplet condensation at higher saturations, but the description is qualitative rather than a quantitative differential equation.\n",
          "url": "https://arxiv.org/pdf/2003.04252.pdf"
        },
        {
          "title": "Universal differential equations for glacier ice flow modelling",
          "author": "",
          "published_date": "2023-11-16T00:00:00+00:00",
          "summary": "This paper does not directly address the rate of ice spread over a surface area using a differential equation.  The paper reviews existing glacier ice flow modeling techniques, citing several related papers, but it doesn't present a new differential equation for ice expansion itself.  The focus is on using universal differential equations for improved modeling, not a specific equation for ice spread rate.\n",
          "url": "https://gmd.copernicus.org/articles/16/6671/2023/"
        },
        {
          "title": "High speed computing of ice thickness equation for ...",
          "author": "",
          "published_date": "2016-08-04T00:00:00+00:00",
          "summary": "This research paper uses a finite difference method on a GPU to improve the speed of calculating ice thickness in a 2D ice flow thermodynamics model.  While it doesn't directly provide a differential equation for the rate of ice spread over a surface area, the paper cites related work applying parallelization techniques to differential equations for predicting ice thickness.  The paper focuses on computational efficiency rather than the specific formulation of the ice spread equation.\n",
          "url": "https://www.researchgate.net/publication/308626724_High_speed_computing_of_ice_thickness_equation_for_ice_sheet_model"
        },
        {
          "title": "Climate Modeling in Differential Equations",
          "author": "",
          "published_date": "2016-02-20T00:00:00+00:00",
          "summary": "This UMAP module on climate modeling uses differential equations to model global average temperature and includes a project focusing on a surface temperature\u2013ice sheet coupled model.  The project specifically explores a latitude-dependent model incorporating glaciers, insolation distribution, meridional heat transport, and Legendre polynomials to simulate ice sheet spread.  While it doesn't present a single, isolated differential equation for ice spread, the project's model incorporates the factors influencing ice sheet expansion and contraction, making it relevant to your query.\n",
          "url": "https://www2.oberlin.edu/math/faculty/walsh/UMAPclimate.pdf"
        },
        {
          "title": "Immersion mode heterogeneous ice nucleation by an illite rich ...",
          "author": "",
          "published_date": "2011-08-12T00:00:00+00:00",
          "summary": "This discussion paper investigates ice nucleation in water droplets containing illite-rich dust, a common component of atmospheric mineral dust.  While the paper presents a temperature-dependent nucleation rate equation (n<sub>s</sub>(236.2 K \u2264 T \u2264 247.5 K) = exp(6.53043\u00d710<sup>4</sup> \u22128.2153088\u00d710<sup>2</sup>T +3.446885376T<sup>2</sup> \u22124.822268\u00d710<sup>\u22123</sup>T<sup>3</sup>)), it does not include a differential equation describing the rate of ice spread across a surface area.  The study focuses on the nucleation process itself, not the subsequent ice growth kinetics.\n",
          "url": "https://acp.copernicus.org/preprints/11/22801/2011/acpd-11-22801-2011-print.pdf"
        },
        {
          "title": "Partial Differential Equation Models in Biology",
          "author": "",
          "published_date": "2010-09-29T00:00:00+00:00",
          "summary": "This document discusses partial differential equation (PDE) models in biology, focusing on population spread and movement.  While it doesn't directly address ice spreading, it details how PDEs have been used to model the spread of populations (animals, plants, genes, diseases) and other biological phenomena.  The text mentions various approaches to solving these equations, including finding steady-state distributions and traveling waves.  The examples provided are primarily related to biological systems, not the physical spreading of ice.\n",
          "url": "http://mitran-lab.amath.unc.edu/courses/MATH564/biblio/text/10.pdf"
        }
      ],
      "full_explanation": "Although no paper explicitly presents a single differential equation for the rate of ice spread *over a surface area* in the way the question might imply, several papers contain relevant partial differential equations that relate to ice growth and movement. The paper \"How ice grows from premelting films and water droplets\" (URL: https://www.nature.com/articles/s41467-020-20318-6.pdf) develops a 1D mesoscopic model for ice growth using two non-conservative phase-field equations. While not a single equation describing the rate of ice spreading over a surface, this paper models ice growth dynamics, thereby addressing the core of the research question. Similarly, \"The unsteady plane flow of ice-sheets: A parabolic problem with two moving boundaries\" (URL: https://www.tandfonline.com/doi/abs/10.1080/03091928708208812) provides a one-dimensional nonlinear parabolic equation with moving boundaries that models the flow of ice sheets. Though it does not specify an equation *for the rate* of ice spread across an area, it models ice movement over time, which relates to the research question. Finally, the UMAP module, \"Climate Modeling in Differential Equations\" (URL: https://www2.oberlin.edu/math/faculty/walsh/UMAPclimate.pdf) presents a latitude-dependent model that incorporates glaciers, insolation, heat transport and Legendre polynomials to model ice sheet spread, which, although not providing a single differential equation for the specific rate of ice spread, also models ice growth and movement in a relevant manner."
    },
    {
      "question": "Has anyone shown Cholecystokinin to increase or decrease weight loss directly? ",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Satiety effects of a physiological dose of cholecystokinin in humans.",
          "author": "R J Lieverse; J B Jansen; A A Masclee; C B Lamers",
          "published_date": "2023-02-07T21:00:55.949000+00:00",
          "summary": "This 1995 study showed that a physiological dose of cholecystokinin (CCK) significantly decreased food intake in both lean and obese women.  While the study doesn't directly measure weight loss, the reduction in food intake suggests a potential link to weight loss.  The effect was consistent between lean and obese participants.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382399/"
        },
        {
          "title": "Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight",
          "author": "Robert C Ritter, Washington State University, Pullman, WA, USA, britter@vetmed.wsu.edu, M  Covasa, Washington State University, Pullman, WA, USA, C A Matson, Washington State University, Pullman, WA, USA",
          "published_date": "2023-11-09T19:56:36.210000+00:00",
          "summary": "Studies show cholecystokinin (CCK) influences meal size, but its direct effect on weight loss remains unclear. While CCK's role in regulating food intake via peripheral CCK-A receptors on vagal sensory neurons is documented,  research reveals inconsistencies suggesting other CCK sources and action sites beyond the vagus nerve may also be involved.  The article reviews existing evidence but doesn't definitively conclude whether CCK directly increases or decreases weight loss.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0143417999900513"
        },
        {
          "title": "Role of cholecystokinin in appetite control and body weight regulation",
          "author": "T J Little, M  Horowitz, C  Feinle-Bisset",
          "published_date": "2023-11-09T19:25:47.304000+00:00",
          "summary": "Research on cholecystokinin (CCK) and weight loss shows it plays a role in appetite regulation, but studies haven't demonstrated that directly manipulating CCK (through agonists or dietary changes) leads to sustained weight loss.  While CCK acutely suppresses energy intake, long-term effects on weight management are unlikely.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2005.00212.x"
        },
        {
          "title": "The Effect of Cholecystokinin on a Behavioral Satiety Deficit in Obese Mice",
          "author": "Alan J Strohmayer, North Shore University Hospital Manhasset, 11030, New York",
          "published_date": "2023-11-09T19:59:43.895000+00:00",
          "summary": "Studies on obese mice show cholecystokinin (CCK) reduces meal size.  However, its effect on satiety behavior (and thus, weight loss) was inconclusive in previous research.  This study aimed to clarify CCK's impact on satiety behavior in obese mice, but the provided text doesn't report the outcome of that investigation.  Therefore, whether CCK directly increases or decreases weight loss remains unanswered by this specific study.\n",
          "url": "https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1985.tb29978.x"
        },
        {
          "title": "Cholecystokinin Decreases Food Intake in Rats1",
          "author": "James  Gibbs, Robert C Young, Gerard P Smith, Edward W Bourne, Frank P Brooks, Alan N Epstein, William T Lhamon, Paul R Mchugh, Eliot  Stellar, Joseph  Antin, Jonathan  Holt, Edward W Bourne Behavioral",
          "published_date": "2023-11-09T19:57:25.463000+00:00",
          "summary": "Studies in rats show that cholecystokinin (CCK) significantly decreases food intake.  The research doesn't directly address weight loss, but the observed suppression of food intake by CCK suggests a potential indirect effect on weight.  Further research would be needed to confirm a direct impact on weight loss.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/j.1550-8528.1997.tb00305.x"
        },
        {
          "title": "Long-acting CCK analogue NN9056 lowers food intake ...",
          "author": "Berit \u00d8 Christoffersen, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Rikke Bjerring Skyggebjerg, Anne  Bugge, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Rikke Kaae Kirk, Bill  Vestergaard, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Henriette Kold Uldam, Johannes Josef Fels, Global Research Technologies, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Charles  Pyke, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Ulrich  Sensfuss, Global Research Technologies, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Annika  Sanfridson, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark, Trine Ryberg Clausen, Novo Nordisk A/S, 2760, Novo Nordisk Park, M\u00e5l\u00f8v, Denmark",
          "published_date": "2023-11-09T20:26:13.419000+00:00",
          "summary": "Yes.  A study using obese G\u00f6ttingen Minipigs showed that NN9056, a long-acting CCK analogue, significantly reduced food intake and body weight over 13 weeks.  Both low and high doses of NN9056 resulted in weight loss compared to a control group which gained weight.  This demonstrates a direct link between CCK activity (via its analogue) and weight loss.\n",
          "url": "https://www.nature.com/articles/s41366-019-0386-0"
        },
        {
          "title": "Effect of weight loss and ketosis on postprandial ...",
          "author": "Supornpim  Chearskul, Elizabeth  Delbridge, Arthur  Shulkes, Joseph  Proietto, Adamandia  Kriketos, a.kriketos@unimelb.edu.au.",
          "published_date": "2023-11-09T20:23:10.447000+00:00",
          "summary": "This study on obese men found that significant weight loss (approximately 10% of initial body weight) reduced postprandial cholecystokinin (CCK) concentrations. However, when participants were in ketosis (high beta-hydroxybutyrate levels), CCK levels remained similar to those before weight loss.  The study doesn't directly show CCK *causing* weight loss or weight gain, but it demonstrates a correlation between reduced CCK and weight loss, a correlation that is altered by ketosis.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0002916523236175"
        },
        {
          "title": "Roles of Cholecystokinin in the Nutritional Continuum ...",
          "author": "",
          "published_date": "2021-06-02T00:00:00+00:00",
          "summary": "Studies on cholecystokinin (CCK) and its role in weight loss have yielded mixed results.  While CCK is a gastrointestinal hormone impacting appetite regulation, and thus potentially weight,  full agonist CCK-1 receptor drugs designed to promote weight loss have failed in clinical trials.  The review explores potential reasons for this failure and suggests alternative pharmacological strategies, such as biased agonists and allosteric modulators,  to target the CCK-1 receptor for obesity management.  The text does not present evidence of CCK directly increasing or decreasing weight loss.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8206557/"
        },
        {
          "title": "Cholecystokinin - an overview | ScienceDirect Topics",
          "author": null,
          "published_date": "2023-02-22T12:38:55.270000+00:00",
          "summary": "Studies on cholecystokinin (CCK) and weight loss show conflicting results.  While CCK is known to induce satiety (feeling full), thus potentially aiding weight loss,  the text doesn't present direct evidence showing CCK increases or decreases weight loss.  Low CCK levels have been linked to bulimia nervosa, a condition associated with weight fluctuations, while elevated CCK levels are seen in some chronic pancreatitis patients.  However, no conclusive studies on CCK's direct impact on weight loss are mentioned.\n",
          "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/cholecystokinin"
        },
        {
          "title": "Intracellular interplay between cholecystokinin and leptin ...",
          "author": "Hayato  Koizumi, Shahid  Mohammad, Tomoya  Ozaki, Kiyokazu  Muto, Nanami  Matsuba, Juhyon  Kim, Weihong  Pan, Eri  Morioka, Takatoshi  Mochizuki, Masayuki  Ikeda, msikeda@sci.u-toyama.ac.jp",
          "published_date": "2023-11-09T20:30:25.037000+00:00",
          "summary": "This study in rats investigated the interaction between cholecystokinin (CCK) and leptin in satiety.  While the study doesn't directly measure weight loss, it shows that CCK, via its interaction with leptin, affects satiety.  Blocking CCK receptors (using lorglumide) increased food intake in rats.  This suggests that CCK may contribute to short-term satiety, potentially indirectly impacting weight over time by influencing meal size and frequency, but the study does not directly demonstrate a causal link between CCK and weight loss.\n",
          "url": "https://www.nature.com/articles/s41598-020-69035-6"
        }
      ],
      "full_explanation": "While many of the provided papers discuss the role of cholecystokinin (CCK) in appetite regulation and satiety, with many inferring a potential impact on weight, the paper \"Long-acting CCK analogue NN9056 lowers food intake...\" directly demonstrates that manipulating CCK levels can cause weight loss. This study showed that a long-acting CCK analogue, NN9056, significantly reduced both food intake and body weight in obese minipigs over 13 weeks, demonstrating a causal link between CCK activity and weight loss. (URL: https://www.nature.com/articles/s41366-019-0386-0). Additionally, the paper titled \"Effect of weight loss and ketosis on postprandial...\" also shows a direct link between CCK levels and weight loss, demonstrating that significant weight loss reduces postprandial CCK concentrations, however, this does not show that CCK causes weight loss, rather it is correlated with weight loss (URL: https://www.sciencedirect.com/science/article/pii/S0002916523236175). The other papers provided discuss CCK's effect on satiety and food intake. For example, \"Satiety effects of a physiological dose of cholecystokinin in humans\" found that CCK decreases food intake (URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382399/), and \u201cCholecystokinin Decreases Food Intake in Rats1\u201d also found CCK to decrease food intake (URL: https://onlinelibrary.wiley.com/doi/10.1002/j.1550-8528.1997.tb00305.x). However, these only demonstrate an indirect effect on weight by changing food intake, not a direct effect. Similarly, \"Role of cholecystokinin in appetite control and body weight regulation\" notes that manipulating CCK does not result in sustained weight loss (URL: https://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2005.00212.x), and \"Roles of Cholecystokinin in the Nutritional Continuum...\" states that CCK agonists have failed in clinical trials, and that it has produced mixed results on weight loss (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8206557/). Finally, the paper \"Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight\" states that while CCK impacts meal size, a direct effect on weight loss is unclear (URL: https://www.sciencedirect.com/science/article/pii/S0143417999900513), and both \"The Effect of Cholecystokinin on a Behavioral Satiety Deficit in Obese Mice\" (URL: https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1985.tb29978.x) and \"Intracellular interplay between cholecystokinin and leptin ...\" (URL: https://www.nature.com/articles/s41598-020-69035-6) are inconclusive about the direct effect on weight loss. While the majority of studies show an effect on food intake, and therefore an indirect effect on weight, only one showed the research question of CCK directly increasing/decreasing weight loss directly, meaning that the research has been done before."
    },
    {
      "question": "Has anyone found good small molecule drug target sites on beta-arrestin 2?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Therapeutic Potential of Targeting \u00df-Arrestin",
          "author": "Richard A Bond; Emilio Y Lucero Garcia-Rojas; Akhil Hegde; Julia K L Walker",
          "published_date": "2023-02-06T10:52:54.139000+00:00",
          "summary": "This article reviews the therapeutic potential of targeting \u03b2-arrestins, focusing on their role in modulating G protein-coupled receptors (GPCRs).  While it details the mechanisms by which \u03b2-arrestins regulate GPCR signaling and their involvement in various diseases,  it does *not* identify specific small molecule drug target sites on \u03b2-arrestin 2.  The review highlights the potential for therapeutic intervention by selectively targeting one signaling pathway (\u03b2-arrestin-dependent) over another (G protein-dependent), but doesn't offer specific drug target locations on \u03b2-arrestin 2 itself.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414794/"
        },
        {
          "title": "Arresting the Development of Addiction: The Role of \u03b2-Arrestin 2 in Drug Abuse",
          "author": "Kirsten A Porter-Stransky; David Weinshenker",
          "published_date": "2023-02-27T06:29:26.972000+00:00",
          "summary": "This research article explores the role of \u03b2-arrestin 2 (\u03b2arr2) in drug addiction, focusing on its interaction with G protein-coupled receptors (GPCRs) involved in the effects of drugs of abuse.  While the article details \u03b2arr2's involvement in the behavioral effects of various drugs, it does *not* identify specific small molecule drug target sites on \u03b2arr2 itself.  The authors instead highlight the need for further research to elucidate the neurobiological mechanisms of \u03b2arr2 and its potential as a therapeutic target, suggesting that this is an area requiring further investigation.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443318/"
        },
        {
          "title": "A non\u2013GPCR-binding partner interacts with a novel surface on \u03b2-arrestin1 to mediate GPCR signaling",
          "author": "Y. Zhuo,V. Gurevich,S. Vishnivetskiy,C. Klug,A. Marchese",
          "published_date": "2023-10-26T19:31:57.431000+00:00",
          "summary": "This research article focuses on \u03b2-arrestin1, not \u03b2-arrestin2.  While it details the interaction of \u03b2-arrestin1 with STAM1 and its role in CXCR4 signaling,  it does not identify any small molecule drug target sites on either \u03b2-arrestin1 or \u03b2-arrestin2.  The study explores the conformational changes in \u03b2-arrestin1 upon GPCR binding, which may influence future drug targeting efforts, but it does not provide specific target sites.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549033/pdf/"
        },
        {
          "title": "The conformational signature of \u03b2-arrestin2 predicts its trafficking and signalling functions - Nature",
          "author": "Lee; Mi-Hye; Appleton; Kathryn M; Strungs; Erik G; Kwon; Joshua Y; Morinelli; Thomas A; Peterson; Yuri K; Laporte; Stephane A; Luttrell; Louis M",
          "published_date": "2023-02-06T17:35:08.134000+00:00",
          "summary": "This Nature article (2016) investigates how G-protein-coupled receptor (GPCR) activation leads to distinct conformational changes in \u03b2-arrestin2, influencing its downstream signaling and trafficking.  The study uses fluorescence resonance energy transfer (FRET) to show that different GPCRs and ligands induce unique \u03b2-arrestin2 conformations. While the paper doesn't directly identify small molecule drug target sites on \u03b2-arrestin2, it highlights that the protein's conformation is a key determinant of its function, suggesting that targeting specific conformations might be a viable drug development strategy.  Further research based on this conformational understanding could potentially reveal such sites.\n",
          "url": "https://www.nature.com/articles/nature17154"
        },
        {
          "title": "Insights into \u03b22\u2010adrenergic receptor binding from structures of the N\u2010terminal lobe of ARRDC3",
          "author": "Shiqian  Qi, University of California, 94720, Berkeley, Berkeley, California, Morgan  O'hayre, National Institutes of Health, 20892, Bethesda, Maryland, J Silvio Gutkind, National Institutes of Health, 20892, Bethesda, Maryland, James H Hurley, University of California, 94720, Berkeley, Berkeley, California, jimhurley@berkeley.edu",
          "published_date": "2023-11-09T20:04:43.708000+00:00",
          "summary": "This article focuses on the structure of ARRDC3, an \u03b1-arrestin, not \u03b2-arrestin 2.  While the study identifies a positively charged region on ARRDC3 crucial for binding the \u03b22-adrenergic receptor (similar to \u03b2-arrestins), it doesn't identify specific small molecule drug target sites on \u03b2-arrestin 2.  The research highlights structural similarities between \u03b1- and \u03b2-arrestins, suggesting potential parallels in receptor recognition, but doesn't directly address small molecule drug target sites on \u03b2-arrestin 2.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/pro.2549"
        },
        {
          "title": "A new inhibitor of the \u03b2-arrestin/AP2 endocytic complex ...",
          "author": "Alexandre  Beautrait, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Justine S Paradis, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Brandon  Zimmerman, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Jenna  Giubilaro, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Ljiljana  Nikolajev, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Sylvain  Armando, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Hiroyuki  Kobayashi, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Lama  Yamani, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Yoon  Namkung, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Franziska M Heydenreich, Laboratory of Biomolecular Research, Paul Scherrer Institut, 5232, Villigen PSI, Switzerland, Switzerland, Etienne  Khoury, McGill University, Montre \u00b4al, H4A 3J1, Quebec, Canada, Martin  Audet, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Philippe P Roux, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, Dmitry B Veprintsev, Laboratory of Biomolecular Research, Paul Scherrer Institut, 5232, Villigen PSI, Switzerland, Switzerland, St\u00e9phane A Laporte, Michel  Bouvier, Universite \u00b4de Montre \u00b4al, Montre \u00b4al, H3T 1J4, Quebec, Canada, michel.bouvier@umontreal.ca",
          "published_date": "2023-11-09T20:20:30.770000+00:00",
          "summary": "This Nature Communications article describes Barbadin, a small molecule inhibitor targeting the interaction between \u03b2-arrestin and the AP2 clathrin adaptor protein.  While not directly targeting \u03b2-arrestin2 itself, Barbadin's binding site on the \u03b2-arrestin/AP2 complex suggests a potential avenue for drug development.  The study shows Barbadin effectively inhibits receptor endocytosis and impacts downstream signaling pathways (ERK1/2 and cAMP), demonstrating the complex's role in GPCR signaling. This research highlights the \u03b2-arrestin/AP2 interaction as a potential drug target site for modulating GPCR activity.\n",
          "url": "https://www.nature.com/articles/ncomms15054"
        },
        {
          "title": "Targeted Disruption of \u03b2-Arrestin 2-Mediated Signaling ...",
          "author": "",
          "published_date": "2014-04-15T00:00:00+00:00",
          "summary": "This research article focuses on inhibiting \u03b2-arrestin 2 using RNA aptamers, not small molecule drugs.  While it highlights the therapeutic potential of targeting \u03b2-arrestin 2 to impede tumorigenesis (specifically in chronic myelogenous leukemia), it does not identify specific small molecule drug target sites on the protein.  The study uses an aptamer, a type of RNA molecule, to successfully inhibit \u03b2-arrestin 2 activity and show anti-cancer effects.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3988186/"
        },
        {
          "title": "The multifaceted functions of \u03b2-arrestins and their ...",
          "author": "Woo, Jung-A A.",
          "published_date": "2024-01-11T00:00:00+00:00",
          "summary": "This review article discusses the roles of \u03b2-arrestin1 and \u03b2-arrestin2 in neurodegenerative diseases like Alzheimer's, frontotemporal dementia, and Parkinson's.  While it highlights \u03b2-arrestins' involvement in disease pathogenesis (e.g.,  \u03b2-arrestin interaction with \u03b3-secretase increasing amyloid-beta production in Alzheimer's), it does *not* identify specific small molecule drug target sites on \u03b2-arrestin2.  The focus is on the proteins' functions and their potential as therapeutic *targets*, not on specific druggable sites.\n",
          "url": "https://www.nature.com/articles/s12276-023-01144-4"
        },
        {
          "title": "Targeting G protein-coupled receptor signalling by ...",
          "author": "",
          "published_date": "2018-09-28T00:00:00+00:00",
          "summary": "This article focuses on targeting G proteins, not \u03b2-arrestin 2, to modulate G protein-coupled receptor (GPCR) signaling.  While it mentions \u03b2-arrestins' role in GPCR desensitization and internalization, and that some previously attributed \u03b2-arrestin signaling may actually be dependent on G protein signaling, it does not discuss small molecule drug target sites on \u03b2-arrestin 2.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6409483/"
        },
        {
          "title": "Implications of \u03b2-Arrestin biased signaling by angiotensin II ...",
          "author": "R.E. Schmieder, K.F. Hilgers, M.P. Schlaich, B.M. Schmidt",
          "published_date": "2024-12-01T00:00:00+00:00",
          "summary": "This research article focuses on biased signaling of the angiotensin II type 1 receptor (AT1R) and its implications for cardiovascular drug discovery.  It does not directly address small molecule drug target sites on \u03b2-arrestin 2. While the article discusses \u03b2-arrestin-dependent signaling in the context of AT1R desensitization and internalization, it does not explore \u03b2-arrestin 2 as a drug target itself.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0898656824003784"
        }
      ],
      "full_explanation": "While several papers discuss the role of \u03b2-arrestin 2 in various biological processes and its potential as a therapeutic target, none of them specifically identify good small molecule drug target sites *on* \u03b2-arrestin 2 itself.\n\n*   The review article, \"Therapeutic Potential of Targeting \u00df-Arrestin\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414794/), discusses the therapeutic possibilities of targeting \u03b2-arrestins but does not provide locations for specific drug targets on \u03b2-arrestin 2. It focuses on the general concept of modulating \u03b2-arrestin signaling and not specific target sites on the protein.\n*   Similarly, \"Arresting the Development of Addiction: The Role of \u03b2-Arrestin 2 in Drug Abuse\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443318/) explores \u03b2-arrestin 2's role in addiction but doesn't identify specific target sites for small molecules. It instead calls for more research into \u03b2-arrestin 2's mechanisms.\n*   The Nature article, \"The conformational signature of \u03b2-arrestin2 predicts its trafficking and signalling functions\" (https://www.nature.com/articles/nature17154), while showing different conformations of \u03b2-arrestin2 and their function, does not provide exact drug target locations. The research suggests that targeting specific conformations could be a potential strategy, but it doesn't reveal any concrete sites for small molecule binding.\n*   The article \"A new inhibitor of the \u03b2-arrestin/AP2 endocytic complex...\" (https://www.nature.com/articles/ncomms15054) identifies a small molecule (Barbadin) that targets the \u03b2-arrestin/AP2 complex, not \u03b2-arrestin2 itself. It does not identify small molecule drug target sites on \u03b2-arrestin 2, although it does suggest the importance of the \u03b2-arrestin/AP2 complex as a target for drugs.\n*   \"Targeted Disruption of \u03b2-Arrestin 2-Mediated Signaling...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC3988186/) uses an RNA aptamer to inhibit \u03b2-arrestin 2, not a small molecule. This does not address the question of small molecule target sites.\n*  The review article, \"The multifaceted functions of \u03b2-arrestins and their...\" (https://www.nature.com/articles/s12276-023-01144-4) describes \u03b2-arrestin functions in neurodegenerative diseases, but does not identify specific small molecule drug target sites on \u03b2-arrestin2. It is aimed at the protein's potential as a therapeutic target, not the location of druggable sites.\n\nWhile the papers demonstrate the importance of \u03b2-arrestin 2 in various biological processes and show the potential to target it, none of them have identified specific locations on \u03b2-arrestin 2 that could serve as good small molecule drug target sites. The research question, therefore, has not been directly addressed by the provided literature."
    },
    {
      "question": "Has anyone investigated if there are benefits or risks related to Alzheimers disease in patients who take statins? E.g. do they increase or decrease AD risk?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease - Alzheimer's Research & Therapy",
          "author": "Geifman; Nophar; Brinton; Roberta Diaz; Kennedy; Richard E; Schneider; Lon S; Butte; Atul J",
          "published_date": "2023-02-07T20:01:21.200000+00:00",
          "summary": "This research investigated the potential benefits of statins in Alzheimer's disease (AD).  Analysis of clinical trial data suggested that simvastatin may slow cognitive decline, particularly in individuals with the ApoE4 gene.  Observational studies showed better cognitive performance and a lower incidence of AD in statin users compared to non-users.  The study concludes that statins may be beneficial for all AD patients, potentially with greater efficacy in those with the ApoE4 gene.\n",
          "url": "https://alzres.biomedcentral.com/articles/10.1186/s13195-017-0237-y"
        },
        {
          "title": "Statin therapy and risk of Alzheimer's and age\u2010related neurodegenerative diseases",
          "author": "Georgina Torrandell\u2010Haro; Gregory L Branigan; Francesca Vitali; Nophar Geifman; Julie M Zissimopoulos; Roberta Diaz Brinton",
          "published_date": "2023-02-06T13:54:31.539000+00:00",
          "summary": "A retrospective cohort study of 288,515 US patients aged 45+ found that statin use was associated with a lower incidence of Alzheimer's disease (AD) (relative risk [RR] 0.46, 95% CI 0.44-0.49, p<0.001).  Statin use was also associated with reduced risk of other neurodegenerative diseases like dementia, multiple sclerosis, Parkinson's disease, and amyotrophic lateral sclerosis.  However,  fluvastatin showed no significant effect. The study suggests that statins may offer benefits in reducing AD risk, but benefits and risks should be considered when prescribing to at-risk populations.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687291/"
        },
        {
          "title": "Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in \u03b54 carriers",
          "author": "Donald R Royall",
          "published_date": "2023-12-06T00:00:00+00:00",
          "summary": "This study investigated the relationship between statin use and Alzheimer's disease (AD) risk and severity, focusing on the interaction with APOE \u03b54 and C-reactive protein (CRP).  Results suggest statin use moderates the association between APOE \u03b54 and CRP with dementia and is linked to less severe dementia in APOE \u03b54 carriers.  While statins are not typically associated with negative cognitive effects, this research indicates a potential benefit in mitigating some AD risk factors.\n",
          "url": "https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13543"
        },
        {
          "title": "Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease",
          "author": "Nophar Geifman; Roberta Diaz Brinton; Richard E Kennedy; Lon S Schneider; Atul J Butte",
          "published_date": "2023-02-06T17:08:06.023000+00:00",
          "summary": "Studies investigating the relationship between statin use and Alzheimer's Disease (AD) show mixed results.  While some clinical trials found no significant benefit, re-analysis of data suggests simvastatin may slow cognitive decline, particularly in individuals homozygous for ApoE4.  Observational studies also indicate better cognitive performance and lower AD incidence in statin users.  However, more research is needed to confirm these findings and determine the overall benefit and risk profile of statins in AD patients.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316146/"
        },
        {
          "title": "Association Between Statin Exposure and Alzheimer Disease by Sex/Race",
          "author": ",",
          "published_date": "2017-02-01T00:00:00+00:00",
          "summary": "This study investigated the association between statin use and Alzheimer's Disease (AD) incidence in over 700,000 individuals aged 65+.  It found hazard ratios depicting the relative risk of AD from 2009-2013 for those with high versus low statin exposure.  The results, shown in tables and figures,  indicate the relative risk of developing AD  associated with different statin exposure levels.  The study analyzed data based on sex and race subgroups, but details on whether statins increased or decreased AD risk are not provided in this summary.  To determine the benefit or risk, you would need to refer to the full study.\n",
          "url": "https://jamanetwork.com/journals/jamaneurology/article-abstract/2591317"
        },
        {
          "title": "Statins and risks of dementia among patients with heart failure",
          "author": "Qing-wen Ren; Tiew-Hwa Katherine Teng; Yi-Kei Tse; Christopher Tze Wei Tsang; Si-Yeung Yu; Mei-Zhen Wu; Xin-li Li; Denise Hung; Hung-Fat Tse; Carolyn S P Lam; Kai-Hang Yiu",
          "published_date": "2024-01-16T00:00:00+00:00",
          "summary": "A Hong Kong study of over 100,000 heart failure patients found that statin use was associated with a 28% lower risk of Alzheimer's disease.  The study, using inverse probability of treatment weighting, controlled for various factors and showed this benefit across different dementia types.  Further research, including randomized trials, is recommended to confirm these findings.\n",
          "url": "https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00324-3/fulltext"
        },
        {
          "title": "Association between statin use and Alzheimer's disease ...",
          "author": "",
          "published_date": "2021-07-27T00:00:00+00:00",
          "summary": "Studies investigating the link between statin use and Alzheimer's Disease (AD) have yielded mixed results.  A recent study of over 119,000 Korean adults found that less persistent statin use was associated with a *higher* risk of AD. However, persistent and adherent statin use (\u2265540 days or cumulative defined daily dose \u2265540) was associated with a *decreased* risk of AD.  The overall association between statin use and AD risk was not significant.  Therefore, the effect of statins on AD risk appears to depend on the duration and adherence to statin treatment.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8316580/"
        },
        {
          "title": "Statins and cognitive decline in patients with Alzheimer's and ...",
          "author": "Garcia-Ptacek, Sara",
          "published_date": "2023-12-20T00:00:00+00:00",
          "summary": "A recent study (published December 2023 in *Alzheimer's Research & Therapy*) investigated the association between statin use and cognitive decline in 15,586 patients with Alzheimer's disease or mixed dementia.  The study found a dose-response effect: taking statins was associated with improved MMSE scores (a measure of cognitive function) after 3 years.  Specifically, simvastatin users showed a greater improvement than atorvastatin users, particularly in younger patients.  The study doesn't directly address *increased or decreased AD risk*, but the results suggest a potential benefit of statins in slowing cognitive decline in individuals already diagnosed with AD or mixed dementia.\n",
          "url": "https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01360-0"
        },
        {
          "title": "Statin therapy and risk of Alzheimer's and age\u2010related ...",
          "author": "",
          "published_date": "2020-11-25T00:00:00+00:00",
          "summary": "A retrospective cohort study of 288,515 US patients aged 45+ found that statin use was associated with a lower incidence of Alzheimer's disease (AD) (relative risk [RR] 0.46, 95% CI 0.44\u20130.49, P<0.001).  The study compared statin users to non-users and adjusted for various factors.  All statins except fluvastatin showed reduced AD risk.  The researchers suggest considering the benefits and risks of statins in at-risk populations.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7687291/"
        },
        {
          "title": "Do Statins Increase or Decrease Alzheimer's Risk?",
          "author": "James M. Ellison, MD, MPH",
          "published_date": "2021-07-07T00:00:00+00:00",
          "summary": "Studies on statins and Alzheimer's risk show mixed results.  Some large studies show statins modestly reduce Alzheimer's risk, particularly in individuals under 65. However, other research indicates a possible increased risk in those over 80, and some case reports link statins to cognitive impairment, though this seems uncommon.  The overall evidence suggests that the cardiovascular benefits of statins likely outweigh any potential negative cognitive effects related to Alzheimer's.\n",
          "url": "https://www.brightfocus.org/alzheimers/article/do-statins-increase-or-decrease-alzheimers-risk"
        }
      ],
      "full_explanation": "The provided papers clearly demonstrate that the research question of whether statins have benefits or risks related to Alzheimer's disease (AD) has been investigated. Multiple studies have explored the association between statin use and AD risk, with several finding evidence that statins might be beneficial in reducing AD risk, while others highlight mixed results or even potential increased risk in specific populations.\n\nSpecifically:\n*   **Several studies have found an association between statin use and a lower incidence of Alzheimer's disease.** For example, the study by Torrandell-Haro et al. (2023-02-06) found a significantly lower risk of AD in statin users (RR 0.46) compared to non-users in a large US cohort. This study is available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687291/  A similar study by an unknown author also reported the same result (2020-11-25): https://pmc.ncbi.nlm.nih.gov/articles/PMC7687291/. Further, the study by Ren et al. (2024-01-16), focusing on heart failure patients, also observed a 28% lower risk of AD among statin users: https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00324-3/fulltext\n*   **Some papers explore the potential mechanisms or specific populations where statins might be more beneficial.** Geifman et al. (2023-02-07) suggest simvastatin may slow cognitive decline, particularly in individuals with the ApoE4 gene, which is a known AD risk factor: https://alzres.biomedcentral.com/articles/10.1186/s13195-017-0237-y. Royall (2023-12-06) indicates statin use may moderate the association between APOE \u03b54 and CRP with dementia and is linked to less severe dementia in APOE \u03b54 carriers: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13543\n*   **Other studies point towards mixed results, potential negative effects, or the importance of adherence.** The study by an unknown author (2021-07-27) shows that less persistent statin use might be associated with *increased* AD risk, while consistent and adherent use is associated with a *decreased* risk: https://pmc.ncbi.nlm.nih.gov/articles/PMC8316580/. Ellison (2021-07-07) summarizes the mixed findings, highlighting that while some studies suggest modest risk reduction, some suggest potential increased risk in older adults, and rare cases report statin-related cognitive impairment: https://www.brightfocus.org/alzheimers/article/do-statins-increase-or-decrease-alzheimers-risk.\n*   **Some studies focus on the effect of statins on cognitive decline *after* diagnosis.** Garcia-Ptacek (2023-12-20) reported a dose-response effect for statins improving MMSE scores after 3 years in patients *with* AD, suggesting a benefit in slowing cognitive decline: https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01360-0\n\nIn conclusion, the research question of whether statins increase or decrease AD risk has been thoroughly investigated, with a body of evidence suggesting a complex relationship influenced by factors like duration of use, genetic predisposition, and age. These papers indicate the topic has been explored from various angles, with the existing literature reporting both potential benefits and risks associated with statin use and Alzheimer's disease."
    },
    {
      "question": "Has anyone ever made a split GFP?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Imaging with Split Fluorescent Proteins Based on the Reconstruction of Separated Asymmetric Protein Fragments",
          "author": "Minato  Watanabe, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan, Yuki  Sakamoto, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan, Sachihiro  Matsunaga, Tokyo University of Science, 2641, 278-8510, Yamazaki, Noda, Chiba, Japan",
          "published_date": "2023-11-09T20:31:06.966000+00:00",
          "summary": "Yes, split GFP has been developed.  The technique involves dividing GFP between its 10th and 11th beta sheets, creating two fragments (GFP1-10 and GFP11).  These fragments are non-fluorescent individually, but reconstitute to produce fluorescence upon association. This allows for analysis of protein localization, interactions, and membrane protein topology.\n",
          "url": "https://www.jstage.jst.go.jp/article/cytologia/83/4/83_830401/_article"
        },
        {
          "title": "Interaction of Haloarchaeal Gas Vesicle Proteins Determined by Split-GFP",
          "author": "K. Winter,J. Born,F. Pfeifer",
          "published_date": "2023-10-26T19:27:47.130000+00:00",
          "summary": "Yes, the researchers used a split-GFP method to investigate protein interactions in haloarchaea.  They adapted a salt-stable mGFP2 for use in high-salt conditions, creating four vectors for N- or C-terminal fusion to proteins of interest.  This method was successfully used to study interactions between several gas vesicle proteins (GvpM, GvpH, GvpJ, GvpL, and GvpF).\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fmicb.2018.01897/pdf"
        },
        {
          "title": "Protease Activation of Split Green Fluorescent Protein",
          "author": "Brian P Callahan, Matthew J Stanger, Marlene  Belfort, belfort@wadsworth.org",
          "published_date": "2023-11-09T19:08:33.390000+00:00",
          "summary": "Yes, this research describes a protease-activatable switch based on split green fluorescent protein (GFP).  The researchers engineered a system where two GFP fragments, initially unable to self-assemble due to a structural distortion, re-assemble and fluoresce upon protease cleavage of a connecting tether.\n",
          "url": "https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.201000453"
        },
        {
          "title": "Improved Split-GFP Systems for Visualizing Organelle Contact Sites in Yeast and Human Cells",
          "author": "S. Tashiro,Yuriko Kakimoto,Manatsu Shinmyo,Shintaro Fujimoto,Y. Tamura",
          "published_date": "2023-10-26T19:30:08.190000+00:00",
          "summary": "Yes, this research paper describes improved split-GFP systems for visualizing organelle contact sites in yeast and human cells.  The authors previously developed split-GFP probes, but improved them to minimize artificial connections between organelles, particularly at high expression levels.  The improved system allows for more accurate quantification of organelle contact sites.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fcell.2020.571388/pdf"
        },
        {
          "title": "Generation of Photon Pairs in Green Fluorescent Protein",
          "author": "Siyuan  Shi, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL, siyuanshi2016@u.northwestern.edu, Abu  Thomas, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL, Neil V Corzo, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL, Prem  Kumar, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL, Yu-Ping  Huang, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL, Kim Fook Lee, Northwestern University, 2145 Sheridan Road, 60208-3118, Evanston, IL",
          "published_date": "2023-11-09T20:12:44.692000+00:00",
          "summary": "This research demonstrates the generation of correlated photon pairs in green fluorescent protein (GFP) using nondegenerate four-wave mixing, achieving a high coincidence-to-accidental ratio (~70).  While the research doesn't directly address splitting GFP into separate functional units, it does explore a novel interaction with the protein at a quantum level.\n",
          "url": "https://opg.optica.org/abstract.cfm?URI=FiO-2014-FW1C.3"
        },
        {
          "title": "Split Green Fluorescent Proteins: Scope, Limitations, and ...",
          "author": "",
          "published_date": "2019-02-20T00:00:00+00:00",
          "summary": "Yes, split green fluorescent proteins (GFPs) have been developed.  The paper reviews their use in investigating protein-protein interactions, as versatile sensors, molecular glues, optogenetic tools, and platforms for photophysical studies.  The earliest example of a split protein, however, predates GFP and was ribonuclease S.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6537611/"
        },
        {
          "title": "FAST, a method based on split-GFP for the detection in ...",
          "author": "Giuliodori, Anna Maria",
          "published_date": "2024-04-05T00:00:00+00:00",
          "summary": "Yes, the research paper describes a method (FAST) using split GFP to detect proteins synthesized in cell-free expression systems.  The method leverages the properties of split GFP, which, unlike traditional GFP, is not a single, naturally occurring protein.  The paper does not detail the creation of split GFP itself, but rather its application in a novel detection method.\n",
          "url": "https://www.nature.com/articles/s41598-024-58588-5"
        },
        {
          "title": "Split-GFP Reassembly Assay: Strengths and Caveats from ...",
          "author": "",
          "published_date": "2022-10-29T00:00:00+00:00",
          "summary": "Yes, the split-GFP reassembly assay was first developed in the early 2000s by Regan's lab and is used to study protein-protein interactions.  The assay involves splitting GFP into two parts, fusing them to interacting proteins, and observing fluorescence upon reassembly.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9658207/"
        },
        {
          "title": "Any suggestion to make recombinant split GPF tagged ...",
          "author": "Benedikt Warth",
          "published_date": "2019-08-02T00:00:00+00:00",
          "summary": "This ResearchGate thread discusses protein expression and purification in *E. coli*, but doesn't directly address the creation of split GFP.  The questions concern improving protein expression (including a mutant protein with low expression) and Ni-NTA purification of an integral membrane protein.  No mention is made of split GFP.\n",
          "url": "https://www.researchgate.net/post/Any-suggestion-to-make-recombinant-split-GPF-tagged-protein"
        },
        {
          "title": "Engineering an efficient and bright split Corynactis ...",
          "author": "Waldo, Geoffrey S.",
          "published_date": "2021-09-16T00:00:00+00:00",
          "summary": "Yes, split GFPs have been developed, starting with an efficient, self-assembling two-part system from *Aequorea victoria* GFP.  This system uses strand 11 as a fusion tag and the remaining strands as a detector.  Further research has led to three-part split GFP systems and numerous applications in various biological studies.\n",
          "url": "https://www.nature.com/articles/s41598-021-98149-8"
        }
      ],
      "full_explanation": "Multiple research papers confirm that split GFP has been successfully created. The paper \"Imaging with Split Fluorescent Proteins Based on the Reconstruction of Separated Asymmetric Protein Fragments\" (https://www.jstage.jst.go.jp/article/cytologia/83/4/83_830401/_article) directly states that GFP has been divided into two fragments (GFP1-10 and GFP11) which reconstitute to produce fluorescence, demonstrating the successful creation of a split GFP. Similarly, \"Interaction of Haloarchaeal Gas Vesicle Proteins Determined by Split-GFP\" (https://www.frontiersin.org/articles/10.3389/fmicb.2018.01897/pdf) details the use of a split-GFP method to investigate protein interactions, again confirming that split GFP has been created and used. The paper \"Protease Activation of Split Green Fluorescent Protein\" (https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.201000453) describes a system where two GFP fragments, initially unable to self-assemble, re-assemble and fluoresce upon protease cleavage further confirming the existence of split GFP. Furthermore, \"Improved Split-GFP Systems for Visualizing Organelle Contact Sites in Yeast and Human Cells\" (https://www.frontiersin.org/articles/10.3389/fcell.2020.571388/pdf) also indicates the creation and refinement of split-GFP probes for visualizing cellular structures. The review paper \"Split Green Fluorescent Proteins: Scope, Limitations, and ...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC6537611/) provides a review of split GFPs and their many uses, reinforcing the fact that split GFPs have been created and used in numerous applications. The paper \"FAST, a method based on split-GFP for the detection in ...\" (https://www.nature.com/articles/s41598-024-58588-5) uses a split GFP approach for protein detection, implying the existence of split GFP. Similarly, \u201cSplit-GFP Reassembly Assay: Strengths and Caveats from ...\u201d (https://pmc.ncbi.nlm.nih.gov/articles/PMC9658207/) describes the early development of a split-GFP reassembly assay for protein-protein interaction studies. Finally, \u201cEngineering an efficient and bright split Corynactis ...\u201d (https://www.nature.com/articles/s41598-021-98149-8) details the creation of efficient and self-assembling split GFP systems, thereby confirming that the research question has been successfully pursued."
    },
    {
      "question": "Has anyone made a database of all the CRISPR-associated proteins and engineering Cas proteins that are used in CRISPR genome engineering? ",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "A catalogue of biochemically diverse CRISPR-Cas9 orthologs",
          "author": "Giedrius  Gasiunas, CasZyme, LT-10257, Vilnius, Lithuania, Joshua K Young, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, josh.young@corteva.com, Tautvydas  Karvelis, Vilnius University, LT-10257, Vilnius, Lithuania, Darius  Kazlauskas, Vilnius University, LT-10257, Vilnius, Lithuania, Tomas  Urbaitis, CasZyme, LT-10257, Vilnius, Lithuania, Monika  Jasnauskaite, CasZyme, LT-10257, Vilnius, Lithuania, Mantvyda M Grusyte, CasZyme, LT-10257, Vilnius, Lithuania, Sushmitha  Paulraj, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Po-Hao  Wang, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Zhenglin  Hou, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Shane K Dooley, Iowa State University, 50011, Ames, IA, USA, Mark  Cigan, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, Clara  Alarcon, Corteva Agriscience\u2122, 50131, Johnston, IA, USA, N Doane Chilcoat, Greta  Bigelyte, Vilnius University, LT-10257, Vilnius, Lithuania, Jennifer L Curcuru, New England Biolabs, 01938, Ipswich, MA, USA, Megumu  Mabuchi, New England Biolabs, 01938, Ipswich, MA, USA, Zhiyi  Sun, New England Biolabs, 01938, Ipswich, MA, USA, Ryan T Fuchs, New England Biolabs, 01938, Ipswich, MA, USA, Ezra  Schildkraut, New England Biolabs, 01938, Ipswich, MA, USA, Peter R Weigele, New England Biolabs, 01938, Ipswich, MA, USA, William E Jack, New England Biolabs, 01938, Ipswich, MA, USA, G Brett Robb, New England Biolabs, 01938, Ipswich, MA, USA, robb@neb.com, \u010ceslovas  Venclovas, Vilnius University, LT-10257, Vilnius, Lithuania, Virginijus  Siksnys, CasZyme, LT-10257, Vilnius, Lithuania, siksnys@ibt.lt",
          "published_date": "2023-11-09T20:31:30.506000+00:00",
          "summary": "This research cataloged 79 Cas9 proteins, identifying at least 7 distinct guide RNA classes and 50 different PAM sequence requirements.  While it doesn't present a complete database of *all* CRISPR-associated proteins used in genome engineering, it significantly expands the known biochemical diversity of Cas9 orthologs, providing a valuable resource for future engineering efforts.  The study directly addresses PAM and gRNA requirements, key aspects of Cas protein engineering.\n",
          "url": "https://www.nature.com/articles/s41467-020-19344-1"
        },
        {
          "title": "Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability",
          "author": "Lisa M Alexander; Daniela S Aliaga Goltsman; Jason Liu; Jyun-Liang Lin; Morayma M Temoche-Diaz; Sarah M Laperriere; Andreas Neerincx; Christien Bednarski; Philipp Knyphausen; Andre Cohnen; Justine Albers; Liliana Gonzalez-Osorio; Rodrigo Fregoso Ocampo; Jennifer Oki; Audra E Devoto; Cindy J Castelle; Rebecca C Lamothe; Gregory J Cost; Cristina N Butterfield; Brian C Thomas; Christopher T Brown",
          "published_date": "2023-12-04T04:12:50.156000+00:00",
          "summary": "This research article focuses on discovering novel Type II CRISPR systems from metagenomic databases and engineering existing ones.  While it doesn't create a database of *all* CRISPR-associated proteins, it does identify and characterize several new Cas9 enzymes with varying PAM specificities, improving the range of genomic targets accessible for CRISPR gene editing.  The study also demonstrates successful PAM swapping in a highly efficient Cas9 variant, suggesting a method for engineering PAM compatibility in distantly related orthologs.  The research expands the toolkit available for CRISPR genome engineering but doesn't create a comprehensive database as requested.\n",
          "url": "https://www.liebertpub.com/doi/10.1089/crispr.2022.0090"
        },
        {
          "title": "CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering - Nature Biotechnology",
          "author": "Vo; Phuc Leo H; Ronda; Carlotta; Klompe; Sanne E; Chen; Ethan E; Acree; Christopher; Wang; Harris H; Sternberg; Samuel H",
          "published_date": "2023-02-27T03:51:57.749000+00:00",
          "summary": "This Nature Biotechnology article describes CRISPR RNA-guided integrases for highly efficient, multiplexed bacterial genome engineering.  It does not, however, address the creation of a database of CRISPR-associated proteins or engineered Cas proteins.  The paper focuses on a new method for genome editing, not on compiling existing protein information.\n",
          "url": "https://www.nature.com/articles/s41587-020-00745-y"
        },
        {
          "title": "Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability",
          "author": "Lisa M Alexander,Daniela S. Aliaga Goltsman,Jason Liu,Jyun-Liang Lin,Morayma M. Temoche-Diaz,S. Laperriere,Andreas Neerincx,C. Bednarski,P. Knyphausen,A. Cohnen,J. Albers,Liliana Gonzalez\u2010Osorio,Rodrigo Fregoso Ocampo,Jennifer Oki,Audra E. Devoto,C. Castelle,R. Lamothe,G. Cost,Cristina N Butterfield,B. Thomas,C. Brown",
          "published_date": "2023-10-26T19:29:09.318000+00:00",
          "summary": "This research article describes the creation of a high-throughput pipeline to identify thousands of CRISPR type II effectors from a metagenomics database of hundreds of thousands of microbial genomes.  While it doesn't create a publicly available database of *all* CRISPR-associated proteins, the study itself represents a significant expansion of known CRISPR systems, including 41 newly described subgroups with diverse protein sequences, guide RNA structures, and PAMs.  The researchers identified several nucleases with activity comparable to or exceeding SpCas9, possessing reduced off-target effects and enhanced targetability through engineering.  Therefore, the research contributes substantially to the knowledge base of available CRISPR-Cas proteins, but doesn't provide a compiled database in the way your query might suggest.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37272861"
        },
        {
          "title": "An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity",
          "author": "Wu; Tong; Liu; Chang; Zou; Siyuan; Lyu; Ruitu; Yang; Bowei; Yan; Hao; Zhao; Minglei; Tang; Weixin",
          "published_date": "2023-12-04T03:37:33.566000+00:00",
          "summary": "This article focuses on engineering a hypercompact CRISPR-Cas12f system with enhanced gene-editing capabilities, not on a database of CRISPR-associated proteins.  Therefore, it does not directly answer your query about the existence of a comprehensive database of CRISPR-associated proteins and engineered Cas proteins.\n",
          "url": "https://www.nature.com/articles/s41589-023-01380-9"
        },
        {
          "title": "WGE: a CRISPR database for genome engineering",
          "author": "Hodgkins; Alex; Farne; Anna; Perera; Sajith; Grego; Tiago; Parry-Smith; David J; Skarnes; William C; Iyer; Vivek",
          "published_date": "2023-02-23T13:02:33.610000+00:00",
          "summary": "This article describes the Wellcome Trust Sanger Institute Genome Editing (WGE) database, a tool for finding and scoring optimal CRISPR sites in a genome browser.  While it doesn't contain *all* CRISPR-associated proteins or engineered Cas proteins, WGE does provide pre-calculated off-target information for CRISPRs in the human and mouse exomes, allowing users to identify high-quality CRISPR sites for genome editing.  The database is freely available at www.sanger.ac.uk/htgt/wge.\n",
          "url": "https://academic.oup.com/bioinformatics/article/31/18/3078/240857"
        },
        {
          "title": "CRISPR-Cas systems: Overview, innovations and ...",
          "author": "",
          "published_date": "2020-09-08T00:00:00+00:00",
          "summary": "This article reviews CRISPR-Cas systems, their innovations, and applications in human disease research and gene therapy.  While it details the mechanism of CRISPR-Cas systems, including the roles of CRISPR RNA (crRNA) and <i>trans</i>-activating CRISPR RNA (tracrRNA) and Cas proteins, it does *not* mention the existence of a database cataloging all CRISPR-associated proteins or engineered Cas proteins used in genome engineering.  The paper focuses on the broader applications and mechanisms, not a specific registry of Cas proteins.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7508700/"
        },
        {
          "title": "The CRISPR tool kit for genome editing and beyond",
          "author": "Adli; Mazhar",
          "published_date": "2023-02-06T07:49:39.887000+00:00",
          "summary": "This article from Nature Communications focuses on CRISPR genome editing tools, but it does not contain a database of CRISPR-associated proteins or engineered Cas proteins.  The text primarily lists historical research papers related to restriction enzymes and gene editing techniques predating CRISPR.  Therefore, the answer to your query is no.\n",
          "url": "https://www.nature.com/articles/s41467-018-04252-2"
        },
        {
          "title": "CasPDB: an integrated and annotated database for Cas ...",
          "author": "",
          "published_date": "2019-08-14T00:00:00+00:00",
          "summary": "Yes, the Cas Protein Data Bank (CasPDB) is an online database containing 287 reviewed and 257,745 putative Cas proteins, as well as 3593 Cas operons from various bacterial and archaeal species.  It's designed to facilitate the exploration of CRISPR systems and the identification of new Cas proteins for genome editing.  The database includes information on type II CRISPR-Cas systems (328 operons are listed).\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6693189/"
        },
        {
          "title": "Recent advances in CRISPR-based genome editing ...",
          "author": "Yang, Xiao",
          "published_date": "2023-03-10T00:00:00+00:00",
          "summary": "This review article on CRISPR-based genome editing in cardiovascular research does not describe a database of CRISPR-associated proteins (Cas) or engineered Cas proteins.  While the article discusses the expansion of the CRISPR toolbox, including newly identified Cas orthologs and engineered variants, it does not mention the existence of a compiled database of these proteins.\n",
          "url": "https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00447-x"
        }
      ],
      "full_explanation": "While several papers discuss the discovery and engineering of novel Cas proteins, only one paper describes the creation of a database that comes close to fulfilling the research question: \"CasPDB: an integrated and annotated database for Cas ...\". This paper ([https://pmc.ncbi.nlm.nih.gov/articles/PMC6693189/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6693189/)) describes the Cas Protein Data Bank (CasPDB), an online database that contains 287 reviewed and 257,745 putative Cas proteins, as well as 3593 Cas operons from various bacterial and archaeal species. CasPDB, though not necessarily all inclusive, does represent a database of CRISPR-associated proteins used in genome engineering, thus answering the research question in the affirmative.\n\nOther papers explored the breadth of Cas proteins, such as \"A catalogue of biochemically diverse CRISPR-Cas9 orthologs\" ([https://www.nature.com/articles/s41467-020-19344-1](https://www.nature.com/articles/s41467-020-19344-1)) which cataloged 79 Cas9 proteins and \"Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability\" ([https://www.liebertpub.com/doi/10.1089/crispr.2022.0090](https://www.liebertpub.com/doi/10.1089/crispr.2022.0090) and [https://pubmed.ncbi.nlm.nih.gov/37272861](https://pubmed.ncbi.nlm.nih.gov/37272861)) which identified several new Cas9 enzymes. These articles all contribute to the knowledge of CRISPR-associated proteins, but they do not represent a comprehensive database. WGE database ([https://academic.oup.com/bioinformatics/article/31/18/3078/240857](https://academic.oup.com/bioinformatics/article/31/18/3078/240857)) does not contain all CRISPR associated proteins; it is focused on target site identification and is thus not relevant to the research query. The remaining papers focused on applications or specific engineering efforts, not databases."
    },
    {
      "question": "Has anyone done research into the impact of microRNA dysregulation on protein-protein interactions in cancer cells?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors",
          "author": "Andrew  Dhawan, University of Oxford, OX3 7DQ, Oxford, UK, Jacob G Scott, Translational Hematology and Radiology, Cleveland Clinic, 44195, Cleveland, USA, Adrian L Harris, University of Oxford, OX3 7DQ, Oxford, UK, Francesca M Buffa, University of Oxford, OX3 7DQ, Oxford, UK, francesca.buffa@oncology.ox.ac.uk",
          "published_date": "2023-11-09T20:24:25.701000+00:00",
          "summary": "This research investigated the association between microRNA expression and cancer hallmarks across 15 epithelial cancer types.  While it doesn't directly address microRNA dysregulation's impact on protein-protein interactions, the study *does* identify extensive microRNA regulation of tumor suppressor genes (e.g., PTEN, FAT4, CDK12), suggesting an alternative mechanism of cancer development independent of mutation, methylation, or copy number variation.  This indirectly implies a potential influence on protein interactions, as these tumor suppressors are involved in many such interactions, but the study doesn't explore this specifically.\n",
          "url": "https://www.nature.com/articles/s41467-018-07657-1"
        },
        {
          "title": "A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer",
          "author": "Ying  Liu, Hunan University, Changsha, China, Chu  Pan, Hunan University, Changsha, China, Dehan  Kong, University of Toronto, Toronto, ON, Canada, Jiawei  Luo, Hunan University, Changsha, China, luojiawei@hnu.edu.cn, Zhaolei  Zhang, University of Toronto, Toronto, ON, Canada, zhaolei.zhang@utoronto.ca",
          "published_date": "2023-11-09T20:31:08.804000+00:00",
          "summary": "This research investigated the interplay between RNA-binding proteins (RBPs) and microRNAs (miRNAs) in cancer, focusing on their overlapping or neighboring binding sites on mRNA transcripts.  While the study doesn't directly address miRNA dysregulation's impact on *protein-protein* interactions, it does analyze the regulatory interactions between RBPs and miRNAs, showing significant interaction effects in most cancer datasets.  This suggests indirect influence on protein expression levels, as RBPs and miRNAs collaboratively regulate mRNA translation, which would subsequently affect protein-protein interaction by altering protein abundance.  The study's focus is on the regulatory interplay at the mRNA level, not the direct protein-protein interaction level.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fgene.2020.515094/full"
        },
        {
          "title": "Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors",
          "author": "Andrew Dhawan; Jacob G Scott; Adrian L Harris; Francesca M Buffa",
          "published_date": "2023-02-26T08:28:27.850000+00:00",
          "summary": "This study analyzed the relationship between microRNA expression and cancer hallmarks across 15 epithelial cancer types.  While it doesn't directly address microRNA dysregulation's impact on protein-protein interactions, it does identify extensive microRNA regulation of tumor suppressor genes (like PTEN, FAT4, and CDK12), suggesting an alternative mechanism of repression independent of mutation, methylation, or copy number changes.  The research focuses on microRNA's role in gene regulation and its association with cancer hallmarks, not specifically on its effect on protein-protein interactions.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286392/"
        },
        {
          "title": "Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma",
          "author": "J. T. Dankert,M. Wieseh\u00f6fer,S. Wach,E. D. Czyrnik,G. Wennemuth",
          "published_date": "2023-10-26T19:31:11.912000+00:00",
          "summary": "This study investigated the role of miR-106b dysregulation in prostate cancer.  The researchers found that miR-106b downregulates RBMS1, an RNA-binding protein.  Reduced RBMS1 expression correlated with increased prostate tumor growth and reduced cell proliferation. While this study doesn't directly address microRNA's impact on protein-protein interactions, it highlights the effect of miRNA dysregulation on a specific protein (RBMS1) and its subsequent impact on cancer cell behavior.  Further research is needed to explore the broader effects of microRNA dysregulation on protein-protein interactions in cancer.\n",
          "url": "https://www.nature.com/articles/s41598-020-75083-9.pdf"
        },
        {
          "title": "The nuclear DICER\u2013circular RNA complex drives the deregulation of the glioblastoma cell microRNAome",
          "author": "A Bronisz; A K Rooj; K Krawczy\u0144ski; P Peruzzi; E Sali\u0144ska; I Nakano; B Purow; E A Chiocca; J Godlewski",
          "published_date": "2023-02-23T05:50:46.986000+00:00",
          "summary": "This research focuses on microRNA deregulation in glioblastoma, linking it to aberrant nuclear localization of DICER, a key enzyme in microRNA maturation.  The study identifies a nuclear DICER complex involving RBM3 and circ2082.  Knockdown of circ2082 restores cytosolic DICER localization, derepressing the microRNAome and reducing glioblastoma tumorigenicity. While the study doesn't directly investigate the impact of microRNA dysregulation on *protein-protein interactions*, its findings strongly suggest that altered microRNA expression, due to DICER mislocalization, significantly affects gene expression and consequently, could indirectly influence protein-protein interactions within the cancer cell.  The research highlights a mechanism for microRNAome deregulation in cancer, which could be a significant area for further investigation concerning protein-protein interactions.\n",
          "url": "https://www.science.org/doi/10.1126/sciadv.abc0221?cookieSet=1"
        },
        {
          "title": "Causes and consequences of microRNA dysregulation in ...",
          "author": "",
          "published_date": "2009-10-01T00:00:00+00:00",
          "summary": "This article focuses on the role of microRNA dysregulation in cancer development, noting that alterations in microRNA expression contribute to most, if not all, human malignancies.  While it details various mechanisms of microRNA dysregulation (deletions, amplifications, mutations, epigenetic silencing, transcription factor dysregulation), and their impact on oncogenes and tumor suppressor genes, it does *not* specifically address the impact of microRNA dysregulation on protein-protein interactions in cancer cells.  Therefore, based on this article, the answer to your query is not directly addressed.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3467096/"
        },
        {
          "title": "Causes and Consequences of microRNA Dysregulation",
          "author": "",
          "published_date": "2011-10-01T00:00:00+00:00",
          "summary": "This article focuses on microRNA dysregulation in cancer, detailing its role in tumorigenesis and metastasis.  While it doesn't directly address the impact of microRNA dysregulation on protein-protein interactions, it highlights how dysregulation affects gene expression and describes the biogenesis and regulatory mechanisms of microRNAs.  The review touches upon the clinical implications of microRNA dysregulation in cancer, but a specific investigation into protein-protein interaction changes resulting from this dysregulation is not explicitly presented.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3528102/"
        },
        {
          "title": "RNA-binding proteins and exoribonucleases modulating ...",
          "author": "Kim, Jong Heon",
          "published_date": "2024-05-01T00:00:00+00:00",
          "summary": "This review focuses on how RNA-binding proteins (RBPs) and exoribonucleases modulate microRNA (miRNA) biogenesis and turnover in cancer, including the impact on hepatitis C virus-related hepatocellular carcinoma.  While the article extensively details the role of RBPs in miRNA regulation and dysregulation in cancer, it does *not* directly address the impact of miRNA dysregulation on protein-protein interactions.  The research presented focuses on the miRNA-RBP interaction itself, rather than the downstream effect on other protein interactions.\n",
          "url": "https://www.nature.com/articles/s12276-024-01224-z"
        },
        {
          "title": "Dysregulation of microRNAs in breast cancer and their ...",
          "author": "Eleni  Van Schooneveld, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, eleni.vanschooneveld@gmail.com, Hans  Wildiers, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, Ignace  Vergote, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium, Peter B Vermeulen, CORE, University of Antwerp, Universiteitsplein 1, B-2016, Antwerp, Belgium, Luc Y Dirix, CORE, University of Antwerp, Universiteitsplein 1, B-2016, Antwerp, Belgium, Steven J Van Laere, University Hospitals Leuven and Catholic University Leuven, Herestraat 49, B-3000, Leuven, Belgium",
          "published_date": "2023-11-09T20:08:10.463000+00:00",
          "summary": "This review article on microRNAs (miRNAs) in breast cancer focuses on their diagnostic, predictive, and prognostic potential as biomarkers,  and their role in personalized cancer management. While it extensively covers miRNA dysregulation's impact on breast cancer development and progression, it does *not* specifically address the impact of miRNA dysregulation on protein-protein interactions within cancer cells.  The article primarily examines miRNAs' correlation with treatment response and prognosis, not their effects on cellular interactions at the protein level.\n",
          "url": "https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0526-y"
        },
        {
          "title": "Dynamic and Modularized MicroRNA Regulation and Its ...",
          "author": "Jiang  Shu, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, Bruno Vieira Resende E Silva, Tian  Gao, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, Zheng  Xu, University of Nebraska-Lincoln, 68588, Lincoln, NE, USA, Juan  Cui, Systems Biology and Biomedical Informatics (SBBI) Laboratory, 68588, Lincoln, NE, USA, jcui@unl.edu",
          "published_date": "2023-11-09T20:21:11.110000+00:00",
          "summary": "This research focuses on microRNA regulation in cancer, identifying 10,726 microRNA-mRNA interactions associated with specific cancer types and stages.  While the study doesn't directly investigate the impact of microRNA dysregulation on *protein-protein interactions*, it does explore the dynamic and conditional nature of microRNA-mediated gene regulation in cancer, identifying functional modules where multiple microRNAs co-regulate processes like glycolysis/gluconeogenesis and focal adhesion.  This suggests a potential indirect influence on protein-protein interactions through the regulation of mRNA targets involved in these pathways.  The study utilizes a novel meta-Lasso regression model analyzing genomic data from ~4,200 cancer patients across 9 cancer types.\n",
          "url": "https://www.nature.com/articles/s41598-017-13470-5"
        }
      ],
      "full_explanation": "While several papers explore microRNA dysregulation in cancer and its impact on gene expression, none of the provided papers directly investigate the impact of microRNA dysregulation on protein-protein interactions. \n\nSeveral papers identify microRNA-mediated downregulation of tumor suppressor genes, like PTEN, FAT4, and CDK12 (e.g., \"Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors\" URL: https://www.nature.com/articles/s41467-018-07657-1 and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286392/ ). These studies suggest an indirect influence on protein-protein interactions, because these tumor suppressors are involved in such interactions. However, the studies do not specifically explore or quantify the changes in these protein-protein interactions resulting from the altered microRNA expression.\n\nOther papers, like \"A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer\" (URL: https://www.frontiersin.org/articles/10.3389/fgene.2020.515094/full) investigate the regulatory interactions between RNA-binding proteins (RBPs) and microRNAs, which may influence protein levels, and subsequently protein-protein interaction, but does not look at the direct effect of microRNA dysregulation on protein-protein interactions. Another study, \"Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma\" (URL: https://www.nature.com/articles/s41598-020-75083-9.pdf) looks at how one specific microRNA affects one protein, but again, not any downstream protein-protein interactions.\n\nAnother relevant paper \"The nuclear DICER\u2013circular RNA complex drives the deregulation of the glioblastoma cell microRNAome\" (URL: https://www.science.org/doi/10.1126/sciadv.abc0221?cookieSet=1) identifies a mechanism for microRNAome deregulation in cancer, however, it still doesn't assess changes to protein-protein interactions. Finally \"Dynamic and Modularized MicroRNA Regulation and Its ...\" (URL: https://www.nature.com/articles/s41598-017-13470-5) investigates the dynamic regulation of mRNAs via microRNA, again, not assessing the protein-protein interactions.\n\nWhile these studies suggest a potential impact of microRNA dysregulation on protein-protein interactions, they do not directly research this specific relationship. Therefore, based on the provided papers, the research question has not been directly investigated."
    },
    {
      "question": "Has anyone ever experimented with giving animals money?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Evolutionary origins of money categorization and exchange: an experimental investigation in tufted capuchin monkeys (Sapajus spp.) - Animal Cognition",
          "author": "De Petrillo; Francesca; Caroli; Martina; Gori; Emanuele; Micucci; Antonia; Gastaldi; Serena; Bourgeois-Gironde; Sacha; Addessi; Elsa",
          "published_date": "2023-02-06T19:51:15.040000+00:00",
          "summary": "Yes. Researchers experimented with capuchin monkeys, giving them tokens that they could exchange for food.  The monkeys understood the tokens' value, even unfamiliar ones, and engaged in both direct and reverse exchanges (trading food for tokens, then tokens for different food).  This suggests that some basic features of money exchange may have evolutionary roots in non-human animals.\n",
          "url": "https://link.springer.com/article/10.1007/s10071-018-01233-2"
        },
        {
          "title": "Non-human primate token use shows possibilities but also limitations for establishing a form of currency | Philosophical Transactions of the Royal Society B: Biological Sciences",
          "author": "Michael J Beran; Audrey E Parrish",
          "published_date": "2023-02-27T16:57:10.984000+00:00",
          "summary": "Yes, researchers have experimented with giving non-human primates tokens as a form of currency to study the cognitive prerequisites for understanding and using currency systems.  The studies explored whether primates could grasp concepts like value, delayed gratification, and exchange, revealing both successes and limitations in their ability to use tokens like humans use money.  The limitations observed are debated as possibly resulting from cognitive differences or environmental constraints that haven't driven the evolution of similar economic behaviors in other species.\n",
          "url": "https://royalsocietypublishing.org/doi/full/10.1098/rstb.2019.0675"
        },
        {
          "title": "Give a dog a bone: Spending money on pets promotes happiness",
          "author": "Michael W White; Nazia Khan; Jennifer S Deren; Jessica J Sim; Elizabeth A Majka",
          "published_date": "2023-02-06T12:30:10.219000+00:00",
          "summary": "This research paper doesn't directly address giving animals money.  It explores the link between pet spending and human happiness, suggesting that spending money on pets positively impacts owner well-being.  No experiments involving giving animals money are described.\n",
          "url": "https://www.tandfonline.com/doi/abs/10.1080/17439760.2021.1897871"
        },
        {
          "title": "Empowering Wildlife Guardians: An Equitable Digital Stewardship and Reward System for Biodiversity Conservation Using Deep Learning and 3/4G Camera Traps",
          "author": "Erik Meijaard",
          "published_date": "2023-05-24T00:00:00+00:00",
          "summary": "This research paper describes a digital system for rewarding wildlife guardians for biodiversity conservation efforts using camera traps and deep learning.  It does not discuss giving animals money.\n",
          "url": "https://www.mdpi.com/2072-4292/15/11/2730"
        },
        {
          "title": "Empowering Wildlife Guardians: An Equitable Digital Stewardship and Reward System for Biodiversity Conservation using Deep Learning and 3/4G Camera Traps",
          "author": "P. Fergus,C. Chalmers,S. Longmore,S. Wich,Carmen Warmenhove,J. Swart,Thuto Ngongwane,A. Burger,J. Ledgard,E. Meijaard",
          "published_date": "2023-10-26T19:29:27.571000+00:00",
          "summary": "This research paper discusses a system for rewarding local people for wildlife conservation efforts, not for directly giving money to animals.  The paper highlights the critical role impoverished communities play in biodiversity conservation, noting that they have historically received little economic incentive despite their deep connection to the environment.  The paper proposes a digital system using camera traps and deep learning to track conservation efforts and fairly distribute rewards.  It does *not* involve giving money to animals.\n",
          "url": "https://arxiv.org/pdf/2304.12703.pdf"
        },
        {
          "title": "Non-human primate token use shows possibilities but also ...",
          "author": "",
          "published_date": "2021-01-11T00:00:00+00:00",
          "summary": "Yes, researchers have experimented with giving non-human primates tokens that function like currency.  These primates learned to associate tokens with rewards (like food), and sometimes demonstrated behaviors like saving tokens for later or exchanging them for preferred rewards. However, the studies also revealed limitations in the primates' ability to fully understand and utilize these tokens in complex economic scenarios, suggesting cognitive or environmental factors may constrain the development of currency systems in non-human species.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7815425/"
        },
        {
          "title": "Monkey Business",
          "author": "Stephen J. Dubner, Steven D. Levitt",
          "published_date": "2005-06-05T00:00:00+00:00",
          "summary": "Yes.  Yale economists Keith Chen and Laurie Santos taught capuchin monkeys to use money to buy grapes, apples, and Jell-O, studying how their behavior compared to humans' responses to economic incentives.  The experiment explored whether monetary exchange is unique to humans.\n",
          "url": "https://www.nytimes.com/2005/06/05/magazine/monkey-business.html"
        },
        {
          "title": "How scientists taught monkeys the concept of money. Not ...",
          "author": "Tibi Puiu",
          "published_date": "2023-12-15T14:16:30+00:00",
          "summary": "Yes.  In 2005, Yale researchers Keith Chen and Laurie Santos taught capuchin monkeys to use tokens as currency to purchase treats like grapes and Jell-O.  The study explored how the monkeys' behavior responded to economic incentives.  While initially successful, the experiment also revealed unexpected social dynamics and behaviors amongst the monkeys, including the emergence of what could be interpreted as prostitution.\n",
          "url": "https://www.zmescience.com/research/how-scientists-tught-monkeys-the-concept-of-money-not-long-after-the-first-prostitute-monkey-appeared/"
        },
        {
          "title": "The Experiment That Taught Monkeys How to Use Money",
          "author": "Freakonomics Radio Network",
          "published_date": "2011-10-11T18:58:57+00:00",
          "summary": "Yes.  This Freakonomics Radio episode discusses research by Keith Chen where monkeys were taught to use money to purchase various goods.  The experiment details how economists trained monkeys to use a token-based monetary system.\n",
          "url": "https://www.youtube.com/watch?v=J8449HgS3FM"
        },
        {
          "title": "That Time Scientists Gave Monkeys Money",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "This YouTube video (114K views, 6K likes) doesn't provide text content for analysis.  Therefore, I cannot determine if it shows experiments involving giving animals money.\n",
          "url": "https://www.youtube.com/watch?v=y2M0fzcYlgI"
        }
      ],
      "full_explanation": "Multiple research papers and articles confirm that experiments involving giving animals tokens or objects that function as money have been conducted. Specifically, several studies focused on capuchin monkeys. The paper \"Evolutionary origins of money categorization and exchange: an experimental investigation in tufted capuchin monkeys (Sapajus spp.)\" (URL: https://link.springer.com/article/10.1007/s10071-018-01233-2) details an experiment where capuchin monkeys were given tokens that could be exchanged for food, demonstrating their understanding of token value and engaging in both direct and reverse exchanges. Similarly, the papers \"Non-human primate token use shows possibilities but also limitations for establishing a form of currency\" (URL: https://royalsocietypublishing.org/doi/full/10.1098/rstb.2019.0675) and another paper with similar title (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7815425/) discuss various experiments using tokens as currency with non-human primates, examining their understanding of value, delayed gratification, and exchange. Furthermore, the article \"Monkey Business\" (URL: https://www.nytimes.com/2005/06/05/magazine/monkey-business.html), along with the articles \"How scientists taught monkeys the concept of money. Not ...\" (URL: https://www.zmescience.com/research/how-scientists-tught-monkeys-the-concept-of-money-not-long-after-the-first-prostitute-monkey-appeared/) and \"The Experiment That Taught Monkeys How to Use Money\" (URL: https://www.youtube.com/watch?v=J8449HgS3FM) describe research conducted by Keith Chen and Laurie Santos where they taught capuchin monkeys to use money to purchase items. These sources collectively confirm that the proposed research question\u2014whether anyone has ever experimented with giving animals money\u2014has been explored, primarily with non-human primates, using tokens as a form of currency."
    },
    {
      "question": "Has anyone created a system or pipeline for automatic metareview of literature?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Prompting LLMs to Compose Meta-Review Drafts from Peer-Review Narratives of Scholarly Manuscripts",
          "author": "Santu; Shubhra Kanti Karmaker; Sinha; Sanjeev Kumar; Bansal; Naman; Knipper; Alex; Sarkar; Souvika; Salvador; John; Mahajan; Yash; Guttikonda; Sri; Akter; Mousumi; Freestone; Matthew; Williams Jr",
          "published_date": "2024-02-23T00:00:00+00:00",
          "summary": "Yes, this paper explores using three large language models (GPT-3.5, LLaMA2, and PaLM2) to automatically generate meta-reviews of scholarly manuscripts.  The authors prompted the LLMs with varying prompts based on the TELeR taxonomy and performed a qualitative analysis of the resulting meta-reviews.  The paper details their findings and recommendations for prompting LLMs for this task, effectively creating a pipeline for automated meta-review generation.\n",
          "url": "https://arxiv.org/abs/2402.15589"
        },
        {
          "title": "Reviewer2: Optimizing Review Generation Through Prompt Generation",
          "author": "Gao; Zhaolin; Brantley; Kiant\u00e9; Joachims; Thorsten",
          "published_date": "2024-02-16T00:00:00+00:00",
          "summary": "This paper introduces Reviewer2, a two-stage framework for automatically generating detailed literature reviews using large language models (LLMs).  Unlike previous methods, Reviewer2 explicitly models the distribution of review aspects, resulting in more comprehensive reviews that better match the range of human reviewer feedback.  The authors also release a dataset of 27,000 papers and 99,000 reviews annotated with aspect prompts to support future research in this area.  While not explicitly a \"meta-review\" system (reviewing reviews),  the improved quality and comprehensiveness of the generated reviews could contribute significantly to automating the meta-review process.\n",
          "url": "https://arxiv.org/abs/2402.10886"
        },
        {
          "title": "Can We Automate Scientific Reviewing?",
          "author": "Weizhe  Yuan, weizhey@cs.cmu.edu, Pengfei  Liu, Graham  Neubig, gneubig@cs.cmu.edu",
          "published_date": "2023-11-16T01:35:01.879000+00:00",
          "summary": "This paper explores automating scientific peer review using NLP models. While not directly addressing automatic meta-review of literature, the authors develop a system to generate first-pass reviews of scientific papers.  The system, trained on the ASAP-Review dataset, produces reviews covering more aspects than human-written ones but suffers from lower constructiveness. The authors acknowledge the complexity of the task and don't claim to replace human reviewers, but suggest their system could assist in the review process.  The paper also discusses challenges and potential solutions for improving automated review generation.\n",
          "url": "https://arxiv.org/pdf/2102.00176.pdf"
        },
        {
          "title": "Scientific paper recommendation systems: a literature review of recent publications",
          "author": "C. Kreutz,Ralf Schenkel",
          "published_date": "2023-10-26T19:29:22.265000+00:00",
          "summary": "This literature review (2019-2021) of scientific paper recommendation systems does not directly address automated meta-review of literature.  While the paper explores various systems for recommending relevant papers based on different inputs (e.g., a given paper, user behavior, keywords), it doesn't discuss systems that automatically synthesize or evaluate multiple papers to produce a meta-review.  The review focuses on the methods, datasets, and evaluation metrics of individual paper recommendation systems, not on higher-level aggregation or analysis.\n",
          "url": "https://arxiv.org/pdf/2201.00682.pdf"
        },
        {
          "title": "Automating Systematic Literature Reviews with Natural Language Processing and Text Mining: a Systematic Literature Review",
          "author": "G. Sundaram,D. Berleant",
          "published_date": "2023-10-26T19:31:43.245000+00:00",
          "summary": "This systematic literature review analyzes 29 studies on automating systematic literature reviews (SLRs) using natural language processing (NLP) and text mining.  While it doesn't describe a complete, single \"automatic meta-review\" system, it examines the automation of individual SLR steps (study selection, quality assessment, data extraction, and synthesis) using various machine learning techniques.  The review highlights significant gaps in automation, particularly in data extraction, monitoring, quality assessment, and data synthesis, suggesting that a fully automated meta-review pipeline is not yet a reality but remains an area of active research.\n",
          "url": "https://arxiv.org/pdf/2211.15397.pdf"
        },
        {
          "title": "Utilizing ChatGPT to select literature for meta-analysis ...",
          "author": "",
          "published_date": null,
          "summary": "The provided text is largely unintelligible, appearing to be corrupted or encoded in a way that prevents meaningful analysis.  Therefore, it's impossible to determine whether it describes a system or pipeline for automatic meta-review of literature.  A response cannot be generated.\n",
          "url": "https://www.medrxiv.org/content/10.1101/2023.09.06.23295072v1.full-text"
        },
        {
          "title": "Automation of literature screening using machine learning in ...",
          "author": "Pan, Hui",
          "published_date": "2022-01-15T00:00:00+00:00",
          "summary": "This systematic review protocol investigates the use of AI algorithms to automate literature screening in medical systematic reviews.  While not directly addressing automated *meta-review*, it focuses on automating the initial screening process, a crucial step in meta-analysis. The authors will analyze existing studies on AI-driven literature screening, assessing their methods and effectiveness to inform future research in this area.  The review will examine various algorithms and their performance, potentially highlighting existing systems or pipelines that could be adapted for broader meta-review applications.\n",
          "url": "https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01881-5"
        },
        {
          "title": "An open source machine learning framework for efficient ...",
          "author": "Van De Schoot; Rens; De Bruin; Jonathan; Schram; Raoul; Zahedi; Parisa; De Boer; Jan; Weijdema; Felix; Kramer; Bianca; Huijts; Martijn; Hoogerwerf; Maarten; Ferdinands; Gerbrich; Harkema; Albert; Willemsen; Joukje; Ma; Yongchao; Fang; Qixiang; Hindriks; Sybren; Tummers; Lars; Oberski; Daniel L",
          "published_date": "2023-02-23T00:48:34.763000+00:00",
          "summary": "This Nature Machine Intelligence article introduces an open-source machine learning framework designed to improve the efficiency and transparency of systematic reviews (a type of meta-analysis).  The framework uses active learning to prioritize relevant studies, reducing the manual effort required for screening large numbers of publications. While not explicitly called an \"automatic meta-review system,\"  it addresses the core problem of efficiently processing vast amounts of literature for meta-analysis by automating the crucial initial screening phase.\n",
          "url": "https://www.nature.com/articles/s42256-020-00287-7"
        },
        {
          "title": "Rayyan: AI-Powered Systematic Review Management Platform",
          "author": "",
          "published_date": "2021-11-08T19:01:59+00:00",
          "summary": "Rayyan is a collaborative systematic review platform used by over 500,000 researchers.  While it doesn't offer fully automated meta-review, its features such as AI-powered in-app help, advanced filtration facets, and  de-duplication could assist in streamlining the meta-review process.  Rayyan facilitates collaboration and organization of literature reviews, potentially making manual meta-review more efficient.\n",
          "url": "https://www.rayyan.ai/"
        },
        {
          "title": "a practical guide to using machine learning tools in research ...",
          "author": "Wallace, Byron C.",
          "published_date": "2019-07-11T00:00:00+00:00",
          "summary": "This article discusses using machine learning to automate parts of systematic reviews, including literature searching, screening, and data extraction.  While it doesn't describe a complete \"automatic meta-review\" system, it explores methods for automating significant portions of the literature review process, potentially contributing to faster and more efficient meta-analyses.  The authors provide guidance on which machine learning methods are currently ready for practical application in systematic reviews.\n",
          "url": "https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1074-9"
        }
      ],
      "full_explanation": "The research question asks if anyone has created a system or pipeline for automatic metareview of literature. Based on the provided papers, there is at least one paper that directly addresses this question. The paper \"Prompting LLMs to Compose Meta-Review Drafts from Peer-Review Narratives of Scholarly Manuscripts\" (URL: https://arxiv.org/abs/2402.15589) explicitly explores using Large Language Models (LLMs) to automatically generate meta-reviews. The authors prompted LLMs with various prompts and performed a qualitative analysis of the resulting meta-reviews. This research effectively created a pipeline for automated meta-review generation, therefore answering the research question in the affirmative. While other papers like \"Reviewer2: Optimizing Review Generation Through Prompt Generation\" (URL: https://arxiv.org/abs/2402.10886) and \"Can We Automate Scientific Reviewing?\" (URL: https://arxiv.org/pdf/2102.00176.pdf) focus on generating individual reviews, they are not focused on metareviews."
    },
    {
      "question": "Has anyone mapped the entire microbiome of the human body and its full impact on health and disease?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species - Nature Communications",
          "author": "Leviatan; Sigal; Shoer; Saar; Rothschild; Daphna; Gorodetski; Maria; Segal; Eran",
          "published_date": "2023-04-13T10:23:28.575000+00:00",
          "summary": "No, a complete map of the entire human microbiome and its full impact on health and disease hasn't been achieved.  However, researchers have created an expanded reference map of the gut microbiome (the richest microbial ecosystem in the human body), identifying 3594 gut microbial species, 310 of which were previously unknown. This research, using 51,052 metagenomic samples, improves upon previous efforts and better captures the diversity of the gut microbiome.  While this advances our understanding, it focuses on the gut and doesn't represent a complete map of the entire human microbiome and its effects on health.\n",
          "url": "https://www.nature.com/articles/s41467-022-31502-1"
        },
        {
          "title": "Microbiome-associated human genetic variants impact phenome-wide disease risk",
          "author": "Seth R.  Bordenstein",
          "published_date": "2022-06-24T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  However, research, like the study linked, is making progress. This study analyzed nearly 1,000 microbiome-associated variants (MAVs) and their link to various diseases (neurological, metabolic, digestive, circulatory).  While it reveals connections between human genetics, the microbiome, and disease risk,  it's not a comprehensive map of the entire human microbiome or its total impact on health.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.2200551119"
        },
        {
          "title": "Organization of the human intestine at single-cell resolution - Nature",
          "author": "Hickey; John W; Becker; Winston R; Nevins; Stephanie A; Horning; Aaron; Perez; Almudena Espin; Zhu; Chenchen; Bokai; Wei; Bei; Chiu; Roxanne; Chen; Derek C; Cotter; Daniel L; Esplin; Edward D; Annika K; Caraccio; Chiara; Venkataraaman; Vishal; Sch\u00fcrch; Christian M; Black; Sarah; Brbi\u0107; Maria; Cao; Kaidi; Shuxiao; Zhang; Monte; Emma; Nancy R; Ma; Zongming; Leskovec; Jure; Zhengyan; Lin; Shin; Longacre; Teri; Plevritis; Sylvia K; Yiing; Nolan; Garry P; Greenleaf; William J; Snyder; Michael",
          "published_date": "2023-07-19T00:00:00+00:00",
          "summary": "No, this study does not map the entire human microbiome.  While it provides a high-resolution map of the human intestinal cell types using single-cell RNA sequencing, open chromatin, and spatial proteomic imaging, it focuses on the host intestinal cells, not the microbiome itself.  The research mentions the microbiome's interaction with the immune system within the gut, but it doesn't provide a complete map of the entire microbiome or its full impact on health and disease.\n",
          "url": "https://www.nature.com/articles/s41586-023-05915-x"
        },
        {
          "title": "Reconstructing the landscape of gut microbial species across 29,000 diverse individuals",
          "author": "Igor Segota,J. Watrous,Edward D. Kantz,S. Nallamshetty,Saumya Tiwari,S. Cheng,Mohit Jain,T. Long",
          "published_date": "2023-10-26T19:27:58.593000+00:00",
          "summary": "No, a complete map of the entire human microbiome and its full impact on health and disease hasn't been achieved.  However, this study analyzed 16S rRNA gene sequencing data from nearly 30,000 individuals to identify gut microbial species.  A new method, RExMap, allowed for species-level identification, revealing a core set of 15 gut microbes shared across populations and their association with BMI. While this research focuses on the gut microbiome, it highlights progress toward understanding the microbiome's role in health and disease at a finer resolution than previously possible.\n",
          "url": "https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkad249/50008702/gkad249.pdf"
        },
        {
          "title": "Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA",
          "author": "Stephen R. Quake",
          "published_date": "2017-09-05T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  However, a study using circulating cell-free DNA from over 1,000 blood samples identified hundreds of previously unknown bacteria and viruses in the human microbiome, significantly expanding our understanding of its diversity.  Many of these microbes are vastly different from known organisms. While this research advances our knowledge, it doesn't represent a complete map of the entire microbiome nor its comprehensive impact on health.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1707009114"
        },
        {
          "title": "NIH Human Microbiome Project defines normal bacterial ...",
          "author": "",
          "published_date": "2015-08-31T18:39:53+00:00",
          "summary": "The NIH Human Microbiome Project (HMP) has mapped the normal microbial makeup of healthy adults, creating a reference database of microbes from 15-18 body sites in 242 volunteers.  While not a completely exhaustive map of *every* microbe in *every* individual, the HMP significantly advanced understanding of the microbiome's composition and its role in health.  The research revealed that healthy individuals routinely carry pathogens, highlighting the need for further research to understand when these microbes cause disease.  The project's findings are a foundation for future research into infectious diseases.\n",
          "url": "https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-defines-normal-bacterial-makeup-body"
        },
        {
          "title": "Current understanding of the human microbiome - PMC",
          "author": "",
          "published_date": "2018-04-10T00:00:00+00:00",
          "summary": "No, a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.  While significant progress has been made in understanding the link between the microbiome (bacteria, archaea, fungi, and viruses) and conditions like obesity, inflammatory bowel disease, arthritis, autism, and cancer,  researchers still face many challenges.  The sheer diversity and variation of the microbiome between individuals, and even within the same person over time, complicate this mapping effort.  Current research focuses on moving from correlation to causation to better understand and utilize this knowledge for improved health outcomes.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7043356/"
        },
        {
          "title": "An expanded reference map of the human gut microbiome ...",
          "author": "Leviatan; Sigal; Shoer; Saar; Rothschild; Daphna; Gorodetski; Maria; Segal; Eran",
          "published_date": "2023-04-13T10:23:28.575000+00:00",
          "summary": "No, a complete map of the entire human microbiome and its full impact on health and disease hasn't been achieved.  However, researchers have created an expanded reference map of the gut microbiome (the richest microbial ecosystem in the body), identifying 3594 species, 310 of which were previously unknown. This improved reference set helps in better understanding the gut microbiome's role in health and disease, though much remains to be discovered about the entire human microbiome and its overall impact.\n",
          "url": "https://www.nature.com/articles/s41467-022-31502-1"
        },
        {
          "title": "A systematic framework for understanding the microbiome ...",
          "author": "Ma; Ziqi; Zuo; Tao; Frey; Norbert; Rangrez; Ashraf Yusuf",
          "published_date": "2024-09-23T00:00:00+00:00",
          "summary": "No, the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined.  While significant progress has been made through projects like the Human Microbiome Project and others mentioned in the article,  research is ongoing.  The article highlights the complexity of the microbiome and its interaction with the human genome, emphasizing that genomic differences between individuals account for only 0.1% of the total genome, with the microbiome playing a much larger role in phenotypic variation.  Current understanding focuses on microbial dysbiosis as a key factor in both health and aging, but complete mapping and understanding remain future goals.\n",
          "url": "https://www.nature.com/articles/s41392-024-01946-6"
        },
        {
          "title": "Human Microbiome Project",
          "author": "Credit",
          "published_date": "2024-06-01T00:00:00+00:00",
          "summary": "No, the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined.  The Human Microbiome Project aims to characterize the microbiome and its role in health and disease, but this is an ongoing research effort.  While significant advances have been made using metagenomics (analyzing genetic material without culturing microbes),  a large percentage of microorganisms remain unidentified and uncultivable using current methods.  The project has identified many microorganisms and their potential functions, but complete mapping and understanding remain future goals.\n",
          "url": "https://www.bcm.edu/departments/molecular-virology-and-microbiology/research/human-microbiome-project"
        }
      ],
      "full_explanation": "Based on the provided papers, a comprehensive map of the entire human microbiome and its full impact on health and disease has not been achieved. While significant progress has been made in mapping specific areas and aspects of the microbiome, the sheer complexity and variability of the microbiome across different body sites and individuals prevents a complete mapping at this time.\n\nSeveral papers explicitly state that a complete map does not exist:\n\n*   The paper titled \"An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species\" (URL: https://www.nature.com/articles/s41467-022-31502-1), while providing an expanded map of the gut microbiome (a major microbial ecosystem), focuses solely on the gut and does not represent the *entire* human microbiome. The summary of this paper explicitly states \"a complete map of the entire human microbiome and its full impact on health and disease hasn't been achieved\". This is reinforced by the secondary listing of this paper, which has the same summary.\n\n*   The paper titled \"Microbiome-associated human genetic variants impact phenome-wide disease risk\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.2200551119) analyzes the relationship between microbiome-associated variants and disease but falls short of a comprehensive map. The summary states, \"it's not a comprehensive map of the entire human microbiome or its total impact on health.\"\n\n*   The paper \"Reconstructing the landscape of gut microbial species across 29,000 diverse individuals\" (URL: https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkad249/50008702/gkad249.pdf) focuses on the gut microbiome and its relation to BMI and is not a comprehensive map of the entire microbiome. The summary says, \"a complete map of the entire human microbiome and its full impact on health and disease hasn't been achieved.\"\n\n*  The paper titled, \"Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.1707009114), states \"a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.\"  It identifies many previously unknown microbes, highlighting our incomplete understanding of the microbiome.\n\n*   The \"Current understanding of the human microbiome\" paper (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7043356/) states explicitly that \"a complete map of the human microbiome and its full impact on health and disease hasn't been achieved.\" and emphasizes the challenges with diversity.\n\n* The systematic framework paper (URL: https://www.nature.com/articles/s41392-024-01946-6) states directly \"the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined\". This paper further explains that this is due to the complexities of the microbiome.\n\n* The Human Microbiome Project paper (URL: https://www.bcm.edu/departments/molecular-virology-and-microbiology/research/human-microbiome-project) states \"the entire human microbiome has not been fully mapped, nor has its complete impact on health and disease been determined.\" and reinforces this, stating it as an ongoing effort.\n\nWhile the NIH Human Microbiome Project (URL: https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-defines-normal-bacterial-makeup-body) has made significant progress, creating a reference database of microbes from multiple body sites, it is not a complete map of *every* microbe in *every* individual and is a basis for further research.\n\nIn summary, these papers, through explicitly stating this, make it clear that the full microbiome mapping and its impact on health and disease has not yet been achieved. Research continues in this field, building on the foundations of projects such as the Human Microbiome Project and new technological advances."
    },
    {
      "question": "Has anyone used language models, agents, or RL to automate coffee production?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Towards autonomous system: flexible modular production system enhanced with large language model agents",
          "author": "[Submitted on 28 Apr 2023 (v1), last revised 24 Jul 2023 (this version, v4)]",
          "published_date": "2023-04-28T00:00:00+00:00",
          "summary": "This paper describes a system using large language models (LLMs) as agents to control a modular production system.  While it doesn't directly address coffee production, it demonstrates the use of LLMs and digital twins to enable autonomous planning and execution of tasks in a flexible manufacturing environment.  The system interprets task instructions and orchestrates low-level functionalities and high-level skills to complete them.  The authors show this with an implemented prototype capable of handling undefined tasks.  Although the application is not coffee production, the underlying methodology could potentially be adapted to automate similar processes.\n",
          "url": "https://arxiv.org/abs/2304.14721"
        },
        {
          "title": "Economical-Epidemiological Analysis of the Coffee Trees Rust Pandemic",
          "author": "T. Lazebnik,A. Rosenfeld,A. Alexi,Labib Shami",
          "published_date": "2023-10-26T19:30:23.489000+00:00",
          "summary": "This paper models the economic and epidemiological impact of coffee leaf rust in Colombia using an agent-based simulation and a deep reinforcement learning agent to find near-optimal pandemic intervention policies.  While it focuses on managing the disease's spread and economic consequences, not on automating coffee production itself, it does employ reinforcement learning (RL) and agents within its simulation framework.  Therefore, the answer to your query is partially yes; RL and agents were used, but in the context of disease management, not direct automation of coffee production processes.\n",
          "url": "https://arxiv.org/pdf/2304.14515.pdf"
        },
        {
          "title": "Computer Vision-Aided Intelligent Monitoring of Coffee: Towards Sustainable Coffee Production",
          "author": "F. Eron,M. Noman,Raphael Ricon de Oliveira,Deigo de Souza Marques,R. Durelli,Andre Pimenta Freire,A. C. Junior",
          "published_date": "2023-10-26T19:31:20.662000+00:00",
          "summary": "This research uses the YOLOv7 machine learning algorithm (a convolutional neural network) to analyze images of coffee plants, aiming to automate aspects of coffee production.  While it doesn't employ language models, agents, or reinforcement learning (RL) directly, it develops a mobile application (\"CoffeApp\") that can predict harvest time, estimate yield and quality, and inform about plant health from images taken in the field.  The goal is to improve precision agriculture in coffee farming by enabling remote monitoring for better irrigation, fertilization, and overall field management.  The study focuses on computer vision for image processing rather than AI agents or RL for automated decision-making.\n",
          "url": "https://arxiv.org/pdf/2304.04966.pdf"
        },
        {
          "title": "FoodPuzzle: Developing Large Language Model Agents as Flavor Scientists",
          "author": "Huang; Tenghao; Lee; Donghee; Sweeney; John; Shi; Jiatong; Steliotes; Emily; Lange; Matthew; May; Jonathan; Chen; Muhao",
          "published_date": "2024-09-19T00:00:00+00:00",
          "summary": "This research paper introduces FoodPuzzle, a benchmark dataset for developing AI agents in flavor science.  While not directly about coffee production automation, it uses large language models and a novel scientific agent approach to predict flavor profiles based on food item and molecule data. The authors demonstrate that their model outperforms traditional methods in flavor prediction, suggesting potential for application in automated food development processes, although no specific application to coffee is mentioned.\n",
          "url": "https://arxiv.org/abs/2409.12832"
        },
        {
          "title": "At Your Service: Coffee Beans Recommendation From a Robot Assistant",
          "author": "Jacopo de Berardinis,Gabriella Pizzuto,Francesco Lanza,A. Chella,Jorge Meira,A. Cangelosi",
          "published_date": "2023-10-26T19:28:06.090000+00:00",
          "summary": "This research paper proposes a computational model using supervised and unsupervised learning to recommend optimal coffee beans based on user preferences.  While it doesn't use language models, agents, or reinforcement learning (RL) to *automate* coffee production, it does create a system for a robot assistant to recommend beans based on predicted user preferences from a dataset of digitized coffee reviews.  The model achieves up to 92.7% accuracy in predicting coffee bean preferences.  The focus is on the recommendation aspect, not the automated physical process of making coffee.\n",
          "url": "https://arxiv.org/pdf/2008.13585.pdf"
        },
        {
          "title": "tmgthb/Autonomous-Agents",
          "author": "tmgthb",
          "published_date": "2023-09-16T15:09:48+00:00",
          "summary": "This GitHub repository tracks research papers on autonomous agents and LLMs, but doesn't contain information about using language models, agents, or reinforcement learning (RL) to automate coffee production.  The papers cover topics such as LLM safety, multi-agent collaboration, benchmarking, and security, but none relate to coffee production automation.\n",
          "url": "https://github.com/tmgthb/Autonomous-Agents"
        },
        {
          "title": "Autonomous Evaluation and Refinement of Digital Agents",
          "author": "",
          "published_date": "2022-02-15T00:00:00+00:00",
          "summary": "This arXiv paper does not address the automation of coffee production using language models, agents, or reinforcement learning.  The provided text is primarily metadata and acknowledgments, lacking any relevant technical content.\n",
          "url": "https://arxiv.org/html/2404.06474v2"
        },
        {
          "title": "(PDF) Machine Learning Techniques for Coffee Classification",
          "author": "",
          "published_date": "2024-06-18T00:00:00+00:00",
          "summary": "This research review focuses on machine learning (ML) techniques for coffee classification,  not automation of coffee production.  While it explores the use of AI for tasks like identifying bean maturity, roast intensity, and disease, it does not discuss the application of language models, agents, or reinforcement learning (RL) to automate the overall production process.\n",
          "url": "https://www.researchgate.net/publication/381632661_Machine_Learning_Techniques_for_Coffee_Classification_A_Comprehensive_Review_of_Scientific_Research"
        },
        {
          "title": "Better language models and their implications",
          "author": "",
          "published_date": "2024-04-24T00:00:00+00:00",
          "summary": "This webpage discusses OpenAI's GPT-2 language model and its performance on various language tasks.  It does not contain information about the use of language models, agents, or reinforcement learning (RL) to automate coffee production.\n",
          "url": "https://openai.com/index/better-language-models"
        },
        {
          "title": "Game On: Towards Language Models as RL Experimenters",
          "author": "Zhang; Jingwei; Lampe; Thomas; Abdolmaleki; Abbas; Springenberg; Jost Tobias; Riedmiller; Martin",
          "published_date": "2024-09-05T00:00:00+00:00",
          "summary": "This paper proposes using a Vision-Language Model (VLM) to automate the reinforcement learning (RL) experiment workflow for embodied agents.  It does *not* address automating coffee production.  The system uses a VLM to monitor experiments, suggest new tasks, decompose tasks into sub-tasks, and retrieve skills, effectively creating an automated curriculum for learning.  The authors demonstrate a prototype using a Gemini model and a language-conditioned Actor-Critic algorithm in a robotics domain, showing promising results in learning and improving control policies.  The focus is on automating the *research process* of RL, not on automating specific real-world tasks like coffee production.\n",
          "url": "https://arxiv.org/abs/2409.03402"
        }
      ],
      "full_explanation": "While several papers explore AI applications related to coffee, none directly address the automation of the *entire* coffee production process using language models, agents, or reinforcement learning (RL) as the core automation method. \n\nThe paper \"Towards autonomous system: flexible modular production system enhanced with large language model agents\" ([https://arxiv.org/abs/2304.14721](https://arxiv.org/abs/2304.14721)) utilizes LLM agents for controlling a production system, but the application is not coffee production. However, it does demonstrate the use of LLMs as agents which is one of the facets of the query.\n\nThe paper \"Economical-Epidemiological Analysis of the Coffee Trees Rust Pandemic\" ([https://arxiv.org/pdf/2304.14515.pdf](https://arxiv.org/pdf/2304.14515.pdf)) uses RL and agents for managing coffee leaf rust, not for automating the production itself. While it touches on the use of agents and RL, it isn't directly linked to the research question's focus.\n\nSimilarly, \"FoodPuzzle: Developing Large Language Model Agents as Flavor Scientists\" ([https://arxiv.org/abs/2409.12832](https://arxiv.org/abs/2409.12832)) uses LLMs as agents in flavor prediction, which has applications in the food industry, but does not focus on coffee *production*.\n\nThe other listed papers focused on image-based monitoring (\"Computer Vision-Aided Intelligent Monitoring of Coffee\" [https://arxiv.org/pdf/2304.04966.pdf](https://arxiv.org/pdf/2304.04966.pdf)), bean recommendation (\"At Your Service: Coffee Beans Recommendation From a Robot Assistant\" [https://arxiv.org/pdf/2008.13585.pdf](https://arxiv.org/pdf/2008.13585.pdf)), machine learning for classification, or general language model research. While they are related to coffee or language models, none of them combine language models, agents, or RL to automate the overall process of *coffee production* from start to finish. Therefore, no research directly answers the proposed question."
    },
    {
      "question": "Has anyone ever created a bacteria composed entirely of non-natural stereoisomers? \"Mirror life\" as some call it?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Tempo-spatial chirogenesis. Limonene-induced mirror symmetry breaking of SiSi bond polymers during aggregation in chiral fluidic media",
          "author": "Michiya  Fujiki, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, fujikim@ms.naist.jp, Keisuke  Yoshida, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, Nozomu  Suzuki, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan, Nor Azura Abdul Rahim, Jalilah Abd Jalil, Nara Institute of Science and Technology (NAIST), 8916-5, 630-0192, Takayama, Ikoma, Nara, Japan",
          "published_date": "2023-11-09T20:15:46.405000+00:00",
          "summary": "This research does not involve creating bacteria or \"mirror life\" composed entirely of non-natural stereoisomers.  The study focuses on inducing chirality in synthetic polysilane polymer aggregates using limonene, an organic molecule with chiral properties.  The researchers observed that the chirality of the limonene influenced the chirality of the resulting polymer aggregates, but this work is far removed from the creation of life forms.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S101060301600023X"
        },
        {
          "title": "Resonance in Chirogenesis and Photochirogenesis: Colloidal Polymers Meet Chiral Optofluidics",
          "author": "Michiya  Fujiki, fujikim@ms.naist.jp, Rui  Tamura, Ivan  Fernandez-Corbaton",
          "published_date": "2023-11-09T20:33:41.663000+00:00",
          "summary": "This research article does not discuss the creation of bacteria composed entirely of non-natural stereoisomers (\"mirror life\").  The study focuses on manipulating the chirality of polymers in colloidal solutions using light and specific refractive indices,  demonstrating control over chiroptical properties (like circular dichroism). While relevant to chirality, it doesn't address the creation of life forms with unnatural stereoisomers.\n",
          "url": "https://www.mdpi.com/2073-8994/13/2/199"
        },
        {
          "title": "Spontaneous mirror symmetry breaking in heterocatalytically coupled enantioselective replicators\u2020 \u2020Electronic supplementary information (ESI) available: Methods and text on stability analysis. Five figures showing simulation examples. See DOI: 10.1039/c6sc02446g Click here for additional data file.",
          "author": "J. Rib\u00f3,J. Crusats,Z. El-Hachemi,A. Moyano,D. Hochberg",
          "published_date": "2023-10-26T19:31:58.697000+00:00",
          "summary": "This research paper does not discuss the creation of bacteria composed entirely of non-natural stereoisomers.  The study focuses on spontaneous mirror symmetry breaking in chemical replicators through computational modeling, investigating conditions under which a racemic mixture transitions to a chiral state.  While relevant to the concept of \"mirror life,\" the paper is a theoretical exploration of chemical processes, not a report on biological creation.\n",
          "url": "https://pubs.rsc.org/en/content/articlepdf/2017/sc/c6sc02446g"
        },
        {
          "title": "A chemically fuelled self-replicator",
          "author": "Sarah M Morrow, Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, Oxford, UK, Ignacio  Colomer, Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, Oxford, UK, Stephen P Fletcher, Chemistry Research Laboratory, University of Oxford, Mansfield Road, OX1 3TA, Oxford, UK, stephen.fletcher@chem.ox.ac.uk",
          "published_date": "2023-11-09T20:25:34.223000+00:00",
          "summary": "This article describes a chemically fueled self-replicating system, but it does not involve the creation of bacteria or organisms composed of non-natural stereoisomers (\"mirror life\").  The research focuses on a synthetic, abiotic replicator maintained out of equilibrium by consuming chemical fuel, analogous to a simple metabolic cycle.  It does not address the creation of life or life-like structures from non-natural components.\n",
          "url": "https://www.nature.com/articles/s41467-019-08885-9"
        },
        {
          "title": "A transient self-assembling self-replicator",
          "author": "Ignacio Colomer,S. Morrow,S. Fletcher",
          "published_date": "2023-10-26T19:29:05.252000+00:00",
          "summary": "This research article describes a synthetic, self-replicating molecule, but it does not involve the creation of bacteria or the use of non-natural stereoisomers (\"mirror life\").  The study focuses on a small molecule system that self-assembles and catalyzes its own formation, but then undergoes a second reaction that leads to its depletion.  The system is described as a model for understanding living systems, but it is not a living organism itself and does not use non-natural components.\n",
          "url": "https://www.nature.com/articles/s41467-018-04670-2.pdf"
        },
        {
          "title": "Leading Scientists Urge Ban On Developing 'Mirror-Image' ...",
          "author": "BeauHD; Desist Dept",
          "published_date": "2024-12-12T00:00:00+00:00",
          "summary": "No, fully mirror-image bacteria have not yet been created.  However, a group of scientists published a policy forum in *Science* urging a ban on research to create such bacteria, citing the potential for catastrophic consequences.  While mirror-image amino acids and peptides have been incorporated into some drugs, creating a self-replicating organism composed entirely of non-natural stereoisomers is considered a significant risk due to its potential to evade natural defenses.  Scientists estimate it will be at least a decade before the technology to create such \"mirror life\" exists.\n",
          "url": "https://science.slashdot.org/story/24/12/13/0014232/leading-scientists-urge-ban-on-developing-mirror-image-bacteria?utm_source=rss1.0mainlinkanon&utm_medium=feed"
        },
        {
          "title": "Biomolecular Significance of Homochirality: The Origin ...",
          "author": "",
          "published_date": "2012-09-01T00:00:00+00:00",
          "summary": "This research paper discusses the homochirality of life (the preference for L-amino acids and D-sugars).  It explores theories about how this preference originated, including the influence of circularly polarized radiation and parity violation by the weak force.  The paper does *not* address the creation of bacteria using non-natural stereoisomers (\"mirror life\").  The focus is on understanding the origin of life's existing chirality, not on artificial creation of opposite chirality life forms.\n",
          "url": "https://www.researchgate.net/publication/286221247_82_Perspective_and_Concepts_Biomolecular_Significance_of_Homochirality_The_Origin_of_the_Homochiral_Signature_of_Life"
        },
        {
          "title": "Mirror image proteins",
          "author": "",
          "published_date": "2014-10-01T00:00:00+00:00",
          "summary": "Research has explored creating mirror-image organisms composed entirely of D-amino acids (the non-natural stereoisomers of the amino acids used in naturally occurring life).  The text mentions the synthesis of *D. coli*, a mirror image of *E. coli*, as an example.  However, the full details of this synthesis and the viability of such a fully \"mirror-image\" organism are not provided in this abstract.\n",
          "url": "https://www.researchgate.net/publication/266397602_Mirror_image_proteins"
        },
        {
          "title": "Young Academy of India",
          "author": "",
          "published_date": null,
          "summary": "The provided text is not in a readable format and does not contain information relevant to the user's query about the creation of bacteria composed entirely of non-natural stereoisomers (\"mirror life\").  Therefore, I cannot provide a summary answering the user's question.\n",
          "url": "https://www.facebook.com/groups/youngacademyofindia/"
        }
      ],
      "full_explanation": "While the concept of \"mirror life\" and the use of non-natural stereoisomers are discussed in some of the provided papers, none of them describe the actual creation of a self-replicating bacteria composed entirely of non-natural stereoisomers. Here's a breakdown of why:\n\n*   **Papers focusing on chirality but not \"mirror life\":** Several papers explore the manipulation of chirality in non-biological systems. These include \"Tempo-spatial chirogenesis. Limonene-induced mirror symmetry breaking of SiSi bond polymers during aggregation in chiral fluidic media\" (https://www.sciencedirect.com/science/article/pii/S101060301600023X), \"Resonance in Chirogenesis and Photochirogenesis: Colloidal Polymers Meet Chiral Optofluidics\" (https://www.mdpi.com/2073-8994/13/2/199), and \"Spontaneous mirror symmetry breaking in heterocatalytically coupled enantioselective replicators\" (https://pubs.rsc.org/en/content/articlepdf/2017/sc/c6sc02446g). These studies delve into the behavior of chirality in polymers and chemical replicators, but they do not involve the creation of biological organisms.\n*   **Papers on self-replicating systems but not using non-natural components:** Papers such as \"A chemically fuelled self-replicator\" (https://www.nature.com/articles/s41467-019-08885-9) and \"A transient self-assembling self-replicator\" (https://www.nature.com/articles/s41467-018-04670-2.pdf) describe synthetic, self-replicating molecules. However, these systems do not involve the use of non-natural stereoisomers to create an analog of bacteria. They do not have the complex biological machinery found in bacteria, nor are they composed of the mirror image of biological molecules.\n*   **Paper discussing homochirality, not mirror life creation:** \"Biomolecular Significance of Homochirality: The Origin...\" (https://www.researchgate.net/publication/286221247_82_Perspective_and_Concepts_Biomolecular_Significance_of_Homochirality_The_Origin_of_the_Homochiral_Signature_of_Life) discusses the origins of homochirality in life, but does not describe work to create \"mirror life\".\n*  **Mirror image proteins:** While \"Mirror image proteins\" (https://www.researchgate.net/publication/266397602_Mirror_image_proteins) mentions the synthesis of *D. coli* as an example, the full details of the synthesis and viability are not provided in the abstract, and there is no indication that a self-replicating organism was made.\n*   **The crucial \"no\" comes from \"Leading Scientists Urge Ban On Developing 'Mirror-Image'...\"**: (https://science.slashdot.org/story/24/12/13/0014232/leading-scientists-urge-ban-on-developing-mirror-image-bacteria?utm_source=rss1.0mainlinkanon&utm_medium=feed) This article explicitly states that \"fully mirror-image bacteria have not yet been created.\" and further indicates scientists believe the technology is at least a decade away. The policy forum also reinforces the idea that while some mirror-image molecules have been made, creating a fully mirrored self-replicating organism is a significant future challenge and has not yet been accomplished.\n\nTherefore, based on the provided papers, the research question has *not* been addressed yet. No one has created a bacteria composed entirely of non-natural stereoisomers."
    },
    {
      "question": "Has anyone made an effective HIV vaccine?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Triggering rare HIV antibodies by vaccination",
          "author": "Penny L Moore",
          "published_date": "2023-02-27T23:21:54.662000+00:00",
          "summary": "No effective HIV vaccine currently exists.  A recent clinical trial showed that a germline-targeting approach elicited rare, broadly neutralizing antibodies (bnAbs) in some participants, offering a potential pathway towards vaccine development. However, much more research is needed before a viable vaccine is available.  The urgency is highlighted by the high rate of new HIV infections, particularly among adolescent girls and young women in sub-Saharan Africa.\n",
          "url": "https://www.science.org/doi/10.1126/science.adf3722?cookieSet=1"
        },
        {
          "title": "A multiclade env\u2013gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques - Nature Medicine",
          "author": "Zhang; Peng; Narayanan; Elisabeth; Liu; Qingbo; Tsybovsky; Yaroslav; Boswell; Kristin; Ding; Shilei; Hu; Zonghui; Follmann; Dean; Lin; Yin; Miao; Schmeisser; Hana; Rogers; Denise; Falcone; Samantha; Elbashir; Sayda M; Presnyak; Vladimir; Bahl; Kapil; Prabhakaran; Madhu; Chen; Xuejun; Sarfo; Edward K; Ambrozak; David R; Gautam; Rajeev; Martin; Malcom A; Swerczek; Joanna; Herbert; Richard; Weiss; Deborah; Misamore; Johnathan; Ciaramella; Giuseppe; Himansu; Sunny; Stewart-Jones; Guillaume; McDermott; Adrian; Koup; Mascola; John R; Finzi; Andr\u00e9s; Carfi; Andrea; Fauci; Anthony S; Lusso; Paolo",
          "published_date": "2023-02-07T21:14:57.779000+00:00",
          "summary": "No effective HIV vaccine currently exists.  While research continues, and some preclinical studies show promise (including one cited study showing reduced risk of infection in macaques),  no vaccine has proven consistently protective in human trials.  The RV144 trial showed limited protection (~30%), but this result hasn't been replicated.  The challenges include HIV's high antigenic variability and the difficulty of eliciting broadly neutralizing antibodies.\n",
          "url": "https://www.nature.com/articles/s41591-021-01574-5"
        },
        {
          "title": "Progress in HIV-1 vaccine development.",
          "author": "Barton F Haynes, hayne002@mc.duke.edu, M Anthony Moody, Munir  Alam, Mattia  Bonsignori, Laurent  Verkoczy, Guido  Ferrari, Feng  Gao, Georgia D Tomaras, Hua-Xin  Liao, Garnett  Kelsoe",
          "published_date": "2023-11-09T20:07:47.988000+00:00",
          "summary": "No, an effective HIV-1 vaccine has not yet been developed.  While recent research has yielded advances in understanding HIV-1 and identifying potential vaccine targets (e.g., envelope targets of protective antibodies, CD8(+) T cells), a 2013 efficacy trial failed to prevent infection.  Significant roadblocks remain, and widespread vaccine deployment is still years away.\n",
          "url": "https://jacionline.org/retrieve/pii/S0091674914006009"
        },
        {
          "title": "Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys - Nature",
          "author": "Borducchi; Erica N; Cabral; Crystal; Stephenson; Kathryn E; Liu; Jinyan; Abbink; Peter; Nga; David; Nkolola; Joseph P; Brinkman; Amanda L; Lauren; Lee; Benjamin C; Jimenez; Jessica; Jetton; Mondesir; Jade; Mojta; Shanell; Chandrashekar; Abishek; Molloy; Katherine; Alter; Galit; Gerold; Jeffrey M; Hill; Alison L; Lewis; Mark G; Pau; Maria G; Schuitemaker; Hanneke; Hesselgesser; Joseph; Geleziunas; Romas; Kim; Jerome H; Robb; Merlin L; Michael; Nelson L; Barouch; Dan H",
          "published_date": "2023-02-06T20:35:55.347000+00:00",
          "summary": "This study used a therapeutic vaccine (Ad26/MVA) and a TLR7 agonist (GS-986) in SIV-infected rhesus monkeys to assess its impact on the viral reservoir.  While the vaccine stimulated immune responses, the study doesn't conclude on the creation of an effective HIV vaccine.  The research demonstrated that the combined approach did improve cellular immune responses compared to the vaccine alone, but  long-term effects on viral rebound after ART discontinuation were not definitively established.  Therefore, the research is ongoing, and no effective HIV vaccine has resulted from this specific study.\n",
          "url": "https://www.nature.com/articles/nature20583"
        },
        {
          "title": "Vaccine protection against SIVmac239 acquisition",
          "author": "Ronald C. Desrosiers",
          "published_date": "2019-01-29T00:00:00+00:00",
          "summary": "No effective HIV vaccine currently exists.  Research using monkey models (SIV, a simian immunodeficiency virus similar to HIV) shows some promise.  A study using a herpesvirus-based vaccine containing a near-full-length SIV genome demonstrated significant protection against SIVmac239 (a difficult-to-neutralize strain) in rhesus monkeys. However, further research is needed to determine the critical components of this protection, its breadth against various strains, and its applicability to humans.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1814584116"
        },
        {
          "title": "HIV vaccine: Can it be developed in the 21st century? - PMC",
          "author": "",
          "published_date": "2015-07-25T00:00:00+00:00",
          "summary": "No, there is currently no effective HIV vaccine.  While research is ongoing and there is hope for future development,  the text states that there is currently no cure for HIV infection, despite the availability of effective antiretroviral (ARV) drugs to manage the disease.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4962743/#:~:text=This%20US.,HIV%2Dinfected%20were%20placebo%20recipients."
        },
        {
          "title": "NIH research identifies opportunities to improve future HIV ...",
          "author": "",
          "published_date": "2023-12-15T17:24:37+00:00",
          "summary": "No, an effective HIV vaccine has not yet been developed.  While research continues, studies show that current vaccine candidates, although producing CD8+ T cells, haven't generated sufficient T-cell receptor sensitivity to effectively destroy HIV-infected cells.  Future vaccines may need to improve the stimulation and maturation of these CD8+ T cells for better efficacy.\n",
          "url": "https://www.nih.gov/news-events/news-releases/nih-research-identifies-opportunities-improve-future-hiv-vaccine-candidates"
        },
        {
          "title": "Encouraging First-in-Human Results for a Promising HIV ...",
          "author": "",
          "published_date": "2023-06-08T00:00:00+00:00",
          "summary": "No, there is not yet an FDA-approved HIV vaccine.  However, early-stage human trials of a new nanoparticle vaccine (eOD-GT8 60-mer) show promising results.  The vaccine was deemed safe and elicited a robust immune response in nearly all participants, expanding production of a rare type of antibody-producing B cell crucial for broadly neutralizing antibodies against HIV variants.  While this is a significant step, it's intended as part of a larger, multi-step vaccination regimen and will not offer protection alone.\n",
          "url": "https://www.hiv.gov/blog/encouraging-first-in-human-results-for-a-promising-hiv-vaccine"
        },
        {
          "title": "HIV Vaccines",
          "author": "",
          "published_date": "2024-03-04T18:06:01+00:00",
          "summary": "No effective HIV vaccine currently exists.  While significant progress has been made in understanding HIV and developing potential vaccine candidates,  including identifying broadly neutralizing antibodies (bnAbs) that can block HIV infection in lab settings and even in some clinical trials using bnAb infusions,  no vaccine has yet proven effective at preventing HIV infection in humans.  Research continues, focusing on next-generation vaccines designed to elicit these bnAbs.\n",
          "url": "https://www.iavi.org/our-work/hiv-vaccines/"
        },
        {
          "title": "A brief history of the global effort to develop a preventive ...",
          "author": "Author links open overlay panel Jos\u00e9 Esparza",
          "published_date": "2023-02-23T05:43:24.073000+00:00",
          "summary": "No, despite significant global effort over 30 years and exploration of various scientific paradigms (inducing neutralizing antibodies, cell-mediated immunity, and combination approaches),  an effective preventive HIV vaccine has not yet been developed.  While the RV144 trial in Thailand showed modest success, it has not led to a widely available vaccine.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0264410X13005963"
        }
      ],
      "full_explanation": "All of the provided papers consistently state that an effective HIV vaccine has not yet been developed, despite decades of research. The papers highlight different approaches and progress in HIV vaccine development, but none of them report the successful creation of a fully effective vaccine.\n\n*   **Moore (2023)** states, \"No effective HIV vaccine currently exists.\" It also highlights a recent clinical trial showing promise in eliciting broadly neutralizing antibodies but concludes that \"much more research is needed before a viable vaccine is available.\" [https://www.science.org/doi/10.1126/science.adf3722?cookieSet=1]\n*   **Zhang et al. (2023)** also explicitly says \"No effective HIV vaccine currently exists\" and explains that while some preclinical studies are promising, no vaccine has consistently proven protective in human trials, citing the limitations of the RV144 trial. [https://www.nature.com/articles/s41591-021-01574-5]\n*   **Haynes et al. (2023)** states, \"No, an effective HIV-1 vaccine has not yet been developed.\" and mentions a failed efficacy trial from 2013. [https://jacionline.org/retrieve/pii/S0091674914006009]\n*   **Desrosiers (2019)** also states, \"No effective HIV vaccine currently exists\" even while highlighting the protective effects of a vaccine in monkeys. [https://www.pnas.org/doi/full/10.1073/pnas.1814584116]\n*  The paper titled **\"HIV vaccine: Can it be developed in the 21st century? - PMC\" (2015)** says that there is \"currently no effective HIV vaccine.\" [https://pmc.ncbi.nlm.nih.gov/articles/PMC4962743/#:~:text=This%20US.,HIV%2Dinfected%20were%20placebo%20recipients.]\n*   The **NIH (2023)** report states, \"No, an effective HIV vaccine has not yet been developed\" and discusses the limitations of current vaccine candidates. [https://www.nih.gov/news-events/news-releases/nih-research-identifies-opportunities-improve-future-hiv-vaccine-candidates]\n*   The paper titled **\"HIV Vaccines\" (2024)** also confirms that \"No effective HIV vaccine currently exists.\" [https://www.iavi.org/our-work/hiv-vaccines/]\n*   **Esparza (2023)** highlights the long-standing efforts and various approaches attempted stating, \"an effective preventive HIV vaccine has not yet been developed.\" [https://www.sciencedirect.com/science/article/pii/S0264410X13005963]\n\nWhile some of the papers mention promising advances in vaccine research, including the elicitation of broadly neutralizing antibodies, and some protection in monkey models, none of them report the existence of an effective HIV vaccine that has been proven to be effective in human trials. Therefore, the answer to the question \"Has anyone made an effective HIV vaccine?\" is NO.\n\nNote: The Borducchi et al. (2023) paper describes a therapeutic approach to SIV in monkeys and is not related to a preventive HIV vaccine. The \"Encouraging First-in-Human Results for a Promising HIV...\" paper (2023) describes very promising results but also notes that it is an early-stage result and part of a multi-step approach, it does not constitute an effective vaccine on its own. Therefore, these papers were not cited as they do not contribute to a conclusion that a preventative vaccine exists."
    },
    {
      "question": "Has anyone showed an effective nootropic in an RCT?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial",
          "author": "Vaccaro; Maria Grazia; Innocenti; Bernardo; Cione; Erika; Gallelli; Luca; De Sarro; Giovambattista; Bonilla; Diego A; Cannataro; Roberto",
          "published_date": "2023-10-24T00:00:00+00:00",
          "summary": "A double-blind, placebo-controlled crossover trial (RCT) showed that a chewable beetroot supplement significantly improved memory consolidation (short and long-term) and enhanced frontal lobe function and cognitive flexibility in healthy participants.  The effects were observed 90 minutes after ingestion.  While some mood and anxiety measures showed mixed results, the study demonstrated a positive nootropic effect from the beetroot supplement.\n",
          "url": "https://link.springer.com/article/10.1007/s00394-023-03265-y"
        },
        {
          "title": "Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers",
          "author": "Hartmann; Helena; Forkmann; Katarina; Schmidt; Katharina; Kleine-Borgmann; Julian; Albers; Johanna; Wiech; Katja; Bingel; Ulrike",
          "published_date": "2023-11-09T00:00:00+00:00",
          "summary": "This study investigated whether open-label placebo (OLP), where participants know they're receiving an inert treatment, improves cognitive performance.  While previous research suggested placebo effects could enhance cognition, this RCT found that OLP did *not* improve objective cognitive abilities in healthy volunteers, despite participants being aware of the treatment.  Therefore, this study does not provide evidence of an effective nootropic in a randomized controlled trial.\n",
          "url": "https://www.nature.com/articles/s41598-023-45979-3"
        },
        {
          "title": "Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial - PubMed",
          "author": "Paul H Falcone 1 ,",
          "published_date": "2018-12-12T00:00:00+00:00",
          "summary": "Yes, a randomized controlled trial (RCT) showed a proprietary spearmint extract (containing at least 14.5% rosmarinic acid and 24% total phenolic content) improved reactive agility.  While the study focused on individuals aged 50-70 with memory impairment, the results suggest a potential nootropic effect translating to improved physical performance.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30541572/?dopt=Abstract"
        },
        {
          "title": "Evidence for Cognitive Placebo and Nocebo Effects in Healthy Individuals",
          "author": "Zsolt  Turi, University Medical Center Goettingen, Goettingen, Germany, Espen  Bj\u00f8rkedal, University of Troms\u00f8, Troms\u00f8, Norway, Luisa  Gunkel, University Medical Center Goettingen, Goettingen, Germany, Andrea  Antal, University Medical Center Goettingen, Goettingen, Germany, Walter  Paulus, University Medical Center Goettingen, Goettingen, Germany, Matthias  Mittner, University of Troms\u00f8, Troms\u00f8, Norway, matthias.mittner@uit.no",
          "published_date": "2023-11-09T20:24:18.135000+00:00",
          "summary": "This study demonstrated both placebo and nocebo effects on cognitive performance (reward-based learning) in a healthy population using sham non-invasive brain stimulation (NIBS), verbal suggestions, and conditioning.  While not testing a specific nootropic, the results highlight the significant impact of expectation on cognitive outcomes, even without a pharmacological intervention.  The study emphasizes the need for rigorous double-blind designs in cognitive enhancement research, particularly in NIBS studies, to control for placebo effects.  Therefore, it doesn't directly answer whether an effective nootropic has been shown in an RCT, but underscores the challenges in demonstrating efficacy due to potent placebo effects.\n",
          "url": "https://www.nature.com/articles/s41598-018-35124-w"
        },
        {
          "title": "A Combination of Nootropic Ingredients (CAF+) Is Not Better than Caffeine in Improving Cognitive Functions - Journal of Cognitive Enhancement",
          "author": "Caldenhove; S; A; Woo; G; Blokland",
          "published_date": "2023-02-06T09:26:20.201000+00:00",
          "summary": "A randomized, double-blind, placebo-controlled crossover study (RCT) of the nootropic CAF+ (containing caffeine, l-theanine, vinpocetine, l-tyrosine, and vitamins B6/B12) found it was not superior to caffeine alone in improving cognitive performance in young adults.  Caffeine improved memory, working memory, and sensorimotor speed, while CAF+ showed no significant cognitive benefits.  Therefore, this study does not demonstrate an effective nootropic combination superior to caffeine in an RCT setting.\n",
          "url": "https://link.springer.com/article/10.1007/s41465-017-0061-0"
        },
        {
          "title": "Effectiveness of Nootropics in Combination with ...",
          "author": "",
          "published_date": "2022-08-09T00:00:00+00:00",
          "summary": "This real-world data study of 583 patients with mild-to-moderate dementia found no overall significant difference in cognitive function (measured by MMSE) between those taking only cholinesterase inhibitors (ChEIs) and those taking ChEIs plus nootropics.  However, in patients with Alzheimer's disease who were highly adherent to treatment, the combination group showed significantly less deterioration in MMSE language subscale scores.  Within this subgroup, choline alfoscerate and ginkgo biloba showed the most significant improvements.  The study concludes that more well-controlled studies (e.g., RCTs) are needed to confirm these findings and generalize the effectiveness of nootropics.  Therefore, the study does not definitively show an effective nootropic in a randomized controlled trial (RCT).\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9409895/"
        },
        {
          "title": "The effectiveness of Bacopa monnieri (Linn.) Wettst. as a ...",
          "author": "James M Brimson, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Sirikalaya  Brimson, Chulalongkorn University, 10330, Bangkok, Thailand, Mani Iyer Prasanth, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Premrutai  Thitilertdecha, Siriraj Research Group in Immunobiology and Therapeutic Sciences, Mahidol University, Bangkok, Thailand, Dicson Sheeja Malar, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, Tewin  Tencomnao, Age-Related Inflammation and Degeneration Research Unit, Chulalongkorn University, 10330, Bangkok, Thailand, tewin.t@chula.ac.th",
          "published_date": "2023-11-09T20:32:26.308000+00:00",
          "summary": "A meta-analysis of studies on Bacopa monnieri, a plant traditionally used to enhance memory, found limited evidence of its effectiveness as a nootropic in randomized controlled trials (RCTs). While some studies showed modest improvements in memory tasks in healthy subjects and those with memory loss, few reached statistical significance.  Furthermore,  the observed benefits in conditions like Alzheimer's disease were seen when Bacopa monnieri was combined with other plant extracts, making it difficult to isolate its specific effects.  More RCTs comparing Bacopa monnieri to standard drugs are needed to confirm its nootropic properties.\n",
          "url": "https://www.nature.com/articles/s41598-020-80045-2"
        },
        {
          "title": "Nootropics as Cognitive Enhancers: Types, Dosage and ...",
          "author": "",
          "published_date": "2022-08-17T00:00:00+00:00",
          "summary": "This review article on nootropics (smart drugs) doesn't cite any randomized controlled trials (RCTs) demonstrating the effectiveness of a specific nootropic.  While it discusses various nootropics, their uses, dosages, and side effects, the article focuses on providing an overview of available substances and their potential, rather than presenting conclusive evidence from rigorous RCTs.  The long-term effects on healthy individuals are also noted as unknown.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9415189/"
        },
        {
          "title": "The Efficacy of A Nootropic Supplement on Information ...",
          "author": "",
          "published_date": "2023-03-07T00:00:00+00:00",
          "summary": "Yes, a double-blind, placebo-controlled study (RCT) showed that the nootropic supplement Mind Lab Pro significantly improved simple reaction time, choice reaction time, and anticipation in healthy adults compared to a placebo group.  The improvements were statistically significant (p<0.001 for SRT and CRT, p=0.001 for anticipation).\n",
          "url": "https://biomedres.us/pdfs/BJSTR.MS.ID.007746.pdf"
        },
        {
          "title": "A Combination of Nootropic Ingredients (CAF+) Is Not ...",
          "author": "Caldenhove; S; A; Woo; G; Blokland",
          "published_date": "2023-02-06T09:26:20.201000+00:00",
          "summary": "A randomized, double-blind, placebo-controlled crossover trial (RCT) found that caffeine improved memory performance and sensorimotor speed in healthy young adults.  However, a combination nootropic (CAF+), containing caffeine, l-theanine, vinpocetine, l-tyrosine, and vitamins B6/B12, did not show superior cognitive benefits compared to caffeine alone.  In fact, caffeine performed better than CAF+ on several cognitive tests.\n",
          "url": "https://link.springer.com/article/10.1007/s41465-017-0061-0"
        }
      ],
      "full_explanation": "Several studies have shown effective nootropics in randomized controlled trials (RCTs). The paper titled \"Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial\" (https://link.springer.com/article/10.1007/s00394-023-03265-y) demonstrated that a beetroot supplement significantly improved memory consolidation and frontal lobe function in healthy participants in a double-blind, placebo-controlled crossover RCT.  Additionally, the paper \"Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial - PubMed\" (https://pubmed.ncbi.nlm.nih.gov/30541572/?dopt=Abstract) showed that a spearmint extract improved reactive agility in an RCT. Finally, \"The Efficacy of A Nootropic Supplement on Information ... \" (https://biomedres.us/pdfs/BJSTR.MS.ID.007746.pdf) provides evidence that Mind Lab Pro improved reaction times and anticipation in an RCT. These papers confirm that studies have, in fact, shown effective nootropics in RCTs.\n\nIt is important to note that some other RCTs did not show efficacy, such as \"A Combination of Nootropic Ingredients (CAF+) Is Not Better than Caffeine in Improving Cognitive Functions - Journal of Cognitive Enhancement\" (https://link.springer.com/article/10.1007/s41465-017-0061-0), which found a caffeine-based nootropic blend was not superior to caffeine alone, and \"Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers\" (https://www.nature.com/articles/s41598-023-45979-3), which showed no effect from open-label placebo, which is not a nootropic. However, the existence of positive results to the research question is all that is necessary to answer it."
    },
    {
      "question": "Has anyone found experimental or observational evidence that explicitly contradicts the dark matter hypothesis?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A possible tension between galaxy rotational velocity and observed physical properties",
          "author": "L. Shamir,Darius Mcadam",
          "published_date": "2023-10-26T19:31:31.955000+00:00",
          "summary": "This paper reports an observation that may challenge the dark matter hypothesis.  The authors found a significant brightness difference between galaxies rotating in the same and opposite directions as the Milky Way. This difference is larger than expected from Doppler shift alone and implies galaxies have much higher rotational velocities than predicted by current models, including those that incorporate dark matter. The observed difference is consistent across multiple telescopes and analysis methods.  While the authors suggest alternative explanations like parity violation, the discrepancy itself presents a potential challenge to the standard dark matter explanation for galaxy rotation curves.\n",
          "url": "https://arxiv.org/pdf/2212.04044.pdf"
        },
        {
          "title": "A Candid Assessment of Standard Cosmology",
          "author": "Fulvio Melia",
          "published_date": "2022-12-19T00:00:00+00:00",
          "summary": "This paper argues that the standard cosmological model (\u039bCDM), which incorporates dark matter, faces significant challenges due to inconsistencies between observations and theoretical predictions.  While \u039bCDM successfully explains some cosmological observations, the authors highlight eight major problems, including inconsistencies with inflation and the CMB anisotropies.  The paper doesn't present direct experimental evidence contradicting dark matter, but rather argues that the ensemble of unresolved issues casts serious doubt on the completeness, and possibly the correctness, of the \u039bCDM model, thereby indirectly questioning the dark matter hypothesis.\n",
          "url": "https://iopscience.iop.org/article/10.1088/1538-3873/aca51f"
        },
        {
          "title": "A Search for Magnetized Quark Nuggets (MQNs), a Candidate for Dark Matter, Accumulating in Iron Ore",
          "author": "[Submitted on 13 Feb 2024]",
          "published_date": "2024-02-13T00:00:00+00:00",
          "summary": "This arXiv paper describes a search for magnetized quark nuggets (MQNs), a potential dark matter candidate, in recycled steel furnace bottoms.  While the study found magnetic anomalies consistent with trapped MQNs (at a rate of ~1 kg per 1.2 x 10\u2078 kg of processed taconite ore), the authors acknowledge that other explanations are possible.  The paper does *not* present evidence contradicting the dark matter hypothesis; rather, it investigates a potential dark matter source and presents inconclusive results.  Further experimentation is proposed to confirm or refute the MQN hypothesis.\n",
          "url": "https://arxiv.org/abs/2402.08163"
        },
        {
          "title": "Modified Newtonian Dynamics as an Alternative to the Planet Nine Hypothesis",
          "author": "Katherine Jones-Smith,H. Mathur",
          "published_date": "2023-10-26T19:27:53.497000+00:00",
          "summary": "This paper proposes Modified Newtonian Dynamics (MOND) as an alternative explanation for the orbital anomalies of a new class of Kuiper Belt Objects, anomalies previously attributed to a hypothetical \"Planet Nine.\"  The authors argue that MOND's galactic field creates quadrupolar and octupolar effects that align the orbits of these objects, matching observations.  While the paper supports MOND, which doesn't require dark matter to explain galactic rotation, it does *not* offer experimental or observational evidence directly contradicting the dark matter hypothesis.  The focus is on an alternative explanation for a specific phenomenon, not a general refutation of dark matter.\n",
          "url": "https://arxiv.org/pdf/2304.00576.pdf"
        },
        {
          "title": "A Modest Proposal for the Non-existence of Exoplanets: The Expansion of Stellar Physics to Include Squars",
          "author": "Charity Woodrum,R. E. Hviding,R. Amaro,Katherine Chamberlain",
          "published_date": "2023-10-26T19:29:30.429000+00:00",
          "summary": "This paper proposes a novel theory suggesting that observed phenomena attributed to exoplanets are actually caused by a new type of star called a \"squar.\"  The authors argue that the evidence supporting exoplanets is not definitive and that current methods rely on untested assumptions.  They propose the squar model as an alternative explanation, citing the example of WASP-12b's light curve being reconstructable using a rotating squar.  The paper does not address the dark matter hypothesis.\n",
          "url": "https://arxiv.org/pdf/2303.16915.pdf"
        },
        {
          "title": "The Scientific Evidence Against the Big Bang",
          "author": "Ivana Karamitsos",
          "published_date": "2022-06-16T03:33:50+00:00",
          "summary": "This article argues against the Big Bang theory, citing several contradictions between its predictions and observations.  It does not, however, address the dark matter hypothesis directly.  Therefore, it offers no evidence for or against the existence of dark matter.\n",
          "url": "https://www.lppfusion.com/science/cosmic-connection/plasma-cosmology/the-growing-case-against-the-big-bang/"
        },
        {
          "title": "Has a new study disproven dark matter and dark energy?",
          "author": "Ethan Siegel",
          "published_date": "2024-03-29T03:20:06+00:00",
          "summary": "No, a recent study claiming to debunk dark matter hasn't presented observational or experimental evidence that explicitly contradicts the hypothesis.  The article explains that the current cosmological model, including dark matter and dark energy, is supported by a multitude of independent lines of evidence.  While alternative theories exist, none have yet provided the same level of explanatory power or consistency with observations as the current model.\n",
          "url": "https://bigthink.com/starts-with-a-bang/new-study-disprove-dark-matter-dark-energy/"
        },
        {
          "title": "Study: Dark matter doesn't exist, the universe is 27B years old",
          "author": "",
          "published_date": "2024-10-15T12:04:30+00:00",
          "summary": "A recent study proposes a cosmological model that eliminates the need for dark matter while remaining consistent with key observations.  However, the discussion on Hacker News highlights that this study doesn't provide direct experimental or observational evidence *contradicting* dark matter; rather, it offers an alternative explanation.  The post emphasizes that many dark matter theories exist, some already tested and ruled out, while others remain unfalsifiable due to the inherent limitations of cosmological testing. The question of dark matter's existence remains open, with current understanding based on the best-fitting model to available observations.\n",
          "url": "https://news.ycombinator.com/item?id=41847656"
        },
        {
          "title": "Have there been any physics experiments or searches to ...",
          "author": "user129079user129079",
          "published_date": "2016-09-03T05:24:00+00:00",
          "summary": "No experimental or observational evidence explicitly contradicts the dark matter hypothesis. While the nature of dark matter remains unknown, observations like galactic rotation curves and gravitational lensing consistently point to the existence of unseen mass.  Alternative explanations, such as modifications to gravity, are considered less likely due to various theoretical and observational reasons.  Research continues to investigate dark matter's properties and potential candidates.\n",
          "url": "https://physics.stackexchange.com/questions/277912/have-there-been-any-physics-experiments-or-searches-to-try-to-disprove-the-hypot"
        },
        {
          "title": "Has Dark Matter Finally Been Detected? | Not Even Wrong",
          "author": "Posted on",
          "published_date": "2009-12-18T03:09:54+00:00",
          "summary": "No experimental evidence explicitly contradicts the dark matter hypothesis.  However, the author cites the CDMS experiment, which reported two events where 0.8 were expected.  While some initially considered this potentially exciting, the author concludes it's not a significant signal and that even these results further constrain the parameter space for supersymmetry, a theory that predicts dark matter.  The author emphasizes that this and previous CDMS results do not constitute evidence *for* dark matter, but their lack of results would have been more problematic for theories that predict its existence.\n",
          "url": "https://www.math.columbia.edu/~woit/wordpress/?p=2597"
        }
      ],
      "full_explanation": "While many of the provided papers discuss challenges to the standard cosmological model and propose alternatives to dark matter, only one paper presents experimental or observational evidence that *explicitly contradicts* the dark matter hypothesis. \n\nSpecifically, the paper titled \"A possible tension between galaxy rotational velocity and observed physical properties\" by L. Shamir and Darius Mcadam (URL: https://arxiv.org/pdf/2212.04044.pdf) reports a significant brightness difference between galaxies rotating in the same and opposite directions as the Milky Way. This observed difference suggests galaxy rotational velocities are higher than predicted by models, including those that incorporate dark matter. This discrepancy, which is observed across multiple telescopes and analysis methods, presents a potential challenge to the standard dark matter explanation for galaxy rotation curves, and therefore is considered to be evidence that is in tension with the dark matter hypothesis.\n\nOther papers, while critical of the standard model, do not present direct contradicting evidence. For example, the paper by Fulvio Melia, \"A Candid Assessment of Standard Cosmology\" (URL: https://iopscience.iop.org/article/10.1088/1538-3873/aca51f) raises several issues with the \u039bCDM model, but does not offer observational evidence directly contradicting dark matter. Similarly, the paper proposing MOND as an alternative explanation for Kuiper Belt object orbital anomalies (\"Modified Newtonian Dynamics as an Alternative to the Planet Nine Hypothesis\" - URL: https://arxiv.org/pdf/2304.00576.pdf) only presents an alternative *explanation*, not experimental or observational data that conflicts with the dark matter hypothesis. The article \"Study: Dark matter doesn't exist, the universe is 27B years old\" (URL: https://news.ycombinator.com/item?id=41847656) also only proposes an alternative cosmological model, but without any direct contradicting evidence. The rest of the papers either explore alternative dark matter candidates, discuss a lack of experimental evidence of dark matter, or do not discuss dark matter at all. Thus, while there is a lot of critical discussion regarding dark matter, only the paper by Shamir and Mcadam offers observational evidence that directly contradicts its predictions."
    },
    {
      "question": "Has anyone had an AI-generated paper accepted at a major journal? ",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Real or Fake Text?: Investigating Human Ability to Detect Boundaries Between Human-Written and Machine-Generated Text",
          "author": "Liam Dugan,Daphne Ippolito,Arun Kirubarajan,Sherry Shi,Chris Callison-Burch",
          "published_date": "2023-10-26T19:32:09.031000+00:00",
          "summary": "This research paper does not address whether AI-generated papers have been accepted by major journals.  Instead, it investigates human ability to detect the boundary between human-written and AI-generated text within a single document.  The study uses a game-based approach to assess detection accuracy, finding significant variance in human skill and identifying factors influencing detection performance (model size, decoding strategy, genre, etc.).  The researchers created a dataset (RoFT) of over 21,000 annotations to support further research in this area.\n",
          "url": "https://arxiv.org/pdf/2212.12672.pdf"
        },
        {
          "title": "The death of the short-form physics essay in the coming AI revolution",
          "author": "W. Yeadon,Oto-Obong Inyang,Arin Mizouri,Alex Peach,Craig P. Testrow",
          "published_date": "2023-10-26T19:31:18.436000+00:00",
          "summary": "This paper does not address the acceptance of AI-generated papers in major journals.  Instead, it focuses on the ability of current AI models (like ChatGPT and davinci-003) to produce high-quality, short-form (300-word) physics essays that achieve first-class grades in a university assessment.  The authors used AI to generate 50 essays for a university assignment, and these received an average mark of 71%, comparable to human students.  They conclude that this highlights a significant threat to the use of short-form essays as an assessment method due to the ease with which AI can produce high-quality work that evades plagiarism detection.\n",
          "url": "https://arxiv.org/pdf/2212.11661.pdf"
        },
        {
          "title": "Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human reviewers",
          "author": "View ORCID ProfileCatherine A. Gao",
          "published_date": "2022-12-27T00:00:00+00:00",
          "summary": "This study did not find any AI-generated papers accepted in major journals.  Researchers used ChatGPT to generate scientific abstracts, which were then evaluated by AI detectors, plagiarism checkers, and human reviewers.  While the AI-generated abstracts were grammatically correct and original (no plagiarism detected), they were easily identified by AI detection software (99.98% detection rate) and often recognized by human reviewers (68% accuracy).  The study concludes that current methods for evaluating scientific work need to adapt to account for AI-generated content, suggesting the use of AI detection software in the editorial process.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2022.12.23.521610v1.full"
        },
        {
          "title": "Generative AI in Writing Research Papers: A New Type of Algorithmic Bias and Uncertainty in Scholarly Work",
          "author": "[Submitted on 4 Dec 2023]",
          "published_date": "2023-12-04T00:00:00+00:00",
          "summary": "The provided text focuses on the risks of using generative AI in writing research papers, including the introduction of new biases and uncertainties due to the models' training data and susceptibility to errors.  It does not address whether any AI-generated papers have been accepted by major journals.  Therefore, this paper offers no information to answer your query.\n",
          "url": "http://arxiv.org/abs/2312.10057"
        },
        {
          "title": "Perceptions and Detection of AI Use in Manuscript Preparation for Academic Journals",
          "author": "[Submitted on 19 Nov 2023 (v1), last revised 30 Jan 2024 (this version, v2)]",
          "published_date": "2023-11-19T00:00:00+00:00",
          "summary": "This preprint study investigates perceptions of AI use in academic manuscript preparation.  It explores whether academics believe AI use should be disclosed and how AI detection tools perform.  The study itself does *not* address whether AI-generated papers have been accepted by major journals, only the surrounding attitudes and detection capabilities.\n",
          "url": "https://arxiv.org/abs/2311.14720"
        },
        {
          "title": "What should I do if I suspect one of the journal reviews I got ...",
          "author": "pintorpintor 82311 gold badge22 silver badges88 bronze badges",
          "published_date": "2023-11-30T07:12:00+00:00",
          "summary": "This question asks whether to inform a journal editor about suspicion of an AI-generated review.  The user suspects AI generation due to oddly phrased, abstract-rephrasing questions, an irrelevant suggested reading list, and positive results from AI detection tools.  A suggested response is to inform the editor, explaining the reasons for suspicion while emphasizing that the concern isn't about the revision request itself but the integrity of the peer-review process and potential IP issues.  The user should also express willingness to revise and resubmit. The question of AI-generated *papers* being accepted wasn't addressed.\n",
          "url": "https://academia.stackexchange.com/questions/204370/what-should-i-do-if-i-suspect-one-of-the-journal-reviews-i-got-is-ai-generated"
        },
        {
          "title": "Science journals set new authorship guidelines for AI- ...",
          "author": "By Jennifer Harker",
          "published_date": "2023-03-01T00:00:00+00:00",
          "summary": "No, the article states that Science journals have explicitly banned the use of AI-generated text in their publications and prohibit AI as an author.  While other journals like Nature have similar policies against AI co-authorship, the article does not mention any instances of AI-generated papers being accepted.\n",
          "url": "https://factor.niehs.nih.gov/2023/3/feature/2-artificial-intelligence-ethics"
        },
        {
          "title": "Use of AI Is Seeping Into Academic Journals\u2014and It's ...",
          "author": "Amanda Hoover",
          "published_date": "2023-08-17T11:00:00+00:00",
          "summary": "A peer-reviewed study in *Resources Policy*, an Elsevier journal, was found to contain a sentence indicating AI generation.  While the journal's policy allows AI use for writing assistance if disclosed, the authors' failure to do so triggered an investigation.  The publisher states the authors intended to use AI for language improvement but accidentally left in the AI's disclaimer.  The incident highlights the challenges faced by academic journals in detecting and managing AI-generated content.  Whether the paper will be retracted or corrected remains unclear.  This is one example of AI-generated text appearing in a major journal, but it is not necessarily an example of a paper being fully accepted without detection.\n",
          "url": "https://www.wired.com/story/use-of-ai-is-seeping-into-academic-journals-and-its-proving-difficult-to-detect/"
        },
        {
          "title": "Using Peer Review to Detect AI-Generated Scientific Papers",
          "author": "",
          "published_date": "2023-01-12T00:00:00+00:00",
          "summary": "The provided text does not contain information about AI-generated papers being accepted by major journals.  While the article discusses the use of AI to write scientific papers and the challenges this poses to peer review, it doesn't offer any examples of successful submissions.  The article focuses on the risks and detection methods rather than instances of acceptance.\n",
          "url": "http://www.morressier.com/post/using-peer-review-to-detect-ai-generated-scientific-papers"
        },
        {
          "title": "Will Scientific Journals Accept Papers Containing AI ...",
          "author": "Scientific Writing with Karen L. McKee",
          "published_date": "2023-04-27T16:00:31+00:00",
          "summary": "This YouTube video discusses how scientific journals are handling AI-generated text in submitted papers.  The video reviews the policies of Nature, Elsevier, and Wiley, but notes that these policies may change.  It does *not* report any instances of an AI-generated paper being accepted by a major journal.  The video references articles expressing disapproval of AI as an author on research papers.\n",
          "url": "https://www.youtube.com/watch?v=2Ddlzh4IGzU"
        }
      ],
      "full_explanation": "While the provided papers discuss the use of AI in academic writing, methods for detecting AI-generated text, and journal policies regarding AI, they do not definitively state that a fully AI-generated paper has been accepted by a major journal without detection. Several papers discuss the threat posed by AI-generated text and the need for increased detection efforts, but this highlights that the process of AI-generated text being undetected and accepted is not widespread. \n\nSpecifically, the paper by Gao et al. (\"Comparing scientific abstracts generated by ChatGPT to original abstracts...\") explicitly states that AI-generated abstracts were easily detected by AI detectors and often by human reviewers ([https://www.biorxiv.org/content/10.1101/2022.12.23.521610v1.full](https://www.biorxiv.org/content/10.1101/2022.12.23.521610v1.full)). The article by Harker (\"Science journals set new authorship guidelines for AI-...\") states that Science journals have banned AI-generated text and AI authorship, indicating that they are actively preventing this ([https://factor.niehs.nih.gov/2023/3/feature/2-artificial-intelligence-ethics](https://factor.niehs.nih.gov/2023/3/feature/2-artificial-intelligence-ethics)). Additionally, the YouTube video by McKee (\"Will Scientific Journals Accept Papers Containing AI...\") also states that major journals have been banning AI-generated text ([https://www.youtube.com/watch?v=2Ddlzh4IGzU](https://www.youtube.com/watch?v=2Ddlzh4IGzU)).\n\nHowever, the article by Hoover (\"Use of AI Is Seeping Into Academic Journals\u2014and It's...\") describes an instance where a sentence, including an AI's disclaimer, was accidentally left in a paper published in *Resources Policy* ([https://www.wired.com/story/use-of-ai-is-seeping-into-academic-journals-and-its-proving-difficult-to-detect/](https://www.wired.com/story/use-of-ai-is-seeping-into-academic-journals-and-its-proving-difficult-to-detect/)). While this paper highlights the possibility of AI text seeping into the journals, it was not fully accepted without detection, as the disclaimer was noticed. Therefore, while this shows that AI-generated text can appear in a major journal, it doesn't show that a full AI-generated paper has been accepted."
    },
    {
      "question": "Has anyone shown that eating oreos is good for your health?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment",
          "author": "William C. Cromwell",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "A case study showed that eating Oreo cookies lowered LDL cholesterol in a person on a ketogenic diet, even more so than high-intensity statin therapy.  However, this was a single individual with a specific genetic and dietary background (lean mass hyper-responder on a ketogenic diet for ulcerative colitis), so the results can't be generalized to say Oreos are good for health in the general population.\n",
          "url": "https://www.mdpi.com/2218-1989/14/1/73"
        },
        {
          "title": "Positive Effects of a Healthy Snack (Fruit) Versus an Unhealthy Snack (Chocolate/Crisps) on Subjective Reports of Mental and Physical Health: A Preliminary Intervention Study",
          "author": "Andrew Paul Smith* Rosannagh Rogers",
          "published_date": "2014-07-16T00:00:00+00:00",
          "summary": "No, this study does not show that eating Oreos (or similar unhealthy snacks like crisps and chocolate) is beneficial for health.  In fact, it finds a correlation between consuming such snacks and higher stress, more cognitive failures, and more injuries.  The research focuses on the contrasting effects of healthy (fruit) versus unhealthy snacks on mental and physical well-being, with unhealthy snacks showing negative correlations.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fnut.2014.00010/full"
        },
        {
          "title": "Patterned Feeding of a Hyper-Palatable Food (Oreo Cookies) Reduces Alcohol Drinking in Rats - PubMed",
          "author": "Zoela Leon 1 ,",
          "published_date": "2021-10-20T00:00:00+00:00",
          "summary": "A study on rats found that intermittent access to Oreo cookies reduced their alcohol consumption.  However, this effect disappeared when the Oreo access stopped.  The study doesn't suggest Oreos are healthy; rather, it explores the relationship between highly palatable food and alcohol intake, showing a complex interaction and not a positive health outcome from Oreo consumption.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34744651/"
        },
        {
          "title": "Understanding the Obesity Problem: Policy Implications of a Motivational Account of (Un)Healthy Eating",
          "author": "Edward  Orehek, University of Pittsburgh, 210 S. Bouquet Street, 15260, Pittsburgh, PA, orehek@pitt.edu",
          "published_date": "2023-11-09T20:18:12.268000+00:00",
          "summary": "No, this research paper does not support the idea that eating Oreos or similar convenient, inexpensive foods is good for your health.  Instead, it argues that obesity stems from prioritizing convenience and cost over health when choosing food, and that healthier choices are made when health is the primary goal and healthy options are readily available.\n",
          "url": "https://spssi.onlinelibrary.wiley.com/doi/10.1111/sipr.12021"
        },
        {
          "title": "Using subtle reminders of love to foster healthy snack choices",
          "author": "David  Raska, raskad1@nku.edu, Bridget S Nichols",
          "published_date": "2023-11-09T19:44:15.678000+00:00",
          "summary": "This study did not examine the health effects of Oreos or any specific food.  Instead, it investigated how subtle reminders of different types of love (companionate vs. sexual) influenced college students' choices between healthy and unhealthy snacks.  The results showed that reminders of companionate love led to healthier choices, while reminders of sexual love had no effect.  The study does not provide any information about the health benefits or drawbacks of eating Oreos.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/cb.1381"
        },
        {
          "title": "Oreo Cookie Treatment Lowers LDL Cholesterol More Than ...",
          "author": "",
          "published_date": "2024-01-22T00:00:00+00:00",
          "summary": "A single case study showed that eating Oreos (providing 100g of carbohydrates) lowered LDL cholesterol more effectively than a high-dose statin in a person following a ketogenic diet who had unusually high LDL cholesterol.  This does *not* mean Oreos are healthy; the study involved a specific individual with a rare metabolic response and should not be interpreted as general health advice.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10818743/"
        },
        {
          "title": "The Truth About Oreos & Lowering Your Cholesterol",
          "author": "By Elizabeth Klodas, MD",
          "published_date": "2024-08-08T19:37:32+00:00",
          "summary": "No, a study showing that Oreos lowered one individual's cholesterol while on a ketogenic diet is not evidence that Oreos are healthy.  The article explains that the cholesterol reduction was likely due to the addition of carbohydrates to a very high-fat keto diet, not the Oreos themselves.  The author emphasizes that a whole-food, plant-based diet is far superior for overall health and longevity compared to a diet including highly processed foods like Oreos.\n",
          "url": "https://www.steponefoods.com/blogs/news/why-you-shouldn-t-lower-your-cholesterol-with-oreos?srsltid=AfmBOorcIJS65pWIOwcd9xsJF9clagGJtIDfy6pPwIb3-9WXK54XfgZu"
        },
        {
          "title": "Truth About Oreos, Heart Disease, Cholesterol & Keto Diet ...",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "This YouTube video (11K views) doesn't offer any information about Oreos being healthy.  The provided text only shows viewership and like counts, offering no insight into the video's content.\n",
          "url": "https://www.youtube.com/watch?v=UtLNuezKxD8"
        },
        {
          "title": "Eating more during the holidays? Don't mistake Oreo ...",
          "author": "Alvin Powell",
          "published_date": "2023-04-13T10:13:53.503000+00:00",
          "summary": "No, this Harvard Gazette article discusses obesity and its causes.  While it uses Oreos as an example of a food that affects the body differently than others (100 calories of Oreos impacts fat storage differently than 100 calories of olives), it does not suggest that Oreos are good for your health.  In fact, the article argues against the \"calories in/calories out\" model of weight management, suggesting that the type of calories consumed is more important than the total number.\n",
          "url": "https://news.harvard.edu/gazette/story/2022/12/eating-more-during-the-holidays-dont-mistake-oreo-calories-for-olive-calories/?utm_source=twitter&utm_campaign=general&utm_medium=social"
        },
        {
          "title": "Harvard Med Student & Scientist Lowers Cholesterol with ...",
          "author": "",
          "published_date": "2024-12-19T00:00:00+00:00",
          "summary": "This YouTube video (38K views) doesn't appear to address the health benefits of eating Oreos.  The provided information only gives view count and like counts, not the video's content.  Therefore, I cannot answer your query based on this data.\n",
          "url": "https://www.youtube.com/watch?v=qk2htmeR6e4"
        }
      ],
      "full_explanation": "While one study does show a positive health effect related to Oreo consumption, it is crucial to note that the study's results cannot be generalized to the general population and that it does not show that Oreos are good for health. The paper, \"Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment\" (URL: https://www.mdpi.com/2218-1989/14/1/73 and https://pmc.ncbi.nlm.nih.gov/articles/PMC10818743/) details a single case study in which an individual on a ketogenic diet saw a reduction in LDL cholesterol from consuming Oreos. However, as noted in the paper itself and in other articles discussing it, \"The Truth About Oreos & Lowering Your Cholesterol\" (URL: https://www.steponefoods.com/blogs/news/why-you-shouldn-t-lower-your-cholesterol-with-oreos?srsltid=AfmBOorcIJS65pWIOwcd9xsJF9clagGJtIDfy6pPwIb3-9WXK54XfgZu)  this positive effect is likely due to the addition of carbohydrates to the very low-carb diet, and is not a generalized effect of Oreos. It is also made clear that they are not considered healthy. The other studies, such as \"Positive Effects of a Healthy Snack (Fruit) Versus an Unhealthy Snack (Chocolate/Crisps) on Subjective Reports of Mental and Physical Health\" (URL: https://www.frontiersin.org/articles/10.3389/fnut.2014.00010/full), \"Patterned Feeding of a Hyper-Palatable Food (Oreo Cookies) Reduces Alcohol Drinking in Rats\" (URL: https://pubmed.ncbi.nlm.nih.gov/34744651/), \"Understanding the Obesity Problem: Policy Implications of a Motivational Account of (Un)Healthy Eating\" (URL: https://spssi.onlinelibrary.wiley.com/doi/10.1111/sipr.12021), and \"Eating more during the holidays? Don't mistake Oreo ...\" (URL: https://news.harvard.edu/gazette/story/2022/12/eating-more-during-the-holidays-dont-mistake-oreo-calories-for-olive-calories/?utm_source=twitter&utm_campaign=general&utm_medium=social) either actively suggest negative health impacts from similar highly processed foods or do not attempt to correlate Oreo consumption with any positive health effects, and one even explicitly states that Oreos are not healthy (Harvard Gazette). The papers either discuss negative health outcomes from similar foods (mental and physical) or explore complex relationships with alcohol intake or weight management. The case study provided in the paper \"Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet\" and its summary in the article from Step One Foods do not constitute a general claim that Oreos are good for your health."
    },
    {
      "question": "Has anyone shown that Amylin increases weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression",
          "author": "Jonathan D Roth, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Heather  Hughes, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Eric  Kendall, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Alain D Baron, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Christen M Anderson, Amylin Pharmaceuticals, Inc, 92121, San Diego, California",
          "published_date": "2023-11-09T20:13:16.011000+00:00",
          "summary": "Yes, a study in diet-induced obese rats showed that amylin (300 \u00b5g/kg daily for 22 days) reduced food intake and weight gain by approximately 10%, similar to pair-feeding.  Importantly, amylin treatment resulted in a three-fold greater fat loss compared to pair-feeding, while preserving lean body mass.  Increased energy expenditure was also observed in amylin-treated rats after three weeks.  These results suggest that amylin promotes weight loss through anorexigenic effects and specific metabolic mechanisms.\n",
          "url": "https://academic.oup.com/endo/article/147/12/5855/2501043"
        },
        {
          "title": "Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies | Proceedings of the National Academy of Sciences",
          "author": "Jonathan D Roth; Barbara L Roland; Rebecca L Cole; James L Trevaskis; Christian Weyer; Joy E Koda; Christen M Anderson; David G Parkes; Alain D Baron; Roth; Jonathan D; Roland; Barbara L; Cole; Rebecca L; Trevaskis; James L; Weyer; Christian; Koda; Joy E; Anderson; Christen M; Parkes; David G; Baron; Alain D",
          "published_date": "2023-02-22T20:44:40.478000+00:00",
          "summary": "Yes.  Studies in both diet-induced obese rats and overweight/obese humans showed that amylin (specifically, the amylin analog pramlintide) significantly increased weight loss.  In rats, combining amylin and leptin led to synergistic weight loss greater than either treatment alone.  A 24-week human clinical trial showed a 12.7% mean weight loss with combined amylin analog and leptin treatment, significantly more than with either treatment individually.  This suggests amylin agonism restores leptin responsiveness in obesity.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.0706473105"
        },
        {
          "title": "Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies",
          "author": "Jonathan D Roth; Barbara L Roland; Rebecca L Cole; James L Trevaskis; Christian Weyer; Joy E Koda; Christen M Anderson; David G Parkes; Alain D Baron; Roth; Jonathan D; Roland; Barbara L; Cole; Rebecca L; Trevaskis; James L; Weyer; Christian; Koda; Joy E; Anderson; Christen M; Parkes; David G; Baron; Alain D",
          "published_date": "2023-12-04T02:39:38.899000+00:00",
          "summary": "Yes.  Studies in both rats and humans show that amylin, and its analog pramlintide, increase weight loss.  In diet-induced obese rats, amylin treatment resulted in fat-specific weight loss, and when combined with leptin, showed synergistic weight loss effects. A clinical trial showed that co-administering pramlintide and leptin resulted in a 12.7% mean weight loss in overweight/obese subjects, significantly more than either treatment alone.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.0706473105"
        },
        {
          "title": "Amylin-Induced Central IL-6 Production Enhances Ventromedial Hypothalamic Leptin Signaling",
          "author": "C. Le Foll,Miranda D. Johnson,A. Dunn-Meynell,C. Boyle,T. Lutz,B. Levin",
          "published_date": "2023-10-26T19:30:21.688000+00:00",
          "summary": "Yes, this study shows that amylin treatment decreased body weight gain and/or food intake in rats.  This effect is linked to amylin's stimulation of IL-6 production in the ventromedial hypothalamus (VMH), which in turn enhances leptin signaling and contributes to weight loss.  The effect was absent in IL-6 knockout mice, confirming the role of IL-6 in amylin's weight-loss mechanism.\n",
          "url": "https://diabetes.diabetesjournals.org/content/diabetes/64/5/1621.full.pdf"
        },
        {
          "title": "Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.",
          "author": "James L Trevaskis, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Todd  Coffey, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Rebecca  Cole, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Chunli  Lei, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Carrie  Wittmer, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Brandon  Walsh, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Christian  Weyer, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Joy  Koda, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Alain D Baron, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, David G Parkes, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Jonathan D Roth, Amylin Pharmaceuticals, Inc, 92121, San Diego, California",
          "published_date": "2023-11-09T20:10:13.753000+00:00",
          "summary": "Yes, studies show a synergistic effect between amylin and leptin in increasing weight loss in diet-induced obese rats.  A combination treatment resulted in up to 15% weight loss, significantly greater than the effect of either treatment alone. This weight loss was primarily due to reduced food intake, but also involved increased fat loss and did not negatively impact energy expenditure or metabolic shifts as seen in other weight loss methods.  The study suggests amylin enhances leptin's effectiveness in promoting weight loss.\n",
          "url": "https://academic.oup.com/endo/article/149/11/5679/2455337?login=false"
        },
        {
          "title": "Amylin as a Future Obesity Treatment - PMC",
          "author": "",
          "published_date": "2021-12-21T00:00:00+00:00",
          "summary": "Yes, studies show that amylin analogues can lead to weight loss.  Pramlintide, an approved amylin analogue for diabetes, causes a small but significant weight loss, though not enough to reverse obesity complications.  Another analogue, AM833 (cagrilintide), shows dose-dependent weight loss by reducing food intake.  The mechanism involves amylin's role as a satiety signal, slowing gastric emptying, and suppressing glucagon secretion, thus impacting appetite control and leading to reduced caloric intake.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8735818/"
        },
        {
          "title": "Amylin and Calcitonin: Potential Therapeutic Strategies to ...",
          "author": "",
          "published_date": "2021-01-08T00:00:00+00:00",
          "summary": "Preclinical studies in rats using dual amylin and calcitonin receptor agonists (DACRAs) have shown significant weight loss.  While the translational aspects to humans are unknown, these studies suggest a potential for amylin-based therapies in weight loss.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7819850/"
        },
        {
          "title": "Combined Amylin/GLP-1 pharmacotherapy to promote and ...",
          "author": "Claudia G Liberini, University of Pennsylvania, 19104, Philadelphia, PA, USA, Kieran  Koch-Laskowski, University of Pennsylvania, 19104, Philadelphia, PA, USA, Evan  Shaulson, University of Pennsylvania, 19104, Philadelphia, PA, USA, Lauren E Mcgrath, University of Pennsylvania, 19104, Philadelphia, PA, USA, Rachele K Lipsky, University of Pennsylvania, 19104, Philadelphia, PA, USA, Rinzin  Lhamo, University of Pennsylvania, 19104, Philadelphia, PA, USA, Misgana  Ghidewon, University of Pennsylvania, 19104, Philadelphia, PA, USA, Tyler  Ling, University of Pennsylvania, 19104, Philadelphia, PA, USA, Lauren M Stein, University of Pennsylvania, 19104, Philadelphia, PA, USA, Matthew R Hayes, University of Pennsylvania, 19104, Philadelphia, PA, USA",
          "published_date": "2023-11-09T20:26:12.407000+00:00",
          "summary": "Yes, research in rats has shown that amylin, combined with GLP-1, leads to synergistic weight loss.  Studies using salmon calcitonin (an amylin analog) and liraglutide (a GLP-1 analog) demonstrated significantly greater reductions in energy intake and body weight compared to either treatment alone, both in lean and obese rats.  This effect was sustained over the long term in obese rats with a stepwise administration regimen.\n",
          "url": "https://www.nature.com/articles/s41598-019-44591-8"
        },
        {
          "title": "Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet ...",
          "author": "Jonathan D Roth, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Heather  Hughes, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Eric  Kendall, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Alain D Baron, Amylin Pharmaceuticals, Inc, 92121, San Diego, California, Christen M Anderson, Amylin Pharmaceuticals, Inc, 92121, San Diego, California",
          "published_date": "2023-11-09T20:13:16.011000+00:00",
          "summary": "Yes, studies in diet-induced obese rats show amylin (300 \u00b5g/kg per day for 22 days) reduces food intake and weight gain, similar to pair-feeding.  Amylin led to a significantly greater fat loss than pair-feeding, while preserving lean tissue mass.  Increased energy expenditure was observed in amylin-treated rats compared to controls and pair-fed rats from week 3 onwards.  These effects suggest amylin promotes weight loss through appetite suppression and metabolic changes.\n",
          "url": "https://academic.oup.com/endo/article/147/12/5855/2501043"
        },
        {
          "title": "Amylin \u2013 Its role in the homeostatic and hedonic control of ...",
          "author": "P.C. Butler, J. Chou, W.B. Carter, Y.N. Wang, B.H. Bu, D. Chang, et al.",
          "published_date": "2018-02-01T00:00:00+00:00",
          "summary": "Yes, studies show chronic amylin administration reduces energy intake and body weight.  This effect has led to the development of amylin analogs as potential anti-obesity treatments.  The research focuses on amylin's role as a satiation signal, impacting both homeostatic and hedonic aspects of eating.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2212877817308700"
        }
      ],
      "full_explanation": "The provided papers demonstrate that the research question, \"Has anyone shown that Amylin increases weight loss?\" has been investigated extensively. Multiple studies in both animal models and human trials have shown that amylin, or its analogues, promote weight loss.\n\nSpecifically, the paper \"Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression\" (URL: https://academic.oup.com/endo/article/147/12/5855/2501043) shows that in diet-induced obese rats, amylin treatment led to reduced food intake and weight gain, with a greater reduction in fat mass compared to pair-fed controls. This effect was further supported by observations of increased energy expenditure in amylin-treated rats. The research was repeated and summarised in \"Antiobesity Effects of the \u03b2-Cell Hormone Amylin in Diet ...\" (URL: https://academic.oup.com/endo/article/147/12/5855/2501043)\n\nThe paper \"Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies\" (URL: https://www.pnas.org/doi/10.1073/pnas.0706473105) and \"Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies\" (URL: https://www.pnas.org/doi/full/10.1073/pnas.0706473105) confirm that both animal models and human trials have shown amylin, and its analog pramlintide, promote weight loss. These studies highlighted a synergistic effect of amylin with leptin, enhancing weight loss beyond that achieved by either treatment alone. A similar effect is shown in \"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.\" (URL: https://academic.oup.com/endo/article/149/11/5679/2455337?login=false).\n\nFurther research, as shown in \"Amylin-Induced Central IL-6 Production Enhances Ventromedial Hypothalamic Leptin Signaling\" (URL: https://diabetes.diabetesjournals.org/content/diabetes/64/5/1621.full.pdf) demonstrates that amylin's weight-loss effect is mediated through its action on IL-6 production in the brain, which, in turn, impacts leptin signaling and contributes to weight loss.\n\nIn \"Amylin as a Future Obesity Treatment - PMC\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8735818/), it is noted that amylin analogs have been shown to induce weight loss by modulating satiety signals, slowing gastric emptying, and suppressing glucagon secretion.\n\n\"Combined Amylin/GLP-1 pharmacotherapy to promote and ...\" (URL: https://www.nature.com/articles/s41598-019-44591-8) and \"Amylin and Calcitonin: Potential Therapeutic Strategies to ...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7819850/) studies also indicate that amylin analogs, sometimes in combination with other hormones, have been shown to induce significant weight loss in rat models.\n\nFinally, \"Amylin \u2013 Its role in the homeostatic and hedonic control of ...\" (URL: https://www.sciencedirect.com/science/article/pii/S2212877817308700) shows the chronic administration of amylin reduces energy intake and body weight, leading to the development of amylin analogs as anti-obesity treatments."
    },
    {
      "question": "Has anyone designed neural networks that compute with protein or DNA?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms",
          "author": "Ryan C. Lee, Ariel Corsano, Chung Yi Tseng, Leo Y. T. Chou",
          "published_date": "2023-07-23T00:00:00+00:00",
          "summary": "Yes. This bioRxiv preprint describes a new design for DNA-based neural networks.  The authors address limitations in scalability of previous DNA computing approaches by using enzymatic synthesis for high-purity neurons, spatially patterning neuron clusters, and encoding connectivity on a single-stranded DNA backbone.  This improved design enables faster activation, higher signal-to-background ratio, and successful implementation of basic neural network motifs.  The modular design is intended to facilitate scaling for applications like portable diagnostics and lab-on-a-chip devices.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1"
        },
        {
          "title": "DNA-based programmable gate arrays for general-purpose DNA computing",
          "author": "Lv; Hui; Xie; Nuli; Li; Mingqiang; Dong; Mingkai; Sun; Chenyun; Zhang; Qian; Zhao; Lei; Jiang; Zuo; Xiaolei; Chen; Haibo; Wang; Fei; Fan; Chunhai",
          "published_date": "2023-12-04T03:09:05.243000+00:00",
          "summary": "This Nature article details the design of DNA-based programmable gate arrays for general-purpose DNA computing.  While not explicitly neural networks, the research explores using DNA to perform computation, addressing a facet of your query about using biomolecules for computation.  The authors provide source code on GitHub (https://github.com/FeiWANG-SJTU/DPGA) for those interested in the methods used.\n",
          "url": "https://www.nature.com/articles/s41586-023-06484-9"
        },
        {
          "title": "Neural network execution using nicked DNA and microfluidics",
          "author": "Arnav Solanki,Zak Griffin,Purab Ranjan Sutradhar,A. Ganguly,Marc D. Riedel",
          "published_date": "2023-10-26T19:31:04.476000+00:00",
          "summary": "Yes, this paper presents a novel method for implementing artificial neural networks (ANNs) using DNA in a microfluidic device.  The computation is performed entirely in the molecular domain, using enzymes to modify DNA strands, without converting data to electrical form.  The system represents data stochastically through the concentration of nicked DNA molecules.  The authors detail the biochemical design and microfluidics device, reporting benchmarks on the neural network computation's performance.\n",
          "url": "https://arxiv.org/pdf/2307.00686.pdf"
        },
        {
          "title": "[PDF] Neural network computation with DNA strand displacement cascades | Semantic Scholar",
          "author": "L Qian; E Winfree; Jehoshua Bruck",
          "published_date": "2023-02-06T17:46:53.956000+00:00",
          "summary": "Yes, several research papers describe neural networks implemented using DNA.  These include a four-neuron network acting as an associative memory,  a convolutional neural network using DNA regulatory circuits, and a neural perceptron using DNA strand displacement to perform Boolean operations and numerical comparisons.  Research also explores using DNA for more general computation, such as ant systems-based DNA circuits for decision-making.  There is no mention of protein-based neural networks in the provided text.\n",
          "url": "https://www.semanticscholar.org/paper/Neural-network-computation-with-DNA-strand-cascades-Qian-Winfree/7017eb6c2fb0ea580bc560f790dc3bbfae545e34"
        },
        {
          "title": "Neural network computation with DNA strand displacement cascades - Nature",
          "author": "Qian; Lulu; Winfree; Erik; Bruck; Jehoshua",
          "published_date": "2023-02-26T08:17:26.729000+00:00",
          "summary": "Yes.  This 2011 *Nature* article describes the design and implementation of a neural network using DNA strand displacement cascades.  The researchers successfully created a Hopfield associative memory with four artificial neurons, capable of pattern recognition and recall using DNA.  The system was trained *in silico* and then implemented using a DNA gate architecture.\n",
          "url": "https://www.nature.com/articles/nature10262"
        },
        {
          "title": "Computational Protein Design with Deep Learning Neural Networks",
          "author": "Qi, Yifei",
          "published_date": "2018-04-20T00:00:00+00:00",
          "summary": "This paper discusses computational protein design using neural networks.  While it doesn't explicitly detail neural networks *computing* with protein or DNA as the computational substrate, it focuses on using neural networks to *design* proteins.  The authors describe how these networks are used to predict protein sequences likely to fold into desired structures, incorporating physics-based and knowledge-based scoring functions.  The goal is to create novel proteins with specific functions, such as enzymes, vaccines, and antibodies.\n",
          "url": "https://www.nature.com/articles/s41598-018-24760-x"
        },
        {
          "title": "Neural networks to learn protein sequence\u2013function relationships ...",
          "author": "",
          "published_date": "2021-11-23T00:00:00+00:00",
          "summary": "Yes, this paper describes neural networks designed to learn the relationship between protein sequence and function using deep mutational scanning data.  The authors tested various architectures, including a graph convolutional network incorporating protein structure, and demonstrated superior performance compared to physics-based and unsupervised methods.  These networks were successfully used to design new proteins with improved properties, such as a GB1 domain variant with significantly higher affinity for immunoglobulin G.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8640744/"
        },
        {
          "title": "An Efficient Deep Learning Approach for DNA-Binding Proteins ...",
          "author": "Musa, Mohamed Elhafiz M.",
          "published_date": "2024-04-11T00:00:00+00:00",
          "summary": "Yes, this paper describes a neural network (CNN-BiLG) designed to classify DNA-binding proteins based on their amino acid sequences.  The network uses convolutional neural networks (CNNs) combined with bidirectional long short-term memory (LSTM) and gated recurrent units (GRUs) to capture contextual information within the sequences, achieving 94% accuracy on a validation set.  This surpasses the accuracy of previous machine learning and deep learning approaches.\n",
          "url": "https://link.springer.com/article/10.1007/s44196-024-00462-3"
        },
        {
          "title": "Cracking the genetic code with neural networks - Frontiers",
          "author": "Marc Joiret1*",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "This research explores using deep learning (a type of neural network) to analyze omics data (genomics, transcriptomics, proteomics).  While the paper doesn't explicitly detail neural networks *computing* with protein or DNA as fundamental processing units, it focuses on using neural networks to analyze data *derived from* proteins and DNA to predict things like gene function, molecular structures, and disease outcomes.  The authors acknowledge challenges in interpreting the \"black box\" nature of these models and the need for high-quality data.\n",
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2023.1128153/full"
        },
        {
          "title": "Modeling in-vivo protein-DNA binding by combining multiple ...",
          "author": "Qinhu  Zhang, tongji University, 201804, Shanghai, P.R. China, Zhen  Shen, tongji University, 201804, Shanghai, P.R. China, De-Shuang  Huang",
          "published_date": "2023-11-09T20:26:13.773000+00:00",
          "summary": "Yes, this research paper describes a hybrid deep neural network designed to model in-vivo protein-DNA binding.  The network uses k-mer encoding of DNA sequences as input and combines convolutional and recurrent neural networks to predict binding.  The method incorporates multiple-instance learning to handle the weakly supervised nature of the data (multiple transcription factor binding sites within a bound DNA sequence).\n",
          "url": "https://www.nature.com/articles/s41598-019-44966-x"
        }
      ],
      "full_explanation": "Yes, the research question of whether neural networks have been designed to compute with protein or DNA has been explored. Several papers detail the creation of neural networks using DNA as the computational substrate, meaning the networks perform computation using DNA molecules, rather than using them as data or training them to model the biomolecules. These examples include:\n*   **Lee et al. (2023)** describe a novel DNA-based neural network design using enzymatic synthesis, spatial patterning, and single-stranded DNA backbones for connectivity. This enables faster activation and higher signal-to-background ratios in the implementation of neural network motifs. [https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1](https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1)\n*   **Solanki et al. (2023)** present a method for implementing artificial neural networks (ANNs) using DNA in a microfluidic device. The computation is performed entirely in the molecular domain using enzymes to modify DNA, with data represented stochastically by the concentration of nicked DNA. [https://arxiv.org/pdf/2307.00686.pdf](https://arxiv.org/pdf/2307.00686.pdf)\n*   The **Qian et al. (2023) Semantic Scholar paper** summarizes other work describing neural networks implemented with DNA, including a four-neuron associative memory, a convolutional neural network based on DNA regulatory circuits, and a neural perceptron utilizing DNA strand displacement.  [https://www.semanticscholar.org/paper/Neural-network-computation-with-DNA-strand-cascades-Qian-Winfree/7017eb6c2fb0ea580bc560f790dc3bbfae545e34](https://www.semanticscholar.org/paper/Neural-network-computation-with-DNA-strand-cascades-Qian-Winfree/7017eb6c2fb0ea580bc560f790dc3bbfae545e34)\n*   **Qian et al. (2011)** in Nature showcase a designed and implemented Hopfield associative memory with four artificial neurons capable of pattern recognition using DNA strand displacement cascades.  [https://www.nature.com/articles/nature10262](https://www.nature.com/articles/nature10262)\n\nWhile the provided papers do show exploration of using proteins in neural network design and analysis, these applications use proteins as data, or use neural networks to design or analyze proteins but do not use proteins as the computational substrate in the same way as the DNA examples above.  Therefore, the papers listed here specifically show that the research question of using DNA (and not protein) as the computational substrate in neural network design has been researched."
    },
    {
      "question": "Has anyone evolved AAV capsids to target pancreatic beta cells in vivo?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset - Nature Neuroscience",
          "author": "Goertsen; David; Flytzanis; Nicholas C; Goeden; Nick; Chuapoco; Miguel R; Cummins; Alexander; Chen; Yijing; Fan; Yingying; Zhang; Qiangge; Sharma; Jitendra; Duan; Yangyang; Wang; Liping; Feng; Guoping; Yu; Ip; Nancy Y; Pickel; James; Gradinaru; Viviana",
          "published_date": "2023-02-07T20:46:57.937000+00:00",
          "summary": "This research focused on evolving AAV capsids for improved brain-wide gene expression after intravenous delivery, reducing liver targeting in mice and marmosets.  The study did not investigate targeting pancreatic beta cells.  While the research highlights challenges in achieving specific cell targeting with AAVs and the limitations of existing serotypes,  it does not address the specific question of pancreatic beta cell targeting.\n",
          "url": "https://www.nature.com/articles/s41593-021-00969-4"
        },
        {
          "title": "A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism | Proceedings of the National Academy of Sciences",
          "author": "Marcus Davidsson; Gang Wang; Patrick Aldrin-Kirk; Tiago Cardoso; Sara Nolbrant; Morgan Hartnor; Janitha Mudannayake; Malin Parmar; Tomas Bj\u00f6rklund; Davidsson; Marcus; Wang; Gang; Aldrin-Kirk; Patrick; Cardoso; Tiago; Nolbrant; Sara; Hartnor; Morgan; Mudannayake; Janitha; Parmar; Malin; Bj\u00f6rklund; Tomas",
          "published_date": "2023-02-23T02:48:47.406000+00:00",
          "summary": "This study details a new method (BRAVE) for evolving AAV capsids with tailored tropism *in vivo*,  identifying  25 variants with improved properties including retrograde axonal transport in dopaminergic neurons (in rodents and humans).  While the research successfully targeted neurons, it does *not* report on the targeting of pancreatic beta cells.\n",
          "url": "https://www.pnas.org/doi/10.1073/pnas.1910061116"
        },
        {
          "title": "Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression",
          "author": "Zengel; James; Wang; Yu Xin; Seo; Jai Woong; Ning; Ke; Hamilton; Wu; Bo; Raie; Marina; Holbrook; Colin; Su; Shiqi; Clements; Derek R; Pillay; Sirika; Puschnik; Andreas S; Winslow; Monte M; Idoyaga; Juliana; Nagamine; Claude M; Yang; Mahajan; Vinit B; Ferrara; Katherine W; Blau; Helen M; Carette; Jan E",
          "published_date": "2023-12-04T01:57:33.451000+00:00",
          "summary": "This research does not describe the evolution of AAV capsids to target pancreatic beta cells specifically.  The study focuses on a system for controlling AAV transduction *in vivo* in mice by engineering the expression of the AAV receptor (AAVR).  While this offers a way to achieve tissue-specific transgene expression using a variety of AAV vectors,  it doesn't detail the development of novel capsids with inherent beta-cell tropism.\n",
          "url": "https://www.nature.com/articles/s41592-023-01896-x?utm_source=twitter&utm_medium=social&utm_campaign=nmeth"
        },
        {
          "title": "AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery",
          "author": "Search for articles by this author",
          "published_date": "2020-12-11T00:00:00+00:00",
          "summary": "This research focused on enhancing AAV transduction efficiency in skeletal muscle, not pancreatic beta cells.  The study engineered AAV9 capsids with an insulin-mimetic peptide (S519) to improve targeting of the insulin receptor, resulting in up to an 18-fold increase in transduction efficiency in mouse muscle *in vivo*.  While the method shows promise for broadly improving AAV delivery, it doesn't address pancreatic beta cell targeting.\n",
          "url": "https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(20)30231-X"
        },
        {
          "title": "Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression",
          "author": "Zengel; James; Wang; Yu Xin; Seo; Jai Woong; Ning; Ke; Hamilton; Wu; Bo; Raie; Marina; Holbrook; Colin; Su; Shiqi; Clements; Derek R; Pillay; Sirika; Puschnik; Andreas S; Winslow; Monte M; Idoyaga; Juliana; Nagamine; Claude M; Yang; Mahajan; Vinit B; Ferrara; Katherine W; Blau; Helen M; Carette; Jan E",
          "published_date": "2023-12-04T04:15:56.579000+00:00",
          "summary": "This research does not describe the evolution of AAV capsids to target pancreatic beta cells specifically.  The study focuses on a novel system for achieving tissue-specific AAV transduction in mice by controlling the expression of the AAV receptor (AAVR).  While this system offers a new approach to targeting specific cell types using existing AAV vectors, the authors do not mention pancreatic beta cell targeting as an application example.\n",
          "url": "https://www.nature.com/articles/s41592-023-01896-x%7C"
        },
        {
          "title": "In vivo genetic engineering of murine pancreatic beta cells ...",
          "author": "V Jimenez 1 ,",
          "published_date": "2023-02-01T00:00:00+00:00",
          "summary": "This study compared the effectiveness of three adeno-associated virus (AAV) serotypes (6, 8, and 9) for in vivo gene delivery to murine pancreatic beta cells.  While the study did not involve evolving AAV capsids, it found that AAV6 and AAV8 were the most efficient at transducing beta cells via intraductal administration.  AAV9, while less efficient, successfully delivered hepatocyte growth factor (HGF), protecting against autoimmune diabetes in a mouse model.  The results demonstrate the potential of these AAV serotypes for gene therapy targeting pancreatic beta cells, but not through capsid evolution.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/21311856/"
        },
        {
          "title": "Various AAV Serotypes and Their Applications in Gene ...",
          "author": "",
          "published_date": "2023-03-01T00:00:00+00:00",
          "summary": "This article reviews adeno-associated virus (AAV) serotypes and their applications in gene therapy, including FDA-approved treatments for hemophilia A and B, spinal muscular atrophy, and retinal dystrophy.  While it details various AAV serotypes and their tropism (tissue targeting), it does *not* discuss the evolution of AAV capsids to specifically target pancreatic beta cells *in vivo*.  Therefore, the answer to your query is not directly addressed within this text.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10000783/"
        },
        {
          "title": "AAV vector-mediated in vivo reprogramming into pluripotency",
          "author": "Sen\u00eds; Elena; Mosteiro; Lluc; Wilkening; Stefan; Wiedtke; Ellen; Nowrouzi; Ali; Afzal; Saira; Fronza; Raffaele; Landerer; Henrik; Abad; Maria; Niopek; Dominik; Schmidt; Manfred; Serrano; Manuel; Grimm; Dirk",
          "published_date": "2023-02-06T15:36:40.008000+00:00",
          "summary": "This article focuses on in vivo reprogramming using adeno-associated virus (AAV) vectors and Oct-3/4, Klf4, Sox2, and c-Myc (OKSM) transcription factors, but it does not discuss the evolution of AAV capsids to specifically target pancreatic beta cells.  While the research explores the use of OKSM in various contexts, including cancer modeling and aging,  no mention is made of targeted AAV delivery to pancreatic beta cells.\n",
          "url": "https://www.nature.com/articles/s41467-018-05059-x"
        },
        {
          "title": "Pancreatic endocrine cells are transduced by adeno ...",
          "author": "Vishal Ahuja, Sanjeev Jeyabalan, View ORCID ProfileEmmanuel S. Tzanakakis",
          "published_date": "2024-08-23T00:00:00+00:00",
          "summary": "This study compared the effectiveness of AAV serotypes 2, 6, and 9 in transducing murine pancreatic \u03b1- and \u03b2-cells, finding AAV2 to be superior to AAV9, while AAV6 caused cytotoxicity.  The research did *not* involve evolving AAV capsids; instead, it tested existing serotypes.  While AAV8 is commonly used for pancreatic cell transduction, this work explored alternatives.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2024.08.22.609291v1.full-text"
        },
        {
          "title": "Evolving AAV-delivered therapeutics towards ultimate cures",
          "author": "Xiangjun  He, The Chinese University of Hong Kong, Hong Kong SAR, China, Brian Anugerah Urip, Zhenjie  Zhang, The Chinese University of Hong Kong, Hong Kong SAR, China, Chun Christopher Ngan, The Chinese University of Hong Kong, Hong Kong SAR, China, Bo  Feng, The Chinese University of Hong Kong, Hong Kong SAR, China, fengbo@cuhk.edu.hk",
          "published_date": "2023-11-09T20:32:13.877000+00:00",
          "summary": "This article reviews the clinical progress of adeno-associated virus (AAV) gene therapies, including those using CRISPR-Cas systems.  While it details advancements in AAV vectors and their applications in treating various diseases, it does *not* address the specific question of whether AAV capsids have been evolved to target pancreatic beta cells in vivo.  The article focuses on approved therapies and emerging technologies, but doesn't contain information on targeted delivery to pancreatic beta cells.\n",
          "url": "https://link.springer.com/article/10.1007/s00109-020-02034-2"
        }
      ],
      "full_explanation": "While several papers explore AAV transduction of pancreatic beta cells, none of them describe the *evolution* of AAV capsids specifically for enhanced targeting of these cells *in vivo*.\n\n*   The paper by Jimenez et al. (https://pubmed.ncbi.nlm.nih.gov/21311856/) compared the effectiveness of AAV serotypes 6, 8, and 9 for *in vivo* gene delivery to murine pancreatic beta cells, finding AAV6 and AAV8 to be the most efficient via intraductal administration. However, this study used existing serotypes and did not attempt to *evolve* the AAV capsid for improved beta cell targeting.\n\n*   Ahuja et al., (https://www.biorxiv.org/content/10.1101/2024.08.22.609291v1.full-text) investigated AAV serotypes 2, 6, and 9 in pancreatic alpha and beta cells, finding AAV2 to be superior to AAV9 with AAV6 causing cytotoxicity. They didn't involve capsid evolution.\n\n*   The study \"AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery\" (https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(20)30231-X) engineered AAV9 capsids with an insulin-mimetic peptide to enhance transduction of the *insulin receptor* in muscle tissue, but did not target pancreatic beta cells specifically. This is modification, but not evolution of capsids.\n\n* The paper by Davidsson et al. (https://www.pnas.org/doi/10.1073/pnas.1910061116) describes a systematic *in vivo* capsid evolution approach (BRAVE) that led to 25 variants with improved properties including retrograde axonal transport in dopaminergic neurons but did not focus on pancreatic beta cells.\n\nTherefore, while AAVs are being used to transduce pancreatic beta cells and AAV capsids are being engineered for various purposes, there is no evidence in the provided papers that AAV capsids have been *evolved* to specifically target pancreatic beta cells *in vivo*."
    },
    {
      "question": "Has anyone designed neural networks that compute with proteins or DNA?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms",
          "author": "Ryan C. Lee, Ariel Corsano, Chung Yi Tseng, Leo Y. T. Chou",
          "published_date": "2023-07-23T00:00:00+00:00",
          "summary": "Yes.  This bioRxiv preprint describes a new design for DNA-based neural networks that addresses scalability limitations of previous approaches.  The authors improve the design by using enzymatic synthesis for high-purity neurons, spatially patterning neuron clusters, and encoding connectivity on a single-stranded DNA backbone.  This allows for faster activation, higher signal-to-noise ratios, and implementation of basic neural network motifs.  The modular design is intended to scale DNA-based neural networks for applications like portable diagnostics and lab-on-a-chip systems.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1"
        },
        {
          "title": "Neural network execution using nicked DNA and microfluidics",
          "author": "Arnav Solanki,Zak Griffin,Purab Ranjan Sutradhar,A. Ganguly,Marc D. Riedel",
          "published_date": "2023-10-26T19:31:04.476000+00:00",
          "summary": "Yes, this paper describes a microfluidic device that performs artificial neural network (ANN) computations using nicked DNA.  The computations occur entirely within the molecular domain, without converting data to electrical form.  Data is represented stochastically via the concentration of DNA molecules nicked at specific sites.  The system leverages enzymes (nickases) to topologically modify DNA strands, achieving the computations.  The authors report benchmarks on the performance of the neural network calculations.\n",
          "url": "https://arxiv.org/pdf/2307.00686.pdf"
        },
        {
          "title": "DNA-based programmable gate arrays for general-purpose DNA computing",
          "author": "Lv; Hui; Xie; Nuli; Li; Mingqiang; Dong; Mingkai; Sun; Chenyun; Zhang; Qian; Zhao; Lei; Jiang; Zuo; Xiaolei; Chen; Haibo; Wang; Fei; Fan; Chunhai",
          "published_date": "2023-12-04T03:09:05.243000+00:00",
          "summary": "This Nature paper details the design of DNA-based programmable gate arrays for general-purpose DNA computing.  While not explicitly neural networks, the research explores using DNA to perform computation, addressing a facet of your query regarding computation with biomolecules like DNA.  The authors provide source code on GitHub (https://github.com/FeiWANG-SJTU/DPGA).\n",
          "url": "https://www.nature.com/articles/s41586-023-06484-9"
        },
        {
          "title": "[PDF] Neural network computation with DNA strand displacement cascades | Semantic Scholar",
          "author": "L Qian; E Winfree; Jehoshua Bruck",
          "published_date": "2023-02-06T17:46:53.956000+00:00",
          "summary": "Yes, several research papers describe neural networks implemented using DNA.  These include a four-neuron network functioning as an associative memory, a convolutional neural network using DNA regulatory circuits, and a neural perceptron using DNA strand displacement to perform Boolean operations and numerical comparisons.  These designs utilize DNA strand displacement cascades and other molecular techniques to perform computations.\n",
          "url": "https://www.semanticscholar.org/paper/Neural-network-computation-with-DNA-strand-cascades-Qian-Winfree/7017eb6c2fb0ea580bc560f790dc3bbfae545e34"
        },
        {
          "title": "Neural network computation with DNA strand displacement cascades - Nature",
          "author": "Qian; Lulu; Winfree; Erik; Bruck; Jehoshua",
          "published_date": "2023-02-26T08:17:26.729000+00:00",
          "summary": "Yes.  This 2011 *Nature* article demonstrates a neural network implemented using DNA strand displacement cascades.  The researchers successfully created a Hopfield associative memory with four artificial neurons, capable of pattern recognition and recall using DNA.  The system was trained *in silico* and then implemented using DNA to show that molecular systems can exhibit brain-like behavior.\n",
          "url": "https://www.nature.com/articles/nature10262"
        },
        {
          "title": "Computational Protein Design with Deep Learning Neural ...",
          "author": "Qi, Yifei",
          "published_date": "2018-04-20T00:00:00+00:00",
          "summary": "This article discusses computational protein design, using methods that include (but aren't limited to) physics-based scoring functions and knowledge-based terms derived from protein structure statistics.  While it details successes in designing novel proteins for various applications (enzymes, vaccines, antibodies etc.), it doesn't specifically address the use of neural networks *to compute* using proteins or DNA as computational substrates.  The focus is on using neural networks *to design* proteins.\n",
          "url": "https://www.nature.com/articles/s41598-018-24760-x"
        },
        {
          "title": "An Efficient Deep Learning Approach for DNA-Binding ...",
          "author": "Musa, Mohamed Elhafiz M.",
          "published_date": "2024-04-11T00:00:00+00:00",
          "summary": "Yes, this paper describes a neural network (CNN-BiLG) designed to classify DNA-binding proteins based on their amino acid sequences.  The model integrates a convolutional neural network (CNN) with bidirectional long-short-term memory (LSTM) and gated recurrent unit (GRU) to analyze contextual information within the sequences, achieving 94% accuracy on a validation set, outperforming previous methods.\n",
          "url": "https://link.springer.com/article/10.1007/s44196-024-00462-3"
        },
        {
          "title": "Neural networks to learn protein sequence\u2013function ...",
          "author": "",
          "published_date": "2021-11-23T00:00:00+00:00",
          "summary": "Yes, this research used neural networks to learn the relationship between protein sequence and function from deep mutational scanning data.  The study tested various neural network architectures, including a graph convolutional network incorporating protein structure, showing superior performance over other methods.  The trained models were then used to design new proteins with improved properties, such as a GB1 domain variant with higher binding affinity.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8640744/"
        },
        {
          "title": "DeepDBP: Deep neural networks for identification of DNA- ...",
          "author": "Shadman  Shadab, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh, Md Tawab Alam Khan, Nazia Afrin Neezi, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh, Sheikh  Adilina, Swakkhar  Shatabda, United International University, Plot-2, Madani Avenue, Dhaka-1212, United City, Badda, Bangladesh",
          "published_date": "2023-11-09T20:29:03.608000+00:00",
          "summary": "Yes.  The paper \"DeepDBP: Deep Neural Networks for Identification of DNA-binding Proteins\" presents two deep learning models, DeepDBP-ANN and DeepDBP-CNN, designed to identify DNA-binding proteins from their sequences.  Both achieved state-of-the-art results on benchmark datasets.  The code is publicly available.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S2352914819304307"
        },
        {
          "title": "Cracking the genetic code with neural networks",
          "author": "Marc Joiret1*",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "Yes, this paper discusses the application of deep learning (a subset of neural networks) to analyze omics data, which includes genomics (DNA) and proteomics (proteins).  The authors highlight the use of deep learning for inferring complex relationships between omics data and responses like gene function, molecular structures, phenotypes, and disease outcomes.  While acknowledging challenges like the \"black box\" nature of deep learning models, the research focuses on improving interpretability and addressing data quality issues.\n",
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2023.1128153/full"
        }
      ],
      "full_explanation": "Several research papers demonstrate the use of neural networks to compute directly with DNA. The paper \"Simple and rewireable biomolecular building blocks for DNA machine-learning algorithms\" (https://www.biorxiv.org/content/10.1101/2023.07.20.549967v1) describes a new design for DNA-based neural networks, utilizing enzymatic synthesis and single-stranded DNA to implement basic neural network motifs. Similarly, \"Neural network execution using nicked DNA and microfluidics\" (https://arxiv.org/pdf/2307.00686.pdf) presents a microfluidic device that performs artificial neural network computations using nicked DNA, representing data as DNA concentration and using enzymes to perform the computations within the molecular domain. Furthermore, \"Neural network computation with DNA strand displacement cascades\" (https://www.semanticscholar.org/paper/Neural-network-computation-with-DNA-strand-cascades-Qian-Winfree/7017eb6c2fb0ea580bc560f790dc3bbfae545e34) and the related Nature article (https://www.nature.com/articles/nature10262) explicitly demonstrate neural networks implemented with DNA strand displacement cascades, including an associative memory with four artificial neurons, showcasing the possibility of brain-like behavior with molecular systems. While some other papers use neural networks to analyze or design proteins and DNA (such as computational protein design https://www.nature.com/articles/s41598-018-24760-x, DNA binding proteins classifiers https://link.springer.com/article/10.1007/s44196-024-00462-3, protein sequence function learners https://pmc.ncbi.nlm.nih.gov/articles/PMC8640744/ , or DNA binding protein identifiers https://www.sciencedirect.com/science/article/pii/S2352914819304307 and deep learning application to omics data https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2023.1128153/full), the aforementioned papers clearly demonstrate that neural networks have been designed to compute *with* proteins or DNA as substrates. The DNA based gate array paper (https://www.nature.com/articles/s41586-023-06484-9) while not a neural network, is also relevant to the question of computations performed using DNA."
    },
    {
      "question": "Has anyone found a small molecule that maintains healthy ovarian reserve?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy",
          "author": "Robert J. Schneider",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "Yes, this study found that inhibiting the mTOR pathway with small-molecule inhibitors, specifically everolimus (approved for certain breast cancers) and the experimental drug INK128, preserved ovarian reserve and fertility in a mouse model undergoing chemotherapy.  Treatment with these inhibitors prevented the chemotherapy-induced depletion of primordial follicles and maintained normal fertility.  Even a modest (two- to fourfold) reduction in mTOR activity was sufficient to achieve this effect.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.1617233114"
        },
        {
          "title": "Postnatal oogenesis leads to an exceptionally large ovarian reserve in naked mole-rats - Nature Communications",
          "author": "Brie\u00f1o-Enr\u00edquez; Miguel Angel; Faykoo-Martinez; Mariela; Goben; Meagan; Grenier; Jennifer K; McGrath; Ashley; Prado; Alexandra M; Sinopoli; Jacob; Wagner; Kate; Walsh; Patrick T; Lopa; Samia H; Laird; Diana J; Cohen; Paula E; Wilson; Michael D; Holmes; Melissa M; Place; Ned J",
          "published_date": "2023-04-13T14:55:44.672000+00:00",
          "summary": "This research article focuses on the exceptionally large ovarian reserve in naked mole-rats, a species with unusually long reproductive lifespans.  The study investigates the mechanisms behind this phenomenon, exploring postnatal oogenesis (egg production after birth) as a key factor.  The article does *not* discuss small molecules that maintain healthy ovarian reserve.  It investigates the naturally occurring mechanisms in a unique species, not pharmaceutical interventions.\n",
          "url": "https://www.nature.com/articles/s41467-023-36284-8"
        },
        {
          "title": "Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice - PubMed",
          "author": "Username",
          "published_date": "2023-02-27T02:00:16.084000+00:00",
          "summary": "Yes, this study found that rapamycin, an mTOR inhibitor, maintained ovarian follicle reserve in mice and human ovarian tissue grafted into mice.  Three weeks of rapamycin treatment suppressed primordial follicle development without harming oocyte developmental potential.  The effects were reversible.  This suggests rapamycin could be a small molecule to help maintain ovarian reserve in women, though further research is needed.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31887337/"
        },
        {
          "title": "Unraveling female reproductive senescence to enhance healthy longevity - Cell Research",
          "author": "Dong; Lu; Teh; Daniel Boon Loong; Kennedy; Brian Keith; Huang; Zhongwei",
          "published_date": "2023-04-13T15:01:18.354000+00:00",
          "summary": "This Cell Research article reviews ovarian aging and strategies to delay it, but doesn't identify a small molecule specifically maintaining healthy ovarian reserve.  Research cited explores the effects of caloric restriction and rapamycin on ovarian lifespan in mice, suggesting potential avenues for pharmacological intervention.  However, the article focuses on summarizing existing research rather than presenting novel findings on specific small molecules.\n",
          "url": "https://www.nature.com/articles/s41422-022-00718-7#Abs1"
        },
        {
          "title": "Unraveling female reproductive senescence to enhance healthy longevity",
          "author": "Dong; Lu; Teh; Daniel Boon Loong; Kennedy; Brian Keith; Huang; Zhongwei",
          "published_date": "2023-01-02T00:00:00+00:00",
          "summary": "This research article discusses the decline in female fertility and the potential to intervene. While it details the molecular events driving ovarian aging and menopause, it does *not* report the discovery of a small molecule that maintains healthy ovarian reserve.  The article focuses on the need for further research to understand and potentially manipulate these pathways to prolong reproductive lifespan, but it doesn't present any such breakthroughs.\n",
          "url": "https://www.nature.com/articles/s41422-022-00718-7%7C"
        },
        {
          "title": "Can ovarian aging be delayed by pharmacological ...",
          "author": "",
          "published_date": "2019-01-23T00:00:00+00:00",
          "summary": "This article reviews pharmacological strategies to delay ovarian aging, but doesn't identify any specific small molecules successfully maintaining healthy ovarian reserve.  Research is ongoing into approaches like calorie restriction mimetics, antioxidants, and autophagy inducers, but the review focuses on mechanisms and potential avenues of research rather than reporting on established treatments.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6366956/"
        },
        {
          "title": "Recent progress in the treatment of women with diminished ...",
          "author": "J. Cohen, N. Chabbert-Buffet, E. Darai",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "Current research on diminished ovarian reserve (DOR) focuses heavily on improving IVF outcomes and identifying medications to enhance ovarian function.  While the article discusses stem cell therapies, it does not mention the discovery of a small molecule specifically designed to maintain healthy ovarian reserve.  The text primarily details risk factors for DOR (age, genetics, disease, etc.) and challenges in treating it, highlighting the lack of a definitive cure or medication to directly address the issue.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S266716462100052X"
        },
        {
          "title": "Examining Use of Small-molecule Inhibitors in Preserving ...",
          "author": "medweb",
          "published_date": "2017-03-21T00:00:00+00:00",
          "summary": "Yes.  Northwestern Medicine researchers found that a clinically available small-molecule mTOR inhibitor, when used alongside chemotherapy in mice, preserved ovarian function and fertility.  While total follicle counts were still lower than in untreated mice, the combination prevented premature activation of immature follicles and maintained normal birth rates.  Further research is needed to determine optimal dosage and effects on tumor growth, but the results are promising for preserving fertility during chemotherapy.\n",
          "url": "https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/"
        },
        {
          "title": "Ovarian Reserve Disorders, Can We Prevent Them? A ...",
          "author": "",
          "published_date": "2022-12-06T00:00:00+00:00",
          "summary": "This review article on ovarian reserve disorders focuses on prevention and mitigation of ovarian damage, not on specific molecules maintaining ovarian reserve.  While it discusses various factors contributing to diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI), including genetic, environmental, and autoimmune factors, it does not mention any research on small molecules achieving this goal.  The article primarily addresses prevention strategies such as identifying and avoiding toxic influences and managing the condition after diagnosis.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9737352/"
        },
        {
          "title": "Protein phosphatase 4 maintains the survival of primordial ...",
          "author": "Sun, Qing-Yuan",
          "published_date": "2024-09-08T00:00:00+00:00",
          "summary": "This research does not identify a small molecule maintaining ovarian reserve.  The study focuses on the role of protein phosphatase 4 (PP4) in regulating autophagy within oocytes, a process linked to primordial follicle survival and thus ovarian reserve.  While the research shows that properly regulated autophagy is crucial for maintaining healthy ovarian reserves, it doesn't identify a small molecule that directly affects this process.\n",
          "url": "https://www.nature.com/articles/s41419-024-07051-4"
        }
      ],
      "full_explanation": "Several papers demonstrate that research has been done on small molecules that can maintain healthy ovarian reserve. Specifically, the papers by Schneider et al. (2017) and the follow-up work by medweb (2017), both found that mTOR inhibitors, including everolimus and INK128, and a third paper, that by Username (2023), identified rapamycin, also an mTOR inhibitor, all preserve ovarian reserve.  The research by Schneider et al. (2017) found that these inhibitors prevented the chemotherapy-induced depletion of primordial follicles and maintained normal fertility in mice undergoing chemotherapy (https://www.pnas.org/doi/full/10.1073/pnas.1617233114). The follow up study by medweb (2017) confirmed these findings using a clinically available small molecule mTOR inhibitor. (https://news.feinberg.northwestern.edu/2017/03/21/examining-use-of-small-molecule-inhibitors-in-preserving-fertility/). Finally, the study by Username (2023), further supported this conclusion with rapamycin, finding it maintained ovarian follicle reserve in both mice and human ovarian tissue grafted into mice (https://pubmed.ncbi.nlm.nih.gov/31887337/). Therefore, the research question of whether a small molecule can maintain ovarian reserve has been answered in the affirmative, with mTOR inhibitors being identified as potential candidates."
    },
    {
      "question": "Has anyone done large scale conversion of CO2 to propene?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Combining CO2 reduction with propane oxidative dehydrogenation over bimetallic catalysts",
          "author": "Elaine  Gomez, Columbia University, 10027, New York, NY, USA, Shyam  Kattel, Brookhaven National Laboratory, Upton, 11973, NY, USA, Binhang  Yan, Brookhaven National Laboratory, Upton, 11973, NY, USA, Siyu  Yao, Brookhaven National Laboratory, Upton, 11973, NY, USA, Ping  Liu, Brookhaven National Laboratory, Upton, 11973, NY, USA, Jingguang G Chen, Columbia University, 10027, New York, NY, USA, jgchen@columbia.edu",
          "published_date": "2023-11-09T20:21:59.438000+00:00",
          "summary": "No, this research investigated the use of CO2 in propane oxidative dehydrogenation (ODHP) to produce propene using FeNi and NiPt catalysts on a laboratory scale.  While promising results were obtained, the study doesn't describe any large-scale conversion of CO2 to propene.\n",
          "url": "https://www.nature.com/articles/s41467-018-03793-w"
        },
        {
          "title": "Multifunctional Catalyst Combination for the Direct Conversion of CO2 to Propane",
          "author": "A. Ram\u00edrez,P. Ticali,D. Salusso,T. Cordero-Lanzac,S. Ould-Chikh,Christian Ahoba-Sam,A. Bugaev,E. Borfecchia,S. Morandi,M. Signorile,S. Bordiga,J. Gasc\u00f3n,U. Olsbye",
          "published_date": "2023-10-26T19:28:01.184000+00:00",
          "summary": "This research focuses on converting CO2 to propane, not propene.  The study details a highly active and selective multifunctional catalyst (PdZn/ZrO\u2082 + SAPO-34) that achieves over 50% selectivity to propane at 350\u00b0C, 50 bar, and a flow rate of 1500 mL g\u207b\u00b9 h\u207b\u00b9.  While the scale isn't explicitly stated as \"large-scale,\" the work demonstrates a significant advance in CO2-to-propane conversion, addressing a gap in current research that largely focuses on olefins and aromatics.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34723275"
        },
        {
          "title": "Selective conversion of CO2 to isobutane-enriched C4 alkanes over InZrOx-Beta composite catalyst - Nature Communications",
          "author": "Wang; Han; Fan; Sheng; Guo; Shujia; Sen; Qin; Zhangfeng; Dong; Mei; Zhu; Huaqing; Weibin; Jianguo",
          "published_date": "2023-05-16T16:55:45.446000+00:00",
          "summary": "This research paper focuses on converting CO2 to isobutane-enriched C4 alkanes, not propene. While it mentions that high selectivity to propene (along with butene) has been achieved in CO2 hydrogenation (around 65%), the paper doesn't address large-scale applications.  The study centers on a novel catalyst aiming for selective conversion to longer-chain hydrocarbons (C4+), and doesn't directly answer your query about large-scale propene production from CO2.\n",
          "url": "https://www.nature.com/articles/s41467-023-38336-5"
        },
        {
          "title": "Demonstration of CO2 Conversion to Synthetic Transport Fuel at Flue Gas Concentrations",
          "author": "Robert J. Farrauto",
          "published_date": "2017-10-12T00:00:00+00:00",
          "summary": "This research paper discusses CO2 conversion to valuable chemicals, but focuses on the challenges of large-scale CO2 utilization rather than specific examples of propene production.  While it mentions the conversion of CO2 to other chemicals, it states that direct conversion of CO2 into hydrocarbons like propene is not likely to become commercially viable in the near future.  Therefore, the answer to your query is likely no, based on the information provided.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fenrg.2017.00026/full"
        },
        {
          "title": "Efficient conversion of carbon dioxide to non-methane light hydrocarbons \u2014 Two stage process with intercooler",
          "author": "Congming  Li, Japan Gas Synthesis Co. LTD, 5-20, Kaigan 1-Chome, Minato-Ku, 105-8527, Tokyo, Japan, Kaoru  Fujimoto, Japan Gas Synthesis Co. LTD, 5-20, Kaigan 1-Chome, Minato-Ku, 105-8527, Tokyo, Japan, fujimoto@env.kitakyu-u.ac.jp",
          "published_date": "2023-11-09T20:05:40.323000+00:00",
          "summary": "This study details a two-stage process for converting CO\u2082 to liquefied petroleum gas (LPG), including propane,  using a hybrid catalyst system.  While not explicitly at a large scale, the process achieved 85% CO\u2082 conversion with high hydrocarbon selectivity, suggesting potential for scaling up.  The research focused on optimizing yield and selectivity of the target product (LPG), not specifically propene yield.  Therefore, the study provides a promising approach, but doesn't directly address large-scale propene production from CO\u2082.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S037838201400383X"
        },
        {
          "title": "Electrochemical synthesis of propylene from carbon ...",
          "author": "Gr\u00e4tzel, Michael",
          "published_date": "2023-04-06T00:00:00+00:00",
          "summary": "No large-scale conversion of CO2 to propene has been achieved.  While researchers have demonstrated electrochemical CO2 reduction to propene using copper nanocrystals, the production rate and Faradaic efficiency remain very low (0.9% at \u22121.8 V versus RHE in one study).  The process is currently hindered by kinetic and thermodynamic barriers associated with the multiple C-C coupling steps involved.\n",
          "url": "https://www.nature.com/articles/s41557-023-01163-8"
        },
        {
          "title": "Direct and selective hydrogenation of CO2 to ethylene and ...",
          "author": "Bin Liu",
          "published_date": "2017-11-27T00:00:00+00:00",
          "summary": "This study demonstrates a method for selectively converting CO2 to light olefins, including propene, using a bifunctional catalyst.  While not explicitly stated as large-scale, the process achieved a propene selectivity of 80-90% within hydrocarbons at a CO2 conversion of ~20% under the tested conditions (15 bar, 400\u00b0C).  This selectivity significantly surpasses that of conventional Fischer-Tropsch catalysts.  The catalyst also showed good stability over 50 hours of continuous operation.\n",
          "url": "https://pubs.rsc.org/en/content/articlelanding/2017/cy/c7cy01549f"
        },
        {
          "title": "Combining CO2 reduction with propane oxidative ...",
          "author": "Elaine  Gomez, Columbia University, 10027, New York, NY, USA, Shyam  Kattel, Brookhaven National Laboratory, Upton, 11973, NY, USA, Binhang  Yan, Brookhaven National Laboratory, Upton, 11973, NY, USA, Siyu  Yao, Brookhaven National Laboratory, Upton, 11973, NY, USA, Ping  Liu, Brookhaven National Laboratory, Upton, 11973, NY, USA, Jingguang G Chen, Columbia University, 10027, New York, NY, USA, jgchen@columbia.edu",
          "published_date": "2023-11-09T20:21:59.438000+00:00",
          "summary": "No large-scale conversion of CO2 to propene is described in this study.  The research focuses on identifying promising bimetallic catalysts (FeNi and NiPt) for propane oxidative dehydrogenation using CO2 at the lab scale (flow reactor studies at 823K).  While the process aims to utilize CO2 and produce propene, the research is at an early stage, not involving large-scale conversion.\n",
          "url": "https://www.nature.com/articles/s41467-018-03793-w"
        },
        {
          "title": "Toward the Development and Deployment of Large-Scale ...",
          "author": "Zhihong  Yuan, Mario R Eden, Rafiqul  Gani",
          "published_date": "2023-11-09T20:13:41.012000+00:00",
          "summary": "The provided text focuses on the challenges of large-scale CO2 capture and conversion in general, mentioning various conversion routes (thermochemical, electrochemical, photochemical, and biochemical).  However, it does *not* provide specific information on whether large-scale conversion of CO2 to propene has been achieved.  The article discusses the technological hurdles to widespread CO2 conversion, implying that large-scale applications, including propene production, remain largely unrealized.\n",
          "url": "https://pubs.acs.org/doi/10.1021/acs.iecr.5b03277"
        },
        {
          "title": "The enhancing effect of Co2+ on propane non-oxidative ...",
          "author": "S.M. Sadrameli",
          "published_date": "2024-04-01T00:00:00+00:00",
          "summary": "This research paper focuses on propane dehydrogenation (PDH) to produce propene, not the conversion of CO2 to propene.  The study explores the use of Co/ZrO2 catalysts as a more environmentally friendly and cost-effective alternative to current Cr- or Pt-based catalysts for large-scale propene production from propane, a component of shale gas.  The research does *not* address CO2 conversion to propene.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0021951724001532"
        }
      ],
      "full_explanation": "Based on the provided research papers, there is no evidence of large-scale conversion of CO2 to propene having been achieved. While several papers explore CO2 conversion to other hydrocarbons, or the use of CO2 in related processes, they either explicitly state the absence of large-scale applications for propene, or they focus on other products. \n\n*   The paper \"Combining CO2 reduction with propane oxidative dehydrogenation over bimetallic catalysts\" (URL: https://www.nature.com/articles/s41467-018-03793-w) and the second identical entry with the same URL explores the use of CO2 in propane oxidative dehydrogenation to produce propene on a laboratory scale but doesn't describe any large-scale conversion.\n*  The paper \"Electrochemical synthesis of propylene from carbon ...\" (URL: https://www.nature.com/articles/s41557-023-01163-8) demonstrates electrochemical CO2 reduction to propene, but states that the production rate and efficiency remain very low, and that the process is hindered by kinetic and thermodynamic barriers. Therefore, there is no indication of any large-scale process.\n* While the paper \"Direct and selective hydrogenation of CO2 to ethylene and ...\" (URL: https://pubs.rsc.org/en/content/articlelanding/2017/cy/c7cy01549f) achieves a high selectivity for propene (80-90%) from CO2 hydrogenation, it doesn't explicitly describe a large-scale application of this process. The research is conducted at 15 bar and 400\u00b0C, which are typical lab conditions.\n\nThe paper \"Demonstration of CO2 Conversion to Synthetic Transport Fuel at Flue Gas Concentrations\" (URL: https://www.frontiersin.org/articles/10.3389/fenrg.2017.00026/full) explicitly states that \"direct conversion of CO2 into hydrocarbons like propene is not likely to become commercially viable in the near future\". This confirms that no large scale conversion to propene is viable.\nWhile other papers such as \"Multifunctional Catalyst Combination for the Direct Conversion of CO2 to Propane\" (URL: https://pubmed.ncbi.nlm.nih.gov/34723275) and \"Efficient conversion of carbon dioxide to non-methane light hydrocarbons \u2014 Two stage process with intercooler\" (URL: https://www.sciencedirect.com/science/article/pii/S037838201400383X) address CO2 conversion, they target other products (propane and LPG, respectively), and not specifically propene.\nThe remaining papers are not relevant to the research question, as they focus on CO2 conversion to other products like isobutane, or challenges of large-scale CO2 conversion in general.\nTherefore, based on the provided papers, there is no evidence of large scale conversion of CO2 to propene."
    },
    {
      "question": "Has anyone discovered how proteins contribute to the mechanical properties of cells and tissues?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "The laminin\u2013keratin link shields the nucleus from mechanical deformation and signalling",
          "author": "Kechagia; Zanetta; S\u00e1ez; Pablo; G\u00f3mez-Gonz\u00e1lez; Manuel; Canales; Brenda; Viswanadha; Srivatsava; Zamarbide; Mart\u00edn; Andreu; Ion; Koorman; Thijs; Beedle; Amy E M; Elosegui-Artola; Alberto; Derksen; Patrick W B; Trepat; Xavier; Arroyo; Marino; Roca-Cusachs; Pere",
          "published_date": "2023-12-04T03:54:56.396000+00:00",
          "summary": "This research explores how extracellular matrix (ECM) proteins, specifically laminin-111, influence cell mechanotransduction (the process by which cells sense and respond to mechanical forces).  The study found that laminin-111, a major component of basement membranes in breast epithelial tissue, hinders the typical cellular response to increased tissue stiffness.  This response usually involves changes in the nucleus, regulated by proteins like YAP. The findings suggest that laminin-111 and other ECM proteins play a significant role in determining the mechanical properties of cells and tissues and how cells respond to changes in those properties.\n",
          "url": "https://www.nature.com/articles/s41563-023-01657-3"
        },
        {
          "title": "The vimentin cytoskeleton: when polymer physics meets cell biology",
          "author": "A. Patteson,Robert J. Carroll,Daniel V. Iwamoto,P. Janmey",
          "published_date": "2023-10-26T19:28:33.989000+00:00",
          "summary": "This review discusses the mechanical role of vimentin, an intermediate filament protein, in cells and tissues.  Vimentin, a component of the cytoskeleton, contributes to a cell's ability to withstand stress and maintain shape.  Mutations in vimentin genes can lead to diseases with observable mechanical defects, highlighting its importance in cellular mechanics.  The authors focus on the unique mechanical properties of vimentin, emphasizing its role in transferring forces between the cell and nuclear surfaces, and its contribution to the overall mechanical resilience of cells and tissues.\n",
          "url": "https://arxiv.org/pdf/2008.10563.pdf"
        },
        {
          "title": "The mechanical cell \u2013 the role of force dependencies in synchronising protein interaction networks",
          "author": "Benjamin T. Goult",
          "published_date": "2022-11-15T00:00:00+00:00",
          "summary": "This review article discusses how mechanical forces influence protein interactions within cells, affecting their overall mechanical properties.  The authors explore the concept of a \"mechanical cell,\" highlighting the interconnectedness of force-dependent protein interactions and the resulting cellular mechanics.  While it doesn't directly state a single discovery, the article synthesizes existing research to explain how these protein interactions contribute to the mechanical properties of cells and tissues.\n",
          "url": "https://journals.biologists.com/jcs/article/135/22/jcs259769/283155/The-mechanical-cell-the-role-of-force-dependencies"
        },
        {
          "title": "The role of single-protein elasticity in mechanobiology - Nature Reviews Materials",
          "author": "Beedle; Amy E M; Garcia-Manyes; Sergi",
          "published_date": "2023-02-06T13:10:13.814000+00:00",
          "summary": "Yes, research indicates that proteins significantly contribute to the mechanical properties of cells and tissues.  Multiple studies cited in \"The role of single-protein elasticity in mechanobiology\" demonstrate the influence of protein elasticity on cellular processes.  For example, research shows that matrix elasticity directs stem cell lineage specification and that the nuclear lamina is mechano-responsive to extracellular matrix elasticity.  Further studies explore how mechanical forces direct stem cell behavior in development and regeneration, and how the extracellular matrix is mechanically coupled to the nucleus.\n",
          "url": "https://www.nature.com/articles/s41578-022-00488-z"
        },
        {
          "title": "Bioinspired stretchable molecular composites of 2D-layered materials and tandem repeat proteins",
          "author": "Melik C.  Demirel",
          "published_date": "2022-07-26T00:00:00+00:00",
          "summary": "This PNAS study investigated how proteins contribute to the mechanical properties of bio-inspired composites.  Researchers created flexible, ultra-tough composites by combining atomistically thin inorganic sheets with genetically engineered proteins.  The proteins, inspired by squid ring teeth, enhanced the material's stretchability (59% fracture strain) and toughness (54.8 MJ/m\u00b3), exceeding current state-of-the-art composites.  The study's findings suggest that the interaction between proteins and inorganic materials at the interface is crucial for determining the overall mechanical properties, offering insights into the design of new, nature-inspired composites.  While the study focuses on synthetic composites, its findings provide valuable clues regarding how protein interactions influence material properties at a fundamental level, potentially offering insights applicable to biological cells and tissues.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.2120021119"
        },
        {
          "title": "Mechanical Players\u2014The Role of Intermediate Filaments ...",
          "author": "",
          "published_date": "2013-10-15T00:00:00+00:00",
          "summary": "Yes, research indicates that proteins, particularly those forming the cytoskeleton (actin, microtubules, and intermediate filaments), significantly contribute to cell mechanical properties.  While actin and microtubules have been extensively studied, intermediate filaments, though abundant, are less understood.  Recent research is elucidating their role in controlling cell stiffness, demonstrating their importance in maintaining cell integrity and responding to environmental changes.  The mechanical properties of intermediate filaments, including their compliance at small deformations and stiffening at larger stretches, are crucial to this function.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3797571/"
        },
        {
          "title": "Cell mechanics and the cytoskeleton - PMC - PubMed Central",
          "author": "",
          "published_date": "2010-01-28T00:00:00+00:00",
          "summary": "Yes, research shows that the cytoskeleton, a network of filamentous polymers and regulatory proteins, significantly contributes to cell and tissue mechanics.  The cytoskeleton enables cells to resist deformation, transport cargo, and change shape.  Researchers are actively investigating how cytoskeletal networks generate, transmit, and respond to mechanical signals, focusing on how long-lived structures influence cell shape, function, and fate.  While much is known about individual proteins, a key challenge is understanding how these components work together to create the complex systems that govern cellular behavior and tissue mechanics.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2851742/"
        },
        {
          "title": "How to define and study structural proteins as biopolymer ...",
          "author": "Keiji  Numata, Kyoto University, Kyoto-Daigaku-Katsura, Nishikyo-ku, 615-8510, Kyoto, Japan, keiji.numata@riken.jp",
          "published_date": "2023-11-09T20:29:43.698000+00:00",
          "summary": "This review article discusses structural proteins, like silk fibroins, and their role in the mechanical properties of cells and tissues.  It highlights how their unique amino acid sequences (often repeating motifs) differentiate them from functional proteins, and explores methods for characterizing these proteins as biopolymer materials relevant to their contribution to cellular and tissue structure.  The article focuses on the application of these proteins in materials science, but implicitly addresses their fundamental role in providing mechanical strength and shape to biological systems.\n",
          "url": "https://www.nature.com/articles/s41428-020-0362-5"
        },
        {
          "title": "Mechanical Properties of Living Cells and Tissues Related ...",
          "author": "Written By Miroslav Hole\u010dek, Petra Kochov\u00e1 and Zbyn\u011bk Tonar",
          "published_date": "2011-11-25T00:00:00+00:00",
          "summary": "This review article discusses the mechanical properties of living cells and tissues from a physics perspective, focusing on thermodynamics and experimental methods.  While it doesn't directly address the contribution of *specific* proteins to cellular mechanics, the text highlights the inherent complexity of modeling living cells as simple materials.  The authors emphasize that cells actively respond to experimental conditions, changing their properties (including viscoelasticity and rheology), making simple models inadequate.  The role of molecular structure and macromolecular chemistry, which would include proteins, is mentioned in the context of describing the cell as a material, but no specific protein contributions are detailed.\n",
          "url": "https://www.intechopen.com/chapters/22184"
        },
        {
          "title": "Review Fibrous proteins and tissue engineering",
          "author": "Xianyan  Wang, Tufts University, 02155, Medford, MA, USA, Joo  Kim, Tufts University, 02155, Medford, MA, USA, Cheryl  Wong, Tufts University, 02155, Medford, MA, USA, Charu  Vepari, Tufts University, 02155, Medford, MA, USA, Akira  Matsumoto, Tufts University, 02155, Medford, MA, USA, David L Kaplan, Tufts University, 02155, Medford, MA, USA, david.kaplan@tufts.edu",
          "published_date": "2023-11-09T19:55:09.836000+00:00",
          "summary": "Research shows fibrous proteins significantly impact the mechanical properties of cells and tissues.  Advances in understanding their structure-function relationships, along with the unique material properties of these protein polymers, are leading to new biomaterials and tissue engineering applications.  Researchers are focusing on controlling the structure, chemistry, and morphology of these biomaterials to direct cell and tissue outcomes.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S1369702106717424"
        }
      ],
      "full_explanation": "The provided papers clearly demonstrate that the research question has been explored extensively. Multiple papers directly address how proteins contribute to the mechanical properties of cells and tissues:\n\n*   **\"The laminin\u2013keratin link shields the nucleus from mechanical deformation and signalling\"** (https://www.nature.com/articles/s41563-023-01657-3) shows that the ECM protein laminin-111 influences cell mechanotransduction, thus playing a role in the mechanical properties of cells and how they respond to mechanical changes.\n*   **\"The vimentin cytoskeleton: when polymer physics meets cell biology\"** (https://arxiv.org/pdf/2008.10563.pdf) specifically focuses on vimentin, an intermediate filament protein, and its contribution to cell's stress resistance and shape maintenance, which are key aspects of mechanical properties.\n*  **\"The mechanical cell \u2013 the role of force dependencies in synchronising protein interaction networks\"** (https://journals.biologists.com/jcs/article/135/22/jcs259769/283155/The-mechanical-cell-the-role-of-force-dependencies) discusses how mechanical forces influence protein interactions within cells, and how this affects the overall mechanical properties.\n*   **\"The role of single-protein elasticity in mechanobiology - Nature Reviews Materials\"** (https://www.nature.com/articles/s41578-022-00488-z) directly states that proteins contribute significantly to the mechanical properties of cells and tissues and gives examples.\n*   **\"Bioinspired stretchable molecular composites of 2D-layered materials and tandem repeat proteins\"** (https://www.pnas.org/doi/full/10.1073/pnas.2120021119) demonstrates the direct impact of proteins on mechanical properties by showing the strength they add to synthetic composite materials, offering strong clues about their role in living tissue as well.\n*   **\"Mechanical Players\u2014The Role of Intermediate Filaments ...\"** (https://pmc.ncbi.nlm.nih.gov/articles/PMC3797571/) highlights the role of cytoskeletal proteins, including intermediate filaments, in controlling cell stiffness, a key mechanical property.\n*   **\"Cell mechanics and the cytoskeleton - PMC - PubMed Central\"** (https://pmc.ncbi.nlm.nih.gov/articles/PMC2851742/) focuses on the cytoskeleton, a network of proteins, as a major contributor to cell and tissue mechanics.\n*   **\"How to define and study structural proteins as biopolymer ...\"** (https://www.nature.com/articles/s41428-020-0362-5) addresses structural proteins like silk fibroins and their role in the mechanical properties of cells and tissues.\n*   **\"Review Fibrous proteins and tissue engineering\"** (https://www.sciencedirect.com/science/article/pii/S1369702106717424) establishes that fibrous proteins significantly impact the mechanical properties of cells and tissues.\n\nThese papers, collectively, provide substantial evidence that the research question of how proteins contribute to the mechanical properties of cells and tissues has been explored in many different aspects."
    },
    {
      "question": "Has anyone made an entire cell with D amino acids?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Consecutive Elongation of D-Amino Acids in Translation",
          "author": "Search for articles by this author",
          "published_date": "2017-01-19T00:00:00+00:00",
          "summary": "No.  This research describes a method for incorporating up to ten consecutive D-serine residues into a peptide chain using a modified cell-free translation system.  It does *not* describe the creation of an entire cell using D-amino acids.\n",
          "url": "https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(16)30435-4"
        },
        {
          "title": "D-amino acid doping peptide hydrogel for the production of a cell colony",
          "author": "Caiwen  Ou, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, Jianwu  Zhang, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, Yang  Shi, Nankai University, 300071, Tianjin, P. R. China, yangzm@nankai.edu.cn, Zhongyan  Wang, Nankai University, 300071, Tianjin, P. R. China, Ling  Wang, Zhimou  Yang, Nankai University, 300071, Tianjin, P. R. China, Minsheng  Chen, Zhujiang Hospital of Southern Medical University, 510280, Guangzhou, P. R. China, gzminsheng@vip.163.com",
          "published_date": "2023-11-09T20:04:57.198000+00:00",
          "summary": "No, this research used D-amino acids to create a peptide hydrogel that supports the growth of a HeLa cell *colony*, not to construct a whole cell from D-amino acids.  The study focuses on using the hydrogel as a scaffold for cell growth, not on building cells entirely from D-amino acids.\n",
          "url": "https://pubs.rsc.org/en/content/articlelanding/2014/RA/c3ra46847j"
        },
        {
          "title": "Adding \u03b1,\u03b1-disubstituted and \u03b2-linked monomers to the genetic code of an organism",
          "author": "Dunkelmann; Daniel L; Piedrafita; Carlos; Dickson; Alexandre; Liu; Kim C; Elliott; Thomas S; Fiedler; Marc; Bellini; Dom; Zhou; Andrew; Cervettini; Daniele; Chin; Jason W",
          "published_date": "2024-01-10T00:00:00+00:00",
          "summary": "This research does not describe the creation of a cell entirely composed of D-amino acids.  The study focuses on expanding the genetic code to incorporate non-canonical amino acids (including some with \u03b2-linkages) into proteins *within* existing cells, but not on replacing all amino acids with D-enantiomers.\n",
          "url": "https://www.nature.com/articles/s41586-023-06897-6"
        },
        {
          "title": "Consecutive Elongation of D-Amino Acids in Translation.",
          "author": "Takayuki  Katoh, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan, katoh@chem.s.u-tokyo.ac.jp, Kenya  Tajima, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan, Hiroaki  Suga, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan, hsuga@chem.s.u-tokyo.ac.jp",
          "published_date": "2023-11-09T20:19:48.822000+00:00",
          "summary": "No, this research does not describe the creation of an entire cell using D-amino acids.  The study focuses on developing a ribosomal translation system capable of incorporating up to ten consecutive D-serine residues into a peptide chain, as well as synthesizing small macrocyclic peptides with D-amino acids.  While this is a significant advance in incorporating D-amino acids into peptides, it does not address the creation of a whole cell.\n",
          "url": "https://cell.com/cell-chemical-biology/retrieve/pii/S2451945616304354?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2451945616304354%3Fshowall%3Dtrue"
        },
        {
          "title": "A d-Amino Acid at the N-Terminus of a Protein Abrogates Its Degradation by the N-End Rule Pathway",
          "author": "Amy E. Rabideau,B. Pentelute",
          "published_date": "2023-10-26T19:31:47.324000+00:00",
          "summary": "This research paper does not address the creation of an entire cell using D-amino acids.  The study focuses on the effect of a single D-amino acid at the N-terminus of a protein, showing that it prevents degradation via the N-end rule pathway.  The experiments involve modifying specific proteins and observing their behavior in cell cultures (HEK-293T and HeLa cells), not the construction of a cell from D-amino acids.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26807441"
        },
        {
          "title": "Highly selective synthesis of d-amino acids via ...",
          "author": "Dan-Ping  Zhang, Xiao-Ran  Jing, Lun-Jie  Wu, An-Wen  Fan, Yao  Nie, ynie@jiangnan.edu.cn, Yan  Xu",
          "published_date": "2023-11-09T20:33:38.692000+00:00",
          "summary": "This research does not describe a cell made entirely of D-amino acids.  Instead, it details the creation of a genetically modified *E. coli* cell factory that efficiently converts L-amino acids into D-amino acids.  This is achieved through the co-expression of three enzymes, resulting in high yields (over 99% ee) of various D-amino acids from their L-counterparts.\n",
          "url": "https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-020-01506-x"
        },
        {
          "title": "Production of D-amino acid using whole cells ...",
          "author": "J H Park 1 , G J Kim, H S Kim",
          "published_date": "2014-07-18T00:00:00+00:00",
          "summary": "This research article describes the production of D-amino acids using genetically modified *Escherichia coli* cells.  The study did not create cells *entirely* composed of D-amino acids, but rather used recombinant *E. coli* expressing D-hydantoinase and N-carbamoylase to produce D-hydroxyphenylglycine from D,L-p-hydroxyphenylhydantoin.  Co-expressing both enzymes in the same cells yielded a significantly higher (98%) product yield compared to separate expression (71%).\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/10933829/"
        },
        {
          "title": "The Role of D-Amino Acids in Humans",
          "author": "Sponsored Content by PittconMar 4 2021",
          "published_date": "2024-02-01T10:56:00+00:00",
          "summary": "This article discusses the role of D-amino acids in human health, particularly in relation to cancer and neurological disorders.  While it details research showing elevated levels of specific D-amino acids (D-aspartic acid, D-serine, D-alanine) in cancer cells and their potential as biomarkers, it does *not* address the creation of an entire cell using only D-amino acids.  The research focuses on the presence and function of D-amino acids within existing cells, not their use to construct artificial cells.\n",
          "url": "https://www.news-medical.net/news/20210304/The-Role-of-D-Amino-Acids-in-Humans.aspx"
        },
        {
          "title": "d-amino acids signal a stress-dependent run-away ...",
          "author": "Irazoki; Oihane; Ter Beek; Josy; Alvarez; Laura; Mateus; Andr\u00e9; Colin; Remy; Typas; Athanasios; Savitski; Mikhail M; Sourjik; Victor; Berntsson; Ronnie P -A; Cava; Felipe",
          "published_date": "2023-12-04T02:09:55.764000+00:00",
          "summary": "This research does not address the creation of an entire cell using D-amino acids.  The study focuses on *Vibrio cholerae*'s response to D-amino acids (DAAs) released into its environment.  These DAAs, produced from L-amino acids by the racemase BsrV, influence various cellular processes in *V. cholerae*, but the paper doesn't explore the possibility of building a cell solely from DAAs.\n",
          "url": "https://www.nature.com/articles/s41564-023-01419-6"
        },
        {
          "title": "d-amino Acids in Health and Disease: A Focus on Cancer",
          "author": "",
          "published_date": "2019-09-12T00:00:00+00:00",
          "summary": "This article focuses on the roles of D-amino acids in human health and disease, particularly cancer.  While it discusses the sources and metabolism of D-amino acids, including endogenous biosynthesis via racemase enzymes, it does *not* address the creation of an entire cell using only D-amino acids.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6770864/"
        }
      ],
      "full_explanation": "None of the provided papers describe the creation of an entire cell constructed solely from D-amino acids. While several papers explore the incorporation of D-amino acids into peptides and proteins, or the production of D-amino acids, none achieve the complete replacement of L-amino acids with D-amino acids for all cellular components. Specifically:\n\n*   **\"Consecutive Elongation of D-Amino Acids in Translation\"** (https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(16)30435-4 and https://cell.com/cell-chemical-biology/retrieve/pii/S2451945616304354?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2451945616304354%3Fshowall%3Dtrue ) focuses on a cell-free system for incorporating up to ten consecutive D-serine residues into peptide chains, and the synthesis of small macrocyclic peptides with D-amino acids. It does not address building a whole cell using D-amino acids.\n*   **\"D-amino acid doping peptide hydrogel for the production of a cell colony\"** (https://pubs.rsc.org/en/content/articlelanding/2014/RA/c3ra46847j) describes the use of D-amino acid-based peptide hydrogels as a scaffold to support the growth of HeLa cells, rather than building a cell entirely from D-amino acids.\n*   **\"Adding \u03b1,\u03b1-disubstituted and \u03b2-linked monomers to the genetic code of an organism\"** (https://www.nature.com/articles/s41586-023-06897-6) deals with expanding the genetic code to incorporate non-canonical amino acids into proteins *within* existing cells, it does not focus on the replacement of L-amino acids with D-amino acids to create a new cell.\n*  **\"A d-Amino Acid at the N-Terminus of a Protein Abrogates Its Degradation by the N-End Rule Pathway\"** (https://pubmed.ncbi.nlm.nih.gov/26807441) examines the impact of a single D-amino acid on protein degradation within existing cells, not the creation of a cell from all D-amino acids.\n* **\"Highly selective synthesis of d-amino acids via ...\"** (https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-020-01506-x) discusses the engineering of *E. coli* to produce D-amino acids, not the construction of a cell from D-amino acids.\n*   **\"Production of D-amino acid using whole cells ...\"** (https://pubmed.ncbi.nlm.nih.gov/10933829/) details the use of modified *E. coli* cells to produce D-amino acids, rather than the creation of a cell constructed from D-amino acids.\n\nAll other papers discuss the role of D-amino acids in biological systems, including human health, cancer, or microbial interactions and are not relevant to the specific research question about building an entire cell."
    },
    {
      "question": "Has anyone identified how many copies of p53 whales have?",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity - PubMed",
          "author": "Martin Bartas 1 ,",
          "published_date": "2021-07-08T00:00:00+00:00",
          "summary": "This study doesn't specify the p53 gene copy number in whales.  However, it does note that African elephants, known for their longevity and cancer resistance, possess 20 copies of the TP53 gene (including 19 retrogenes), while humans have only one.  The research focuses on identifying correlations between specific amino acid variations in the p53 protein and lifespan across various animal species, including cetaceans (whales), but doesn't provide a p53 gene copy number for any whale species.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34445220/"
        },
        {
          "title": "The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity",
          "author": "Martin Bartas; V\u00e1clav Br\u00e1zda; Adriana Voln\u00e1; Ji\u0159\u00ed \u010cerve\u0148; Petr Pe\u010dinka; Joanna E Zawacka-Pankau",
          "published_date": "2023-02-06T18:48:01.083000+00:00",
          "summary": "This research article does not contain information on the number of p53 gene copies in whales.  The study focuses on the correlation between p53 amino acid sequence variations and lifespan across different species, using African elephants (with 20 copies of TP53) as a key example of a long-lived species with multiple p53 copies.  It analyzes p53 sequences to identify amino acid substitutions associated with longevity but doesn't provide data on whale p53 gene copy number.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395165/"
        },
        {
          "title": "Nucleotide sequence of the p53 cDNA of beluga whale (Delphinapterus leucas).",
          "author": "Ning  Xu, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, Takashi  Shiraki, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, Tadasu  Yamada, National Science Museum, 3-23-1, Hyakunin-cho, Shinjuku-ku, 169-0073, Tokyo, Japan, Masayuki  Nakajima, Hakkeijima Sea Paradise Aquarium, Kanazawa-ku, 236-0006, Hakkeijima, Yokohama, Japan, Julie M Gauthier, University of Que \u00b4bec, Montre \u00b4al, Que \u00b4bec, Canada, Carl J Pfeiffer, Virginia Polytechnic Institute and State University, 24061-0442, Blacksburg, VA, USA, Shigeaki  Sato, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan, sato@kobe-u.ac.jp",
          "published_date": "2023-11-09T19:58:42.557000+00:00",
          "summary": "This study sequenced the beluga whale p53 cDNA, finding it to be 2150 nucleotides long and encoding a 387-amino acid protein.  The research doesn't specify the copy number of the p53 gene in whales; it focuses on sequencing a single cDNA copy.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0378111902004729"
        },
        {
          "title": "P53 at the start of the 21st century: lessons from elephants",
          "author": "Sue Haupt; Ygal Haupt",
          "published_date": "2023-02-06T07:37:48.943000+00:00",
          "summary": "This article discusses the role of p53 in cancer suppression, comparing humans and elephants.  Elephants have at least 20 copies of the TP53 gene, which is thought to contribute to their low cancer rates.  The article does *not* contain information about the number of p53 copies in whales.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701437/"
        },
        {
          "title": "Functional Diversity of p53 in Human and Wild Animals",
          "author": "Li; Yi; Zhang; Meng-Chen; Xu; Xiao-Kang; Zhao; Yang; Mahanand; Chatoo; Zhu; Tao; Deng; Hong; Nevo; Eviatar; Du; Ji-Zeng; Chen",
          "published_date": "2023-02-06T07:43:30.407000+00:00",
          "summary": "This article focuses on the diverse functions of p53 and its mutations in humans and animals, but it does not contain information on the number of p53 gene copies in whales.  Therefore, I cannot answer your query using the provided text.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fendo.2019.00152/full"
        },
        {
          "title": "Evolution of p53 pathway-related genes provides insights ...",
          "author": "",
          "published_date": "2023-09-18T00:00:00+00:00",
          "summary": "This study doesn't specify the copy number of the p53 gene itself in whales.  However, it does identify several other genes in the p53 pathway with increased copy numbers (e.g.,  tumor suppressor genes) correlated with body size in long-lived cetaceans.  The research focuses on the evolution of the *entire* p53 pathway, not just the p53 gene's copy number, to explain the low cancer rates in these large, long-lived mammals.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10559092/"
        },
        {
          "title": "How Do Whales Fight Off Cancer? Scholar in Duke's ...",
          "author": "By Lindsay Key",
          "published_date": "2019-08-14T00:00:00+00:00",
          "summary": "This article discusses the surprisingly low cancer rates in whales despite their large size (Peto's Paradox).  While it mentions researchers are interested in investigating the p53 protein in whales as a potential factor in their cancer resistance,  the article does *not* state how many copies of p53 whales possess.  The research is ongoing.\n",
          "url": "https://medschool.duke.edu/stories/how-do-whales-fight-cancer-scholar-dukes-marine-medicine-program-breaks-new-ground"
        },
        {
          "title": "Peto's Paradox: how has evolution solved the problem of ...",
          "author": "Tollis; Marc; Boddy; Amy M; Maley; Carlo C",
          "published_date": "2023-02-06T08:47:05.871000+00:00",
          "summary": "This article does not contain information about the number of p53 copies in whales.  The article discusses Peto's Paradox, which observes that larger, longer-lived animals don't experience a proportionally higher cancer rate, despite having more cells and more cell divisions over their lifetime.  The article explores potential evolutionary solutions to this paradox but doesn't delve into specific genes like p53 in any particular species.\n",
          "url": "https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-017-0401-7"
        },
        {
          "title": "TP53 copy number expansion is associated with the ...",
          "author": "",
          "published_date": "2016-09-19T00:00:00+00:00",
          "summary": "This study examined the number of TP53 gene copies in 61 animals of varying sizes, including Minke whales. While the exact number of TP53 copies in Minke whales isn't specified, the research found that African elephants, the largest animals studied, possessed 19 TP53 retrogenes in addition to their original TP53 gene.  Other large animals also had extra copies, suggesting a correlation between body size and TP53 copy number.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5061548/"
        },
        {
          "title": "The changes in the p53 protein across the animal kingdom ...",
          "author": "View ORCID ProfileMartin Bartas",
          "published_date": "2021-07-12T00:00:00+00:00",
          "summary": "This research paper does not contain information on the number of p53 gene copies in whales.  The study focuses on the correlation between p53 amino acid sequence variations and lifespan across various species, using elephants (with 20 copies of TP53) as a comparative example.  The study does not provide data on whale p53 gene copy number.\n",
          "url": "https://www.biorxiv.org/content/10.1101/2020.05.06.080200.full"
        }
      ],
      "full_explanation": "While the majority of the papers focus on the p53 pathway, amino acid sequence variations, and the general link between p53 and cancer resistance in various species, including whales, one paper directly addresses the research question. The paper titled \"TP53 copy number expansion is associated with the...\" (URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5061548/) explicitly states that it examined TP53 copy numbers in 61 animals, including Minke whales. Although the summary does not specify the exact copy number for Minke whales, the fact that this paper directly explored the copy number of the TP53 gene in Minke whales (and other animals) indicates that the research question has been previously investigated, at least partially. Therefore, the research has been done before, even if the specific number for each whale species is not always available within these articles."
    },
    {
      "question": "Has anyone successfully identified the precise mechanisms by which prion proteins propagate their misfolded conformations across different species?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "A structural basis for prion strain diversity - Nature Chemical Biology",
          "author": "Manka; Szymon W; Wenborn; Adam; Betts; Jemma; Joiner; Susan; Saibil; Helen R; Collinge; John; Wadsworth; Jonathan D F",
          "published_date": "2023-04-13T18:51:23.128000+00:00",
          "summary": "The article explores the structural basis of prion strain diversity and its implications for cross-species transmission.  While it details how prion propagation occurs through fiber elongation and fission of misfolded prion proteins (PrP),  it doesn't describe a precisely identified mechanism for cross-species transmission beyond mentioning the \"conformational selection model\" and the role of species barriers related to structural compatibility between prion strains and host PrP<sup>C</sup>. The study highlights the importance of PrP polymorphisms in influencing both inter- and intra-species transmission and the emergence of novel prion strains, emphasizing the need for further research to fully understand cross-species propagation mechanisms.\n",
          "url": "https://www.nature.com/articles/s41589-022-01229-7"
        },
        {
          "title": "Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations - Nature Communications",
          "author": "Farag; Mina; Cohen; Samuel R; Borcherds; Wade M; Bremer; Anne; Mittag; Tanja; Pappu; Rohit V",
          "published_date": "2023-04-13T16:49:39.982000+00:00",
          "summary": "This article focuses on the phase separation and network structures of prion-like low complexity domains (PLCDs) within biomolecular condensates, not on interspecies prion propagation.  Therefore, it does not address the mechanism of prion misfolding propagation across species.\n",
          "url": "https://www.nature.com/articles/s41467-022-35370-7"
        },
        {
          "title": "Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein",
          "author": "David  Westaway",
          "published_date": "2022-12-27T00:00:00+00:00",
          "summary": "This research identifies dipeptidyl peptidase-4 (DPP4) and fibroblast activation protein (FAP) as enzymes that cleave the cellular prion protein (PrPC), a process linked to prion disease.  While the study focuses on the cleavage mechanism itself and its impact on disease progression, it does *not* address interspecies propagation of misfolded prion conformations.  The paper investigates the role of DPP4 and FAP in prion disease pathogenesis within a single species (mouse models are used), not the transmission of misfolded proteins between different species.\n",
          "url": "https://www.pnas.org/doi/full/10.1073/pnas.2209815120"
        },
        {
          "title": "The E46K mutation modulates \u03b1-synuclein prion replication in transgenic mice",
          "author": "Sara A. M. Holec,",
          "published_date": "2022-12-01T00:00:00+00:00",
          "summary": "This study does not address interspecies prion propagation.  It focuses on the effect of the E46K mutation in \u03b1-synuclein on prion replication *within* a mouse model, finding that this mutation modulates the propagation of different \u03b1-synuclein prion strains.  The research shows resistance to certain strains in mice expressing the mutated protein, suggesting that the mutation constrains the number of \u03b1-synuclein prion conformations that can propagate.  However, it does not investigate or offer insight into cross-species prion transmission mechanisms.\n",
          "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010956"
        },
        {
          "title": "Tau monomer encodes strains",
          "author": "Apurwa M Sharma; Talitha L Thomas; DaNae R Woodard; Omar M Kashmer; Marc I Diamond",
          "published_date": "2023-02-06T10:54:09.013000+00:00",
          "summary": "This research focuses on tau proteins, not prion proteins, so it doesn't directly address interspecies propagation of misfolded prion conformations.  The study finds that tau monomers exist in multiple stable conformations, each encoding a limited number of strains that cause distinct tauopathies.  While the research uses a \"prion-like\" model, the mechanisms described are specific to tau and don't address the cross-species transmission of prion proteins.\n",
          "url": "https://elifesciences.org/articles/37813"
        },
        {
          "title": "Prion disease: experimental models and reality - PMC",
          "author": "",
          "published_date": "2017-01-13T00:00:00+00:00",
          "summary": "This article reviews models used to understand prion diseases, including their transmission, replication, and toxicity.  While in vitro and in vivo studies have significantly advanced our understanding of prion propagation, the precise mechanisms of misfolded prion protein conformation transfer across species remain incompletely understood. The concept of a \"species barrier\" is discussed, highlighting the reduced transmission efficiency and longer incubation periods observed in cross-species infections.  The article focuses on the limitations of current models in fully recapitulating all aspects of human prion disease, and doesn't provide a definitive answer regarding the specific mechanisms of cross-species propagation.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5250673/"
        },
        {
          "title": "Understanding the key features of the spontaneous formation ...",
          "author": "Castilla, Joaqu\u00edn",
          "published_date": "2023-09-07T00:00:00+00:00",
          "summary": "This research article describes a novel methodology for generating prions, focusing on their spontaneous formation.  It does *not* address interspecies prion propagation mechanisms.  The study's aim is to understand the spontaneous misfolding of cellular PrP into the pathogenic isoform, not cross-species transmission.\n",
          "url": "https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01640-8"
        },
        {
          "title": "Prion Diseases and Their Biochemical Mechanisms - PMC",
          "author": "",
          "published_date": "2009-03-31T00:00:00+00:00",
          "summary": "The provided text focuses on the biochemical mechanisms of prion diseases and their various strains, but it doesn't describe successful identification of the precise mechanisms of prion misfolded conformation propagation across species.  While it mentions interspecies transmissibility and the role of prion protein conformation in strain variation,  it does not detail a successful elucidation of the *precise* mechanisms involved in this interspecies transmission.  Therefore, the answer to the query is no, not according to this research article.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2805067/"
        },
        {
          "title": "A structural basis for prion strain diversity",
          "author": "Manka; Szymon W; Wenborn; Adam; Betts; Jemma; Joiner; Susan; Saibil; Helen R; Collinge; John; Wadsworth; Jonathan D F",
          "published_date": "2023-04-13T18:51:23.128000+00:00",
          "summary": "The article discusses the structural basis of prion strain diversity and its implications for cross-species transmission. While it details how prion strains propagate through fiber elongation and fission, and acknowledges the \"species barrier effects\" limiting cross-species transmission due to structural compatibility issues (conformational selection model), it doesn't describe the precise mechanisms of misfolded conformation propagation across species.  The research highlights the significance of understanding this for assessing zoonotic risks, but a definitive answer to the query isn't provided within the text.\n",
          "url": "https://www.nature.com/articles/s41589-022-01229-7"
        },
        {
          "title": "What is the evidence that tau pathology spreads through prion ...",
          "author": "Amrit  Mudher, University of Southampton, SO17 1BJ, Southampton, UK, a.mudher@soton.ac.uk, Morvane  Colin, Simon  Dujardin, Univ. Lille, Inserm, Miguel  Medina, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIEN Foundation, Madrid, Queen, Spain, Ilse  Dewachter, Dementia Research Group, Hasselt University, 3500, Hasselt, Belgium, Seyedeh Maryam Alavi Naini, Eva-Maria  Mandelkow, Eckhard  Mandelkow, Luc  Bu\u00e9e, Univ. Lille, Inserm, Michel  Goedert, MRC Laboratory of Molecular Biology, Francis Crick Avenue, CB2 0QH, Cambridge, UK, Jean-Pierre  Brion, Laboratory of Histology, ULB Neuroscience Institute (UNI, 808, route de Lennik 1070, Brussels, Belgium, jpbrion@ulb.ac.be",
          "published_date": "2023-11-09T20:22:13.702000+00:00",
          "summary": "This article focuses on the spread of tau pathology, not prion protein propagation across species.  While it discusses the \"prion-like\" mechanism of tau spread, emphasizing similarities to prion propagation, it doesn't address the specific mechanisms of prion protein cross-species transmission. The article notes that tau pathology hasn't been shown to exhibit all the properties of bona fide prions, including cross-species transmission, and that further research is needed to clarify the precise mechanisms of tau propagation.  Therefore, it does not answer your query.\n",
          "url": "https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-017-0488-7"
        }
      ],
      "full_explanation": "The research question asks if anyone has successfully identified the precise mechanisms by which prion proteins propagate their misfolded conformations across different species. Based on the provided papers, the answer is no. While several papers discuss aspects related to prion propagation and cross-species transmission, none have pinpointed the *precise* mechanisms involved.\n\nSeveral papers highlight the concept of a \"species barrier\" and the role of structural compatibility in prion transmission. For example, Manka et al. (2023) in \"A structural basis for prion strain diversity\" discuss how \"conformational selection\" and structural compatibility between prion strains and host PrP<sup>C</sup> affect cross-species transmission. They also note that PrP polymorphisms influence both inter- and intra-species transmission, but don't detail a precise mechanism of misfolded protein propagation. This is further reinforced by the 2023 version of the same paper, both found at: https://www.nature.com/articles/s41589-022-01229-7.\n\nAdditionally, the review \"Prion disease: experimental models and reality\" discusses the limitations of current models and highlights that the precise mechanisms of misfolded prion protein conformation transfer across species remain incompletely understood (https://pmc.ncbi.nlm.nih.gov/articles/PMC5250673/). It also mentions the reduced transmission efficiency and longer incubation periods in cross-species infections, but does not describe a specific mechanism.\n\nFinally, the paper \"Prion Diseases and Their Biochemical Mechanisms\" also acknowledges interspecies transmissibility and the role of prion protein conformation, but states that \"it doesn't describe successful identification of the precise mechanisms of prion misfolded conformation propagation across species\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC2805067/).\n\nWhile all these articles discuss factors influencing cross-species transmission and barriers, they collectively reveal that the *precise* mechanisms remain elusive and that further research is needed. None of these studies have definitively identified the specific molecular processes that enable misfolded prion proteins to replicate their conformation across different species. They do detail the importance of structural compatibility and conformational selection, but don't detail *how* this actually occurs in detail at the mechanistic level."
    },
    {
      "question": "Has anyone found a way to transfer memories between organisms?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "A sperm peptide enhances long-term memory in female Drosophila",
          "author": "T. Preat",
          "published_date": "2019-11-01T00:00:00+00:00",
          "summary": "No, this study does not demonstrate memory transfer between organisms.  Research on *Drosophila* females shows that a peptide in male sperm (sex peptide) enhances long-term memory in the female after mating. This effect is mediated by the sex peptide acting on specific brain neurons, activating a cAMP/protein kinase A pathway.  The study focuses on how mating affects memory within a single organism, not on transferring memories between individuals.\n",
          "url": "https://www.science.org/doi/10.1126/sciadv.aax3432?cookieSet=1"
        },
        {
          "title": "Inheritance of associative memories and acquired cellular changes in C. elegans",
          "author": "Deshe; Noa; Eliezer; Yifat; Hoch; Lihi; Itskovits; Eyal; Bokman; Eduard; Ben-Ezra; Shachaf; Zaslaver; Alon",
          "published_date": "2023-07-15T00:00:00+00:00",
          "summary": "Studies in mice and *C. elegans* show evidence of transgenerational inheritance of learned associations, suggesting a form of memory transfer.  Mice trained to associate an odor with a shock passed this aversion to subsequent generations, and *C. elegans* showed inherited avoidance of *Pseudomonas* bacteria across multiple generations.  While not a direct transfer between organisms, these findings demonstrate the inheritance of learned behaviors across generations.\n",
          "url": "https://www.nature.com/articles/s41467-023-39804-8"
        },
        {
          "title": "Direct transfer of learned behaviour via cell fusion in non-neural organisms | Proceedings of the Royal Society B: Biological Sciences",
          "author": "David Vogel; Audrey Dussutour",
          "published_date": "2023-04-13T17:12:19.410000+00:00",
          "summary": "Research using the slime mold *Physarum polycephalum* demonstrates the transfer of learned behavior between individuals via cell fusion.  The study showed that habituation (a simple form of learning) to a repellent could be passed from one slime mold to another after they fused.  While not memory transfer in the human sense, it represents the transfer of a learned behavioral response.\n",
          "url": "https://royalsocietypublishing.org/doi/10.1098/rspb.2016.2382"
        },
        {
          "title": "Vertically- and horizontally-transmitted memories \u2013 the fading boundaries between regeneration and inheritance in planaria",
          "author": "Moran  Neuhof, Tel Aviv University, 69978, Tel Aviv, Israel, neuhofmo@gmail.com, Michael  Levin, Tufts University, 200 Boston Avenue, Suite 4600, 02155, Medford, MA, USA, michael.levin@tufts.edu, Oded  Rechavi, Tel Aviv University, 69978, Tel Aviv, Israel, odedrechavi@gmail.com",
          "published_date": "2023-11-09T20:18:32.253000+00:00",
          "summary": "This research paper explores the unusual regenerative abilities of planaria flatworms, which challenge the traditional understanding of how traits are inherited.  While it doesn't demonstrate memory transfer *between* organisms, it proposes that the asymmetrical fission of planaria could lead to a biased distribution of epigenetic effects, potentially influencing the inheritance of acquired characteristics, including potentially those related to \"memories\" encoded in biochemical or physiological states.  The paper focuses on *within-organism* inheritance, not transfer to another organism.\n",
          "url": "https://journals.biologists.com/bio/article/5/9/1177/1233/Vertically-and-horizontally-transmitted-memories"
        },
        {
          "title": "Interanimal \"Memory\" Transfer: Results from Brain and Liver Homogenates",
          "author": "Jeffrey Rosen",
          "published_date": "2024-07-05T00:00:00+00:00",
          "summary": "This 1970 Science article investigated whether memories could be transferred between mice.  Researchers injected brain and liver homogenates from shocked or un-shocked mice into naive recipients.  While recipients of homogenates from shocked/stressed donors showed higher stress responses, the study concluded this indicated stress transfer, not memory transfer.  Although several prior studies suggested the possibility of memory transfer via RNA or other brain extracts, this research did not support that hypothesis.\n",
          "url": "https://www.science.org/doi/10.1126/science.169.3943.399"
        },
        {
          "title": "The memory-transfer episode",
          "author": "Stern, Larry",
          "published_date": "2024-06-01T00:00:00+00:00",
          "summary": "Experiments in the 1960s attempted to transfer memories between organisms, primarily using planarians (flatworms).  While James McConnell's initial research suggested memory transfer via cannibalism of trained worms by untrained ones,  and spurred hundreds of follow-up studies across various species, these results were ultimately not consistently replicated and the findings haven't been widely accepted within the scientific community.  Therefore, a reliable method for memory transfer between organisms has not yet been found.\n",
          "url": "https://www.apa.org/monitor/2010/06/memory-transfer"
        },
        {
          "title": "Scientists successfully transfer memory of one animal to ...",
          "author": "By Dr. Ananya Mandal, MDMay 16 2018",
          "published_date": "2019-06-24T08:47:00+00:00",
          "summary": "Yes.  UCLA researchers successfully transferred the memory of an electric shock from one sea snail (Aplysia californica) to another via RNA injections.  Snails receiving RNA from shocked snails exhibited a longer withdrawal response to touch than those receiving RNA from unshocked snails, suggesting memory transfer.  However, experts are skeptical about whether this can be replicated in more complex organisms.\n",
          "url": "https://www.news-medical.net/news/20180516/Scientists-successfully-transfer-memory-of-one-animal-to-another.aspx"
        },
        {
          "title": "Can we transfer memories from one living being to another?",
          "author": "",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "Yes, researchers at UCLA have reported transferring a simple defensive memory from one sea snail to another by injecting RNA extracted from the trained snail into untrained ones.  The untrained snails then exhibited a similar defensive response to electrical stimulation. While this research is preliminary and uses a simple organism, it suggests that memory may be encoded in RNA and potentially transferable, raising the possibility of future applications in treating memory disorders like Alzheimer's.  However, further research is needed to confirm these findings and explore their applicability to more complex organisms.\n",
          "url": "https://www.happy-neuron.com/scientific-news/can-we-transfer-memories-from-one-living-being-to-another"
        },
        {
          "title": "Amazing breakthrough shows transfer of memories is ...",
          "author": "Colm Gorey",
          "published_date": "2018-05-15T10:07:49+00:00",
          "summary": "Yes, researchers have transferred a simple defensive reflex memory between California sea snails by injecting RNA from a trained snail into an untrained one.  The untrained snails then exhibited the same defensive response. However, this does not involve complex memories like personal experiences or factual knowledge.  While some scientists are optimistic about the implications, others remain skeptical about whether this truly constitutes memory transfer.\n",
          "url": "https://www.siliconrepublic.com/innovation/transfer-memories-possible-rna"
        },
        {
          "title": "Memory Transferred between Snails, Challenging ...",
          "author": "Usha Lee McFarling; STAT",
          "published_date": "2023-02-23T04:13:49.365000+00:00",
          "summary": "Yes.  Researchers have reported transferring a memory from one sea snail to another by injecting RNA extracted from the brain of a trained snail into an untrained one. The untrained snail then exhibited the same learned behavior as the trained snail.  However, this finding is controversial and challenges established theories of memory storage in the brain.  Further research is needed to confirm these results and explore their implications for more complex organisms.\n",
          "url": "https://www.scientificamerican.com/article/memory-transferred-between-snails-challenging-standard-theory-of-how-the-brain-remembers/"
        }
      ],
      "full_explanation": "Several studies have explored the possibility of transferring memories between organisms, though the methods and results vary significantly. \n\nMost relevantly, research using sea snails (Aplysia californica) has demonstrated a form of memory transfer via RNA injections. Specifically, multiple sources confirm that researchers were able to transfer a defensive reflex memory from trained snails to untrained ones by injecting RNA extracted from the trained snails' brains. These sources include: \"Scientists successfully transfer memory of one animal to...\" (https://www.news-medical.net/news/20180516/Scientists-successfully-transfer-memory-of-one-animal-to-another.aspx), \"Can we transfer memories from one living being to another?\" (https://www.happy-neuron.com/scientific-news/can-we-transfer-memories-from-one-living-being-to-another), \"Amazing breakthrough shows transfer of memories is...\" (https://www.siliconrepublic.com/innovation/transfer-memories-possible-rna), and \"Memory Transferred between Snails, Challenging...\" (https://www.scientificamerican.com/article/memory-transferred-between-snails-challenging-standard-theory-of-how-the-brain-remembers/). These papers all describe the same research result of transferring a basic memory of an electric shock in sea snails using RNA, indicating some level of success in transferring memories between organisms. However, they also emphasize that this is a basic form of memory and the results are controversial and might not be transferable to more complex organisms.\n\nFurthermore, \"Direct transfer of learned behaviour via cell fusion in non-neural organisms\" (https://royalsocietypublishing.org/doi/10.1098/rspb.2016.2382) shows that a simple learned behavior (habituation) can be transferred between slime molds through cell fusion.\n\nWhile earlier research, such as the studies on planarians and memory transfer via cannibalism described in \"The memory-transfer episode\" (https://www.apa.org/monitor/2010/06/memory-transfer), were ultimately not consistently replicated, they do represent an earlier attempt to explore this topic. Similarly, the 1970 study described in \"Interanimal \"Memory\" Transfer: Results from Brain and Liver Homogenates\" (https://www.science.org/doi/10.1126/science.169.3943.399) also attempted memory transfer, but concluded that only stress transfer occurred and not memory transfer.\n\nTherefore, while the specific techniques and the complexity of the memories transferred vary, the general question of whether memory can be transferred between organisms has been explored."
    },
    {
      "question": "Has anyone discovered all the protein conformations that exist in different cellular environments?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "Protein Allostery at Atomic Resolution",
          "author": "Dr Dean Strotz",
          "published_date": "2023-02-22T20:50:09.660000+00:00",
          "summary": "This research article focuses on protein allostery at the atomic level, not on a comprehensive catalog of all protein conformations across various cellular environments.  Therefore, the paper does not address whether all protein conformations have been discovered.\n",
          "url": "https://onlinelibrary.wiley.com/doi/10.1002/anie.202008734"
        },
        {
          "title": "Effect of micro-environment on protein conformation studied by fluorescence-based techniques",
          "author": "Sabera  Millan, National Institute of Technology (NIT), Rourkela, Odisha, India, Bikash Chandra Swain, Umakanta  Tripathy, Indian Institute of Technology (Indian School of Mines), Dhanbad, Jharkhand, India, Padmaja P Mishra, Saha Institute of Nuclear Physics, 1/AF Bidhannagar, Kolkata, West Bengal, India, Harekrushna  Sahoo, National Institute of Technology (NIT), Rourkela, Odisha, India, sahooh@nitrkl.ac.in",
          "published_date": "2023-11-09T20:31:08.294000+00:00",
          "summary": "No, a complete catalog of all protein conformations across diverse cellular environments is not yet available.  Research, such as the study of cellular retinoic acid-binding protein I (CRABP I) in varying anion concentrations, uses fluorescence techniques (FCS, steady-state and time-resolved fluorescence, CD spectroscopy) to investigate how micro-environmental factors (e.g., different anions) influence protein conformation. This research highlights the complexity of protein folding in vivo and the challenge of comprehensively mapping all possible conformations.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0167732220344779"
        },
        {
          "title": "Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations - Nature Communications",
          "author": "Farag; Mina; Cohen; Samuel R; Borcherds; Wade M; Bremer; Anne; Mittag; Tanja; Pappu; Rohit V",
          "published_date": "2023-04-13T16:49:39.982000+00:00",
          "summary": "No, the paper does not claim to have discovered all protein conformations in different cellular environments.  It focuses on the conformations of prion-like low-complexity domains (PLCDs) within biomolecular condensates, specifically examining how their sequence features influence phase transitions and the resulting network structures.  While the research contributes to understanding protein behavior in specific condensate environments, it's a far cry from a complete catalog of all protein conformations across all cellular contexts.\n",
          "url": "https://www.nature.com/articles/s41467-022-35370-7"
        },
        {
          "title": "Detecting and quantifying liquid\u2013liquid phase separation in living cells by model-free calibrated half-bleaching - Nature Communications",
          "author": "Muzzopappa; Fernando; Hummert; Johan; Anfossi; Michela; Tashev; Stanimir Asenov; Herten; Dirk-Peter; Erdel; Fabian",
          "published_date": "2023-04-13T18:37:46.429000+00:00",
          "summary": "This research article focuses on distinguishing liquid-liquid phase separation (LLPS) from other mechanisms, such as interactions with clustered binding sites (ICBS), for forming cellular structures.  It does *not* address the question of discovering all protein conformations in different cellular environments.  The paper describes methods to identify LLPS in living cells, but doesn't explore the full range of protein conformations.\n",
          "url": "https://www.nature.com/articles/s41467-022-35430-y"
        },
        {
          "title": "Conserved degronome features governing quality control associated proteolysis - Nature Communications",
          "author": "Mashahreh; Bayan; Armony; Shir; Johansson; Kristoffer En\u00f8e; Chappleboim; Alon; Friedman; Nir; Gardner; Richard G; Hartmann-Petersen; Rasmus; Lindorff-Larsen; Kresten; Ravid; Tommer",
          "published_date": "2023-02-06T17:23:22.819000+00:00",
          "summary": "This research article focuses on identifying protein degradation signals (degrons) involved in cellular quality control, not on cataloging all protein conformations in different cellular environments.  The study uses a yeast model and a machine learning approach to predict degron sequences, revealing amino acid preferences in these degradation signals.  While understanding degrons is related to protein stability and potentially conformation, this paper does not address the broader question of comprehensively identifying all protein conformations across various cellular contexts.\n",
          "url": "https://www.nature.com/articles/s41467-022-35298-y"
        },
        {
          "title": "Protein interaction patterns in different cellular environments are ...",
          "author": "Letizia Barbieri 1 2 ,",
          "published_date": "2015-09-24T00:00:00+00:00",
          "summary": "No, this study does not identify all protein conformations in different cellular environments.  It uses in-cell NMR to investigate the interactions of profilin 1 (a human protein) in human and bacterial cells.  The researchers found that mutations in profilin 1 affected its interactions, recovering NMR signals lost due to both specific and non-specific interactions in human cells, but only non-specific interactions in bacterial cells.  This highlights the complexity of protein interactions within cells and the challenges in comprehensively mapping all possible conformations.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26399546/"
        },
        {
          "title": "Spatially resolved profiling of protein conformation and interactions ...",
          "author": "Zhao, Qun",
          "published_date": "2024-09-27T00:00:00+00:00",
          "summary": "No, a complete catalog of all protein conformations across diverse cellular environments has not been achieved.  While techniques like cryo-electron tomography and in-cell NMR offer insights into protein structure and interactions, they lack proteome-wide coverage.  Furthermore, proximity labeling, while improving spatial resolution, doesn't fully elucidate the structural changes underlying protein interactions.  Chemical cross-linking mass spectrometry (CXMS) shows promise in analyzing protein complexes, but  a comprehensive understanding remains a significant challenge.\n",
          "url": "https://www.nature.com/articles/s41467-024-52558-1"
        },
        {
          "title": "Uncovering protein structure - PMC - PubMed Central",
          "author": "",
          "published_date": "2020-09-25T00:00:00+00:00",
          "summary": "No, this article does not claim that all protein conformations in different cellular environments have been discovered.  While it details methods for uncovering protein structure and discusses the dynamics and multiple conformations proteins can adopt, it emphasizes that this is an ongoing area of research.  The article highlights the complexity of protein folding and the existence of an \"ensemble\" of rapidly interconverting conformations, implying a vast and currently incompletely characterized range of possibilities.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7545034/"
        },
        {
          "title": "Structure prediction of alternative protein conformations - Nature",
          "author": "No\u00e9, Frank",
          "published_date": "2024-08-26T00:00:00+00:00",
          "summary": "No, the paper does not claim that all protein conformations in different cellular environments have been discovered.  Current methods for predicting protein structure, like AlphaFold2, are highly accurate for single-chain proteins with ordered structures, but predicting alternative conformations (which are crucial for understanding function and are affected by cellular environments) remains a challenge.  The researchers highlight limitations in existing approaches, including reliance on limited datasets and the computational cost of molecular dynamics simulations.  They created a larger dataset to improve conformation prediction, but acknowledge this still represents only a small fraction of potential protein structures.\n",
          "url": "https://www.nature.com/articles/s41467-024-51507-2"
        },
        {
          "title": "Protein assembly systems in natural and synthetic biology",
          "author": "Chiesa; Giulio; Kiriakov; Szilvia; Khalil; Ahmad S",
          "published_date": "2023-02-06T09:26:29.943000+00:00",
          "summary": "No, the paper does not claim that all protein conformations in different cellular environments have been discovered.  It discusses how proteins self-assemble into higher-order complexes, often involving intrinsically disordered regions (IDRs) that allow for flexibility and multiple interactions.  The paper highlights that the resulting spectrum of assembly phenomena is influenced by factors like interaction strength and the cellular environment.  While research is advancing in this area, a complete catalog of all protein conformations remains elusive.\n",
          "url": "https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-020-0751-4"
        }
      ],
      "full_explanation": "Based on the provided research papers, it is clear that the proposed research question - discovering all protein conformations that exist in different cellular environments - has not been accomplished. While numerous studies explore protein conformations and dynamics, none have achieved a comprehensive catalog of all possible states. Here's a breakdown of the reasoning, citing relevant papers:\n\n*   **Lack of Comprehensive Coverage:** Several papers explicitly state that a complete catalog of all protein conformations across diverse cellular environments is not yet available. For instance, the paper \"Effect of micro-environment on protein conformation studied by fluorescence-based techniques\" states \"No, a complete catalog of all protein conformations across diverse cellular environments is not yet available.\" and describes using fluorescence-based techniques to investigate how micro-environmental factors influence protein conformation, highlighting the ongoing nature of this research. [https://www.sciencedirect.com/science/article/pii/S0167732220344779] Similarly, \"Spatially resolved profiling of protein conformation and interactions ...\" explicitly states that \"a complete catalog of all protein conformations across diverse cellular environments has not been achieved\". [https://www.nature.com/articles/s41467-024-52558-1]\n\n*   **Focus on Specific Aspects:** Many studies delve into specific aspects of protein behavior in certain environments but do not offer a global perspective. For example, the paper \"Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations\" focuses on prion-like low-complexity domains within condensates, not a general catalog of conformations. [https://www.nature.com/articles/s41467-022-35370-7] Similarly, \"Protein interaction patterns in different cellular environments are...\" uses in-cell NMR to investigate profilin 1 interactions, but doesn't claim to have identified *all* conformations. [https://pubmed.ncbi.nlm.nih.gov/26399546/]\n\n*   **Limitations of Current Methods:** The paper \"Spatially resolved profiling of protein conformation and interactions...\" also notes that while techniques like cryo-electron tomography and in-cell NMR offer insights, they lack proteome-wide coverage, and that proximity labeling doesn't fully elucidate structural changes. [https://www.nature.com/articles/s41467-024-52558-1]. This highlights a technological limitation in achieving complete conformational characterization across all cellular contexts. Similarly, the paper \"Structure prediction of alternative protein conformations\" highlights that current structure prediction methods struggle with alternative protein conformations. [https://www.nature.com/articles/s41467-024-51507-2].\n\n*   **Dynamic Nature of Protein Conformations:** The article \"Uncovering protein structure - PMC - PubMed Central\" discusses the dynamic nature of protein conformations and the existence of an \"ensemble\" of rapidly interconverting states, implying a vast number of possibilities that are not yet fully characterized. [https://pmc.ncbi.nlm.nih.gov/articles/PMC7545034/] This highlights the inherent complexity and the ongoing nature of this research area.\nIn summary, while research continues to make progress in understanding protein structures and interactions within different environments, the goal of identifying *all* possible protein conformations is an ongoing and complex challenge that has not yet been accomplished."
    },
    {
      "question": "Has anyone shown that  GLP-1 increases weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice",
          "author": "I. Grattagliano",
          "published_date": "2021-02-01T00:00:00+00:00",
          "summary": "Yes, research shows GLP-1 analogs can increase weight loss.  Studies using GLP-1 receptor agonists like EGLP-1 in diet-induced obese mice demonstrate reduced body weight compared to exendin-4.  This is achieved through decreased food intake and increased basal energy expenditure.  While exendin-4 mimics some GLP-1 effects (insulin release, appetite reduction),  EGLP-1's unique structure allows for a greater weight loss effect by impacting energy metabolism.  Other GLP-1 fragments (GLP-1(28\u201336) amide, GLP-1(32\u201336) amide) have also shown weight loss benefits in mice.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0014482720307072"
        },
        {
          "title": "Effects of GLP-1 on appetite and weight",
          "author": "Shah; Meera; Vella; Adrian",
          "published_date": "2023-12-04T03:32:42.371000+00:00",
          "summary": "This webpage lists several research articles on the effects of GLP-1 (glucagon-like peptide 1) on appetite and weight, but doesn't directly answer whether GLP-1 *increases* weight loss.  The articles explore GLP-1's role in regulating feeding behavior and its physiological effects, including its secretion patterns in relation to meals.  Further research would be needed to definitively answer the query regarding weight loss increases.\n",
          "url": "https://link.springer.com/article/10.1007/s11154-014-9289-5"
        },
        {
          "title": "GLP-1 and weight loss: unraveling the diverse neural circuitry",
          "author": "Scott E Kanoski; Matthew R Hayes; Karolina P Skibicka",
          "published_date": "2023-04-13T10:23:06.278000+00:00",
          "summary": "Yes, research shows that GLP-1 analogs, like liraglutide, effectively reduce food intake and body weight in both human clinical trials and animal models.  This is due to GLP-1's action on brain receptors, affecting multiple neural pathways involved in appetite regulation.  The article highlights several brain regions involved in this process.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888559/"
        },
        {
          "title": "Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity",
          "author": "A. Anandhakrishnan,M. Korbonits",
          "published_date": "2023-10-26T19:32:16.765000+00:00",
          "summary": "Yes, studies show that the GLP-1 analogue liraglutide (at a high dose of 3mg/day) resulted in significantly greater weight loss in obese individuals compared to placebo and other currently available anti-obesity medications.  While longer-term data is still needed,  the results suggest promise for GLP-1 analogues in achieving sustainable weight loss.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28031776"
        },
        {
          "title": "GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress",
          "author": "Yaojing  Jiang, Fudan University, Shanghai, China, Zhihong  Wang, Fudan University, Shanghai, China, Bo  Ma, Linling  Fan, Fudan University, Shanghai, China, Na  Yi, Fudan University, Shanghai, China, Bin  Lu, Fudan University, Shanghai, China, Qinghua  Wang, Fudan University, Shanghai, China, Rui  Liu, Fudan University, Shanghai, China",
          "published_date": "2023-11-09T20:24:04.233000+00:00",
          "summary": "This study in obese mice showed that the GLP-1 analog liraglutide improved systemic insulin tolerance and reduced markers of endoplasmic reticulum (ER) stress in fat cells.  While the study doesn't directly measure weight loss, improved insulin sensitivity is a key factor contributing to weight management.  The research focuses on the mechanism of GLP-1's action, not its overall effect on weight.\n",
          "url": "https://www.frontiersin.org/articles/10.3389/fphar.2018.01168/full"
        },
        {
          "title": "Real-world weight loss effectiveness of GLP-1 agonists ...",
          "author": "",
          "published_date": "2023-01-09T00:00:00+00:00",
          "summary": "Yes, multiple studies show GLP-1 agonists lead to weight loss in patients with type 2 diabetes.  A retrospective cohort study of over 2400 patients showed a mean weight loss of 2.2% at 72 weeks with standard doses.  While randomized controlled trials using higher doses show more significant weight loss (e.g., 9.6% in one study), even standard doses for glycemic control result in modest but measurable weight reduction.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9877131/"
        },
        {
          "title": "Research shows GLP-1 drugs are effective but complex",
          "author": "Grace Niewijk",
          "published_date": "2024-05-30T00:00:00+00:00",
          "summary": "Yes, research shows GLP-1 receptor agonist (GLP-1RA) drugs like Ozempic, Wegovy, and Mounjaro are highly effective for weight loss.  Multiple studies, including one comparing 15 different GLP-1RAs, demonstrate significant weight loss in patients.  Another study showed GLP-1RAs outperformed other diabetes medications in reducing cardiovascular risk and overall mortality, further supporting their effectiveness in weight management.  However, experts caution against viewing them as a universal cure-all and emphasize the importance of considering individual patient factors when prescribing.\n",
          "url": "https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2024/may/research-on-glp-1-drugs"
        },
        {
          "title": "Emerging Role of GLP-1 Agonists in Obesity",
          "author": "",
          "published_date": "2023-06-21T00:00:00+00:00",
          "summary": "Yes, numerous studies reviewed in this article show that GLP-1 agonists are effective in promoting weight loss in both preclinical and clinical settings.  The review summarizes findings from trials on several GLP-1 agonists (liraglutide, semaglutide, tirzepatide, lixisenatide, and exenatide), highlighting the maximum weight loss achievable with each.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10341852/"
        },
        {
          "title": "Reflections on the discovery GLP-1 as a satiety hormone",
          "author": "Astrup; Arne",
          "published_date": "2024-06-18T00:00:00+00:00",
          "summary": "This article traces the discovery of GLP-1 as a satiety hormone.  While it details the development of a methodology to measure appetite and food intake, and describes research showing GLP-1's role in satiety (feelings of fullness), it doesn't directly address whether GLP-1 *increases* weight loss.  The research described focuses on establishing GLP-1's impact on appetite and food consumption, a necessary step in understanding its potential for weight management, but doesn't present conclusive evidence on weight loss itself.\n",
          "url": "https://www.nature.com/articles/s41430-024-01460-6"
        },
        {
          "title": "GLP-1 receptor agonists for weight reduction in people ...",
          "author": "Search for articles by this author",
          "published_date": "2024-07-01T00:00:00+00:00",
          "summary": "Yes, this study shows that GLP-1 receptor agonists (GLP-1 RAs) significantly increase weight loss in individuals with obesity but without diabetes.  Over two years, 375 out of 1000 treated individuals achieved a 10% weight loss compared to placebo.  However, the net benefit of weight loss depended on the target weight loss (10% showed a net benefit, 5% did not) and individual tolerance for side effects (e.g., abdominal pain, nausea, constipation).  The benefits were highest for semaglutide, followed by liraglutide and tirzepatide.\n",
          "url": "https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext"
        }
      ],
      "full_explanation": "Multiple research papers clearly demonstrate that GLP-1 increases weight loss. The paper titled \"EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice\" (https://www.sciencedirect.com/science/article/abs/pii/S0014482720307072) shows that GLP-1 analogs, specifically EGLP-1, lead to weight loss in mice through reduced food intake and increased energy expenditure. The paper \"GLP-1 and weight loss: unraveling the diverse neural circuitry\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888559/) also confirms this, stating that GLP-1 analogs like liraglutide reduce food intake and body weight in humans and animals by acting on brain receptors involved in appetite. Furthermore, the paper \"Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity\" (https://pubmed.ncbi.nlm.nih.gov/28031776) highlights that the GLP-1 analogue liraglutide leads to significant weight loss in obese individuals when compared to placebo and other anti-obesity medication. The paper titled \"Real-world weight loss effectiveness of GLP-1 agonists...\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC9877131/) provides evidence that even standard doses of GLP-1 agonists for type 2 diabetes result in measurable weight reduction, with higher doses resulting in more significant weight loss. Similarly, the paper \"Research shows GLP-1 drugs are effective but complex\" (https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2024/may/research-on-glp-1-drugs) confirms that GLP-1 receptor agonist drugs are effective for weight loss, and the paper \"Emerging Role of GLP-1 Agonists in Obesity\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC10341852/) summarizes findings from trials of multiple GLP-1 agonists and their effects on weight loss. Finally, the paper \"GLP-1 receptor agonists for weight reduction in people...\" (https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext) directly addresses the question, demonstrating significant weight loss achieved by GLP-1 receptor agonists in individuals with obesity, but without diabetes."
    },
    {
      "question": "Has anyone used machine learning based exchange functionals in protein molecular dynamics simulations?",
      "true_answer": "no",
      "predicted_answer": "no",
      "is_correct": true,
      "search_results": [
        {
          "title": "NNP/MM: Accelerating Molecular Dynamics Simulations with Machine Learning Potentials and Molecular Mechanics.",
          "author": "Raimondas Galvelis,Alejandro Varela-Rial,Stefan Doerr,R. Fino,P. Eastman,T. Markland,J. Chodera,G. de Fabritiis",
          "published_date": "2023-10-26T19:27:47.995000+00:00",
          "summary": "This paper introduces NNP/MM, a hybrid method combining neural network potentials (NNPs) and molecular mechanics (MM) for accelerating molecular dynamics (MD) simulations.  While it doesn't explicitly use machine learning *exchange functionals*, it employs NNPs to improve the accuracy of force calculations, particularly for drug-like molecules where traditional force fields are less accurate.  The authors demonstrate a 5x speed increase in MD simulations of protein-ligand complexes using this approach, achieving microsecond-long simulations.  The study focuses on improving the accuracy and efficiency of force field calculations in MD, a related but distinct area from exchange functionals.\n",
          "url": "https://arxiv.org/pdf/2201.08110.pdf"
        },
        {
          "title": "Machine Learning with and for Molecular Dynamics Simulations.",
          "author": "Sereina S Riniker, sriniker@ethz.ch, Shuzhe  Wang, Patrick  Bleiziffer, Lennard  B\u00f6selt, Carmen  Esposito",
          "published_date": "2023-11-09T20:28:24.520000+00:00",
          "summary": "This article discusses the application of machine learning (ML) to molecular dynamics (MD) simulations, but it doesn't specifically address the use of ML-based exchange functionals in protein MD simulations.  The article covers two approaches: using MD data to train ML models for understanding molecular systems and using ML to improve MD simulations themselves.  Therefore, it does not directly answer your query.\n",
          "url": "https://www.chimia.ch/chimia/article/view/2019_1024"
        },
        {
          "title": "On-line Optimization of Hamiltonian Replica Exchange Simulations",
          "author": "Justin L. MacCallum, Mir Ishruna Muniyat, Kari Gaalswyk",
          "published_date": "2017-12-03T00:00:00+00:00",
          "summary": "This bioRxiv preprint describes a machine learning-based algorithm for optimizing Hamiltonian replica exchange in molecular simulations.  The algorithm, inspired by deep neural network optimization, optimizes a heuristic objective function to improve the efficiency of replica exchange.  While not explicitly stated as using \"exchange functionals,\" the method's application to a protein folding simulation suggests relevance to the query.  The algorithm is presented as generalizable to multiple control parameters and works online without pre-simulation.\n",
          "url": "https://www.biorxiv.org/content/10.1101/228262v1"
        },
        {
          "title": "Utilizing Machine Learning to Greatly Expand the Range and Accuracy of Bottom-Up Coarse-Grained Models through Virtual Particles.",
          "author": "Patrick G Sahrmann,Timothy D Loose,Aleksander E. P. Durumeric,G. Voth",
          "published_date": "2023-10-26T19:28:15.128000+00:00",
          "summary": "This paper does not discuss machine learning-based exchange functionals in protein molecular dynamics simulations.  Instead, it focuses on using machine learning to improve the accuracy of coarse-grained (CG) models of lipid bilayers.  The authors employ machine learning within a relative entropy minimization framework to optimize virtual particle interactions in a bottom-up CG model, thereby capturing solvent-mediated behavior not achievable with standard CG models.  The work is relevant to molecular dynamics but not directly to the use of machine learning within exchange functionals for proteins.\n",
          "url": "https://arxiv.org/pdf/2212.04530.pdf"
        },
        {
          "title": "Learning high-dimensional reaction coordinates of fast-folding proteins using State Predictive information bottleneck and Bias Exchange Metadynamics",
          "author": "Nancy D. Pomarici,S. Mehdi,Patrick K. Quoika,Suemin Lee,J. R. Loeffler,K. Liedl,P. Tiwary,Monica L. Fern\u00e1ndez-Quintero",
          "published_date": "2023-10-26T19:31:30.310000+00:00",
          "summary": "This study uses a machine learning model, the State Predictive Information Bottleneck (SPIB) neural network, to learn high-dimensional reaction coordinates for enhanced sampling of protein unfolding in molecular dynamics (MD) simulations.  While it doesn't directly employ machine learning-based exchange functionals, the research uses SPIB to improve the efficiency of  Bias Exchange Metadynamics (BE-metaD), an enhanced sampling technique.  The results demonstrate accelerated sampling of protein unfolding using AI-learned coordinates, showing the potential of integrating AI and enhanced sampling methods.  The study focuses on improving the selection of reaction coordinates, not on modifying the exchange functional itself.\n",
          "url": "https://www.biorxiv.org/content/biorxiv/early/2023/07/26/2023.07.24.550401.full.pdf"
        },
        {
          "title": "Protein Function Analysis through Machine Learning - PMC",
          "author": "",
          "published_date": "2022-09-06T00:00:00+00:00",
          "summary": "This review article discusses the application of machine learning (ML) in various aspects of computational biology related to protein function, including structure prediction, engineering, molecular docking, and protein-protein interactions.  While it broadly covers ML's role in enhancing protein function understanding, it does *not* specifically address the use of ML-based exchange functionals within the context of protein molecular dynamics simulations.  The article focuses on the integration of ML into existing computational models rather than the development of novel ML-based force fields for MD simulations.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9496392/"
        },
        {
          "title": "Machine learning/molecular dynamic protein structure ...",
          "author": "Ulander, Johan",
          "published_date": "2022-06-15T00:00:00+00:00",
          "summary": "This research uses machine learning to predict protein conformations, combining deep learning with molecular dynamics (MD) simulations.  The study does not, however, utilize machine learning-based exchange functionals within the MD simulations themselves.  Instead, it employs machine learning to predict residue-residue distances, which are then used to refine the protein models generated by MD simulations.  The focus is on comparing predicted protein ensembles to experimental data (X-ray crystallography and MD simulations), assessing the accuracy of current state-of-the-art methods in protein folding and dynamics prediction.\n",
          "url": "https://www.nature.com/articles/s41598-022-13714-z"
        },
        {
          "title": "Machine learning in the analysis of biomolecular simulations",
          "author": "Shreyas Kaptan; Ilpo Vattulainen",
          "published_date": "2023-02-07T20:39:24.679000+00:00",
          "summary": "This article discusses the application of machine learning (ML) to analyze biomolecular simulations, particularly molecular dynamics (MD) simulations of proteins.  While it highlights the use of ML for analyzing the vast datasets generated by MD simulations to understand protein function, it does *not* mention the use of ML-based exchange functionals within the MD simulations themselves.  The article focuses on using ML to *analyze* the results of simulations, not on modifying the simulation methods with ML.\n",
          "url": "https://www.tandfonline.com/doi/full/10.1080/23746149.2021.2006080"
        },
        {
          "title": "Deep learning-based molecular dynamics simulation for ...",
          "author": "Y.-C. Wu, C.-S. Chen, Y.-J. Chan",
          "published_date": "2022-01-01T00:00:00+00:00",
          "summary": "This research paper investigates deep learning-based molecular dynamics simulations for structure-based drug design against SARS-CoV-2.  While the paper focuses on applying deep learning to molecular dynamics for drug discovery, it does *not* use machine learning-based exchange functionals within the simulations themselves.  The study utilizes deep learning to accelerate and improve the efficiency of the drug design process, not to modify the underlying physics of the molecular dynamics simulations.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S200103702200407X"
        },
        {
          "title": "Machine learning heralding a new development phase in ...",
          "author": "Bori\u0161ek, Jure",
          "published_date": "2024-03-29T00:00:00+00:00",
          "summary": "This review article discusses the application of AI, including machine learning, to enhance molecular dynamics (MD) simulations. While it doesn't explicitly mention machine learning-based exchange functionals in protein MD simulations, it highlights AI's use in optimizing simulation speed, extracting information from trajectories, and predicting macromolecular behavior.  The article acknowledges challenges like the need for large datasets and the slower speed of neural network potentials compared to classical force fields.  Further investigation of the specific cited works may reveal relevant information regarding the use of machine learning in exchange functionals within protein simulations.\n",
          "url": "https://link.springer.com/article/10.1007/s10462-024-10731-4"
        }
      ],
      "full_explanation": "While several papers explore the use of machine learning in the context of molecular dynamics (MD) simulations of proteins, none of them explicitly describe the use of machine learning-based *exchange functionals*. The research question specifically asks about whether machine learning has been used to create or modify the exchange functionals themselves, which are a component of density functional theory calculations, not classical force fields. While most of the papers use ML to improve or enhance the simulations in different ways, none are manipulating the exchange functional itself. For example, the paper \"NNP/MM: Accelerating Molecular Dynamics Simulations with Machine Learning Potentials and Molecular Mechanics\" (https://arxiv.org/pdf/2201.08110.pdf) uses neural networks to create potentials that replace classical force fields, but this is distinct from manipulating exchange functionals in a density functional theory framework. Similarly, \"On-line Optimization of Hamiltonian Replica Exchange Simulations\" (https://www.biorxiv.org/content/10.1101/228262v1) optimizes the parameters for replica exchange using machine learning, not the exchange functionals. The paper \"Learning high-dimensional reaction coordinates of fast-folding proteins using State Predictive information bottleneck and Bias Exchange Metadynamics\" (https://www.biorxiv.org/content/biorxiv/early/2023/07/26/2023.07.24.550401.full.pdf) is also relevant, as it uses machine learning to improve enhanced sampling, not exchange functionals. Even though the paper \"Machine learning heralding a new development phase in ...\" (https://link.springer.com/article/10.1007/s10462-024-10731-4) discusses the use of machine learning in MD, it does not go into modifying the exchange functional. Therefore, based on the provided papers, there is no evidence of machine learning being used specifically to create or modify exchange functionals within the context of protein MD simulations."
    },
    {
      "question": "Has anyone figured out the mechanism of cellular aging?",
      "true_answer": "yes",
      "predicted_answer": "no",
      "is_correct": false,
      "search_results": [
        {
          "title": "Molecular damage in aging - Nature Aging",
          "author": "Gladyshev; Vadim N; Kritchevsky; Stephen B; Clarke; Steven G; Cuervo; Ana Maria; Fiehn; Oliver; De Magalh\u00e3es; Jo\u00e3o Pedro; Mau; Theresa; Maes; Michal; Moritz; Robert L; Niedernhofer; Laura J; Van Schaftingen; Emile; Tranah; Gregory J; Walsh; Kenneth; Yura; Yoshimitsu; Zhang; Bohan; Cummings; Steven R",
          "published_date": "2023-02-06T09:44:51.648000+00:00",
          "summary": "The mechanism of cellular aging is not fully understood, but research points to several key factors.  Studies highlight the accumulation of molecular damage, including protein oxidation (Stadtman, 1992) and damaging mutations (Kinzina et al., 2019), as contributors.  The \"hallmarks of aging\" (Lopez-Otin et al., 2013) propose a broader framework encompassing multiple processes.  While no single mechanism has been definitively identified, ongoing research explores diverse aspects of the aging process, such as the asynchronous and contagious nature of aging (Rando & Wyss-Coray, 2021).\n",
          "url": "https://www.nature.com/articles/s43587-021-00150-3"
        },
        {
          "title": "Nucleophagy delays aging and preserves germline immortality - Nature Aging",
          "author": "Papandreou; Margarita-Elena; Konstantinidis; Georgios; Tavernarakis; Nektarios",
          "published_date": "2023-04-13T21:21:49.056000+00:00",
          "summary": "This study in *Nature Aging* investigates the role of nucleophagy (selective autophagy of nuclear components) in aging.  Researchers found that impaired nucleophagy, specifically the degradation of nuclear anchorage proteins ANC-1/nesprin-2, leads to nuclear enlargement,  impaired stress resistance, and reduced lifespan in *C. elegans* and mice.  Conversely, efficient nucleophagy maintains nuclear homeostasis, contributing to germline immortality and longevity.  The findings suggest that the regulation of nucleophagy is a key mechanism influencing the aging process.\n",
          "url": "https://www.nature.com/articles/s43587-022-00327-4"
        },
        {
          "title": "Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration - Nature",
          "author": "Moiseeva; Victoria; Cisneros; Andr\u00e9s; Sica; Valentina; Deryagin; Oleg; Lai; Yiwei; Jung; Sascha; Eva; An; Juan; Segal\u00e9s; Jessica; Ortet; Laura; Lukesova; Vera; Volpe; Giacomo; Benguria; Alberto; Dopazo; Benitah; Salvador Aznar; Urano; Yasuteru; Del Sol; Esteban; Miguel A; Ohkawa; Yasuyuki; Serrano; Perdiguero; Eusebio; Mu\u00f1oz-C\u00e1noves; Pura",
          "published_date": "2023-04-13T10:10:00.109000+00:00",
          "summary": "This Nature article investigates the role of senescent cells in muscle regeneration, finding that these cells, which accumulate with age, become a significant part of the muscle's regenerative niche and impair its function.  While the study focuses on the impact of senescent cells on muscle regeneration, it does not fully elucidate the mechanism of cellular aging itself.  The research highlights the increased inflammation and dysfunction associated with aging cells within the muscle, indicating a connection between cellular senescence and impaired tissue repair, but doesn't detail the root causes of senescence.\n",
          "url": "https://www.nature.com/articles/s41586-022-05535-x"
        },
        {
          "title": "Issue Information",
          "author": "Apratim  Bajpai, Rui  Li, Weiqiang  Chen, Neha  Mishra, Komal  Raina, Rajesh  Agarwal, Hye-Na  Kang, Robin  Thorpe, Ivana  Knezevic, Mary Casas Levano, Bernice  Mumbi, Parichard  Chilufya,   Chirachanakul, Ming  Hui, Dina  Chua, Freddie  Dalili, Kai  Foo, Suna  Gao, Hugo  Habahbeh,   Hamel, Hyun  Gi, Violeta  Kim,   Perez Rodriguez, Eka  Desi, Jacqueline  Putri, Maria  Rodgers, Oleh  Savkina, Shraddha  Semeniuk, Jo\u00e3o Tavares Srivastava, Meenu  Neto, Teruhide  Wadhwa,   Yamaguchi, Samuel  Scott, Hong  Nguyen, Sumanta  Neupane, Priyanjana  Pramanik, Priya  Nanda, Zulfiqar A Bhutta, Kaosar  Afsana, Purnima  Menon, Yujie  Liang, Hong  Yu, Xiaoyin  Ke, Darryl  Eyles, Ruoyu  Sun, Zichen  Wang, Saijun  Huang, Ling  Lin, John J Mcgrath, Jianping  Lu, Xiaoling  Guo, Paul  Yao, Wim  Pouw, Lisette  De Jonge-Hoekstra, Steven J Harrison, Alexandra  Paxton, James A Dixon, Douglas  Braaten, Patrick C H Lo, Anar  Murphy, Steven E Bohall, Jerry  Hultin, Thomas  Pompidou, Laura  Sachar, Nicholas B Dirks, Ellen  De Brabander, Natarajan  Chandrasekaran, Jacqueline  Corbelli, Kirsten  Davies, Maryellen  Elia, Dario  Gil, Reid  Hoffman, Paul  Horn, Seema  Kumar, Ravi  Kumar, S R May Lee, Pablo  Legorreta, David K A Mordecai, Martin  Nesbitt, Gregory A Petsko, Lowell  Robinson, Jaclyn  Safier, Konstantin  Shakhnovich, Peter  Thor, Grace  Wang, Sanford  Weill, Jeremy  Wertheimer, Michael  Young, Nadav  Zafrir, Seth F Berkley, Gerald  Chan, Alice P Gast, S \" Kris, \"  Gopalakrishnan, Toni  Hoover, Johan  Rockstr, Paul  Stoffels, Ellis  Rubinstein, John E Sexton, Torsten N Wiesel, Nancy L Zimpher, Karen E Burke, John F Niblack, Dan  Nicholas, dnicholas@wiley.com",
          "published_date": "2023-11-09T20:32:46.386000+00:00",
          "summary": "This webpage provides issue information for a journal article (Volume 8, Issue 4, July/August 2016) in *WIREs Computational Statistics*, but does not contain information about cellular aging mechanisms.  The provided text offers no insights relevant to the user's query.\n",
          "url": "https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/nyas.14150"
        },
        {
          "title": "Loss of epigenetic information as a cause of mammalian aging",
          "author": "Search for articles by this author",
          "published_date": "2023-01-19T00:00:00+00:00",
          "summary": "Research suggests that loss of epigenetic information, driven by cellular responses to DNA damage, accelerates aging.  This loss,  manifested as erosion of the epigenetic landscape and cellular exdifferentiation, contributes to senescence and advancement of the DNA methylation clock.  Interestingly, this process appears reversible through epigenetic reprogramming, suggesting that manipulating the epigenome could potentially reverse aspects of aging.  While genetic mutations were previously considered the primary driver of aging, this research highlights the significant role of epigenetic changes.\n",
          "url": "https://www.cell.com/cell/fulltext/S0092-8674(22)01570-7"
        },
        {
          "title": "The cell biology of aging - PMC",
          "author": "",
          "published_date": "2015-12-15T00:00:00+00:00",
          "summary": "Research suggests aging is not solely due to entropy but is partially genetically regulated.  Studies using model organisms like *C. elegans* have identified mutations extending lifespan, indicating cellular processes are genetically controlled.  While the exact mechanism remains unclear, dysregulation of processes like autophagy and proteostasis contributes to age-related diseases such as Alzheimer's and Parkinson's.  Cellular health is a complex interplay of nuclear processes, protein quality control, and extracellular signaling; disruption of these systems leads to accumulating cellular damage and reduced effectiveness of clearance mechanisms.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4678010/"
        },
        {
          "title": "Molecular mechanisms of aging and anti-aging strategies",
          "author": "Wu, Xin",
          "published_date": "2024-05-24T00:00:00+00:00",
          "summary": "No single mechanism fully explains cellular aging, but research points to several interconnected factors.  This review article highlights telomere attrition, DNA damage, mitochondrial dysfunction, reduced NAD+ levels, impaired autophagy, stem cell exhaustion, inflammation, protein imbalance, disrupted nutrient sensing, altered intercellular communication, and dysbiosis as key contributors.  While a complete understanding remains elusive, these processes are being investigated as targets for anti-aging interventions.\n",
          "url": "https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01663-1"
        },
        {
          "title": "Aging and aging-related diseases: from molecular ...",
          "author": "Guo; Jun; Huang; Xiuqing; Dou; Lin; Yan; Mingjing; Shen; Tao; Tang; Weiqing; Li; Jian",
          "published_date": "2023-04-13T11:35:49.645000+00:00",
          "summary": "Research into cellular aging mechanisms is ongoing.  Early studies, dating back to the 1920s, explored the effects of light intensity and caloric restriction on lifespan in Drosophila and rats, respectively.  Later research identified longevity mutants in C. elegans, providing genetic insights. While a single, unified mechanism hasn't been definitively established,  the relationship between aging and increased risk of diseases like Alzheimer's is well-documented.  Further investigation into these areas continues to reveal more about the complex processes of cellular aging.\n",
          "url": "https://www.nature.com/articles/s41392-022-01251-0"
        },
        {
          "title": "A synopsis on aging\u2014Theories, mechanisms and future ...",
          "author": "",
          "published_date": "2016-06-25T00:00:00+00:00",
          "summary": "This article reviews various theories of aging but doesn't definitively explain the mechanism of cellular aging.  It highlights the complexity of the aging process, involving changes at multiple biological levels, and notes that an integrative approach combining aging research with systems biology is needed to understand how and why we age. While several biochemical processes accompanying aging are discussed, a single, unified mechanism isn't presented.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5991498/"
        },
        {
          "title": "Principles of the Molecular and Cellular Mechanisms ...",
          "author": "J. Alcedo, C. Kenyon",
          "published_date": "2021-04-01T00:00:00+00:00",
          "summary": "Research indicates that cellular aging is driven by the accumulation of cellular damage, including DNA lesions, misfolded proteins, and shortened telomeres.  This damage impairs cellular function and contributes to age-associated diseases.  While a complete mechanism isn't fully understood, studies of premature aging syndromes highlight the role of DNA repair gene mutations and the causal link between somatic genome damage and aging.  The accumulation of stochastic errors and damage from normal cell metabolism are also implicated.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0022202X20323642"
        }
      ],
      "full_explanation": "While the provided papers extensively discuss factors contributing to cellular aging, none definitively pinpoint a single, universally agreed-upon mechanism. Instead, research emphasizes multiple, interconnected processes. The paper \"Molecular damage in aging - Nature Aging\" (https://www.nature.com/articles/s43587-021-00150-3) explicitly states, \"The mechanism of cellular aging is not fully understood,\" and highlights the accumulation of molecular damage, alongside the \"hallmarks of aging\" framework, but doesn't identify a singular mechanism. Similarly, \"Molecular mechanisms of aging and anti-aging strategies\" (https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01663-1) lists multiple contributors like telomere attrition, DNA damage, mitochondrial dysfunction, and impaired autophagy, confirming no single mechanism is known. Although \"Loss of epigenetic information as a cause of mammalian aging\" (https://www.cell.com/cell/fulltext/S0092-8674(22)01570-7) identifies epigenetic information loss as a significant factor, it does not claim to be *the* mechanism of cellular aging, rather it is another significant contributor. The article \"Principles of the Molecular and Cellular Mechanisms ...\" (https://www.sciencedirect.com/science/article/pii/S0022202X20323642) attributes aging to accumulated damage but acknowledges the lack of a complete understanding. The paper, \"The cell biology of aging - PMC\" (https://pmc.ncbi.nlm.nih.gov/articles/PMC4678010/), while highlighting genetic regulation of aging and dysregulation of cellular processes, again doesn't propose a single mechanism. The research consistently points to a complex, multi-factorial process with no single identified mechanism, implying that the research question is not yet answered. While \"Nucleophagy delays aging and preserves germline immortality\" (https://www.nature.com/articles/s43587-022-00327-4) presents an important mechanism in aging in the context of *C. elegans* and mice, it does not claim to be the sole mechanism of cellular aging for all organisms. Therefore, based on the provided papers, the research question of figuring out the *mechanism* of cellular aging remains open."
    },
    {
      "question": "Has anyone been able to impute previously unknown relationships from a knowledge graph? ",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Data Imputation with Iterative Graph Reconstruction",
          "author": "J. Zhong,Weiwei Ye,Ning Gui",
          "published_date": "2023-10-26T19:29:50.600000+00:00",
          "summary": "This paper proposes Iterative Graph Generation and Reconstruction for Missing data imputation (IGRM).  While it focuses on imputing missing values in tabular data by leveraging relationships *within* the data to create a \"friend network\" representing sample relationships, it does *not* address imputation of previously unknown relationships from an existing knowledge graph.  The method improves upon existing graph neural network-based imputation techniques by considering sample similarity, but its scope is limited to completing existing data, not expanding the knowledge graph itself.\n",
          "url": "https://arxiv.org/pdf/2212.02810.pdf"
        },
        {
          "title": "Contextual Parameter Generation for Knowledge Graph Link Prediction",
          "author": "George  Stoica, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, Otilia  Stretcu, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, ostretcu@cs.cmu.edu, Emmanouil Antonios Platanios, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, e.a.platanios@cs.cmu.edu, Tom M Mitchell, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, tom.mitchell@cs.cmu.edu, Barnab\u00e1s  P\u00f3czos, Carnegie Mellon University, 5000 Forbes Ave, 15213, Pittsburgh, Pennsylvania, bapoczos@cs.cmu.edu",
          "published_date": "2023-11-09T20:30:54.758000+00:00",
          "summary": "Yes, this paper presents a method for knowledge graph link prediction, which effectively imputes previously unknown relationships.  The authors improve upon existing methods by using contextual parameter generation, allowing the model to learn more complex interactions between entities and relations. This leads to significant performance gains and faster convergence in predicting missing links within the knowledge graph.\n",
          "url": "https://ojs.aaai.org/index.php/AAAI/article/view/5693"
        },
        {
          "title": "Robust Knowledge Graph Completion with Stacked Convolutions and a Student Re-Ranking Network",
          "author": "Justin  Lovelace, Carnegie Mellon University, USA, jlovelac@cs.cmu.edu, Denis  Newman-Griffis, University of Pittsburgh, USA, dnewmangriffis@pitt.edu, Shikhar  Vashishth, t-svashishth@microsoft.com, Jill  Fain Lehman, Carnegie Mellon University, USA, Carolyn Penstein Ros\u00e9, Carnegie Mellon University, USA",
          "published_date": "2023-11-16T01:35:14.593000+00:00",
          "summary": "This paper introduces a new knowledge graph completion (KGC) method that outperforms existing methods, particularly on sparsely connected graphs which are more representative of real-world scenarios.  The method uses a deep convolutional network with textual entity representations to improve robustness to sparsity.  A student re-ranking network further enhances performance.  While not explicitly stated as \"imputation,\" the improved ability to predict missing relationships in incomplete knowledge graphs directly addresses the user's question about inferring previously unknown relationships.\n",
          "url": "https://arxiv.org/pdf/2106.06555.pdf"
        },
        {
          "title": "One-Shot Relational Learning for Knowledge Graphs",
          "author": "Wenhan Xiong,Mo Yu,Shiyu Chang,Xiaoxiao Guo,William Yang Wang",
          "published_date": "2023-10-26T19:30:50.755000+00:00",
          "summary": "Yes.  This paper introduces a one-shot relational learning framework for knowledge graph completion that addresses the challenge of predicting new facts with limited training data (e.g., only one example).  The model uses knowledge graph embeddings and considers one-hop graph structures to learn a matching metric, improving performance over existing methods and eliminating the need to retrain models for newly added relations.  This directly addresses the imputation of previously unknown relationships in knowledge graphs.\n",
          "url": "https://www.aclweb.org/anthology/D18-1223.pdf"
        },
        {
          "title": "From low resource information extraction to identifying influential nodes in knowledge graphs",
          "author": "[Submitted on 10 Jan 2024]",
          "published_date": "2024-01-10T00:00:00+00:00",
          "summary": "This research paper introduces a pipeline for identifying important entities in intelligence reports by constructing a knowledge graph.  While it focuses on *extracting* relationships (edges) between entities, rather than *imputing* unknown ones, it does address the impact of errors in relation extraction on the identification of central nodes.  The study highlights that the impact of these errors varies depending on the graph's topology, suggesting that the reliability of automatically extracted relationships (and by implication, any inferences drawn from them) needs careful consideration.  The paper doesn't directly answer whether unknown relationships have been imputed, but it acknowledges the challenges and potential pitfalls in using automatically extracted relations for further analysis like relationship imputation.\n",
          "url": "http://arxiv.org/abs/2401.04915"
        },
        {
          "title": "Knowledge graph revision in the context of unknown ...",
          "author": "",
          "published_date": "2024-07-05T00:00:00+00:00",
          "summary": "This paper investigates updating knowledge graphs when initial knowledge is unknown, a situation where access to complete information (e.g., full software code) is unavailable.  The authors prove that finding the optimal solution for revising such a graph is strongly NP-complete.  They propose two algorithms, Flaccid_search and Tight_search, to address this challenge and demonstrate that both can identify desired revisions, effectively imputing previously unknown relationships in the context of incomplete knowledge.  The paper uses propositional logic to represent knowledge graph relationships.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226096/"
        },
        {
          "title": "Building product graphs automatically",
          "author": "Xin Luna Dong",
          "published_date": "2020-08-13T13:00:26+00:00",
          "summary": "Yes, Amazon's AutoKnow system, presented at the KDD conference, successfully imputes previously unknown relationships in product knowledge graphs.  By combining structured data with information extracted from free-form text (reviews, Q&A), AutoKnow increased the number of facts in Amazon's consumables graph by almost 200%, demonstrating the ability to uncover previously unknown relationships in a large dataset.\n",
          "url": "https://www.amazon.science/blog/building-product-graphs-automatically"
        },
        {
          "title": "Exploiting Semantic Patterns over Biomedical Knowledge ...",
          "author": "",
          "published_date": "2018-05-12T00:00:00+00:00",
          "summary": "This research used semantic graph patterns from the SemMedDB knowledge graph to predict previously unknown \"treats\" and \"causes\" relationships between biomedical entities.  Logistic regression and decision tree models achieved F-scores of 99% and 90%, respectively.  The models identified highly discriminative patterns, and some predicted relationships were deemed plausible by physician co-authors.  The study demonstrates the successful imputation of previously unknown relationships using graph features.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6070294/"
        },
        {
          "title": "Knowledge Graph Imputation - UWSpace",
          "author": "AuthorsNiknamian, Mohammadali",
          "published_date": "2021-05-27T00:00:00+00:00",
          "summary": "The provided text is empty.  Therefore, I cannot answer whether anyone has been able to impute previously unknown relationships from a knowledge graph based on the given URL and text.\n",
          "url": "https://uwspace.uwaterloo.ca/items/189c536b-a75a-4101-8601-86637b8152cf"
        },
        {
          "title": "Knowledge Graphs in Practice: Characterizing their Users ...",
          "author": "\\authororcidHarry Li0000-0002-2288-6039",
          "published_date": "2023-03-24T00:00:00+00:00",
          "summary": "This paper focuses on the challenges and visualization opportunities for Knowledge Graph (KG) users, not on relationship imputation.  The study interviewed 19 KG practitioners (builders, analysts, and consumers) to understand their needs.  While the paper mentions applications like question-answering and explainable AI, which might *involve* inferring relationships, it doesn't directly address whether unknown relationships are imputed from the KG itself.  The research concentrates on improving KG usability through better visualization and tools, not on the algorithms used to expand the graph.\n",
          "url": "https://arxiv.org/html/2304.01311"
        }
      ],
      "full_explanation": "Several papers demonstrate that researchers have successfully imputed previously unknown relationships from knowledge graphs. The paper \"Contextual Parameter Generation for Knowledge Graph Link Prediction\" explicitly addresses knowledge graph link prediction, which is a method of imputing previously unknown relationships, and claims significant performance gains in this area (https://ojs.aaai.org/index.php/AAAI/article/view/5693). Similarly, \"Robust Knowledge Graph Completion with Stacked Convolutions and a Student Re-Ranking Network\" introduces a method for knowledge graph completion that effectively predicts missing relationships, which directly addresses the imputation of previously unknown connections (https://arxiv.org/pdf/2106.06555.pdf). The paper \"One-Shot Relational Learning for Knowledge Graphs\" focuses on predicting new facts with limited training data, again, imputing previously unknown relationships in a knowledge graph (https://www.aclweb.org/anthology/D18-1223.pdf). Furthermore, the paper \"Knowledge graph revision in the context of unknown ...\" proposes algorithms to revise a knowledge graph with incomplete information, effectively imputing previously unknown relationships (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226096/). The work described in \"Building product graphs automatically\" by Amazon's AutoKnow system showcases the imputation of unknown relationships by integrating structured data and free-form text, significantly expanding the factual content of their knowledge graph (https://www.amazon.science/blog/building-product-graphs-automatically). The research \"Exploiting Semantic Patterns over Biomedical Knowledge ...\" demonstrates the use of semantic graph patterns to predict previously unknown \"treats\" and \"causes\" relationships, further solidifying the presence of research in this area (https://pmc.ncbi.nlm.nih.gov/articles/PMC6070294/). Thus, based on these multiple examples, it is clear that the research question has been addressed before."
    },
    {
      "question": "Has anyone tried to have an LLM prompt set-up where one LLM pretends to be the user and the other the assistant and they accomplish a complex task via chatting? I think the paper had a camel in it or something",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "Thinking Assistants: LLM-Based Conversational Assistants that Help Users Think By Asking rather than Answering",
          "author": "[Submitted on 10 Dec 2023 (v1), last revised 29 Feb 2024 (this version, v2)]",
          "published_date": "2023-12-10T00:00:00+00:00",
          "summary": "This research paper introduces \"thinking assistants,\" LLMs designed to help users think critically by prompting reflection rather than directly answering questions.  The authors created Gradschool.chat, a thinking assistant for prospective graduate students in HCI, which interacts with users through conversation.  While the paper doesn't describe an LLM prompting setup where one LLM plays the user and another the assistant to complete a complex task (there's no mention of a camel), it does explore using an LLM to guide a user through complex decision-making (choosing a graduate program and advisor).  The system showed positive user engagement, with users brainstorming research interests engaging significantly longer than those only asking factual questions.\n",
          "url": "https://arxiv.org/abs/2312.06024"
        },
        {
          "title": "Chatbots in Knowledge-Intensive Contexts: Comparing Intent and LLM-Based Systems",
          "author": "Freire; Samuel Kernan; Wang; Chaofan; Niforatos; Evangelos",
          "published_date": "2024-02-07T00:00:00+00:00",
          "summary": "This paper compares intent-based and LLM-based cognitive assistants (chatbots) in knowledge-intensive tasks.  A user study found that the LLM-based system resulted in better user experience, task completion rates, usability, and perceived performance.  The paper does *not* describe a setup where two LLMs interact to complete a task; there is no mention of camels.\n",
          "url": "https://arxiv.org/abs/2402.04955"
        },
        {
          "title": "CAMEL: Communicative Agents for \"Mind\" Exploration of Large Language Model Society https://www.camel-ai.org",
          "author": "Guohao  Li, King Abdullah University of Science and Technology (KAUST), *  Hasan, King Abdullah University of Science and Technology (KAUST), Abed  Al, King Abdullah University of Science and Technology (KAUST), Kader  Hammoud, King Abdullah University of Science and Technology (KAUST), Hani  Itani, King Abdullah University of Science and Technology (KAUST), Dmitrii  Khizbullin, King Abdullah University of Science and Technology (KAUST), Bernard  Ghanem, King Abdullah University of Science and Technology (KAUST), Human  User, King Abdullah University of Science and Technology (KAUST), Stock  Trader, King Abdullah University of Science and Technology (KAUST)",
          "published_date": "2023-11-16T01:36:20.238000+00:00",
          "summary": "Yes, the CAMEL framework described in this paper uses multiple LLMs in a role-playing setup.  One LLM acts as the user, providing instructions, while another acts as the assistant, carrying out the task.  This approach aims to reduce the need for constant human intervention in complex tasks, allowing the agents to cooperate autonomously.  The paper focuses on creating scalable techniques to facilitate this type of autonomous cooperation and analyze the resulting \"cognitive\" processes of the agents.\n",
          "url": "https://arxiv.org/pdf/2303.17760.pdf"
        },
        {
          "title": "LLM Harmony: Multi-Agent Communication for Problem Solving",
          "author": "[Submitted on 2 Jan 2024]",
          "published_date": "2024-01-02T00:00:00+00:00",
          "summary": "This arXiv preprint (2401.01312) introduces \"LLM Harmony,\" a multi-agent framework for improving LLMs' problem-solving abilities.  It uses multiple LLMs, each with a distinct role (like a user and an assistant),  to collaboratively solve problems through communication.  This approach aims to overcome limitations of single LLMs in complex reasoning tasks, addressing your query about using an LLM to simulate a user-assistant interaction for problem-solving.  The paper's abstract mentions inspiration from the CAMEL model.\n",
          "url": "http://arxiv.org/abs/2401.01312"
        },
        {
          "title": "Navigating the Unknown: A Chat-Based Collaborative Interface for Personalized Exploratory Tasks",
          "author": "Peng; Yingzhe; Qin; Xiaoting; Zhang; Zhiyang; Jue; Lin; Yang; Xu; Dongmei; Rajmohan; Saravan; Qi",
          "published_date": "2024-10-31T00:00:00+00:00",
          "summary": "This arXiv paper introduces CARE, a multi-agent LLM system designed for personalized exploratory tasks.  It uses a chat interface with a user agent (simulating a user) and an assistant agent to collaboratively solve complex problems.  A user study showed CARE was preferred over a standard LLM chatbot, demonstrating improved personalization and reduced cognitive load.  There is no mention of camels in the abstract or provided text.\n",
          "url": "https://arxiv.org/abs/2410.24032"
        },
        {
          "title": "The LLM wants to talk. Large language model prompt and\u2026",
          "author": "Chris Ismael",
          "published_date": "2023-08-06T09:35:04+00:00",
          "summary": "This Medium post discusses various aspects of LLM prompting and conversation, including system prompts, hallucinations, and reasoning methods like Chain-of-Thought and ReAct.  While it doesn't directly address using two LLMs to collaboratively complete a complex task (as in your query), it provides foundational knowledge about how LLMs understand and respond to prompts, which is crucial for such an endeavor. The article focuses on single-LLM interactions and doesn't mention any papers or examples involving a camel.\n",
          "url": "https://chrispogeek.medium.com/the-llm-wants-to-talk-e1514043ae9c"
        },
        {
          "title": "An example of LLM prompting for programming",
          "author": null,
          "published_date": "2023-05-16T16:35:36.764000+00:00",
          "summary": "This Hacker News thread discusses using LLMs for programming, specifically the limitations of using a single chat session to complete a complex task.  Users found that after a certain point (often after completing one or two subtasks), the LLM loses context, hallucinates, and becomes unreliable.  The suggested solution is to restart the chat session for each new subtask, copying over relevant previous prompts and code.  The discussion doesn't mention a setup where one LLM acts as a user and another as an assistant working together on a complex task, nor is there mention of a paper involving camels.\n",
          "url": "https://news.ycombinator.com/item?id=35612494"
        },
        {
          "title": "Need help deciding what to put in System vs User prompt ...",
          "author": "",
          "published_date": "2024-08-02T11:51:43+00:00",
          "summary": "Summary:  The provided webpage is currently loading and contains no information to answer your question about using two LLMs to collaboratively complete a complex task, one simulating a user and the other an assistant (even if a paper mentioning camels was involved).\n",
          "url": "https://community.openai.com/t/need-help-deciding-what-to-put-in-system-vs-user-prompt-for-dialogue-generation/891133"
        },
        {
          "title": "Prompt Patterns: What They Are and 16 You Should Know",
          "author": "Dan Cleary",
          "published_date": "2024-10-30T04:00:00+00:00",
          "summary": "This article discusses prompt patterns for improving Large Language Model (LLM) outputs, drawing from a Vanderbilt University paper.  While it doesn't directly address your question about one LLM pretending to be a user and another the assistant to complete a complex task, the article categorizes and explains 16 prompt patterns designed to enhance LLM performance.  These patterns cover aspects like input semantics, output customization, error identification, prompt improvement, interaction, and context control. The article suggests that combining these patterns can lead to even better results.  There's no mention of camels in the provided text.\n",
          "url": "https://www.prompthub.us/blog/prompt-patterns-what-they-are-and-16-you-should-know"
        },
        {
          "title": "Protecting LLMs from prompt injections and jailbreaks",
          "author": "",
          "published_date": "2024-04-25T16:43:20+00:00",
          "summary": "The provided text only contains \"Loading,\" so I cannot summarize the OpenAI paper regarding LLM prompt injections and jailbreaks, nor can I answer your question about an LLM setup where one LLM acts as a user and another as an assistant to complete a complex task.  The mention of a camel is not found in the provided text.  To answer your question, I need the actual content of the OpenAI paper.\n",
          "url": "https://community.openai.com/t/protecting-llms-from-prompt-injections-and-jailbreaks-new-openai-paper/727636"
        }
      ],
      "full_explanation": "Yes, the research question has been explored. Several papers describe setups where two or more LLMs interact, with one simulating a user and another acting as an assistant, to collaboratively accomplish complex tasks.\n\nSpecifically, the paper titled **\"CAMEL: Communicative Agents for \"Mind\" Exploration of Large Language Model Society\"** (URL: https://arxiv.org/pdf/2303.17760.pdf) directly addresses the research question. This paper introduces the CAMEL framework, where one LLM acts as a user providing instructions, and another LLM functions as the assistant, completing the task. This mirrors the proposed research question of having an LLM pretend to be a user while another acts as the assistant.\n\nAdditionally, the paper **\"LLM Harmony: Multi-Agent Communication for Problem Solving\"** (URL: http://arxiv.org/abs/2401.01312) also uses a similar approach. It describes a multi-agent framework called \"LLM Harmony\" where multiple LLMs, each with distinct roles (including a user and assistant), communicate with each other to solve problems. This also matches the proposed setup. The abstract even mentions inspiration from the CAMEL model, further highlighting the link to your research question.\n\nLastly, the paper **\"Navigating the Unknown: A Chat-Based Collaborative Interface for Personalized Exploratory Tasks\"** (URL: https://arxiv.org/abs/2410.24032) introduces CARE, which also utilizes a chat interface with a user agent and an assistant agent, again addressing the research question's core concept."
    },
    {
      "question": "Has anyone investigated osteocalcin as a drug for weight loss?",
      "true_answer": "yes",
      "predicted_answer": "yes",
      "is_correct": true,
      "search_results": [
        {
          "title": "Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice",
          "author": "Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy",
          "published_date": "2023-02-06T07:31:06.171000+00:00",
          "summary": "This study investigated osteocalcin's role in regulating glucose metabolism and fat mass in wild-type mice.  Researchers found that administering osteocalcin to these mice lessened the negative effects of high-fat diets and induced hyperphagia on body mass and glucose metabolism.  While the research doesn't explicitly frame osteocalcin as a weight-loss drug, the results suggest its potential therapeutic value in treating metabolic diseases, including obesity.  Different concentrations of osteocalcin affected insulin secretion/\u03b2-cell proliferation and fat mass, indicating potential for targeted therapeutic applications.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278202/"
        },
        {
          "title": "Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway.",
          "author": "Bo  Zhou, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Huixia  Li, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Lin  Xu, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Weijin  Zang, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Shufang  Wu, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China, Hongzhi  Sun, Key Laboratory of Environment and Genes Related to Diseases, Medical School of Xi'an Jiaotong University, 710061, Xi'an, Shaanxi, China",
          "published_date": "2023-11-09T20:04:47.632000+00:00",
          "summary": "Yes, research suggests osteocalcin may have potential as a weight-loss drug.  Studies in mice fed a high-fat diet showed that osteocalcin treatment reduced weight gain, fat accumulation, and improved insulin sensitivity.  These effects were linked to its ability to reverse endoplasmic reticulum stress and restore insulin sensitivity through the NF-\u03baB signaling pathway.  While this research is pre-clinical (animal studies), it indicates a potential therapeutic avenue for obesity and related metabolic disorders.\n",
          "url": "https://academic.oup.com/endo/article/154/3/1055/2423406?login=false"
        },
        {
          "title": "Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway - PubMed",
          "author": "Bo Zhou 1 , Huixia Li, Lin Xu, Weijin Zang, Shufang Wu, Hongzhi Sun",
          "published_date": "2021-12-01T00:00:00+00:00",
          "summary": "Yes, this study investigated osteocalcin's effects on weight and metabolism in obese mice.  Mice fed a high-fat diet and treated with osteocalcin showed reduced weight gain, less fat accumulation, and improved insulin sensitivity.  The researchers suggest that osteocalcin's action involves the NF-\u03baB signaling pathway and its ability to alleviate endoplasmic reticulum stress, a factor contributing to obesity and insulin resistance.  These findings suggest potential for osteocalcin as a treatment for obesity and diabetes, though further research is needed.\n",
          "url": "https://pubmed.ncbi.nlm.nih.gov/23407450/"
        },
        {
          "title": "Osteocalcin and its endocrine functions.",
          "author": "Akiko  Mizokami, Laboratory of Molecular and Cellular Biochemistry, Tomoyo  Kawakubo-Yasukochi, Fukuoka University, 814-0180, Fukuoka, Japan, Masato  Hirata, Laboratory of Molecular and Cellular Biochemistry, hirata1@dent.kyushu-u.ac.jp",
          "published_date": "2023-11-09T20:20:00.898000+00:00",
          "summary": "Yes, research suggests osteocalcin, a protein produced by bone cells, shows promise as a potential weight loss drug.  Animal studies demonstrate that increasing osteocalcin levels prevents obesity and glucose intolerance.  While still under investigation,  its ability to stimulate insulin production and increase energy expenditure suggests it could be a feasible therapeutic agent for metabolic disorders, including obesity.\n",
          "url": "https://www.sciencedirect.com/science/article/pii/S0006295217300631"
        },
        {
          "title": "Osteocalcin is necessary and sufficient to maintain muscle mass in older mice",
          "author": "Paula Mera; Kathrin Laue; Jianwen Wei; Julian Meyer Berger; Gerard Karsenty",
          "published_date": "2023-02-06T21:12:14.743000+00:00",
          "summary": "This study investigated the role of osteocalcin in maintaining muscle mass in aging mice, not weight loss.  Researchers found that osteocalcin signaling in muscle fibers is necessary to prevent age-related muscle loss.  Supplementing older mice with osteocalcin increased their muscle mass.  While the study doesn't directly address osteocalcin's use for weight loss, the findings suggest a potential role in age-related muscle loss, a factor that can influence overall body composition.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034485/"
        },
        {
          "title": "Effect of Weight Loss on Serum Osteocalcin and Its ...",
          "author": "",
          "published_date": "2015-02-15T00:00:00+00:00",
          "summary": "This study investigated the effect of weight loss on serum osteocalcin levels in obese men, but it did not explore osteocalcin *as a treatment* for weight loss.  The researchers found that weight loss increased undercarboxylated osteocalcin (uOC), a form of osteocalcin, but this increase wasn't linked to changes in adipokines (hormones related to fat metabolism).  Therefore, the study provides no evidence supporting osteocalcin's use as a weight-loss drug.\n",
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345075/"
        },
        {
          "title": "Osteocalcin has a muscle-protective effect during weight ...",
          "author": "",
          "published_date": "2023-11-29T00:00:00+00:00",
          "summary": "This study investigated the relationship between osteocalcin (OC) and muscle mass during weight loss in overweight or obese men without metabolic syndrome.  While the study did not investigate OC as a *drug* for weight loss, it found a positive correlation between OC levels and the preservation of muscle mass during a high-protein, energy-restricted diet.  Specifically,  OC showed a significant protective effect on muscle loss in males.  The research focused on the natural role of OC, not its potential as a pharmaceutical intervention.\n",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10716436/"
        },
        {
          "title": "The role of osteocalcin in the endocrine cross-talk between ...",
          "author": "Ducy; P",
          "published_date": "2023-02-06T13:58:51.872000+00:00",
          "summary": "This article discusses osteocalcin's role in regulating glucose metabolism and energy expenditure.  While it notes that osteocalcin-deficient mice have increased fat mass and decreased energy expenditure, and that osteocalcin administration improves insulin sensitivity, the article does *not* investigate osteocalcin as a drug for weight loss.  The research focuses on its effects on glucose homeostasis and insulin secretion, not directly on weight reduction.\n",
          "url": "https://link.springer.com/article/10.1007/s00125-011-2155-z"
        },
        {
          "title": "Inverse relationship between serum osteocalcin levels and ...",
          "author": "Yu-Qi  Luo, Xiao-Jing  Ma, Ya-Ping  Hao, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Xiao-Ping  Pan, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Yi-Ting  Xu, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Qin  Xiong, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Yu-Qian  Bao, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China, Wei-Ping  Jia, Shanghai Key Laboratory of Diabe-tes Mellitus, Shanghai Diabetes Institute, 200233, Shanghai, China",
          "published_date": "2023-11-09T20:13:30.649000+00:00",
          "summary": "This study investigated the relationship between serum osteocalcin levels and nonalcoholic fatty liver disease (NAFLD) in postmenopausal Chinese women, not its potential as a weight-loss drug.  The research found an inverse correlation: lower osteocalcin levels were associated with NAFLD. While the study identifies osteocalcin levels as a risk factor for NAFLD, it does *not* explore its use as a medication for weight loss.\n",
          "url": "https://www.nature.com/articles/aps201581"
        },
        {
          "title": "Relationships between serum osteocalcin, leptin and the ...",
          "author": "N.K. Lee",
          "published_date": "2013-03-15T00:00:00+00:00",
          "summary": "This study investigated the relationship between serum osteocalcin levels and weight loss in obese Korean adults undergoing pharmacological treatment.  While the study did not investigate osteocalcin *as* a weight-loss drug, it found that serum osteocalcin levels significantly increased three months after weight loss, correlating negatively with BMI, visceral fat mass, leptin levels, and HOMA scores.  The findings suggest a link between bone and adipose tissue, but do not support the use of osteocalcin itself as a weight-loss medication.\n",
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0009898112005712"
        }
      ],
      "full_explanation": "Several studies have investigated osteocalcin as a potential drug for weight loss, specifically in animal models. The paper titled \"Osteocalcin differentially regulates \u03b2 cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice\" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278202/) found that administering osteocalcin to mice lessened the negative effects of high-fat diets and induced hyperphagia on body mass and glucose metabolism, suggesting a therapeutic potential for treating obesity. Additionally, the papers \"Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway\" (https://academic.oup.com/endo/article/154/3/1055/2423406?login=false and https://pubmed.ncbi.nlm.nih.gov/23407450/) both report that osteocalcin treatment in mice fed a high-fat diet reduced weight gain and fat accumulation, and improved insulin sensitivity. These findings, particularly the second paper, explicitly state osteocalcin may be a potential therapeutic avenue for obesity. The paper \"Osteocalcin and its endocrine functions\" (https://www.sciencedirect.com/science/article/pii/S0006295217300631) further supports this by stating that animal studies have shown increasing osteocalcin levels prevents obesity and glucose intolerance."
    },
    {
      "question": "Has anyone beaten stockfish as a human",
      "true_answer": "no",
      "predicted_answer": "yes",
      "is_correct": false,
      "search_results": [
        {
          "title": "[2402.04494] Grandmaster-Level Chess Without Search",
          "author": null,
          "published_date": null,
          "summary": "No human has beaten Stockfish 16, currently the strongest publicly available chess engine.  This paper describes a 270M parameter transformer model trained on 10 million chess games that achieves a Lichess blitz Elo of 2895, surpassing AlphaZero's policy and value networks (without MCTS) and GPT-3.5-turbo-instruct.  While this model doesn't beat Stockfish, it demonstrates strong chess play without using traditional search algorithms.\n",
          "url": "https://arxiv.org/pdf/2402.04494.pdf"
        },
        {
          "title": "[2402.04494] Grandmaster-Level Chess Without Search",
          "author": null,
          "published_date": null,
          "summary": "No human has beaten Stockfish 16, currently the strongest publicly available chess engine.  This paper describes a 270M parameter transformer model that achieves a Lichess blitz Elo of 2895, surpassing AlphaZero's policy and value networks (without MCTS) and GPT-3.5-turbo-instruct, but it doesn't specify whether it beats Stockfish directly.  The model plays at a grandmaster level without using traditional search algorithms.\n",
          "url": "https://arxiv.org/pdf/2402.04494.pdf"
        },
        {
          "title": "Bridging the Human-AI Knowledge Gap: Concept Discovery and Transfer in AlphaZero",
          "author": "Lisa  Schut, University of Oxford, Nenad  Toma\u0161ev, Tom  Mcgrath, Demis  Hassabis, Ulrich  Paquet, Been  Kim",
          "published_date": "2023-11-16T01:36:45.223000+00:00",
          "summary": "This research paper does not address whether any human has beaten Stockfish.  It focuses on extracting knowledge from AlphaZero, a different chess AI, to improve human chess understanding.  The study shows that chess grandmasters improved their game after learning concepts identified within AlphaZero's decision-making processes.  The paper explores how AI can teach humans, not whether humans can surpass specific AI chess engines like Stockfish.\n",
          "url": "https://arxiv.org/pdf/2310.16410.pdf"
        },
        {
          "title": "Karpov's Queen Sacrifices and AI",
          "author": "Shivanand Maharaj,Nicholas G. Polson",
          "published_date": "2023-10-26T19:27:59.543000+00:00",
          "summary": "The paper analyzes Anatoly Karpov's chess games, comparing his queen sacrifices to evaluations by the Stockfish 14 NNUE chess engine.  While the paper doesn't directly address whether a human has beaten Stockfish, it finds Karpov's sacrifices were optimal over 90% of the time, suggesting a high level of strategic similarity between Karpov's play and the AI's optimal moves.  The study focuses on comparing human strategic thinking with AI, not on competitive wins or losses against Stockfish itself.\n",
          "url": "https://arxiv.org/pdf/2109.08149.pdf"
        },
        {
          "title": "Benchmarking Parallel Chess Search in Stockfish on Intel Xeon and Intel Xeon Phi Processors",
          "author": "Czarnul; Pawel",
          "published_date": "2023-02-06T09:25:29.086000+00:00",
          "summary": "No, the provided text focuses on benchmarking Stockfish's performance on different processors and doesn't mention any humans beating it.  The paper discusses parallel chess engine performance and compares Stockfish's strength across various hardware configurations, including Intel Xeon and Xeon Phi processors.  While it references AlphaZero defeating Stockfish, AlphaZero is another AI program, not a human.\n",
          "url": "https://link.springer.com/chapter/10.1007/978-3-319-93713-7_40"
        },
        {
          "title": "Finally!! A actual human who manages to beat Stockfish!!",
          "author": "",
          "published_date": "2020-09-14T00:00:00+00:00",
          "summary": "A YouTube video claims a human, Jonathan Schrantz, defeated Stockfish using the Urusov Gambit.  However, forum users are skeptical, suggesting the Stockfish version used was weaker than the full-strength engine and that Schrantz likely exploited the engine's limitations by memorizing a long theoretical line.  One user points out that even a strong human player could beat a weaker engine occasionally.  Therefore, whether a human has definitively beaten a full-strength Stockfish remains unproven and debated.\n",
          "url": "https://www.chess.com/forum/view/general/finally-a-actual-human-who-manages-to-beat-stockfish"
        },
        {
          "title": "Human Defeats Stockfish with Urusov Gambit",
          "author": "Jonathan Schrantz",
          "published_date": "2020-09-13T12:00:07+00:00",
          "summary": "Yes.  This YouTube video shows a human chess player defeating Stockfish level 8 using the Urusov Gambit.\n",
          "url": "https://www.youtube.com/watch?v=FC2P6VUYu78"
        },
        {
          "title": "Is it possible for any titled player to beat a chess engine?",
          "author": "LynobLynob 5,78455 gold badges4242 silver badges8080 bronze badges",
          "published_date": "2022-06-04T12:12:00+00:00",
          "summary": "No human has beaten Stockfish in a standard chess game.  A series of matches between Hikaru Nakamura and Stockfish saw Nakamura win one game (with assistance) and lose two.  The question of whether a grandmaster could defeat Stockfish by exploiting time pressure or draw rules is posed, but no such victory has been achieved.\n",
          "url": "https://chess.stackexchange.com/questions/6184/is-it-possible-for-any-titled-player-to-beat-a-chess-engine"
        },
        {
          "title": "Is it really possible to beat a stockfish level 8 computer in ...",
          "author": "David NiDavid Ni 28711 gold badge33 silver badges1212 bronze badges",
          "published_date": "2018-03-03T09:28:00+00:00",
          "summary": "No verifiable cases of a human beating Stockfish level 8 in blitz games (3+0 to 15+0) have been found.  While theoretically possible due to rare Stockfish miscalculations,  it's extremely unlikely given the engine's strength.  Even strong grandmasters would struggle immensely.  A weaker Stockfish level 8 (estimated 2200-2400 Elo) might be more beatable, and a human player using a mobile device to run the Lichess version (reducing engine strength) might have a better chance.\n",
          "url": "https://chess.stackexchange.com/questions/20036/is-it-really-possible-to-beat-a-stockfish-level-8-computer-in-any-time-that-is-b"
        },
        {
          "title": "Has any human ever beaten a computer at chess?",
          "author": "",
          "published_date": "2024-01-01T00:00:00+00:00",
          "summary": "No human has ever beaten the top-level chess engines like Stockfish or LC0, and it's considered highly unlikely to ever happen.  While humans beat computers in the past (before the 1990s), current top engines are far superior.\n",
          "url": "https://chessforbeginners.quora.com/Has-any-human-ever-beaten-a-computer-at-chess?top_ans=3542080"
        }
      ],
      "full_explanation": "The research question of whether a human has beaten Stockfish has been addressed in several sources. While multiple papers highlight the difficulty and improbability of a human beating a full-strength Stockfish, there are a few claims of it happening, with supporting evidence. Multiple sources assert that no human has beaten Stockfish, or a high level of it. For example, the papers \"[2402.04494] Grandmaster-Level Chess Without Search\" (URL: https://arxiv.org/pdf/2402.04494.pdf) states that \"No human has beaten Stockfish 16, currently the strongest publicly available chess engine.\" The paper \"Has any human ever beaten a computer at chess?\" (URL: https://chessforbeginners.quora.com/Has-any-human-ever-beaten-a-computer-at-chess?top_ans=3542080) also confirms that \"No human has ever beaten the top-level chess engines like Stockfish or LC0\". Similarly, the StackExchange discussion \"Is it possible for any titled player to beat a chess engine?\" (URL: https://chess.stackexchange.com/questions/6184/is-it-possible-for-any-titled-player-to-beat-a-chess-engine) states that \"No human has beaten Stockfish in a standard chess game.\" and the paper \"Is it really possible to beat a stockfish level 8 computer in ...\" (URL: https://chess.stackexchange.com/questions/20036/is-it-really-possible-to-beat-a-stockfish-level-8-computer-in-any-time-that-is-b) concludes that \"No verifiable cases of a human beating Stockfish level 8 in blitz games... have been found.\"\n\nHowever, a youtube video claims to show a human beating stockfish, as referenced in the chess.com forum \"Finally!! A actual human who manages to beat Stockfish!!\" (URL: https://www.chess.com/forum/view/general/finally-a-actual-human-who-manages-to-beat-stockfish), and the youtube video, \"Human Defeats Stockfish with Urusov Gambit\" (URL: https://www.youtube.com/watch?v=FC2P6VUYu78) where a human is claimed to have defeated Stockfish level 8. Note that these claims are disputed and may have involved a weaker version of the engine or exploitation of known weaknesses."
    }
  ]
}